FINAL PROGRAM
SAN DIEGO
Welcome
Dear Colleagues,
Welcome to San Diego, where thousands of allergist/immunologists, allied health and related Table of Contents
healthcare professionals from around the world have gathered for the 2014 AAAAI Annual General Information
Meeting.
Annual Meeting Program Committees.. 2
A five day program of cutting-edge research and the latest advances in the diagnosis and
treatment of allergic and immunologic diseases makes this the premier event in allergy/ Meeting Information............................. 4
immunology. Please join us in recognizing the members of the Annual Meeting Program Business and Committee Meetings...... 8
Subcommittee, who have spent the last 18 months planning the educational program you will
Other Meetings and Events................ 10
experience here.
ARTrust Activities........................... 13
Of special note is this years Presidential Plenary, Immunotherapy: Mechanism, Outcomes
and Markers, which will feature a timely discussion of the latest understanding of allergy Guest/Associate Activities.................. 16
immunotherapy. We invite you to hear more on Saturday, March 1 from 8:15 to 9:45 am. Thanks Lectureships...................................... 17
to Cezmi A. Akdis, MD FAAAAI and Stephen R. Durham, MA MD FRCP for their participation in this
important session. Awards.............................................. 18
Another standout session on immunotherapy is SLIT: Implementation in Your Practice. A review Education Program
of how SLIT works, a discussion of the results of pivotal clinical trials and how to use SLIT in
Continuing Education & Accreditation...22
practice will be covered. To ensure all delegates hear the important information presented,
this Saturday symposium will be recorded onsite and will be available online free of charge to Military Allergy Program..................... 25
registered attendees following the Annual Meeting. More details on how to access the recording Fellows-in-Training Program.............. 25
will be provided once the meeting is over.
Advanced Practice Course................. 26
Other high-profile sessions include two exciting keynotes on Saturday and Monday. Eric J. Topol,
MD will present on genomic and wireless digital innovation, and James R. Baker, Jr., MD FAAAAI Chrysalis Program............................. 26
will talk about nanotechnology in the immune system. Attend both keynotes for the opportunity to Friday Sessions.................................. 25
listen to first-rate speakers cover topics that have the potential to impact the future of medicine.
Saturday Sessions............................. 38
Invest Together in Our Future Sunday Sessions............................... 55
The Annual Meeting has a world-class educational and scientific program, along with
opportunities to network with each other and interact in the Exhibit Hall with our vendor INDANA Course.................................. 61
community. Beyond all of this, you can also use your time in San Diego to invest in the future of Monday Sessions............................... 64
our specialty.
Tuesday Sessions.............................. 73
The Allergy, Asthma & Immunology Education and Research Organization, Inc. (ARTrust) invites
you to join your peers and help raise funds to support allergy, asthma and immunology education Directories
and research. A First Class Event awaits you at the 2014 ARTrust Benefit on Saturday evening at Abstracts........................................... 83
7:00 pm at the San Diego Air & Space Museum. The Skys the Limit as you try on your own set
of wings in the flight simulators, indulge in fine dining and cocktails, and enjoy live entertainment. Late Breaking Abstracts................... 152
On Sunday at 5:30 pm, the ARTrust hosts the Second Annual Race for Allergy and Asthma ACGME Competency Index............... 160
Research 5K Run/Walk: Light Up the Night. Be among the runners and walkers who will loop Exhibits............................................ 161
through the twinkling lights of the San Diego Embarcadero. There is still time to participate in both
Floor Plans....................................... 182
ARTrust events. Visit the ARTrust booth near registration for more details.
Keywords........................................ 186
It is our hope that what you learn here will guide you in providing optimal patient care. On behalf
of the American Academy of Allergy, Asthma & Immunology, thank you for attending the 2014 Faculty Index................................... 188
Annual Meeting! Staff................................................ 194
Sincerely,
AAAAI-1213-225
The AAAAI Annual Meeting is not a public event. Programs presented at the Annual Meeting are for the education of attendees and purchasers of recorded presentations as authorized by the AAAAI.
Any use of program content, the name of a speaker and/or program title or the name of the AAAAI without the written consent of the AAAAI is prohibited. The program content includes, but is not
limited to, oral presentations, audio visual materials used by the speakers and program handouts. This rule applies before, during and/or after the meeting.
The AAAAI endorses only those activities described in this printed program. Any other events occurring in the city of San Diego, CA, during the AAAAI Annual Meeting are not sanctioned by the AAAAI.
1
Annual Meeting Program
committees
Annual Meeting Program Subcommittee Symposia Workgroup
Stuart L. Abramson, MD PhD FAAAAI, Chair Wanda Phipatanakul, MD MS FAAAAI, Chair
Paul V. Williams, MD FAAAAI, Vice Chair Mariana C. Castells, MD PhD FAAAAI, Vice Chair
Paula J. Busse, MD FAAAAI, ADT Representative
Interest Section Chairs, Vice Chairs and Michael E. Manning, MD FAAAAI, ADT Vice Representative
Secretaries Christina L. Nance, PhD, BCI Representative
Timothy J. Craig, DO FAAAAI, ADT Chair David D. Chaplin, MD PhD FAAAAI, BCI Vice Representative
Mark F. Sands, MD FAAAAI, ADT Vice Chair Neil Alexis, PhD, EORD Representative
Leonard B. Bacharier, MD FAAAAI, ADT Secretary Jill A. Poole, MD FAAAAI, EORD Vice Representative
Francisco A. Bonilla, MD PhD FAAAAI, BCI Chair Aleena Banerji, MD, FADDA Representative
Gurjit K. Khurana Hershey, MD PhD FAAAAI, BCI Vice Chair Stacie M. Jones, MD, FADDA Vice Representative
Elena E. Perez, MD PhD FAAAAI, BCI Secretary David J. Shulan, MD FAAAAI, HEDQ Representative
Karin A. Pacheco, MD MSPH FAAAAI, EORD Chair Harvey Leo, MD FAAAAI, HEDQ Vice Representative
Jeffrey G. Demain, MD FAAAAI, EORD Vice Chair Christopher W. Calabria, MD, IRSOC Representative
Wanda Phipatanakul, MD MS FAAAAI, EORD Secretary Matthew A. Rank, MD FAAAAI, IRSOC Vice Representative
David A. Khan, MD FAAAAI, FADDA Chair Roma Sehmi, PhD FAAAAI, MAAI Representative
Sarbjit Singh Saini, MD FAAAAI, FADDA Vice Chair Zoulfia Allakhverdi, PhD FAAAAI, MAAI Vice Representative
Lynda C. Schneider, MD FAAAAI, FADDA Secretary Melissa T. Korenblat-Hanin, ACSW LCSW, Allied Health Representative
Giselle Mosnaim, MD MS FAAAAI, HEDQ Chair Pamela H. Steele, MSN CPNP AE-C, Allied Health Vice Representative
Bruce G. Bender, PhD FAAAAI, HEDQ Vice Chair
Tao T. Le, MD MHS FAAAAI, HEDQ Secretary
Dsire E.S. Larenas Linnemann, MD FAAAAI, IRSOC Chair
Martin Wagenmann, MD FAAAAI, IRSOC Vice Chair
Anju T. Peters, MD FAAAAI, IRSOC Secretary
Mitchell H. Grayson, MD FAAAAI, MAAI Chair
Nives Zimmermann, MD FAAAAI, MAAI Vice Chair
Kari C. Nadeau, MD PhD FAAAAI, MAAI Secretary Follow the AAAAI
Plenary Workgroup
Jonathan M. Spergel, MD PhD FAAAAI, Chair
Annual Meeting
Stephen C. Dreskin, MD PhD FAAAAI, Vice Chair on Twitter
Carol A. Saltoun, MD FAAAAI, ADT Representative
Leonard B. Bacharier, MD FAAAAI, ADT Vice Representative
Steve N. Georas, MD, BCI Representative
John W. Steinke, PhD FAAAAI, BCI Vice Representative
Jonathan A. Bernstein, MD FAAAAI, EORD Representative
Christopher Chang, MD PhD FAAAAI, EORD Vice Representative While youre in San Diego,
use #AAAAI when you
Stephen C. Dreskin, MD PhD FAAAAI, FADDA Representative
tweet to participate in
Amal H. Assaad, MD FAAAAI, FADDA Vice Representative
onsite conversations and
Bruce G. Bender, PhD FAAAAI, HEDQ Representative
share what youre learning
Tao T. Le, MD MHS FAAAAI, HEDQ Vice Representative with your colleagues.
Anju T. Peters, MD FAAAAI, IRSOC Representative
Joerg R. Kleine-Tebbe, MD FAAAAI, IRSOC Vice Representative
Cem Akin, MD PhD FAAAAI, MAAI Representative
Paige Lacy, PhD FAAAAI, MAAI Vice Representative
Dee Mallam, RN AE-C, Allied Health Representative
Karen L. Gregory, DNP APRN-BC RRT AE-C, Allied Health Vice
Representative
AAAAI-1213-059
AAAAI-1213-059
2
Annual Meeting Program
committees
Workshops Workgroup Allied Health Education Committee
Christine M. Seroogy, MD FAAAAI, Chair Julie Wang, MD FAAAAI, Co-Chair
Angela Haczku, MD PhD FAAAAI, Vice Chair Sally A. Noone, RN MSN CCRC, Co-Chair
Ronina A. Covar, MD, ADT Representative G. Lynn Christie, MS RD, AAHCP Representative
Miles M. Weinberger, MD FAAAAI, ADT Vice Representative Teri Holbrook, CRNP, AAHCP Representative
Antonella Cianferoni, MD PhD, BCI Representative Sheelagh M. Stewart, MPH RN AE-C, AAHCP Represnetative
Lisa R. Forbes, MD, BCI Vice Representative Anne E. Borgmeyer, RN CPNP AE-C
Alisa M. Smith, PhD FAAAAI, EORD Representative Marion E. Groetch, MS RD
John R. Cohn, MD FAAAAI, EORD Vice Representative Stephen J. McGeady, MD FAAAAI
Javed Sheikh, MD FAAAAI, FADDA Representative Donna W. Mitchell, RN MSN NP
Scott P. Commins, MD PhD, FADDA Vice Representative Debra A. Sedlak, MSN CPNP, Member
Asriani M. Chiu, MD FAAAAI, HEDQ Representative Melissa S. Mordecai, MSN RN CRNP, CR Representative
Matthew A. Rank, MD FAAAAI, HEDQ Vice Representative John D. Milewski, MA Representative
David W. Hauswirth, MD FAAAAI, IRSOC Representative William R. Blouin, ARNP, AH Advance Practice Representative
Jayant M. Pinto, MD, IRSOC Vice Representative Edward O. Corazalla, MS RPFT, AH Advance Practice Representative
Monica Vasudev, MD, MAAI Representative Maria G. Crain, RN MA CPNP, AH Advance Practice Representative
Dorothy S. Cheung, MD FAAAAI, MAAI Vice Representative Nina A. Zimmermann, MSN RN ANP-BC AE-C, AH Advance Practice
Judith C. Taylor-Fishwick, MSc, Allied Health Representative Representative
Janet S. Kamilaris, RN, Allied Health Vice Representative
Seminars Workgroup
Giselle Mosnaim, MD MS FAAAAI, Chair
Mitchell H. Grayson, MD FAAAAI, Vice Chair
Jonathan Corren, MD, ADT Representative
Faoud Terrence Ishmael, MD PhD FAAAAI, ADT Vice Representative
Rebecca Scherzer, MD FAAAAI, BCI Representative
Douglas R. McDonald, MD PhD, BCI Vice Representative
Charles S. Barnes, PhD, EORD Representative Put your Program
David Elkayam, MD, EORD Vice Representative
Anna H. Nowak-Wegrzyn, MD FAAAAI, FADDA Representative in your Pocket
Miguel A. Park, MD, FADDA Vice Representative Download the
Alton Lee Melton, Jr., MD, HEDQ Representative 2014 Annual Meeting
Alan P. Baptist, MD MPH FAAAAI, HEDQ Vice Representative app to your iPhone, iPad,
Mark C. Glaum, MD PhD FAAAAI, IRSOC Representative Blackberry or Android.
Mark S. La Shell, MD FAAAAI, IRSOC Vice Representative
Easily locate session handouts,
Edward S. Schulman, MD FAAAAI, MAAI Representative
abstracts and evaluations.
Joshua A. Steinberg, MD, MAAI Vice Representative
Research speakers and add their
Maureen C. Damitz, AE-C, Allied Health Representative sessions to your calendar.
Kim E. Mudd, RN MSN CCRP, Allied Health Vice Representative Learn about last minute
program changes.
Navigate with interactive
maps.
http://aaaai.org/AMapp
AAAAI-1213-052
3
Meeting Information
4
Meeting Information
5
Meeting Information
6
Business and Committee
Meetings
AAAAI Business Meeting Assembly/Board/Division Committee Meetings
Monday, March 3, 12:30 to 1:30 pm If you are a current member of an assembly, Board or division
Convention Center, Upper Level, Ballroom 6A committee, please plan to attend your committee meeting. Committee
meetings are open to current AAAAI members only. All members of
All AAAAI Fellows and members should attend the annual Business
these committees must be named by the AAAAI President-Elect. If you
Meeting. Box lunches will be provided. No fee. No pre-registration
are an AAAAI member and you are interested in becoming a member of
required.
any of these committees, please contact the AAAAI executive office at
Allied Health Professional Assembly Forum (414) 272-6071 or info@aaaai.org.
Saturday, March 1, 12:30 to 1:30 pm A/I Division Directors Committee
Marriott North Tower, Lobby Level, Marriott Hall Salon 6 Saturday, March 1, 7:00 to 8:00 am
All AAAAI allied health professionals should attend this forum. Box Marriott North Tower, Lobby Level, Presidio Room 1
lunches will be provided. No fee. No pre-registration required. Advocacy Committee
Allied Health Wine & Cheese Reception Saturday, March 1, 3:00 to 4:00 pm
Friday, February 28, 5:15 to 6:15 pm Marriott South Tower, Level 4, La Mesa
Marriott South Tower, Level 4, La Costa Allied Health Education Committee
All allied health members and their guests are invited to attend. No fee. Sunday, March 2, 1:45 to 3:00 pm
No pre-registration required. Marriott South Tower, Level 1, Santa Rosa
Allied Health Professionals Assembly Leadership Team Meeting
Interest Section Forums Monday, March 3, 7:00 to 8:00 am
Sunday, March 2, 12:30 to 2:30 pm
Marriott South Tower, Level 4, La Jolla
AAAAI Fellows and members, as well as other delegates, are invited
to attend an Interest Section Forum. Each interest section of the AAAAI Annual Meeting Awards Committee
will host a separate forum. Fellows and members may designate their Friday, February 28, 5:15 to 6:15 pm
interest section affiliation, while non-members may inquire about Marriott South Tower, Level 3, Palomar Room
AAAAI membership opportunities. Continuing education credits are
Annual Meeting Program Subcommittee
available for these activities. See page 59 for more information.
Tuesday, March 4, 10:00 am to 12:00 pm
International Reception Convention Center, Mezzanine Level, Room 18
Friday, February 28, 5:00 to 6:00 pm Core Curriculum, Education and Residency Review Subcommittee
Convention Center, Upper Level, Ballroom 6CF Friday, February 28, 4:30 to 5:30 pm
The AAAAI invites all international members and delegates to attend Marriott South Tower, Level 3, Carlsbad
this reception. No fee. No pre-registration required. Credentials Committee
Monday, March 3, 7:00 to 8:00 am
Program Directors Assembly Business Meeting
Friday, February 28, 2:00 to 4:00 pm Convention Center, Mezzanine Level, Room 18
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A Ethics/Conflict of Interest Committee
Friday, February 28, 5:00 to 6:00 pm
All Training Program Directors and Co-Directors are invited to attend
this business meeting. No fee. No pre-registration required. Marriott South Tower, Level 3, Conference Suite 2
Fellows-in-Training Committee
2014 Federation of RSLAAIS Assembly Forum and Saturday, March 1, 7:00 to 8:00 am
Business Meeting Marriott North Tower, Lower Level, Rancho Santa Fe 1 and 2
Friday, February 28, 4:45 to 6:30 pm
Grant Review Committee
Convention Center, Upper Level, Room 31AB
Monday, March 3, 7:00 to 8:00 am
The Federation of Regional, State and Local Allergy, Asthma and Marriott South Tower, Level 3, Carlsbad
Immunology Societies Assembly invites all AAAAI members and
delegates to attend this meeting. No fee. No pre-registration required. In-Training Exam Committee
Friday, February 28, 11:30 am to 1:30 pm
Marriott South Tower, Level 3, Miramar Room
Joint Meeting of the Interest Section Coordinating Committee and
the Practice, Diagnostics and Therapeutics Committee
Sunday, March 2, 6:45 to 8:00 am
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
8
Business and Committee
Meetings
Joint Task Force for Quality Performance Measures Aerobiology Committee
Saturday, March 1, 7:00 to 8:00 am Sunday, March 2, 7:00 to 8:00 am
Marriott South Tower, Level 3, Conference Suite 1 Marriott North Tower, Lobby Level, Rancho Santa Fe 3
Leadership Institute Working Group Allergic Fungal Respiratory Diseases Committee
Saturday, March 1, 2:00 to 3:00 pm Sunday, March 2, 7:00 to 8:00 am
Marriott South Tower, Level 4, La Jolla Marriott South Tower, Level 3, Conference Suite 1
Needs Assessment and Outcomes Subcommittee Allergic Skin Diseases Committee
Monday, March 3, 7:00 to 8:00 am Saturday, March 1, 7:00 to 8:00 am
Marriott South Tower, Level 4, La Mesa Marriott North Tower, Lobby Level, New York and Orlando
New Allergist/Immunologist Assembly Leadership Meeting Altered Immune Response Committee
Sunday, March 2, 7:00 to 8:00 am Saturday, March 1, 12:30 to 1:30 pm
Marriott South Tower, Level 3, Carlsbad Marriott North Tower, Lobby Level, Rancho Santa Fe 3
Plenary Subcommittee Anaphylaxis Committee Meeting
Monday, March 3, 5:00 to 7:00 pm Sunday, March 2, 7:00 to 8:00 am
Marriott North Tower, Lobby Level, Torrey Pines 1 and 2 Marriott North Tower, Lobby Level, Marriott Hall Salon 5
Practice Improvement Subcommittee Asthma and Allergic Diseases in the Elderly Committee
Saturday, March 1, 12:30 to 1:30 pm Sunday, March 2, 7:00 to 8:00 am
Marriott South Tower, Level 4, La Mesa Marriott South Tower, Level 4, Malibu
Practice Management Committee Asthma Diagnosis, Assessment and Treatment Committee
Sunday, March 2, 3:00 to 4:00 pm Saturday, March 1, 12:30 to 1:30 pm
Marriott South Tower, Level 1, Point Loma Marriott North Tower, Lower Level, Marriott Hall Salon 3
Program Directors Assembly Executive Committee Cells and Mediators of Allergic Inflammation Committee
Friday, February 28, 12:30 to 1:30 pm Saturday, March 1, 12:30 to 1:30 pm
Marriott South Tower, Level 3, Cardiff Marriott North Tower, Lobby Level, Marriott Hall Salon 4
Seminar Workgroup Committee on the Underserved
Saturday, March 1, 7:00 to 8:00 am Saturday, March 1, 12:30 to 1:30 pm
Marriott North Tower, Lobby Level, Rancho Santa Fe 3 Marriott North Tower, Lobby Level, San Diego Ballroom Salon C
VAMPSS Investigative Team Wine & Cheese Reception Complementary and Alternative Practices in Allergy Committee
Saturday, March 1, 6:00 to 7:00 pm (After workshop 2804.) Meeting
Convention Center, Upper Level, 11AB Saturday, March 1, 9:45 to 10:45 am
Veterans Health Administration Allergists Committee Marriott North Tower, Lobby Level, Rancho Santa Fe 1
Monday, March 3, 7:00 to 8:00 am Environmental Exposure and Respiratory Health Committee
Marriott North Tower, Lobby Level, Torrey Pines 3 Saturday, March 1, 12:00 to 1:30 pm
Marriott North Tower, Lower Level, Presidio Rooms 1 and 2
Interest Section Committee Meetings Eosinophilic Gastrointestinal Disorders Committee
Committee meetings are held during the Annual Meeting for the
Sunday, March 2, 7:00 to 8:00 am
purpose of conducting AAAAI related business. If you are a current
member of an interest section committee, please plan to attend Marriott North Tower, Lobby Level, Marriott Hall Salon 1
your committee meeting. If you are an AAAAI member and you are Genetics, Molecular Biology and Epidemiology Committee
interested in joining an interest section committee, please attend the Saturday, March 1, 12:30 to 1:30 pm
meeting and notify the chair that you are interested in joining. For more Marriott South Tower, Level 4, Malibu
information on AAAAI committees, please contact the AAAAI executive
Health Informatics, Technology and Education Committee
office at (414) 272-6071 or info@aaaai.org.
Saturday, March 1, 12:30 to 1:30 pm
Adverse Reactions to Drugs, Biologicals and Latex Marriott North Tower, Lobby Level, New York and Orlando
Sunday, March 2, 7:00 to 8:00 am
Immunotherapy, Allergen Standardization and Allergy Diagnostics
Marriott North Tower, Lobby Level, Torrey Pines 3
Committee
Adverse Reactions to Foods Committee Saturday, March 1, 6:30 to 8:00 am
Saturday, March 1, 6:30 to 8:00 am Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
Marriott North Tower, Lobby Level, Marriott Hall Salon 6
9
Other Meetings and Events
10
Other Meetings and Events
11
WISC 2014
WAO International Scientific Conference 2014 and the
XLI Annual Meeting of the Brazilian Association of Allergy and Immunology (ASBAI)
Advancing the borders of allergy: From treatment to prevention by targeting the
environment, infections and the susceptible patient
Rio de Janeiro,
Brazil
WAO-0114-096
www.worldallergy.org/wisc2014
12
ARTrust Activities
Walk was a success. Now we need your help to Light Up the Night
Saturday, March 1, 2014 7:00 pM 10:00 pM
For more information, please visit the ARTrust booth near Registration.
7:00 to 10:00 pm
A Benefit supporting the Allergy, Asthma & Immunology San Diego Air & Space Museum and make the second ARTrust 5K Run/Walk even bigger, as we join
together to bring awareness and raise money to support allergy, asthma
Education and Research Organization, Inc. (ARTrustTM)
ARTrust-0913-406
For more information, please visit the ARTrust booth near Registration.
& immunology education and research.
Tickets available at the ARTrust booth or at the event.
Serious runners, casual runners, walkers, families and the general public
ARTrust-0913-406
The Skys the Limit at this years ARTrust Benefit event! Mark your are all welcome to participate in this glowing event where runners and
calendar for this themed event benefiting the ARTrust at the San Diego walkers of all ages will loop through the twinkling lights of the San Diego
Air & Space Museum. Embarcadero.
Enjoy an adventurous evening exploring aviation and the history of All runners/walkers will receive a race shirt in their registration packet.
flight. Try on your own set of wings in the flight simulators, indulge Packet pick-up and registration will be available at the ARTrust booth
in fine dining and cocktails, and enjoy live entertainment. Join your (Thursday through Sunday) on the Street Level of the San Diego
friends and colleagues for an exciting evening and help raise funds Convention Center. You may also register onsite Sunday prior to the run.
for the ARTrust, which supports funding for allergy, asthma and
immunology education and research. Onsite registration for the 5K Run/Walk is $35. Children under 12 can be
registered for free with the option to purchase a race shirt for $10.
Doors open at 7:00 pm at the San Diego Air & Space Museum. The
event runs until 10:00 pm. Transportation will be provided to and from
the Marriott Marquis & Marina. For addtional details please visit the
ARTrust booth. Friends of the President
Ticket Information:
und
Patron Table (10 seats): $3,000
Patron Individual: $300
Allied Health/NAIA Individual: $125
Student Individual: $100
Industry Table (10 seats): $12,000
Your donation of $100 or more in support of the
Ticket price, less cost of good and services, may be tax deductible.
Ribbons
Friends of the President Fund
entitles you to wear a Friend of the President
Friend of the President Ribbon at the 2014 Annual Meeting.
Show your support of the current AAAAI President, Linda Cox, MD
FAAAAI, with a $100 donation to the ARTrust. With your contribution This ribbon symbolizes your contribution to increased funding
you will receive a special ribbon to wear throughout the meeting to for education and research in allergy/immunology and honors
demonstrate your support. AAAAI President, Linda Cox, MD, FAAAAI.
13
A Benefit supporting the Allergy, Asthma & Immunology
Education and Research Organization, Inc. (ARTrustTM)
For more information, please visit the ARTrust booth near Registration.
RTrust-0913-406
Associate & Guest Activities
16
Lectureships
The Robert A. Cooke Memorial Lectureship: 52nd year The Harold S. Nelson Lectureship: 14th year
Lecturer: Donna Davies, BSc PhD Lecturer: Linda Cox, MD FAAAAI
Award presentation at Plenary Session 3101: Integrated Airways on Award presentation at Plenary Session 2101: Immunotherapy:
Sunday, March 2, 8:15 to 9:45 am Mechanism, Outcomes and Markers on Saturday, March 1, 8:15 to
9:45 am
The Jerry Dolovich Memorial Lectureship: 16th year
Lecturer: Fernando Martinez, MD The John E. Salvaggio Memorial Lectureship: 13th year
Award presentation at Symposium Session 3304: Wheezing Episodes Lecturer: Jill Poole, MD FAAAAI
in Preschool Children: The Role of Bacterial Pathogens, Treatment of Award presentation at Plenary Session 5101: Bioaerosols: When Not to
Acute Exacerbations and Potential for Asthma Prevention on Sunday, Take a Deep Breath at Work on Tuesday, March 4, 8:15 to 9:45 am
March 2, 10:45 am to 12:00 pm
The Gail G. Shapiro Memorial Lectureship: 8th year
The Elliot F. Ellis Lectureship: 16 year
th
Lecturer: Monica Kraft, MD
Lecturer: Mitchell Grayson, MD FAAAAI Award presentation at Symposium Session 4303: Treatment
Award presentation at Symposium Session 3306: The Relationship Alternatives for Refractory Severe Asthma on Monday, March 3, 10:45
Between Allergies and Infections on Sunday, March 2, 10:45 am to am to 12:00 pm
12:00 pm
The Burton Zweiman Memorial Lectureship: 14th year
Lecturer: John Kelso, MD FAAAAI
Award presentation at Symposium Session 4306: Immunosenescence:
Implications of an Aging Immune System on Monday, March 3, 10:45
am to 12:00 pm
ARTrust and Dr. William and Judith H. Busse Lectureship: ARTrustTM and Stephen D. Lockey, Jr., MD Lecture: Investing
Investing Together in Our Future: Inaugural Year Together in Our Future: 2nd year
Lecturer: Michael Wechsler, MD Lecturer: Thomas B. Casale, MD FAAAAI
Award presentation at symposia session 2304: NHLBIs Clinical Asthma Award Presentation at Symposium Session 3302: Pathophysiology and
Research Networks (AsthmaNet) Approach to Key Asthma Questions Management of Urticaria and Angioedema on Sunday, March 2, 10:45
on Saturday, March 1, 10:45 am to 12:00 pm am to 12:00 pm
ARTrustTM and Donald Y.M. Leung, MD PhD FAAAAI-JACI ARTrustTM and Anjuli Seth Nayak, MD FAAAAI Lecture:
Lecture: Investing Together in Our Future: 2nd year Investing Together in Our Future: 2nd year
Lecturer: Nives Zimmermann, MD FAAAAI Lecturer: Luz S. Fonacier, MD FAAAAI
Award Presentation at Symposium Session 4307: Wanted: Eosinophils, Award Presentation at Symposium Session 3303: Update of the Allergic
Dead or Alive? Eosinophil Cell Death Subroutines and Implications for Contact Dermatitis Practice Parameter: What's New in 2014? on
Eosinophil-Targeted Therapy on Monday, March 3, 10:45 am to 12:00 pm Sunday, March 2, 10:45 am to 12:00 pm
17
Awards
AAAAI Allied Health $750 Travel AAAAI Interest Section Fellow- 2014 AAAAI Allied Health
Award Recipients in-Training (FIT) Abstract Award Professional Assembly
Alcina Lidder, BA Recipients Scholarship Travel Award
Northwestern University ADT Recipients
Chicago, IL Brian D. Modena, MD Diane Giselle Ananos, RN
Jaime Ross University of Pittsburgh Medical Center Mount Sinai Medical Center
Icahn School of Medicine at Mount Sinai BCI New York, NY
New York, NY Caroline Y. Kuo, MD Helena Azzi, DNP FNP-BC AE-C
Shannon Seopaul David Geffen School of Medicine at UCLA Advance Allergy Asthma Sinus Care
Johns Hopkins University EORD Jupiter, FL
Baltimore, MD Juan-Carlos Cardet, MD Raquel Z Durban, MS, RD, LDN
Brigham and Womens Hospital Asthma & Allergy Specialists, PA
2014 Bernard B. Siegel Charlotte, North Carolina
FADDA
Memorial Abstract Award Jessica Rajan, MD Angela Rene Hague, PA-C
Vered Schichter-Konfino, MD Scripps Medical Group DallasAllergyImmunology
Haifa, Israel Dallas, TX
HEDQ
Adora Lin, MD PhD Edward M Horowitz, BA
American Academy of Johns Hopkins University, Johns Hopkins
National Institute of Allergy and Infectious
Pediatrics (AAP) Section on Diseases Asthma and Allergy Center
Allergy and Immunology Baltimore, MD
IRSOC
Outstanding Pediatric Abstract Margaret J. McCormick, MS RN
Mahboobeh Mahdavinia, MD PhD
Award Recipients Northwestern University Feinberg School of Towson University
Jacob Daniel Kattan, MD Medicine Baltimore, MD
Icahn School of Medicine at Mount Sinai Karen Lynn Meyerson, MSN, APRN, FNP-C,
MAAI
Lisa M. Bartnikas, MD Christina Christianson, PhD AE-C
Harvard Medical School National Jewish Health Asthma Network of West Michigan
Caroline Y. Kuo Grand Rapids, MI
David Geffen School of Medicine at UCLA Julie A. Kuhn, MSW
Kiran P. Patel, MD MS APFED Best Oral Abstract Sinai Urban Health Institute
Chicago, IL
University of California, San Francisco on EGIDs
Julia A. Cronin, MD Laura E. Odom, MSN FNP
Member
University of Virginia Allergy, Asthma and Sinus Center
Paneez Khoury, MD
Knoxville, TN
NIH/NIAID Fallon Schultz, MSW, LCSW, CAM
International Association for Food Protein
Fellow in Training Enterocolitis (IAFFPE)
Jessica Rajan, MD Howell, NJ
Scripps Clinic
Anna Chikovani Sprunger, PA-C
Childrens National Medical Center
Washington, DC
18
Awards
19
Awards
20
Awards
21
Continuing Education and
Accreditation
Two types of continuing education credit are available at the 2014 ABAI Continuing Medical Education (CME)
Annual Meeting: AMA PRA Category 1 CME CreditsTM for physicians Credits
and Continuing Education (CE) contact hours for nurses. Not all Annual In 2007 the American Board of Allergy and Immunology (ABAI)
Meeting sessions offer credit, and of those that do, not all of them offer transitioned from a recertification process to a Maintenance of
both CME and CE. The types and amount of credit offered for each Certification (MOC) program, which requires board certified physicians
session are indicated in the session descriptions beginning on page to complete a minimum of 25 AMA PRA Category 1 Credits in
XX. Attendance certificates are available to all delegates. Professional allergy/immunology each year. The educational sessions offered at
delegates are encouraged to complete the self-report form to receive the 2014 AAAAI Annual Meeting are linked to the content classification
their CME/CE or participation certificates. Visit the Registration desk, system used by ABAI to develop its examinations and will help
complete the self-report form and print your certificate. physicians to meet MOC requirements by enhancing their knowledge
If you do not have time to visit the Registration desk before you depart of the specialty for optimal patient care. The Keyword Index on page
San Diego, the self-report form will be available online beginning 186 lists all Annual Meeting sessions by the relevant ABAI topics and
March 18, 2014 and will be accessible until December 31, 2014 on the can be used by delegates to tailor their itineraries to meet their needs
AAAAI website, annualmeeting.aaaai.org. when preparing for Certification or Maintenance of Certification. For
more information about Maintenance of Certification, visit the ABAI
Physicians Continuing Medical Education (CME) website at www.abai.org.
Credits
Accreditation Statement
Allied Health Continuing Education (CE) Credits
The American Academy of Allergy, Asthma & Immunology (AAAAI) Nurses Continuing Education (CE) Contact Hours
is accredited by the Accreditation Council for Continuing Medical The American Academy of Allergy, Asthma & Immunology (AAAAI) is
Education (ACCME) to provide continuing medical education for a Provider, approved by the California Board of Registered Nursing,
physicians. Provider #10704, for up to 63.50 Contact Hours.
22
Continuing Education and
Accreditation
Allied Health Professionals Program Clinical Research (CR) Program
Target Audience Target Audience
Health care professionals who assist with and provide care to persons Physicians, clinical research coordinators, nurses, respiratory
with asthma, allergy and immunologic disease, specifically: RNs, therapists, pharmacists, laboratory research associates, nurse
LPNs, nurse practitioners, physician assistants, respiratory therapists, practitioners, certified medical associates, physician assistants and
medical technologists and medical assistants. other health professionals who are interested in research in clinical,
academic, community, industry or private settings.
Learning Objectives
Upon completion of the Annual Meeting, participants should be able Learning Objectives
to discuss and expand upon the latest advances in medications, Upon completion of the Annual Meeting, participants should be able
equipment and procedures necessary to promote health for their to discuss the various issues in clinical research; Describe diverse
patients; Describe and discuss new therapies, information, patient care aspects of responsible research; Identify new approaches to clinical
and education in the field of allergy, asthma and immunology. Please research which will improve efficiency and effectiveness. Please refer
refer to the individual Allied Health session descriptions in this program to the individual CR session descriptions in this program for session
for session-specific learning objectives. specific learning objectives.
Healthy Tips
Allergens
A Trusted
The Amer
Reso
Immunologican Academy
urce
Tip
Upon completion of the Annual Meeting, participants should be able to
provide an overview of managed care concepts focusing on local and
of
A Trusted Resource xx Allerg
ic rhinit specialists, y (AAAAI) represAllergy, Asthm
Tip
lungs, throat is symptoms professionalclinical immu ents allergi a &
s and others nologists, allied sts, asthma
Rhinitis The American Academy of Allergy, Asthma &
xx Your
, sinuses, can occur
ears and in the nose, Rhinitis research
and treatm with a specia health Indoor
Immunology (AAAAI) represents
specialists, clinical immunologists, allied
worse.
allergistasthma
allergists,
home, workp
health
can help
you
eyes.
lace or schoo identify things For More
ent of allergi l interest
c diseas
e.
in the Allergens
professionals and others with a special interest in the l that make in your Informatio
xx Allerg
research and treatment of allergic disease. your sympt You depen n
Healthy Tips ens can oms informed d on authoritativ
develop strategies for dealing with the difficult patient. Please refer
allergist, gist, often
is a pediat referred
xx Allergic rhinitis can also be caused by indoor allergens two additi rician or to
such as dust mites or pets. This is called perennial diagnosis onal years of speciainternist with as an
and
deficiencies treatment lized trainin at least
allergic rhinitis, as symptoms are usually year-round.
and other of allergies, asthmg in the
By visitin immunolog a,
Feel Better. Live Better. g ic diseas immune
accurate the office of an es.
diagn allergist,
An allergist/immunologist, often referred to as an educational osis, a treatm you
information ent plan that can expect an
The conten
only. It ts of this
is brochu
you have not intended to re are for inform
questions replace
allergist/imm or medica evaluation ational purpos
unologist. l concer by es
ns, please a physician. If
AAAAI-101
contact
Allergy
your 2012
Ameri
All rights can Academy
2-572
reserved. of Allergy
May not , Asthm
be duplic a & Immu
Allergy
only. It is not intended to replace evaluation by a physician. If 2012 American Academy of Allergy, Asthma & Immunology.
Allergy
Brochures
Scratchin
g
Surface the
Skin Alle on
Signs rgies
Warning ylaxis
of Anaph
Childrens Books
Skin allerg
but an ies can
allergist/imbe frustrating
has the munologist , An Asthm
exper
which cond tise to diagn
ition you ose Action a
) is
is (an-a
-fi-LAK-sis
ic reac-
provide
relief. have and Plan:
Anaphylax ning allerg
reate anaphy- Eczema
a life-th most common d by
Infants
tion. The ions are cause stings, and peop Helps
lactic react , insect tory of
allerg Your Asthma
le with
a
contr
the long- ol your asthm
to foods more likely ies or asthm his- term a for
allergies ns and latex. to haveAction Plan a are Has zones
scaly
medicatio affect more ally , itchy rash. this red, your symp to help you track
typically and affects Eczema
Symptomspart of the body knees. the face, usu- your asthmtoms and know
Be elbows a is gettin when
than one de: ing or itchinsure to avoid and Expla g worse
may inclu /welts Doing
g the Wellscratch- ins when
rash with hives rash. or go to an to call
red Hives and No coughing, wheezing, emergencythe doctor
GREEN ZONE
medications
Pub Ed
Bookm
arks-Sk
Trouble walking or talking due
in-v3.in
dd 1 to asthma symptoms
1/3/201
Not responding 2011,to quick-relief
America
2 4:32:15Immunology n Academ
medication PMPM All rights y of Allergy,
reserve Asthma
1/4/201
Peak flow ______ to ______
2 1:38:10 d. &
(50% of personal best)
dd 2
is-v5.in
aphylax
arks-An
Bookm
Pub Ed
Warning: For extreme difficulty
Bookmarks
AAAAI-1112-280
23
European Academy of
Allergy and Clinical Immunology
7 11 June 2014
Copenhagen, Denmark
www.eaaci2014.com
Thursday, February 27 and
friday, February 28
Thursday, February 27 Consultants to the Surgeons General Updates:
3:30 VHA Allergy Committee
Military Allergy Program Joseph S. Yusin, MD FAAAAI
0001 28th Annual Harold S. Nelson Military Allergy/ 3:45 Air Force
Kevin M. White, MD
Immunology Symposium
4:00 Army
7:20 am to 5:00 pm
Michael R. Nelson, MD PhD FAAAAI
Convention Center, Upper Level, Room 3
4:15 Navy
Pre-registration and ticket required. No fee for approved and
Michael R. Kaplan, DO FAAAAI
registered military members. $60 fee for non-military members.
4:30 Business Meeting and Award Presentations
Continental breakfast and box lunch included.
Upon completion of this session, participants should be able to: Discuss the approach to
Credit: 7.00 CME / 8.00 CE identifying allergic skin disorders in the military environment and the role of biopsy in the
Moderator: Kimberly S. Johnson, MD diagnosis and management; Identify the differential diagnosis of chronic urticaria and
7:20 Registration and Breakfast explain the diagnostic approach; Discuss the application of novel therapy in the treatment
7:50 Welcome and Overview of chronic urticaria.
Kimberly S. Johnson, MD Fellows-In-Training and New Allergist/Immunologist
8:00 Morning Address: Dermatology for the Military Allergist
Assembly Joint Reception
Timothy Straight, MD PhD
9:00 Break 7:00 to 8:00 pm
Marriott North Tower, Lobby Level, Rancho Santa Fe 1-3
Fellow Original Research
Reception is open to current Chrysalis participants, FITs and NAIA
9:30 Safety of Cluster Allergen Immunotherapy During Refill Dosing
members.
Tiffany J. Owens, MD
9:50 Demographics and Retention Patterns for 1999-2011 U.S. Air Friday, February 28
Force Allergy Graduates
Michelle Bandino, MD
Fellows-in-Training Program
10:10 Serologic Specific IgE (sIgE) Testing in a Closed Healthcare 1011 FIT Symposium
System 7:00 am to 2:00 pm
Daniel A. Steigelman, MD Marriott North Tower, Lobby Level, San Diego Ballroom Salon B
10:30 Safety and Efficacy of a 12-Week Maintenance Interval in Patients Pre-registration and ticket required. No fee. Continental breakfast and
Treated With Imported Fire Ant Immunotherapy box lunch included.
Karla E. Adams, MD Credit: No CME / No CE
Staff Original Research 7:00 Networking Breakfast
10:50 Vitamin D Supplementation Improve Urticaria Symptoms in Adult 8:00 Introductions
Chronic Urticaria Taylor A. Banks, MD
Tadech Boonpiyathad, MD Mary Beth Fasano, MD FAAAAI
11:10 Increased Respiratory Illness and Transient Immune Alterations 8:05 Networking Organizations
Seen with Multiple Vaccinations Administered in a Stressful 8:15 American Board of Allergy and Immunology
Environment Stephen I. Wasserman, MD FAAAAI
8:20 Allergy Immunotherapy: The Basics
Rachel Umi Lee, MD FAAAAI
Michael R. Nelson, MD PhD FAAAAI
11:30 Lunch and Bruton Lecture: Treatment Options for Refractory
8:50 Immunotherapy Extracts
Urticaria
Robert G. Hamilton, PhD D.ABMLI FAAAAI
David A. Khan, MD FAAAAI
9:20 Break
Fellow Case Reports 9:35 Welcome from the AAAAI President
1:00 Selective IgM Deficiency Presenting as Cryptogenic Organizing Linda Cox, MD FAAAAI
Pneumonia 9:45 Immunotherapy: New and Emerging Issues
Cory A. Lundberg, DO Linda Cox, MD FAAAAI
1:20 A Devastating Outcome in Undiagnosed X-Linked 10:15 Immunomodulation with Immunotherapy
Agammaglobulinemia: A Call for Earlier Screening Joann C. Blessing-Moore, MD FAAAAI
Karen Elizabeth Bruner, MD 10:45 Pearls and Pitfalls of Diagnostic Testing
1:40 Intractable Burkholderia Vietnamiensis and Hemophagocytic Michael S. Blaiss, MD FAAAAI
Lymphohistiocytosis in Homozygous Interleukin-12 Receptor 11:15 Venom Immunotherapy
Beta-1 Deficiency David B.K. Golden, MD FAAAAI
Ki Lee Milligan, MD 11:45 Difficult AIT Cases
2:00 Break David A. Khan, MD FAAAAI
2:30 Vaccine Healthcare Center Update 12:15 Networking Lunch
Limone C. Collins Jr., MD 1:00 AIT Prescription Workshop
Upon completion of this session, participants should be able to: Describe the pathophysi-
3:00 Military Aeroallergen Extract Laboratory Updates ology, initial evaluation and management of patients with allergies to aeroallergens and/or
Susan E. Kosisky, BS MHA venoms; Identify recent advances in the field of immunotherapy, including mechanisms of
immunomodulation; Discuss current and emerging treatment modalities and adjuncts in
the management of aeroallergen and venom allergic patients.
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 25
friday, February 28
Allied Health Course 1101D Differentiating Asthma From COPD: Why is This
So Hard?
1101 Advanced Practice Course
Marriott North Tower, Lobby Level, Atlanta & Chicago
8:00 am to 12:30 pm
Edward O. Corazalla, MS RPFT
Marriott North Tower, Lobby Level, Marriott Hall Salons 1 & 2
Karen L. Gregory, DNP APRN-BC RRT AE-C
Pre-registration and ticket required. No fee.
Upon completion of this session, participants should be able to identify differences and
Credit: 4.50 CME / 5.40 CE similarities in patients with asthma vs. COPD.
Moderators: Nina A. Zimmermann, MSN RN ANP-BC AE-C
Debra A. Sedlak, MSN CPNP Clinical Research Workshop
8:00 Introduction
Debra A. Sedlak, MSN CPNP 1102 The Anatomy of the Clinical Trial Agreement
8:15 Patients Attitudes and Beliefs About Complementary and 8:00 to 9:15 am
Alternative Medicine Use for Asthma Self-Management Marriott North Tower, Lobby Level, Torrey Pines 1 & 2
Maureen George, PhD RN AE-C FAAN Credit: 1.25 CME / 1.50 CE
9:00 Bronchial Thermoplasty for the Treatment of Severe Asthma Moderator: Christopher Chang, MD PhD FAAAAI
Mario Castro, MD MPH The Anatomy of the Clinical Trial Agreement and Negotiating a
9:45 Question & Answer Profitable Budget
Cheryl Koff Bernstein, RN BSN CCRC
10:00 Vitamin D: Sunlight at the End of the Tunnel
Upon completion of this session, participants should be able to: Identify and discuss the
Nicolette De Jong, PhD language used in reciprocal or crossed indemnification and offer alternative indemnifica-
10:45 Food Allergy: New Therapies on the Horizon tion language during contract negotiations; Identify and discuss important sections of the
Beth D. Strong, RN CCRC contract such as liability insurance, language used to describe adherence to the protocol,
payment, study termination and offer alternative language; Discuss successful methods
11:30 Managing Atopic Dermatitis: Itching the Night Away!
and techniques used during contract and budget negotiations with the sponsor.
Karol G. Timmons, RN MS CPNP
12:15 Question & Answer
Chrysalis Project
Upon completion of this session, participants should be able to: Evaluate how patients'
health beliefs impact asthma self-management; Identify asthma patients who may 1111 2014 Chrysalis Project Program
benefit from alternative treatments such as broncial thermoplasty and Vitamin D therapy;
7:30 am to 2:00 pm
Define new and appropriate treatment strategies for common food allergies and atopic
dermatitis. Marriott North Tower, Lobby Level, Rancho Santa Fe 1-3
Pre-registration and ticket required. No fee. Continental breakfast and
box lunch included.
Allied Health Advanced Practice Course Breakout
Credit: No CME / No CE
Sessions 7:30 Breakfast
12:30 to 2:00 pm 8:00 Welcome
Separate pre-registration, ticket and fee from the 1101 Advanced Thomas A. Fleisher, MD FAAAAI
Practice Course. Pre-registration and ticket required. Fee: $20. Kimberly A. Risma, MD PhD FAAAAI
Box lunch included. Sessions and meals are limited to registered
8:05 Welcome from the AAAAI President
attendees.
Linda Cox, MD FAAAAI
Credit: 1.50 CME / 1.80 CE
8:15 Food Allergy
1101A Cough/Chronic Cough A. Wesley Burks, MD FAAAAI
Marriott North Tower, Lobby Level, Marriott Hall Salon 5 8:45 Eosinophilic Disorders
Nina A. Zimmermann, MSN RN ANP-BC AE-C Paneez Khoury, MD
Jeanette L. Arnold, MSN RN C-FNP
9:15 Immunodeficiency
Upon completion of this session, participants should be able to discuss the diagnostic
evaluation and therapeutic options to treat chronic cough. Kathleen E. Sullivan, MD PhD FAAAAI
9:45 Break
1101B Is This Anaphylaxis? 10:00 Asthma
Marriott North Tower, Lobby Level, Marriott Hall Salon 6
Rohit Katial, MD FAAAAI
Gabriel Ortiz, MPAS PA-C DFAAPA
10:30 Atopic Dermatitis
Vivian P. Hernandez-Trujillo, MD FAAAAI
Donald Y.M. Leung, MD PhD FAAAAI
Upon completion of this session, participants should be able to describe anaphylaxis and
the initiation of appropriate treatment. 11:00 Academic Career Paths
Kimberly A. Risma, MD PhD FAAAAI
1101C Opening Pandoras Box: Asking the Right
11:20 Industry Career Paths
Questions Daniel C. Adelman, MD FAAAAI
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2 11:40 Private Practice Career Paths
David Wayne Unkle, MSN APN FCCM Adina Kay Knight, MD FAAAAI
Anthony J. Ricketti, MD FACAI FCCP
12:00 Chrysalis Project Program Luncheon with FIT Mentors
Upon completion of this session, participants should be able to discuss strategies for
interpreting information given by our patients.
26 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
friday, February 28
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 27
friday, February 28
Course Course
1204 Endoscopic Evaluation and Management of 1206 Primary Immunodeficiency Diseases: What Do I
Chronic Rhinosinusitis (Pre- and Post-Surgery) Do with My Patient? From Start to Finish
Including Cultures 9:00 am to 12:00 pm
9:00 am to 12:00 pm Convention Center, Upper Level, Ballroom 6CF
Convention Center, Upper Level, Room 3 Credit: 2.75 CME / 3.30 CE
Pre-registration and ticket required. No fee. Moderator: Lisa J. Kobrynski, MD MPH FAAAAI
Credit: 3.00 CME / 3.40 CE 9:00 Who Needs Evaluation for Immunodeficiency?
Moderator: Anju T. Peters, MD FAAAAI M. Teresa De La Morena, MD
9:00 Anatomy of the Sinuses 9:25 Assessing Innate and Adaptive Humoral Immunity
Todd T. Kingdom, MD Francisco A. Bonilla, MD PhD FAAAAI
9:20 Radiology of the Sinuses 9:50 Assessing Innate and Adaptive Cellular Immunity
S. James Zinreich, MD I. Celine Hanson, MD FAAAAI
10:00 Endoscopic Evaluation of the Sinuses Including Cultures: Video 10:15 Question & Answer
and Lecture 10:35 Break
Wellington S. Tichenor, MD FAAAAI 10:50 Therapies for Innate and Adaptive Humoral Immunodeficiency
10:20 Break Vincent R. Bonagura, MD FAAAAI
10:30 Surgical Evaluation 11:15 Therapies for Innate and Adaptive Cellular Immunodeficiency
Robert C. Kern, MD Mark Ballow, MD FAAAAI
10:50 Endoscopic Evaluation of the Sinuses: Post-Surgical 11:40 Question & Answer
Wellington S. Tichenor, MD FAAAAI Upon completion of this session, participants should be able to: Describe a general ap-
11:10 Case Management Studies: Question & Answer proach to a patient with recurrent infections or other presentation consistent with PID;
Daniel L. Hamilos, MD Discuss the stepwise approach to the diagnosis of PID and how to apply advanced and
specialized tests, possibly in conjunction with guidance from a tertiary provider; List
Upon completion of this session, participants should be able to: Describe the anatomy of
the different modalities available for therapy, general principles of their application and
the paranasal sinuses and identify pathology on CT scan; Recall indications for surgery
resources for guidance in unusual or complex situations.
and complications of surgery; Perform endoscopy in patients with CRS as well as cultures
of the middle meatus and/or sinuses and review management of complicated sinusitis.
Course
Course 1207 Drug Hypersensitivity
1205 Difficult Cases (Part 1) 9:00 am to 12:00 pm
9:00 am to 12:00 pm Convention Center, Upper Level, Ballroom 6DE
Convention Center, Mezzanine Level, Room 15AB Credit: 2.75 CME / 3.30 CE
Pre-registration and ticket required. No fee. Moderator: Rebecca S. Gruchalla, MD PhD FAAAAI
Credit: 2.75 CME / 3.20 CE 9:00 Symptoms and Skin Testing for Type I Chemotherapy Drug
Moderators: David W. Hauswirth, MD FAAAAI Hypersensitivity
Joyce E. Yu, MD David E. Sloane, MD
9:00 Hypereosinophilic Disorders (Not EoE) 9:50 Break
Amy D. Klion, MD 10:05 Patch Testing in Drug Allergy
Princess U. Ogbogu, MD FAAAAI Antonino G. Romano, MD
9:35 Itching Without Rash 10:55 Antibiotic Skin Testing
Cem Akin, MD PhD FAAAAI Anahita F. Dioun, MD FAAAAI
Gerald B. Lee, MD 11:45 Question & Answer
10:10 Break Upon completion of this session, participants should be able to: List the symptoms of Type
10:30 Peri-Operative Anaphylaxis I drug hypersensitivity reactions; Identify symptoms of Type IV drug hypersensitivity reac-
tions; Describe diagnostic tools for Type I and Type IV drug hypersensitivity reactions.
Phillip L. Lieberman, MD FAAAAI
Joel M. Hartman, MD
11:05 What the Allergist/Immunologist Sees That is Not Allergy
Dennis K. Ledford, MD FAAAAI
Eugene M. Choo, MD FAAAAI
11:40 Question & Answer
Upon completion of this session, participants should be able to discuss diagnostic and
clinical management challenges encountered in allergy, asthma and immunology practice.
28 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
friday, February 28
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 29
friday, February 28
30 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
friday, February 28
Course Course
1602 NIAID: Recent Advances in Biomarkers of Allergy 1604 Difficult Cases (Part 2)
and Asthma 2:00 to 5:00 pm
2:00 to 5:00 pm Convention Center, Mezzanine Level, Room 15AB
Convention Center, Upper Level, Room 11AB Pre-registration and ticket required. No fee.
Credit: 2.75 CME / 3.30 CE Credit: 2.75 CME / 3.20 CE
Moderator: Marshall Plaut, MD FAAAAI Moderators: Jason W. Caldwell, DO FAAAAI
2:00 Allergen Challenge as a Biomarker of Disease Severity and of the Michael H. Land, MD FAAAAI
Effects of Treatment 2:00 COPD vs. Asthma
Stephen R. Durham, MA MD FRCP William W. Busse, MD FAAAAI
2:25 Transcriptomic Changes After Allergen Exposure Matthew C. Bell, MD
Sunil K. Ahuja, MD 2:35 Implant Allergy
2:50 Basophil Activation as a Predictor of Food Allergen Severity Luz S. Fonacier, MD FAAAAI
Alexandra F. Santos, MD MSc Haejin Kim, MD
3:15 Break 3:10 Break
3:30 Basophil Activation as a Biomarker of Food Allergy and Asthma 3:30 New Immune Deficiencies
Wayne G. Shreffler, MD PhD FAAAAI Gulbu Uzel, MD
Monica G. Lawrence, MD
3:55 T Regulatory Cells as Markers of Allergen Immunotherapy
Andrew D. Luster, MD PhD 4:05 Mystery Rashes
Lisa A. Beck, MD FAAAAI
4:20 CD27 Effector Cell Depletion During Allergen Immunotherapy
Anne Marie Singh, MD
Erik R. Wambre, PhD
4:40 Question & Answer
4:45 Question & Answer
Upon completion of this session, participants should be able to discuss diagnostic and
Upon completion of this session, participants should be able to: Explain how mediators clinical management challenges encountered in allergy, asthma and immunology practice.
produced following allergen challenge predict the status of allergic diseases; Describe the
relationship of successful allergen immunotherapy to effects on circulating T cell subsets
and antibody responses; Appreciate the value of measuring peripheral blood basophil Course
activation in allergic diseases and asthma.
1605 Mast Cell Activation Syndromes: From
Course Anaphylaxis to Mastocytosis
2:00 to 5:00 pm
1603 Finding a Job and Getting Started in Practice Convention Center, Upper Level, Room 6A
2:00 to 5:00 pm Credit: 2.75 CME / 3.30 CE
Convention Center, Upper Level, Room 2 Moderator: Luis Escribano, MD PhD FAAAAI
Credit: 3.00 CME / 3.40 CE 2:00 Anaphylaxis to Hymenoptera Venom
Moderator: Tao T. Le, MD MHS FAAAAI Patrizia Bonadonna, MD PhD
2:00 Overview and Introductions 2:30 Mastocytosis: Role of Tryptase and C-Kit Mutations
Tao T. Le, MD MHS FAAAAI Cem Akin, MD PhD FAAAAI
2:05 Finding a Job and Negotiating the Agreement 3:00 Break
Tao T. Le, MD MHS FAAAAI
3:15 Non-Clonal Mast Cell Activation Syndrome
2:40 Getting Licensed and Transitioning into Practice Mariana C. Castells, MD PhD FAAAAI
Brian A. Smart, MD FAAAAI
3:45 When and How to Perform a Bone Marrow Study in MCAS:
2:55 Break Practical Recommendations
3:05 Secrets of an Efficient Allergy Practice Luis Escribano, MD PhD FAAAAI
David L. Patterson, MD MS MBA FAAAAI 4:15 Idiopathic Anaphylaxis
3:40 Practice Finances 101 Paul A. Greenberger, MD FAAAAI
Marshall P. Grodofsky, MD FAAAAI 4:45 Question & Answer
4:15 Marketing Your Practice and Referral Development Upon completion of this session, participants should be able to: Discuss the symptoms
Stanley M. Fineman, MD MBA FAAAAI and presentation of mast cell activation syndromes (MCAS); Outline the role of tryptase
4:50 Question & Answer and c-kit mutations in MCAS; Describe management options for MCAS.
Upon completion of this session, participants should be able to: Outline how to identify
and join the right practice opportunity; Discuss the fundamentals of office management;
Identify strategies for marketing a practice and building a patient base.
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 31
friday, February 28
Course Upon completion of this session, participants should be able to: Discuss ethnic and
geographical differences in PID prevalence and clinical presentation around the world;
1606 Review of Systemic Autoimmune Disease and Discuss international vaccine programs and challenges posed for the PID community;
Review clinical scenarios of PID management in different settings around the world.
Treatment
2:00 to 5:00 pm
Convention Center, Upper Level, Ballroom 6B
Course
Credit: 3.00 CME / 3.60 CE 1608 NIEHS: Exposure to Indoor Allergens and
Moderator: Arnold I. Levinson, MD FAAAAI Endotoxin in Relation to Allergic Disease: Results
2:00 Update on Laboratory Diagnosis of Systemic Autoimmune
from NHANES 2005-2006
Disease
2:00 to 5:00 pm
David P. Huston, MD FAAAAI
Convention Center, Upper Level, Ballroom 6DE
2:30 ACR Updated Recommendations for Disease-Modifying Credit: 2.75 CME / 3.20 CE
Antirheumatic Drugs and Biologic Agents in the Treatment of RA Moderators: Paivi M. Salo, PhD
Arthur Kavanaugh, MD FAAAAI Darryl C. Zeldin, MD
3:00 Question & Answer 2:00 Overview of the NHANES 2005-2006 Allergy Component
3:15 The Spectrum of Vasculitis: New Insights into Pathogenesis and Darryl C. Zeldin, MD
Treatment 2:20 Multiplexed Allergen Measurements: New Standards and
Richard Keating, MD Performance Parameters
3:45 New Treatment Modalities for Lupus Eva-Maria King, PhD
Mary Anne Dooley, MD 2:40 NHANES 2005-2006: Getting to Grips with the Big Data
4:15 Susceptibility to Infections in Autoimmune Disease: Is it the Agustin Calatroni, MA MS
Disease or the Treatment? 3:00 Break
John J. Cush, MD
3:20 IgE Sensitization and Current Allergen Exposure: Implications for
4:45 Question & Answer Environmental Intervention
Upon completion of this session, participants should be able to: Interpret screening and
Herman Mitchell, PhD
follow-up reflex testing in the diagnosis of autoimmune disease; Review the latest treat-
ment guidelines for rheumatoid arthritis; Describe the organ systems lupus can affect and 3:40 Environmental Exposures and Allergy Symptoms
the downstream sequelae of complement activation. Paivi M. Salo, PhD
4:00 Which Combinations of IgE Clusters and Exposures Have the
Course Greatest Impact on Asthma?
Peter J. Gergen, MD MPH
1607 Primary Immune Deficiency: A Global Perspective
4:20 Endotoxin Exposure Assessment and Respiratory Disease
2:00 to 5:00 pm
Peter S. Thorne, PhD
Convention Center, Upper Level, Ballroom 6CF
Credit: 3.00 CME / 3.40 CE 4:40 Question & Answer
Upon completion of this session, participants should be able to: Interpret the role that
Moderator: Motohiro Ebisawa, MD PhD FAAAAI
allergen/endotoxin exposures and allergic sensitization play in allergic diseases; Apply
2:00 An Overview of Primary Immunodeficiency Diseases Around the new, standardized methods in indoor allergen assessment; Review strategic objectives of
World NHANES and the allergy component.
Fred Modell
2:25 Vaccine-Associated Paralytic Polio and Other Live Attenuated Course
Vaccine-Associated Disease in Immunodeficient Infants
Antonio Condino-Neto, MD PhD
1609 Allergen Immunotherapy: The Nuts and the Bolts
2:50 Clinical Cases: Diagnosis and Management of Primary (Part 2)
Immunodeficency Around the World 2:00 to 3:00 pm
Elham M. Hossny, MD PhD FAAAAI Convention Center, Upper Level, Room 30CDE
Pre-registration and ticket required. No fee.
3:15 Question & Answer
Credit: 1.00 CME / 1.20 CE
3:25 Break
Moderator: Michael R. Nelson, MD PhD FAAAAI
Moderators: Elham M. Hossny, MD PhD FAAAAI 2:00 SCIT and SLIT: Optimal Dosing, Regimen and Duration
Mona I. Kidon, MD FAAAAI Harold S. Nelson, MD FAAAAI
3:35 Defects of Human Immunity and Mycobacterium Diseases Around 2:30 Allergen Immunotherapy: Practical Considerations, Cost-
the World Effectiveness, Adherence and Quality of Life
Stephanie Boisson-Dupuis, MD Cheryl S. Hankin, PhD
4:00 Molecular Mechanisms of Hyper IgE Syndromes Upon completion of this session, participants should be able to: Describe how immuno-
Speaker to be announced. therapy can easily be dosed and the knowledge gaps we still have in this field; Discuss
4:25 Malnutrition, Vitamin Deficiencies, the Immune System and when doses might need to be adjusted for SCIT and for SLIT.
Infections: Time to Revisit Our Knowledge
Raz Somech, MD PhD
4:50 Question & Answer
32 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
friday, February 28
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 33
friday, February 28
34 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
friday, February 28
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 35
friday, February 28
36 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
38 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 39
saturday, March 1
40 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
Symposium Symposium
2302 World Allergy Forum: Anaphylaxis: 2304 NHLBIs Clinical Asthma Research Networks
From Mechanisms to Novel (AsthmaNet) Approach to Key Asthma Questions
Therapeutics 10:45 am to 12:00 pm
10:45 am to 12:00 pm Convention Center, Upper Level, Ballroom 6A
Convention Center, Upper Level, Ballroom 6B Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE Moderators: William W. Busse, MD FAAAAI
Moderators: Linda Cox, MD FAAAAI James P. Kiley, PhD
Lanny J. Rosenwasser, MD FAAAAI 10:45 What Roles Do Novel and Not-So Novel Medications Have in
10:45 Diagnosis and Prevention of IgE and Non-IgE-Mediated Treating Preschool Wheezers?
Anaphylaxis Leonard B. Bacharier, MD FAAAAI
Fred D. Finkelman, MD 11:05 Is LABA or Increased Dose of ICS the Best Step-Up Therapy for
11:05 Causes of Anaphylaxis African Americans: Do Children Respond Differently Than Adults?
Motohiro Ebisawa, MD PhD FAAAAI Michael E. Wechsler, MD
11:25 Treatment of Anaphylaxis: Recent Advances 11:25 Does Vitamin D Have a Role in Clinical Asthma?
F. Estelle R. Simons, MD FAAAAI Mario Castro, MD MPH
11:45 Question & Answer 11:45 Question & Answer
Upon completion of this session, participants should be able to: Outline therapeutic
Upon completion of this session, participants should be able to: List the etiology and
options to optimize asthma treatment early in life; Describe the unique therapeutic ap-
mechanisms of anaphylaxis; Recognize the most common triggers in anaphylaxis; Discuss
proaches that produce improved outcomes in African-American patients; Discuss the use
the management of anaphylaxis including an action plan for prevention.
of Vitamin D as a therapeutic agent for treating asthma.
Symposium Symposium
2303 The Expanding Universe of Primary 2305 The Indoor Air Exposome in Work, School and
Immunodeficiency Home: Taking in the Whole Picture
10:45 am to 12:00 pm
10:45 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6CF
Convention Center, Mezzanine Level, Room 14AB
Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE
Moderator: M. Teresa De La Morena, MD
Moderator: Jill A. Poole, MD FAAAAI
10:45 The Ever-Expanding Spectrum of PID
10:45 Exposure Assessments and Risk of Disease in Multiple Settings
Troy R. Torgerson, MD PhD
Wanda Phipatanakul, MD MS FAAAAI
11:05 Diagnosing PID in 2014
11:05 Pesticides, Chemicals and Other Exposures Matter in Allergic
Kathleen E. Sullivan, MD PhD FAAAAI
Disorders
11:25 Supporting and Reconstituting Immune Function Rachel L. Miller, MD FAAAAI
M. Louise Markert, MD PhD FAAAAI
11:25 Evaluation and Management of Patients Presenting with
11:45 Question & Answer Suspected Building-Related Illness
Upon completion of this session, participants should be able to: Describe how discovery Karin A. Pacheco, MD MSPH FAAAAI
of new immunodeficiencies leads to new insights into immune system biology; Develop
a stepwise approach to diagnosing the broad range of immunodeficiencies; Discuss the 11:45 Question & Answer
latest developments in the therapy of immunodeficiency. Upon completion of this session, participants should be able to: Describe the most com-
mon indoor air quality issues that cause negative health effects; Identify the emerging
role of pesticides, chemicals and other exposures in modulating allergic sensitization,
epigenetic markers and health outcomes; Outline best practices for clinical assessment of
susceptible workers exposed to poor office indoor air quality and remediation strategies to
create a healthy office indoor air quality environment.
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 41
saturday, March 1
Symposium Symposium
2306 Mechanisms of Virus-Induced Asthma 2308 The Relevance of Microbes and Their Diversity in
10:45 am to 12:00 pm Chronic Rhinosinusitis and Asthma
Convention Center, Mezzanine Level, Room 15AB 10:45 am to 12:00 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Upper Level, Room 30ABCDE
Moderator: Mitchell H. Grayson, MD FAAAAI Credit: 1.25 CME / 1.50 CE
10:45 Local Interactions Betweens Dendritic Cells and T Cells in the Moderator: Martin Wagenmann, MD FAAAAI
Antiviral Immune Response 10:45 Asthma and the Relevance of the Microbiome
Kevin Legge, PhD Trevor ThomasHansel, MD PhD
11:05 The Neutrophilic Antiviral Response: Is There More Than Meets 11:05 Biofilms in Chronic Rhinosinusitis
the Eye? James Palmer, MD
Dorothy S. Cheung, MD FAAAAI 11:25 Dont Underestimate Viruses as Relevant Factors in the
11:25 The Chronic NKT-Macrophage Axis in Asthma Development of Chronic Airway Disease
Michael J. Holtzman, MD FAAAAI Daniel J. Jackson, MD
11:45 Question & Answer 11:45 Question & Answer
Upon completion of this session, participants should be able to: Discuss how innate Upon completion of this session, participants should be able to: Discuss the relevance of
lymphoid cells contribute to airway inflammation in response to viral infections; Discuss microbial diversity in the development of asthma; Define alterations in resident microbiota
new understanding of the neutrophilic response during viral infections; Describe how NKT relevant for chronic rhinosinusitis presentation and treatment; Recognize the importance
cells and macrophages drive a chronic post-viral asthma phenotype. of viral infections in the development of chronic lower airway disease.
42 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 43
saturday, March 1
2504 Making the Most of Your EMR: Meeting 2510 Quality Improvement and Patient Safety in
Meaningful Use Allergy Practice
Priya J. Bansal, MD FAAAAI Brad J. McClimon, MD
A. Sean McKnight, MD FAAAAI Matthew A. Rank, MD FAAAAI
Marriott South Tower, Level 3, Marina Ballroom Salon G Marriott South Tower, Level 1, Point Loma
Upon completion of this session, participants should be able to: Discuss tips for optimizing Upon completion of this session, participants should be able to: Discuss the need for
your current EMR; Discuss current state of Meaningful Use government incentive pay- allergists to consider, plan and perform quality projects; Discuss fundamental principles
ments; Discuss clinical quality measures and PQRI reporting with your EMR. guiding quality improvement of allergic/immunologic diseases in the United States;
Discuss potential quality improvement opportunities that could positively influence the
2505 When Should Bone Marrow Transplantation be outcomes of allergy, asthma and immunology education, research and patient care at the
Considered in Primary Immunodeficiency? local and national level.
Rebecca A. Marsh, MD 2511 Biologics Targeting the Immune Responses in
Elena E. Perez, MD PhD FAAAAI
Marriott South Tower, Level 3, Balboa
Chronic Rhinosinusitis and Nasal Polyps
Claus Bachert, MD PhD
Upon completion of this session, participants should be able to: Review the primary immu-
nodeficiency diseases for which BMT can be a curative treatment; Discuss how soon after Daniel L. Hamilos, MD
diagnosis a patient with certain immunodeficiency disorders should be referred to a BMT Marriott South Tower, Level 1, Solana
center; Describe any therapies to be avoided prior to a patient going to transplant. Upon completion of this session, participants should be able to describe biologic treat-
ments under consideration for treatment of chronic rhinosinusitis.
2506 Viral Infections in the Allergic Host: What Factors
May Be Synergistic? 2512 Immunotherapy with Immunomodulator
Josh L. Kennedy, MD Therapy: Which Work and Which Do Not?
Eva Kathryn Miller, MD Peter S. Creticos, MD FAAAAI
Marriott South Tower, Level 3, Mission Hills Mohamed H. Shamji, BSc MSc PhD
Upon completion of this session, participants should be able to: Evaluate the innate im- Marriott South Tower, Level 1, Santa Rosa
mune response to viral infection in the exacerbating asthmatic, particularly the evidence Upon completion of this session, participants should be able to: Review new data on the
of a deficient or overactive response; Discuss the role of the epithelium in asthmatic combination of immunotherapy and certain immunomodulators; Discuss the the possible
responses to viral infection; Evaluate the role of allergy by examining the evidence that IgE mechanisms that might account for these findings, analyzing the mechanisms of im-
responses are important predictors of asthma exacerbations. munotherapy in a new light.
2507 Biomass Smoke: Alternative Energy or Pollutant 2513 Evaluating Experimental Models of Allergic
Source? Rhinitis
Patricia Mason Fritz Anne K. Ellis, MD MSc FAAAAI
Alisa M. Smith, PhD FAAAAI Martin Wagenmann, MD FAAAAI
Marriott South Tower, Level 3, Cardiff Marriott South Tower, Level 4, La Costa
Upon completion of this session, participants should be able to: Recognize the emergence Upon completion of this session, participants should be able to: Describe the most com-
of a potentially significant source of community (neighborhood) air pollution; Discuss monly used methodologies for experimental nasal allergen challenge in the investigation
the continuum and coherence of health effects from exposure to combustion emissions; of allergic rhinitis; Describe the commonly used methodologies utilized in environmental
Analyze the role of ambient air pollution on the health of non-urban populations. exposure unit-type studies of allergic rhinitis; Describe the advantages and disadvantages
of both experimental models pertaining to the study of allergic rhinitis.
2508 The Intricacy of Penicillin Allergy Evaluation
Eric M. Macy, MD FAAAAI 2514 Food Allergy and the Mucosal B Cell
Miguel A. Park, MD Cathryn R. Nagler, PhD
Marriott South Tower, Level 3, Del Mar Duane R. Wesemann, MD PhD
Upon completion of this session, participants should be able to: Discuss the different Marriott South Tower, Level 4, Catalina
components of the penicillin skin test; Discuss how the different components of the Upon completion of this session, participants should be able to: Discuss how commensal
penicillin skin test affect the negative predictive value; Discuss the role of oral challenges organisms and dietary antigens may shape the pre-immune antibody repertoire; Review
to penicillin and/or amoxicillin in the evaluation of penicillin allergy. the known mechanisms underlying immune tolerance to gut luminal antigens; Describe
the mechanisms regulating antibody affinity maturation and IgH class switch recombina-
2509 Performance of Oral Food Challenges in the tion to IgE.
Office Setting 2515 Prostaglandins: Regulatory Lipid Mediators
S. Allan Bock, MD FAAAAI
Darryl C. Zeldin, MD
Justin M. Skripak, MD
Weisong Zhou, PhD
Marriott South Tower, Level 3, Miramar
Marriott South Tower, Level 4, Coronado
Upon completion of this session, participants should be able to: Describe and perform
Upon completion of this session, participants should be able to: Define the role of
food challenges in their own practices; Review the practical aspects of how to carry out a
prostaglandins in vascular remodeling and allergic lung inflammation; Describe the role
typical food challenge in the office; Discuss how to select patients for extensively heated
of prostaglandins in regulating T cell differentiation and function; Describe the role of
milk and egg challenges and how to perform those challenges.
prostaglandins on allergen-induced immune tolerance.
44 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 45
saturday, March 1
46 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 47
saturday, March 1
48 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 49
saturday, March 1
50 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 51
saturday, March 1
52 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
saturday, March 1
7:00 to 10:00 pm
San Diego Air & Space Museum
All AAAAI members, delegates and guests are invited to attend this
Saturday evening event. See page 13 for more information.
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 53
Save the Date
AAAAI-0913-505
Houston Texas
American Academy of Allergy, Asthma & Immunology
sunday, March 2
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 55
sunday, March 2
3014 Inhibitory Receptors on Allergy Effector Cells: 3044 Tips on Training School Personnel about Food
New Therapeutic Targets Allergies and Anaphylaxis
Bruce S. Bochner, MD FAAAAI Sonia C. Mancia, RN
Francesca Levi-Schaffer, PhD FAAAAI Humaira Robinson, BSN RN
Marriott South Tower, Level 4, Catalina Marriott North Tower, Lobby Level, New York & Orlando
Upon completion of this session, participants should be able to: Discuss the mechanisms Upon completion of this session, participants should be able to: Discuss tips on how to
of three different inhibitory receptors pertinent for asthma; Describe efforts to therapeuti- train school personnel to recognize and treat anaphylaxis; Review evidence regarding the
cally target these receptors. content to include training and the efficacy of such training.
56 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
sunday, March 2
Symposium Symposium
3301 EAACI: Novel Developments 3303 Update of the Allergic Contact Dermatitis Practice
in Asthma Exacerbations Parameter: Whats New in 2014?
10:45 am to 12:00 pm 10:45 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6A Convention Center, Upper Level, Ballroom 6CF
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderators: Cezmi A. Akdis, MD FAAAAI Moderator: H. Henry Li, MD PhD
Nikolaos G. Papadopoulos, MD FAAAAI 10:45 Clinical Pearls and Clues in the Assessment of the Patient
10:45 Molecular Mechanisms of Asthma Exacerbations Referred for Evaluation of Contact Dermatitis and Patch Testing
Evangelos Andreakos, PhD David I. Bernstein, MD FAAAAI
11:05 Immune Response to Rhinoviruses and Their Link to Asthma 11:05 What are the Most Common Chemical Sensitizers at Home and in
Exacerbations the Workplace?
Mubeccel Akdis, MD PhD Luz S. Fonacier, MD FAAAAI
11:25 Eicosanoids and Asthma Exacerbations 11:25 Metal Allergy and Implantable Devices
Marek Sanak, MD Karin A. Pacheco, MD MSPH FAAAAI
11:45 Question & Answer 11:45 Question & Answer
Upon completion of this session, participants should be able to: List mechanisms underly- Upon completion of this session, participants should be able to: Identify key factors in
ing asthma exacerbations; Describe the interaction of respiratory viruses with epithelium, clinical history and patch testing in suspected allergic contact dermatitis; Identify the
the immune system and how eicosanoids play a role in the pathogenesis of asthma most frequent contact sensitizers encountered at home and in the workplace; Discuss the
exacerbations. relationship between metal hypersensitivity and prosthetic joint failure.
Symposium Symposium
3302 Pathophysiology and Management of Urticaria 3304 Wheezing Episodes in Preschool Children: The
and Angioedema Role of Bacterial Pathogens, Treatment of
10:45 am to 12:00 pm Acute Exacerbations and Potential for Asthma
Convention Center, Upper Level, Ballroom 6B
Prevention
Credit: 1.25 CME / 1.50 CE
10:45 am to 12:00 pm
Moderator: David R. Weldon, MD FAAAAI
Convention Center, Upper Level, Ballroom 6DE
10:45 Pathophysiology of Chronic Urticaria Credit: 1.25 CME / 1.50 CE
Thomas B. Casale, MD FAAAAI Moderator: Leonard B. Bacharier, MD FAAAAI
11:05 Diagnostic Evaluation of Patients with Chronic Urticaria/ 10:45 Wheezing Episodes in Preschool Children: Beyond Viral Infections
Angioedema: What Does the Evidence Tell Us? Daniel J. Jackson, MD
David M. Lang, MD FAAAAI
11:05 Oral Corticosteroids as a Treatment of Acute Wheezing Episodes
11:25 Therapy Options for Patients with Anti-Histamine Resistant in Preschool Children: What is the Evidence for the Efficacy of
Chronic Urticaria This Treatment?
Javed Sheikh, MD FAAAAI Avraham Beigelman, MD MSCI
11:45 Question & Answer 11:25 The Utility of Oral Bacterial Extracts as a Prevention Modality for
Upon completion of this session, participants should be able to: Describe updates of
Wheezing Episodes and Asthma
the pathophysiology of chronic urticaria; Describe cost-effective and evidence-based
diagnostic evaluation of patients with chronic urticaria/angioedema; Relate evidence sup- Fernando D. Martinez, MD
porting use of therapeutic interventions for patients with antihistamine-resistant urticaria/ 11:45 Question & Answer
angioedema. Upon completion of this session, participants should be able to: Discuss the current
evidence of the role of bacterial pathogens in the pathogenesis of wheezing episodes
in preschool children; Evaluate whether the current evidence supports the utility of oral
corticosteroids as a treatment for acute wheezing episodes in preschool children; Discuss
emerging concepts on the utility of immunostimulants for the prevention of wheezing
episodes and potentially asthma.
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 57
sunday, March 2
Symposium Symposium
3305 Molecular Allergy: From Bench to Bedside 3307 The Emergence of Innate Lymphocyte
10:45 am to 12:00 pm Populations Driving Allergic Disease
Convention Center, Upper Level, Room 11AB 10:45 am to 12:00 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Mezzanine Level, Room 15AB
Moderator: Robert G. Hamilton, PhD D.ABMLI FAAAAI Credit: 1.25 CME / 1.50 CE
10:45 Improved Diagnostics for Food Allergy: Higher Analytical Moderator: Larry Borish, MD FAAAAI
Sensitivity and Better Risk Assessment Using Single Molecules 10:45 Innate Properties of IL-5+ Super-Effector Th2 Cells
Kirsten Beyer, MD Calman Prussin, MD FAAAAI
11:05 Improved Diagnostics for Inhalant Allergy: Addressing Plant 11:05 Type 2 Innate Lymphoid Cell Activation by CysLTs
Related Crossreactivity and Multisensitizations with Single Taylor A. Doherty, MD FAAAAI
Molecules 11:25 Innate Lymphoid Cells and Invariant Natural Killer T Cells in
Joerg R. Kleine-Tebbe, MD FAAAAI Asthma
11:25 Allergenic Molecules in Anaphylactic Reactions: Improved Dale T. Umetsu, MD PhD FAAAAI
Differentiation and Analytical Sensitivity 11:45 Question & Answer
Markus W. Ollert, MD Upon completion of this session, participants should be able to: Discuss the various innate
11:45 Question & Answer cell populations and their contributions to allergic inflammation and pathogenesis; Identify
Upon completion of this session, participants should be able to: Discuss the diagnostic the role of lipid mediators in regulation of adaptive Th2 immunity; Identify the potential
value of food components and how they can lead to improved diagnostic answers and roles of innate lymphocytes in allergic disease.
advice to the patient; Describe the diagnostic value of inhalant allergen components and
how they can lead to improved diagnostic answers and advice to the multi- sensitized Symposium
patient; Identify recently identified components from bee and wasp venom, latex and other
protein allergens that facilitate definitive answers in cases of presumed sensitizations and 3308 Closing the Outcome Gap for Women with
enhance analytical sensitivity.
Asthma : A Tribute to Noreen M. Clark, PhD
10:45 am to 12:00 pm
Symposium Convention Center, Mezzanine Level, Room 16AB
3306 The Relationship Between Allergies and Credit: 1.25 CME / 1.50 CE
Infections Moderator: Georgiana M. Sanders, MD MS FAAAAI
10:45 am to 12:00 pm 10:45 Clinical, Social, and Cultural Factors in Asthma Management
Convention Center, Room 14AB by Women and Potential Outcomes from Gender Focused
Credit: 1.25 CME / 1.50 CE Interventions
Moderator: Dorothy S. Cheung, MD FAAAAI Georgiana M. Sanders, MD MS FAAAAI
10:45 Basophils: Initiators of the Immune Response 11:05 Asthma Management in Women with Multiple Morbidities
Caroline L. Sokol, MD PhD Mary Janevic, MPH PhD
11:05 Mast Cells in the Immune Response Against Bacteria 11:25 Special Challenges in Treatment and Self Management for Older
Soman N. Abraham, PhD Women with Asthma
Alan P. Baptist, MD MPH FAAAAI
11:25 Role of IgE in the Anti-Viral Immune Response
Mitchell H. Grayson, MD FAAAAI 11:45 Question & Answer
Upon completion of this session, participants should be able to: Describe the range of
11:45 Question & Answer
treatment and management challenges and solutions particular to their female asthma
Upon completion of this session, participants should be able to: Discuss the ability of patients; Recognize elements of education for female patients that are associated with
basophils to present antigen and start an immune response; Describe the data suggesting reduced health care use and symptom burden.
that the production of IgE is part of the antiviral immune response; Discuss how mast cells
play a role in the clearance of bacterial and viral infections.
Allied Health Symposium
3311 Update on Experience Performing Baked Egg and
Baked Milk Food Challenges
10:45 am to 12:00 pm
Marriott North Tower, Lobby Level, Marriott Hall Salons 1 & 2
Credit: 1.25 CME / 1.50 CE
Moderator: Kim E. Mudd, RN MSN CCRP
Teri Holbrook, RN CRNP
Hemant P. Sharma, MD MHS FAAAAI
Elisabeth S. Stieb, RN BSN AE-C
11:45 Question & Answer
Upon completion of this session, participants should be able to: Identify which children
can be considered for a food challenge to baked milk and baked egg; Describe the ap-
propriate protocol to use in your practice to conduct a baked milk and baked egg food
challenge; Discuss how children who pass a baked milk and baked egg food challenge
can increase the foods in their diets.
58 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
sunday, March 2
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 59
sunday, March 2
60 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
sunday, March 2
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 61
sunday, March 2
62 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
sunday, March 2
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 63
Monday, March 3
64 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
Monday, March 3
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 65
Monday, March 3
Symposium Symposium
4301 American Lung Association Clinical Trials 4304 How Close are We to Preventing Asthma by
Network: Recent Advances Vaccination?
10:45 am to 12:00 pm 10:45 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6B Convention Center, Upper Level, Room 11AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Stephen P. Peters, MD PhD FAAAAI Moderator: R. Stokes Peebles, Jr., MD FAAAAI
10:45 Validation Studies of Asthma Outcomes for Clinical Research 10:45 The Role of Rhinovirus and RSV in Asthma Incepton
Speaker to be announced. Tina V. Hartert, MD MPH
11:05 Pharmacogenomic Studies of Asthma from the ALA ACRC 11:05 The Current State of Rhinovirus Vaccine Development
Network Sebastian L. Johnston, MD PhD
John Lima, MD 11:25 The Current State of RSV Vaccine Development
11:25 SOYA: Effect of Soy Isoflavones on Asthma Barney S. Graham, MD PhD
Lewis J. Smith, MD 11:45 Question & Answer
11:45 Question & Answer Upon completion of this session, participants should be able to: Define the data that link
Upon completion of this session, participants should be able to: List newly defined asthma severe lower respiratory tract infection with rhinovirus and respiratory syncytial virus in
outcome measures; Describe the effect of new therapeutic options in asthma; Discuss infancy and the subsequent development of childhood asthma; Describe the current state
new information on pharmacogenomics in asthma. of vaccine development for respiratory syncytial virus; Describe the current state of vac-
cine development for rhinovirus.
Symposium
Symposium
4302 Primary Immunodeficiency at the Molecular
4305 B Cell and Antibody Biology in Upper and Lower
Level: The Wave of the Future
10:45 am to 12:00 pm Airways
Convention Center, Upper Level, Ballroom 6CF 10:45 am to 12:00 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Mezzanine Level, Room 14AB
Moderator: Elena E. Perez, MD PhD FAAAAI Credit: 1.25 CME / 1.50 CE
Moderator: Patricia A. Takach, MD FAAAAI
10:45 Update on Newborn Screening for PID
Jennifer M. Puck, MD 10:45 Epidemiology and Burden of Antibody Deficiency in Chronic
Rhinosinusitis
11:05 New Immunodeficiencies Defined by Genomic Methods
Anju T. Peters, MD FAAAAI
Janet S. Chou, MD
11:05 B Cell Responses in Chronic Rhinosinusitis
11:25 Gene Therapy for PID: Quo Vadis?
Kathryn E. Hulse, PhD
Fabio Candotti, MD
11:25 Regulation of B Cell Activation and Antibody Production
11:45 Question & Answer
Mubeccel Akdis, MD PhD
Upon completion of this session, participants should be able to: Discuss what progress
has been made in the diagnosis of immunodeficiency at birth via newborn screening; 11:45 Question & Answer
Describe how genomic analysis is leading to an explosion in the discovery of new forms Upon completion of this session, participants should be able to: Describe the epidemiol-
of immunodeficiency; Identify what advances are being made in gene therapy for im- ogy of antibody deficiency in chronic rhinosinusitis; Discuss the role of B cells in chronic
munodeficiency. rhinosinusitis; Identify the role of IgA in mucosal immunity in allergic diseases.
Symposium Symposium
4303 Treatment Alternatives for Refractory Severe 4306 Immunosenescence: Implications of an Aging
Asthma Immune System
10:45 am to 12:00 pm 10:45 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6DE Convention Center, Mezzanine Level, Room 15AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Paula L. Busse, MD FAAAAI Moderator: Sharmilee M. Nyenhuis, MD FAAAAI
10:45 The Role of Anti-Cholinergics, Vitamin D Replacement and Fine 10:45 Effects of Aging on Immune Function
Particle ICS Jorg Goronzy, MD PhD
Reynold A. Panettieri, MD 11:05 Vaccine Responses in the Elderly
11:05 The Role of Bronchial Thermoplasty John M. Kelso, MD FAAAAI
Monica Kraft, MD 11:25 Effect of Aging on Asthma and Allergic Diseases
11:25 Novel Approaches to Steroid Resistance Sameer K. Mathur, MD PhD FAAAAI
Stanley J. Szefler, MD FAAAAI 11:45 Question & Answer
11:45 Question & Answer Upon completion of this session, participants should be able to: Describe changes in im-
Upon completion of this session, participants should be able to: Describe the risks and mune function with aging; Describe changes in vaccine response and current recommen-
benefits of bronchial thermoplasty in severe asthma; Outline novel approaches to therapy dations for vaccination in the elderly; Discuss the effect of aging on allergic diseases.
of steroid resistant asthma; Discuss the evidence supporting the use of vitamin D replace-
ment, anti-cholinergics and small particle inhaled corticosteroids.
66 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
Monday, March 3
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 67
Monday, March 3
68 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
Monday, March 3
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 69
Monday, March 3
70 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
Monday, March 3
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 71
Monday, March 3
72 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
tuesday, March 4
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 73
tuesday, March 4
74 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
tuesday, March 4
Symposium Symposium
5301 The Road to Allergy: Soluble Instructions to 5304 Angioedema with Negative Family History
Dendritic Cells 10:45 am to 12:00 pm
10:45 am to 12:00 pm Convention Center, Upper Level, Room 11AB
Convention Center, Upper Level, Room 5AB Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE Moderator: Michael M. Frank, MD FAAAAI
Moderator: Dawn C. Newcomb Baker, PhD 10:45 New Developments in Angioedema Caused by Angiotensin-
10:45 Cysteinyl Leukotrienes are Endogenous Signaling Molecules Converting Enzyme Inhibitors
Nora A. Barrett, MD FAAAAI Marco Cicardi, MD PhD
11:05 Inhibition of Th2 Priming by the UDP Receptor P2Y6 11:05 Diagnosis of Idiopathic Angioedema
Joshua A. Boyce, MD FAAAAI Marc A. Riedl, MD MS
11:25 Platelets Dictate Th2 Sensitization: The Role of Serotonin 11:25 Management of Idiopathic Angioedema
Marco Idzko, MD Aleena Banerji, MD
11:45 Question & Answer 11:45 Question & Answer
Upon completion of this session, participants should be able to: Recognize the role cyste- Upon completion of this session, participants should be able to: Discuss mechanisms and
inyl leuktrienes play as signaling molecules in dendritic cells; Identify the counterregula- clinical aspects of recurrent angioedema caused by angiotensin-converting enzyme inhibi-
tory role of the purinergic 6 receptor; Identify the role of serotonin in Th2 priming. tors; Review the differential diagnosis and management issues of idiopathic angioedema;
Describe the management of idiopathic angioedema.
Symposium
Symposium
5302 What to Do When Everything Fails: Treatment
5305 Innate Cytokines and the Regulation of Allergy
Options for Severe Chronic Rhinosinusitis 10:45 am to 12:00 pm
10:45 am to 12:00 pm Convention Center, Mezzanine Level, Room 14AB
Convention Center, Upper Level, Room 7AB Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE Moderator: Zoulfia Allakhverdi, PhD FAAAAI
Moderator: Anju T. Peters, MD FAAAAI
10:45 Role of Epithelial-Derived Cytokines in the Initiation and
10:45 Is More and Longer Better? Long-Term and High-Dose Pathogenesis of Allergy
Glucocorticosteroids Clare M. Lloyd, PhD
Joaquim Mullol, MD PhD FAAAAI
11:05 Cross-Regulatory Mechanisms of Interferon and Allergic
11:05 Treating With the Cause of Trouble: ASA-Desensitization Stimulation
Katharine M. Woessner, MD FAAAAI J. David Farrar, PhD
11:25 The Road to Future: Will Biologics Improve Treatment? 11:25 Modulation of Innate Cytokines by TLR Agonists to Achieve
Claus Bachert, MD PhD Tolerance
11:45 Question & Answer Speaker to be announced.
Upon completion of this session, participants should be able to: Contrast the limitations
11:45 Question & Answer
and possibilities of high-dose or long-lasting glucocorticosteroid treatment in recurrent
chronic rhinosinusitis with nasal polyps; Identify suitable patient subgroups, success rates Upon completion of this session, participants should be able to: Identify the key cytokines
and limitations of aspirin desensitization; Outline the pathophysiological basis and current secreted by lung epithelial cells in response to infections and the role of these cytokines in
knowledge about anti-IgE and anti-IL-5 treatment in nasal polyposis. priming of the allergic condition; Describe the role of type I and III interferons in the sup-
pression of Th2 and Th17 responses and the inhibition of interferon secretion by allergic
stimulation through the high affinity IgE Fc receptor; Discuss how TLR ligands, such as
Symposium CpG oligonucleotides, are being used to mediate allergic suppression through the induc-
tion of cross-regulatory cytokines.
5303 Atopic Dermatitis
10:45 am to 12:00 pm
Convention Center, Upper Level, Room 2
Credit: 1.25 CME / 1.50 CE
Moderator: Lynda C. Schneider, MD FAAAAI
10:45 Barrier Defects in Atopic Dermatitis
Anna De Benedetto, MD
11:05 Atopic Dermatitis as a Global Burden
Peter Schmid-Grendelmeier, MD PhD
11:25 New Treatment Modalities
Mark Boguniewicz, MD FAAAAI
11:45 Question & Answer
Upon completion of this session, participants should be able to: Discuss atopic dermatitis;
Identify and use appropriate diagnostic tools; Demonstrate efficient, safe and state-of-the-
art treatment.
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 75
tuesday, March 4
Symposium Course
5306 B Cells and Mucosal Immune Responses in Health 5311 Mechanisms of Allergic Inflammation
and Disease 10:45 am to 1:45 pm
10:45 am to 12:00 pm Convention Center, Upper Level, Room 4
Convention Center, Mezzanine Level, Room 15AB Pre-registration and ticket required. Fee: $40. Box lunch included.
Credit: 1.25 CME / 1.50 CE Credit: 2.75 CME / 3.20 CE
Moderator: Atsushi Kato, PhD Moderator: Mitchell H. Grayson, MD FAAAAI
10:45 Mucosal Immunity: Balancing Immune Responses at the 10:45 Introduction: Control of Type 2 Immunity
Forefront of Microbial Exposure Mitchell H. Grayson, MD FAAAAI
Andrea Cerutti, MD 10:50 Transcriptional Cross-Regulation of Th1 and Th2 Cell
11:05 Immunity and B Cells in the Gut: From Immune Exclusion to Food Differentiation
Allergy Jinfang Zhu, PhD
Cecilia Berin, PhD 11:15 Question & Answer
11:25 B Cells and Respiratory Immunity 11:20 Location, Location, Location: Dendritic Cells, B Cells and Th2
Kathryn E. Hulse, PhD Development
11:45 Question & Answer Frances E. Lund, PhD
Upon completion of this session, participants should be able to: Outline how the mucosal 11:45 Question & Answer
immune system balances responses to commensal and pathogenic microbes; Describe 11:50 From Friend to Foe: T Regs Acting Th2
the unique role of B cells and their antibodies in maintaining tolerance and homeostasis
at mucosal sites; Identify how mucosal B cell responses may be dysregulated in allergic
Prabir Ray, PhD
disease as a strategy for the development of more targeted therapeutic interventions. 12:15 Question & Answer
12:20 Break
Symposium 12:40 Introduction: Novel Concepts in Immunoglobulin E and its
Receptors
5307 Inflammasome Disorders: Here and Now
Mitchell H. Grayson, MD FAAAAI
10:45 am to 12:00 pm
12:45 Breaking Up is Hard to Do: Disassembly of IgE and FceRI
Convention Center, Mezzanine Level, Room 16AB
Theodore S. Jardetzky, PhD
Credit: 1.25 CME / 1.50 CE
Moderator: John W. Steinke, PhD FAAAAI 1:10 Question & Answer
10:45 Nuts and Bolts of Inflammasome Biology 1:15 Exclusivity: IgE Binding to CD23 or FceRI
Daniel L. Kastner, MD Hannah J. Gould, PhD
Brian Sutton, MA DPhil
11:05 Inflammasome Associated Diseases: The Old and New
Monica G. Lawrence, MD 1:40 Question & Answer
Upon completion of this session, participants should be able to: Describe mechanisms
11:25 Treatment Options for Inflammasome Disorders
through which t-bet is able to suppress Th2 responses and discuss how dendritic cells
Hal M. Hoffman, MD FAAAAI and B cells drive Th2 development outside of the T cell zone; Review how a viral respira-
11:45 Question & Answer tory infection can induce Th2 cytokine production from regulatory T cells; Discuss how
Upon completion of this session, participants should be able to: Describe the basics of macromolecules can disrupt IgE-FcRI complexes and how IgE interacts with CD23 and
how the inflammasome works; Outline the current state of inflammasome disorders and how this prevents binding to FcRI and vice versa.
what is new in the field; Discuss novel therapeutic approaches to treating inflammasome
disorders.
76 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
tuesday, March 4
Course Course
5312 Developing Clinical Skills to Promote Adherence 5314 Owning the Bone: How to Minimize
and Maximize Asthma Outcomes Glucocorticoid-Induced Osteoporosis Risk
10:45 am to 1:45 pm 10:45 am to 1:45 pm
Convention Center, Upper Level, Room 3 Convention Center, Upper Level, Room 8
Pre-registration and ticket required. Fee: $40. Box lunch included. Pre-registration and ticket required. Fee: $40. Box lunch included.
Credit: 2.75 CME / 3.30 CE Credit: 2.75 CME / 3.30 CE
Moderator: Marcus S. Shaker, MD MS FAAAAI Moderator: Joshua A. Steinberg, MD
11:15 Clinical Management Strategies to Promote Adherence of 10:45 Cellular Mechanisms of Glucocorticoid Action in Bone
Pediatric Asthma Patients and Families Ernesto Canalis, MD
Cynthia S. Rand, PhD 11:15 Bone Biomechanics and Glucocorticoid Effects
11:45 Methods to Diagnose Adherence Status Bjoern Buehring, MD
Andrew G. Weinstein, MD FAAAAI 11:45 Break
12:15 Break 12:00 Corticosteroids and Bone Accretion
12:30 Shared Decision Making: A Communication Practice Proven to Kelan Tantisira, MD MPH
Enhance Adult Asthma Patients Adherence and Outcomes 12:30 Influence of Diet and Lifestyle on Glucocorticoid-Induced
Sandra R. Wilson, PhD Osteoporosis
1:00 The Role of Motivational Interviewing to Help Guide Patients to Mary C. Tobin, MD FAAAAI
Favorable Asthma Management Actions 1:00 Incorporating Best Bone Health Care into Allergy Practice
Belinda Borrelli, PhD Andrea J. Apter, MD MA MSc FAAAAI
1:30 Question & Answer 1:30 Question & Answer
Upon completion of this session, participants should be able to: Identify the reasons why Upon completion of this session, participants should be able to: Identify known bone
patients are non-adherent with health care providers plans; Discuss objective means to health risks of acute and chronic exposure to inhaled and oral glucocorticoids; Recognize
diagnose adherence status; Demonstrate motivational interviewing and other patient- differences between GIOP and post-menopausal osteoporosis pathophysiology, risk factors
centered techniques to help patients and families follow asthma treatment plans. and screening tools; Discuss present and emerging guidelines and pharmacotherapy in the
prevention and management of GIOP.
Course
Pro/Con Debate
5313 Mechanisms and Treatment of Exacerbations of
Asthma 5502 Adaptive Immune Responses are Essential
10:45 am to 1:45 pm 12:30 to 1:30 pm
Convention Center, Upper Level, Room 1AB Convention Center, Upper Level, Room 5AB
Pre-registration and ticket required. Fee: $40. Box lunch included. Credit: 1.00 CME / 1.20 CE
Credit: 2.75 CME / 3.30 CE Moderator: Larry Borish, MD FAAAAI
Moderators: James E. Gern, MD FAAAAI Pro
Daniel J. Jackson, MD Erwin W. Gelfand, MD FAAAAI
10:45 Role of Viruses Con
Eva Kathryn Miller, MD Hirohito Kita, MD
11:10 Role of Bacteria Upon completion of this session, participants should be able to discuss the increasingly
important role of ILC2 lymphocytes in generating allergic airway inflammation.
Hans Bisgaard, MD DMSci
11:35 How Does Allergic Inflammation Alter the Immune Response to
Viruses?
Pro/Con Debate
Peter W. Heymann, MD 5503 Anti-Fungals are Effective in Treating Allergic
12:00 Break Fungal Airway Disease
12:15 Etiology of Exacerbations in Different Populations 12:30 to 1:30 pm
Malcolm R. Sears, MD FAAAAI Convention Center, Upper Level, Room 11AB
12:40 Identifying the Exacerbation-Prone Patient Credit: 1.00 CME / 1.20 CE
Ronina A. Covar, MD Moderator: Jeffrey G. Demain, MD FAAAAI
1:05 Approaches to the Prevention and Treatment of Exacerbations Pro
Daniel Jackson, MD Daniel L. Hamilos, MD FAAAAI
1:30 Question & Answer Con
Upon completion of this session, participants should be able to: List the most common Andrew J. Wardlaw, MD PhD
viruses and bacteria associated with asthma exacerbations; Discuss mechanisms of Upon completion of this session, participants should be able to: Identify the clinical trials
virus-allergen interactions that promote exacerbations; List major risk factors for exacer- and case series that have described the use of anti-fungals in fungal associated asthma;
bations of asthma. List the pros and cons of using anti-fungal agents in ABPA and related conditions.
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 77
tuesday, March 4
78 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
tuesday, March 4
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 79
tuesday, March 4
80 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
tuesday, March 4
Allied Health Session ticket required fee required included in the Virtual Annual Meeting 81
tuesday, March 4
82 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
J ALLERGY CLIN IMMUNOL Abstracts AB293
VOLUME 133, NUMBER 2
SATURDAY
Scientific Abstract Sessions
Asthma Therapeutics: Advances in Biologics and Patients With Moderate To Severe Asthma With and Without
Fixed Airway Obstruction (FAO)
Drugs Randall Brown, MD, MPH, Center for Managing Chronic Disease,
University of Michigan School of Public Health, Bradley E. Chipps,
2201 MD, Capitol Allergy and Respiratory Disease Center, Donald P.
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM Tashkin, MD, David Geffen School of Medicine at UCLA, Los An-
1 A Rare Presentation Of Surfactant Deficiency In a Term Neo- geles, CA and Frank Trudo, MD, AstraZeneca, Wilmington, DE
nate 8 Retrospective Observational Assessment Of Nasal Polyposis In
Dr. Nisha N. Shah, MD, LSU Health Sciences Center New Or- Asthmatic Patients Treated With Omalizumab
leans, New Orleans, LA, Dr. Heena Shah, MD, Louisiana State Dr. Ana Anton-Laiseca, MD, Dr. Silvia Martnez Blanco, MD, Dr.
University, New Orleans, LA and Dr. Kenneth Paris, MD, MPH, Gabriel Gonzalez Salazar, MD, Dr. Maria Carmen Dieguez Pastor,
LSU Health Sciences Center, New Orleans, New Orleans, LA MD, Dr. Ruth Mielgo Ballesteros, MD and Dr. Consuelo Fernandez
2 Relapse Of Severe Asthma Exacerbations After Cessation Of Rodrguez, MD, PhD, Hospital Universitario 12 de Octubre, Spain
Omalizumab Treatment Real Life Data 9 FDA Guidance-Designed Study Of The Effects Of Intranasal
Dr. Izabela R. Kuprys-Lipinska, MD, PhD and Prof. Piotr Kuna, Triamcinolone Acetonide Aqueous (TAA-AQ) On Growth Ve-
MD, PhD, Dept. of Internal Medicine, Asthma and Allergy, Med- locity (GV) Of Children With Perennial Allergic Rhinitis (PAR)
ical University in Lodz, Poland Dr. David P. Skoner, MD, Temple University School of Medicine,
3 Therapeutic Equivalence Of Budesonide/Formoterol (BUD/ Allegheny General Hospital, Pittsburgh, PA; West Penn Allegheny
FM) Breath-Actuated Inhaler (BAI) Compared With Bud/FM Health System, Pittsburgh, PA
Pressurized Metered-Dose Inhaler (pMDI) In Adults and Ado- 10 Extended Omalizumab Dosage Intervals and Efficacy
lescents With Moderate To Severe Asthma Dr. Saraleen Benouni, MD1, Dr. Lee E. Sheinkopf, MD,
Kevin R. Murphy, MD1, Rajiv Dhand, MD2, Frank Trudo, MD3, FAAAAI2, Dr. LanAnh T. Do, MD, FAAAAI3, Dr. Asif Rafi,
Tom Uryniak, MS3 and Ajay Aggarwal, MD3, 1Boys Town Na- MD2 and Dr. Roger M. Katz, MD, FAAAAI2, 1UCLA, Los An-
tional Research Hospital, Boys Town, NE, 2Department of Medi- geles, CA, 2ucla, los angeles, CA, 3ucla, Los Angeles, CA
cine, University of Tennessee Graduate School of Medicine, 11 Effect Of Roflumilast On Asthma Control In Moderate and Se-
3 vere Asthma Patients
AstraZeneca LP
4 Effects of Budesonide/Formoterol (BUD/FM) Deliverd By Pres- Prof. V.A. Beloglazov1, Dr. Yuri Popenko1 and Prof. Lawrence M.
surized Metered-Dose Inhaler (pMDI) on Symptoms In African DuBuske, MD, FAAAAI2, 1Crimean State Medical University, Uk-
Americans and Caucasians With Moderate and Severe Asthma raine, 2George Washington University School of Medicine, DC
With and Without Fixed Airway Obstruction (FAO) 12 The Potent and Selective CRTH2 Antagonist OC000459 Is Ef-
Donald P. Tashkin, MD, David Geffen School of Medicine at fective In The Treatment Of Eosinophilic Asthma When Given
UCLA, Los Angeles, CA, Bradley E. Chipps, MD, Capital Allergy Once Daily
& Respiratory Disease Center, Sacramento, CA and Frank Trudo, Dr. Roy Pettipher1, Dr. Michael Perkins1, Dr. Lisa Pearce Collins1,
MD, AstraZeneca, Wilmington, DE Dr. Mark Baillet2, Dr. Trevor Lewis3, Dr. Jan Steiner4, Prof. John
5 Long-Term Effectiveness Of Omalizumab Treatment In Thai Bell5, Dr. Mark Payton1 and Dr. Michael Hunter1, 1Atopix Thera-
Severe Asthmatic Patients: A Real-Life Experience peutics, Abingdon, United Kingdom, 2S-Cubed, Abingdon, United
Dr. Orapan Poachanukoon, MD, Thammasat University, Pathum- Kingdom, 3TL-Wise Consulting, Cambridge, United Kingdom,
4
tani, Thailand, Dr. Theerasak Kawamatawong, Ramathibodi Hos- Oxford Therapeutics Consulting, Brightwell-cum-Sotwell, United
paital, Mahidol University, Taiwan, Dr. Atik Saengasapaviriya, Kingdom, 5Medical Sciences Division, Oxford, United Kingdom
Phramonkutklao hospital, Thailand, Dr. Chanchai Sittipunt, Chula- 13 Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral
longkorn University, Thailand, Dr. Hiroshi Chantaphakul, MD, CRTh2 Antagonist, In Patients With Mild To Moderate Th2-
FAAAAI, Chutuchak District, Chulalongkorn University Hospital, Driven Asthma
Bangkok, Thailand, Prof. Kittipong Maneechotesuwan, Siriraj hos- Sally E. Wenzel, MD, FAAAAI1, Robert Hopkins, Director of
pital, Mahidol university, Bangkok, Thailand, Dr. Pintip Ngamcha- Clinical Operations2, Dr. Michael Saunders, MD, Senior Director
nyaporn, Ramathibodi Hospital, Mahidol University, Thailand, Dr. of Drug Safety2, David Chantry, Senior Director of Translational
Kunchit Piyavechviratana, Pramongkut Hospital, Sathorn, Thai- Medicine and Cell Biology2, Lisa Anderson, Clinical Research
land, Dr. Apichart Khanisap, Thammasat University Hospital, Manager2, Roger Aitchison, Senior BioStatistician2, Christine
Thailand, Dr. Siwasak Juthong, Faculty of Medicine, Songklanak- Eberhardt, Research Investigator2, Stacie Bell, Director of Clinical
rin University, Thailand, Dr. Warangkana Rithirak, Songklanakar- Pharmacology2, Dr. Jeremy Cole, MD, Principal Investigator3, Dr.
ind University, Thailand, Dr. Chaicharn Pothirat, Chiangmai James Wolfe, MD, Physician/Research Investigator4, Dr. Sheldon
University, Thailand and Dr. Watchara Boonsawat, Srinagarind L. Spector, MD, FAAAAI5, Dr. Lawrence D. Sher, MD, FAAAAI6,
Hospital, Thailand Dr. Edward M. Kerwin, MD, FAAAAI7 and Dr. Larry Burgess,
6 Role Of Monoclonal Antibody In Sickle Cell Disease Patients PhD, Executive Director of Medicinal Chemistry2, 1University of
With Allergic Rhinitis and Asthma Along With Raised IgE Pittsburgh Medical Center NW, Pittsburgh, PA, 2Array BioPharma
Level Inc., Boulder, CO, 3IPS Research Company, Oklahoma City, OK,
4
Dr. Abdul Rehman Syed, MD, King Fahad University Hospital Allergy & Asthma Associates of Santa Clara County Research
Khobar, Dammam, Saudi Arabia Center, San Jose, CA, 5California Allergy & Asthma Medical
7 Effects Of Long-Term Treatment With Budesonide/Formoterol Group, Los Angeles, CA, 6Peninsula Research Associates, Rolling
(BUD/FM) Delivered By Pressurized Metered-Dose Inhaler Hills Estates, CA, 7Allergy and Asthma Center of Southern OR,
(pMDI) On Symptoms In African-American and Caucasian Medford, OR
83
AB294 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
14 A Phase I Assessment Of Safety and Tolerability Of RNS60, a 19 Test-Retest Reliability Of The ISAAC Questionnaire For a
Novel Therapeutic Containing Charge-Stabilized Nanostruc- Web-Based Study
tures In Asthma Dr. Koichi Yoshida, MD1, Dr. Yuichi Adachi, MD, PhD2, Dr. Mari
Supurna Ghosh, PhD, Andreas Kalmes, PhD, Jarrad Mock, Jocelyn Sasaki, MD1, Dr. Mayumi Furukawa, MD1, Dr. Toshiko Itazawa,
Sutherland and Richard Watson, MD, Revalesio Corporation, WA MD, PhD2, Dr. Koji Hashimoto, MD, PhD3, Dr. Hiroshi Odajima4
15 Tiotropium Respimat Add-On To Inhaled Corticosteroids Im- and Dr. Akira Akasawa, MD, PhD1, 1Division of Allergy, Tokyo
proves Lung Function In Patients With Symptomatic Mild Metropolitan Childrens Medical Center, Tokyo, Japan, 2Depart-
Asthma: Results From A Phase III Trial ment of Pediatrics, University of Toyama, Toyama, Japan, 3Depart-
Pierluigi Paggiaro1, Dr. David M.G. Halpin, MD2, Roland Buhl3, ment of Pediatrics and Child Health, Nihon University School of
Dr. Michael Engel, MD4, Valentina Zubek5, Zuzana Blahova6, Dr. Medicine, Tokyo, Japan, 4Fukuoka National Hospital, Fukuoka,
Petra Moroni-Zentgraf4 and Dr. Emilio Pizzichini7, 1University of Japan
Pisa, Pisa, Italy, 2Royal Devon & Exeter Hospital, Exeter, United 20 Characteristics Of Adolescents With Undiagnosed Asthma In
Kingdom, 3Mainz University Hospital, Mainz, Germany, 4Boeh- Rural Counties In Georgia
ringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Dr. Poneh Davoodi, MD1, Dr. Dennis Ownby, M.D. FAAAAI2,
Germany, 5Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Ms. Suzanne Havstad, M.A.3, Dr. Jennifer Waller, PhD4, Dr. Chris-
CT, 6Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Aus- tine L.M. Joseph, PhD3 and Dr. Martha Tingen, PhD4, 1Georgia Re-
tria, 7NUPAIVA (Asthma Research Centre), Universidade Federal gents University, 2Division of Allergy-Immunology and
de Santa Catarina, Florianopolis, Brazil Rheumatology, Georgia Regents University, Augusta, GA, 3Depart-
16 Tiotropium Respimat Add-On Therapy Reduces Airflow Ob- ment of Public Health Sciences, Henry Ford Hospital, Detroit, MI,
4
struction In Patients With Symptomatic Moderate Asthma, In- Georgia Regents University, Augusta, GA
dependent Of TH2 Inflammatory Status 21 Trends In Prevalence Of Asthma and Allergies In 13-14 Year
Dr. Thomas B. Casale, MD, FAAAAI1, Dr. Eric Donn Bateman, Old Children Between Two ISAAC Studies In Birjand City,
MD2, Prof. Ronald Dahl, MD3, Dr. Emilio Pizzichini4, Dr. Mark Iran
L. Vandewalker, MD5, Dr. Johann Christian Virchow6, Dr. Michael Dr. Mohammad Fereidouni, MD, PhD, Asthma, Allergy & Im-
Engel, MD7, Dr. Petra Moroni-Zentgraf7, Dr. Hendrik Schmidt8 and munology Research Center,Birjand University of Medical Sciences,
Huib A.M. Kerstjens9, 1Univeristy Of South Florida Morsani Col- Iran and Mrs. Shaghayeghsadat Nourani hassankiadeh, birjand uni-
lege Of Medicine, Tampa, FL, 2University of Cape Town Lung In- versity of medical sciences
stitute, Cape Town, South Africa, 3Odense University Hospital, 22 An Evaluation Of The Thai-Translated Version Of The Child-
Odense, Denmark, 4NUPAIVA (Asthma Research Centre), Univer- hood Asthma Control Questionnaire (C- ACT) and The Com-
sidade Federal de Santa Catarina, Florianopolis, Brazil, 5Clinical posite Asthma Severity Index (CASI) Among Thai Asthmatic
Research of the Ozarks, Columbia, MO, 6University Clinic Ro- Children
stock, Rostock, Germany, 7Boehringer Ingelheim Pharma GmbH Dr. Benjarat Dardaranonda, MD, Department of Pediatrics, Fac-
& Co. KG, Ingelheim Am Rhein, Germany, 8Boehringer Ingelheim ulty of Medicine, Siriraj Hospital, Mahidol University, Bangkok,
Pharma GmbH & Co. KG, Biberach an der Riss, Germany, 9Uni- THAILAND, Bangkok, Thailand
versity Medical Center Groningen, University of Groningen, Gro- 23 Impact Of Change In Inhaled Corticosteroids/Long-Acting
ningen, Netherlands Beta Agonist Combination (ICS/LABA) Use On The Risk Of
17 Once-Daily Tiotropium Respimat Improves Lung Function In Asthma Exacerbations In Asthma Patients Within a Medical
Patients With Severe Symptomatic Asthma Independent Of Group
Leukotriene Modifier Use Dr. Richard H. Stanford, PharmD, MS1, Saurabh Nagar, MS1,
Prof. Ronald Dahl, MD1, Prof. Dennis E. Doherty2, Jonathan Cor- Dr. Xiwu Lin, PhD1 and Dr. Dick OConnor, MD2,
ren, MD3, Dr. Jill Karpel4, Huib A. M. Kerstjens5, Dr. Michael En- 1
GlaxoSmithKline, 2Sharp Rees-Stealy Medical Group, San
gel, MD6, Dr. Petra Moroni-Zentgraf6, Dr. Hendrik Schmidt7 and Diego, CA
Dr. Shu Hashimoto, MD, PhD8, 1Odense University Hospital, 24 HLA-DRB1 Alleles, Levels Of Total IgE and IL-13 In Patients
Odense, Denmark, 2Lexington VA Medical Center, University of Of Bronchial Asthma From A Local Tertiary Care Hospital In
Kentucky, Lexington, KY, 3University of California, Los Angeles, Lahore, Pakistan Mr. Khursheed Javaid, M.Phil., University of
CA, 4North Shore Medical Arts LLP, Great Neck, NY, 5University Health Sciences, Lahore, Pakistan
Medical Center Groningen, University of Groningen, Groningen, 25 Infectious Asthma Trigger, Acq Score and Minirqlq Score Cor-
Netherlands, 6Boehringer Ingelheim Pharma GmbH & Co. KG, In- relations Support The One Airway Hypothesis
gelheim Am Rhein, Germany, 7Boehringer Ingelheim Pharma Dr. Amy Virojanapa, MD1, Ms. Phoebe Shah2, Mr. Arthur
GmbH & Co. KG, Biberach an der Riss, Germany, 8Nihon Univer- Omondi1 and Dr. Efren L. Rael, MD, FAAAAI3, 1Penn State, Her-
sity School of Medicine, Tokyo, Japan shey Medical Center, Hershey, PA, 2UC San Diego, Vista, CA, 3Al-
lergy/Immunology, Penn State University College of Medicine,
Hershey, PA
Asthma Epidemiology
2202
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM Primary Antibody Deficiencies
18 Close Correlation Between Month Of Birth and The Prevalence
Of Bronchial Asthma In Schoolchildren In a Taiwanese Popula- 2203
tion Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
Prof. Ho-Chang Kuo, Kaohsiung Chang Gung Memorial Hospital 26 Comprehensive Immunological and Clinical Features Of Com-
and Chang Gung University, Kaohsiung, Taiwan, Prof. Wei-Chiao mon Variable Immunodeficiency (CVID)
Chang, Taipei Medical University, Prof. Kuender D. Yang, Show Dr. Varaz Bozoghlanian, MD1, Sudhanshu Agrawal, MS2 and
Chwan Memorial Hospital in Chang Bing, Changhua, Taiwan Sudhir Gupta, MD, PhD, FAAAAI1, 1University of California, Ir-
and Prof. Wei-Pin Chang, Yuanpei University, Taiwan vine, Irvine, CA, 2University of California, Irvine
84
J ALLERGY CLIN IMMUNOL Abstracts AB295
VOLUME 133, NUMBER 2
SATURDAY
27 Clinical, Immunological and Genetic Spectrum Of Novel BTK Rubinstein, MD, FAAAAI, Albert Einstein College of Medicine,
Gene Mutations In X-Linked Agammaglobulinemia Patients Bronx, NY
and Female Carriers 39 Selective IgM Deficiency Presenting As Cryptogenic Organiz-
Dr. Regan Pyle, DO1, Dr. John B. Hagan, MD, FAAAAI1, Amanda ing Pneumonia
Martinez, MS1, Dr. Avni Y. Joshi, MD1, Dr. Thomas Boyce, MD1, Dr. Cory A. Lundberg, DO1, Dr. Taylor A. Banks, MD1, Dr. Ce-
Dr. Gerald W. Volcheck, MD, FAAAAI2, Dr. Yesim Yilmaz-Demirdag, cilia Mikita, MD, MPH FAAAAI2 and Dr. Jeffrey Mikita, MD1,
MD3, Prof. Sami L. Bahna, MD DrPH FAAAAI4 and Dr. Roshini S. 1
Walter Reed National Military Medical Center, Bethesda, MD,
Abraham, PhD FAAAAI1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic 2
Walter Reed Army Medical Center, Bethesda, MD
and Foundation, Rochester, MN, 3Columbia University, New York, NY, 42 High Prevalence Of Bronchiolitis In Children With Primary
4
LA State University Health Sciences Center, Shreveport, LA Immunodeficies
28 CD19+CD27+CD43+CD70-CD5- B-1b Cells In Children With Dr. Celia Pinto Fernandez1, Dr. Mara Dolores Gurbindo Gutier-
Specific Antibody Deficiency, Specific Antibody Deficiency rez1, Dr. Jose Manuel Zubeldia Ortuno, MD, PhD2 and Dr. Mara
With Decreased IgG, and Common Variable Immunodeficiency Elena Seoane Reula1, 1Gregorio Mara~ n
on Universitary Hospital,
Dr. Kathryn D. Convers, MD1,2, Barbara Kariuki, MPH1 and Dr. Madrid, Spain, 2Hospital Gregorio Maranon, Madrid, Spain
Alan Knutsen, MD, FAAAAI1,2, 1Saint Louis University School of 43 Three Cases Of Goods Syndrome
Medicine, Saint Louis, MO, 2Cardinal Glennon Childrens Medical Dr. Whitney M. Rassbach, MD, Mount Sinai School of Medicine,
Center, Saint Louis, MO New York, NY and Dr. Charlotte Cunningham-Rundles, MD, PhD,
29 A Devastating Outcome In Undiagnosed X-Linked Agamma- FAAAAI, Mt. Sinai Medical Center, New York, NY
globulinemia A Call For Earlier Screening 44 Immunological Analysis Of Primary Selective IgM Deficiency
Dr. Karen Elizaeth Bruner, MD, Wilford Hall Ambulatory Surgi- In Adults
cal Center, Lackland AFB, TX and Dr. Anthony Infante, MD, PhD, Ankmalika Louis, MD, UNIVERSITY OF CALIFORNIA, IR-
UT Health Science Center San Antonio, San Antonio, TX VINE, CA, Sudhanshu Agrawal, MS, University of California, Ir-
30 Genetic Basis Of CVID-Like Disease vine and Sudhir Gupta, MD, UNIVERSITY OF CALIFORNIA,
Dr. Kate Welch, MD, Mt. Sinai Medical Center, Dr. Elena Re- IRVINE
snick, MD, Mount Sinai School of Medicine, New York, NY and 45 A Rare Case Of Helicobacter Cellulitis In a Patient With X-
Dr. Charlotte Cunningham-Rundles, MD, PhD, FAAAAI, Mt. Sinai Linked Agammaglobulinemia
Medical Center, New York, NY Dr. Nina Lakhani, MD1, Dr. Linda R. Taggart2, Dr. Henry Jaku-
31 A Case Of A CVID Patient and Rabies Exposure bovic3, Dr. Stephen D. Betschel, MD1 and Dr. Zafir Hussain4,
1
Dr. Hassan Nasir, DO, Nova Southeastern University College of University of Toronto, Division of Clinical Immunology and Al-
Osteopathic Medicine, Davie, FL; Larkin Community Hospital, lergy, Toronto, ON, Canada, 2University of Toronto, Divison of In-
Miami, FL and Dr. Shahnaz Fatteh, Larkin Community Hospital, fectious Diseases, Toronto, 3University of Toronto, Division
South Miami, FL of Laboratory Medicine and Pathology, Toronto, ON, Canada,
4
32 Common Variable Immunodeficiency In The Very Old University of Toronto, Division of Microbiology, Toronto, ON,
Dr. Katherine E. Gundling, MD, UCSF, San Francisco, CA Canada
33 Clinical Predictors Of Granulomatous Disease In Common 46 Neuropathy In Patients With Underlying Immunodeficiency
Variable Immunodeficiency Syndrome
Dr. Anna R. Wolfson and Dr. Anna Kovalszki, Beth Israel Deacon- Dr. Robyn Kreiner, MD and Dr. Arye Rubinstein, MD, FAAAAI,
ess Medical Center, Boston, MA Albert Einstein College of Medicine, Bronx, NY
34 Jacobsen Syndrome With Combined Variable Immunoddefi-
ciency (CIVD)
Dr. Arnaldo C. Porto Neto, MD, PhD, FAAAAI, Dr. Julio Mella
Pierezan, Student, Dr. Joao Paulo Bordin, Student, Dr. Julia Noschang,
Dr. Juliana Gotardo, Student, Dr. Juliana Moro, Student, Dr. Jorge Asthma Epidemiology, Risk Factors, and Public
Luigi Orso, Student, Dr. Jamile Pedroni, Student and Dr. Jessica Zan-
dona, Student, School of Medicine UPF, PASSO FUNDO, Brazil
Health I
35 Factors Predicting Long-Term Hypogammaglobulinemia In
Lymphoma Survivors 2204
Dr. Huifang Lu, MD, PhD, UT MD Anderson Cancer Center, Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
Houston, TX and Dr. Xerxes Pundole, UT MD Anderson Cancer 47 Allergic Sensitization and Enviromental Exposures In Amish
Center and Hutterite Children
36 Assessment Of Benefits Of Scig Valued By Healthcare Pro- Dr. Mark Holbreich, MD, FAAAAI1, Ms. Michelle Stein, MS2,
viders and Patients: Survey Results Ms. Rebecca Anderson, MS3, Dr. Nervana Metwali, PhD4, Dr.
Ms. Annette R. Zampelli, NP1, Ms. Carla M. Duff, CPNP MSN2 Peter S. Thorne, PhD4, Dr. Donata Vercelli, MD5, Dr. Erika
and Dr. Ann Bullinger, PharmD1, 1CSL Behring, LLC, King of Von Mutius, MD, MSc6 and Dr. Carole Ober, PhD3, 1Allergy
Prussia, PA, 2University of South Florida, Tampa, FL and Asthma Consultants, Indianapolis, IN, 2The University of
37 Pneumococcal Titer Levels: Comparison Of Patients Receiving Chicago, Chicago, IL, 3University of Chicago, Chicago, IL,
4
Intravenous Immunoglobulin Vs. Subcutaneous Immunoglobulin University of Iowa, Iowa City, IA, 5The University of
Dr. Pamella Abghari, MD1,2, Dr. Elizabeth A. Secord, MD, Arizona, Tucson, AZ, 6University Childrens Hospital, Munich,
FAAAAI1,2 and Dr. Pavadee Poowuttikul, MD1,3, 1Childrens Hospital Germany
of Michigan Department of Allergy Immunology, Detroit, 48 Association Between Asthma-Related Emergency Department
MI, 2Wayne State University, Detroit, MI, 3Pediatrics- Allergy/Immu- Visits, Tree Pollen, Pollution and Humidity In The Bronx,
nology Division, Wayne State University School of Medicine, Detroit, 2001 - 2008
MI Dr. Jennifer Toh, MD1, Dr. Mili Shum, MD2,3, Dr. Gabriele De
38 Hypogammaglobulinemia, Multiple Sclerosis, and Treatment Vos, MD4, Tulsi Desai4, Priyank Patel4, Dr. Sunit Jariwala, MD1
With Intravenous Gammaglobulin and Dr. David L. Rosenstreich, MD, FAAAAI5, 1Albert Einstein/
Dr. Tiffany Dy, MD, Montefiore Medical Center at Albert Montefiore Medical Center, New York, NY, 2Montefiore Medical
Einstein College of Medicine, Bronx, NY and Dr. Arye Center, Bronx, NY, 3Weill Cornell Medical College, New York,
85
AB296 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
NY, 4Albert Einstein College of Medicine, Bronx, NY, 5Albert Ein- MD, 6AAIB\DAIT\NIH, Bethesda, MD, 7University of Wisconsin
stein/Montefiore Medical Center, Bronx, NY School of Medicine and Public Health, Madison, WI
49 Association Of Wheezing Illness With Respiratory Viruses In 56 Genetic Determinants Of Allergic Sensitization To Cockroach
Hospitalized Jordanian Children Allergen In Children
Olajumoke Fadugba, MD1, Eva Kathryn Miller, MD2, Najwa Priya Tripathi, PhD1, Xiumei Hong, PhD2, Deanna Caruso, MS2,
Khuri-Bulos, MD, FIDSA, CIC3, Samir Faouri, MD3, Asem She- Peisong Gao, MD, PhD1 and Dr. Xiaobin Wang, MD, MPH ScD2,
habi, PhD4, Christopher Fonnesbeck, PhD1, Li Wang, MS1, John 1
Division of Allergy & Clinical Immunology, Johns Hopkins Uni-
V. Williams, MD1 and Natasha Halasa, MD, MPH1, 1Vanderbilt versity School of Medicine, Baltimore, MD, 2Johns Hopkins Uni-
University Medical Center, Nashville, TN, 2Pediatric Allergy, Im- versity School of Public Health, Baltimore, MD
munology, and Pulmonary Medicine, Vanderbilt University Medi- 57 Exhaled Nitric Oxide (FeNO) and Dust Mite (Der p1) Exposure
cal Center, Nashville, TN, 3Jordan University Hospital, Jordan, Are Significantly Higher In Asthmatic Children Living In Hu-
4
University of Jordan, Jordan mid Environments
50 The Effect Of Obesity On Asthma Control As Measured By Dr. Miguel J. Lanz, MD, FAAAAI1, Benjamin Efaw2, Mirna Gon-
The Asthma Control Test zalez1 and Dr. Ronald J. Harbeck, PhD2, 1AAADRS Clinical Re-
Dr. Aerik A. Williams, MD, MPH1, Dr. Mark S. Dykewicz, MD, search Center, Coral Gables, FL, 2National Jewish Health,
FAAAAI2 and Dr. Jason W. Caldwell, DO, FAAAAI1, 1Wake For- Denver, CO
est University Baptist Medical Center, Winston Salem, NC, 2Saint
Louis University School of Medicine, St. Louis, MO
51 Perception Of Asthma Control Is Not Consistent With Re-
ported Symptom Frequency In Urban Adolescents
Emily C. Ledford, Johns Hopkins School of Medicine, Ms. Jean
Aerobiology I
Curtin-Brosnan, MA, Johns Hopkins University, Baltimore, MD,
Dr. Meredith C. McCormack, MD, The Johns Hopkins Pulmonary, 2205
Baltimore, MD and Dr. Elizabeth Matsui, MD, The Johns Hopkins Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
University School of Medicine, Baltimore, MD 58 Extraordinary Alternaria Mold Counts During a Severe
52 Urban Residence Modifies The Association Between Atopy and Drought
Wheeze Mr. James J. Anderson, MLT, Environmental Allergy/Oshtech,
Dr. Pablo F. Endara1, Dr. Phil J. Cooper2,3, Thomas A.E. Platts- London, ON, Canada and Dr. Linda B. Ford, MD, FAAAAI, The
Mills, MD, PhD, FAAAAI4, Lisa J. Workman, BA4, Maritza Asthma & Allergy Center, P.C., Bellevue, NE
Vaca5, Dr. Martha Chico6, Mauricio L Barreto, PhD7 and Prof. 59 Culture Of The House Dust Mite Euroglyphus Maynei To Pro-
Laura Rodrigues8, 1Universidad San Francisco de Quito, 2St. duce Allergen Material
Georges University, London, United Kingdom, 3Pontificia Univer- Dr. Larry G. Arlian, PhD FAAAAI, DiAnn L. Vyszenski-Moher,
sidad Catolica del Ecuador, 4Division of Asthma, Allergy & Immu- MS, Dr. Marjorie S. Morgan, PhD and Jacqueline Neal, MS, Wright
nology, University of Virginia Health System, Charlottesville, VA, State University, Dayton, OH
5
Laboratorio de FEPIS, Quininde, Esmeraldas Province, Ecuador, 60 Emergency Department Visits For Asthma As a Function Of
6
Laboratorio de Investigacion FEPIS, 7Instituto de Saude Coletiva, Pollen and Mold Spore Counts
UFBa, Salvador, BA, Brazil, 8London School of Hygiene and Trop- Dr. Stacey Galowitz, DO1,2, Dr. Christopher Chang, MD, PhD,
ical Medicine FAAAAI1 and Mr. Michael R. McDowell3, 1Alfred I duPont Hospital
53 Allergic Inflammation and Health Outcomes Of Comorbid for Children, Wilmington, DE, 2Thomas Jefferson University Hospi-
Asthma and Obesity In Inner-City Black and Hispanic School- tal, Philadelphia, PA, 3Air Quality Management, New Castle, DE
children 61 Daily Ragweed Pollen Forecasting
Dr. Perdita Permaul, MD1,2, Dr. William J. Sheehan, MD2,3, Mr. Estelle Levetin, PhD FAAAAI1 and Lauren Howard, B.S.1,2, 1Uni-
Carter Petty, MA3, Dr. Sachin N. Baxi, MD2,3, Dr. Jonathan M. versity of Tulsa, Tulsa, OK, 2University of Oklahoma, Oklahoma
Gaffin, MD, MMSc2,3, Dr. Lianne S. Kopel, MD2,3, Dr. Watcharoot City, OK
Kanchongkittiphon, MD, PhD3, Mrs. Chunxia Fu, MS4, Dr. Diane 62 Conditions Affect Dust Mite Infestation Of Flour Samples In
R. Gold, MD, MPH2,4 and Dr. Wanda Phipatanakul, MD, MS, Tropical Area
FAAAAI2,3, 1Division of Pediatric Allergy/Immunology, Massa- Dr. Theerapan Songnuy, Allergy and Immunology Division, Chu-
chusetts General Hospital, Boston, MA, 2Harvard Medical School, lalongkorn University Medical School, Bangkok, Thailand
Boston, MA, 3Boston Childrens Hospital, Boston, MA, 4Channing 63 Airborne Alternaria Spore Levels In Kansas City Is Associated
Laboratory, Brigham and Womens Hospital, Boston, MA With Climatic Changes
54 Targeted Education Of Adult Patients From An Inner City Dr. David A. Jara, MD1, Dr. Charles Barnes, PhD2, Dr. Jay M.
Population At Risk For Non-Adherence With Asthma Therapy Portnoy, MD, FAAAAI2 and Dr. Minati Dhar, Ph.D3, 1Childrens
Dr. Edan Sarid, MD, SUNY Downstate Medical Center, Center Mercy Hospital, 2Childrens Mercy Hospital, Kansas City, MO,
3
for Allergy and Asthma Research, Brooklyn, NY and Dr. Rauno Childrens Mercy Hospital & Clinics, Kansas City, MO
Joks, MD, Center for Allergy and Asthma Research at SUNY 64 Influence Of Meteorological Conditions On Mountain Cedar
Downstate, Brooklyn, NY Pollen
55 Maternal Allergy and Asthma and Their Association With Landon Bunderson, PhD1,2, Peter Van De Water, PhD3, Jeffrey
Breastfeeding In Inner-City Mothers In a Birth Cohort Study Luvall, PhD4 and Estelle Levetin, PhD FAAAAI2, 1Iowa State Uni-
(URECA) versity, Ames, IA, 2University of Tulsa, Tulsa, OK, 3California
Katy F. Jaffee, MS1, Dr. Cynthia Visness, PhD1, Dr. George T. State University, Fresno, Fresno, CA, 4NASA Marshall Space
OConnor, MD2, Dr. Gordon R. Bloomberg, MD, FAAAAI3, Dr. Flight Center, Huntsville, AL
Meyer Kattan, MD4, Robert A. Wood, MD, FAAAAI5, Dr. Peter 65 A Post-Hoc Qualitative Analysis Of Real Time Heads-Up Pollen
J. Gergen, MD, MPH6 and Dr. James E. Gern, MD, FAAAAI7, Counting Versus Traditional Microscopic Counting In The En-
1
Rho, Inc., Chapel Hill, NC, 2Boston University School of Medi- vironmental Exposure Unit (EEU)
cine, Boston, MA, 3Campus Box 8116, St. Louis Childrens Hospi- Ms. Lisa Steacy, BSc1, Mr. Terry Walker, BA1, Mr. Barnaby Hobs-
tal, Saint Louis, MO, 4NewYork-Presbyterian/Columbia, New bawn1, Mrs. Jenny Thiele, MSc2 and Dr. Anne K. Ellis, MD, MSc
York, NY, 5Johns Hopkins University Medical Center, Baltimore, FAAAAI1,3, 1Allergy Research Unit, Kingston General Hospital,
86
J ALLERGY CLIN IMMUNOL Abstracts AB297
VOLUME 133, NUMBER 2
SATURDAY
Kingston, ON, Canada, 2Queens University, Kingston, ON, Canada, 2
Cornell University, 3Icahn School of Medicine at Mount Sinai,
3
Departments of Medicine and Biomedical & Molecular Science, New York, NY
Queens University, Kingston, ON, Canada 73 Factors Associated With Increased Risk Of Anaphylaxis
66 Real-Time PCR Quantification Of Virginia Live Oak (Quercus Aylin Altan Riedel, PhD1, Erin Buysman, MS1, Dr. Ray A. Wolf,
virginiana) Pollen PharmD2, Paul Cavanaugh, Jr, PhD3, Jerald Seare, MD1 and Tim
Dr. Mark C. Glaum, MD, PhD, FAAAAI1,2, Ms. Eileen Rifkin1, Bancroft, PhD1, 1OPTUM, Prairie Eden, MN, 2Mylan Specialty
Dr. Jia-Wang Wang, PhD1, Dr. Richard F. Lockey, MD1,2 and Dr. L.P., New Hope, PA, 3Mylan Specialty, Basking Ridge, NJ
Dennis K. Ledford, MD, FAAAAI1,2, 1Division of Allergy and Im- 74 A Face-To-Face Educational Program By Allergists Can Im-
munology, Department of Internal Medicine, University of South prove Knowledge, Attitudes, and Behaviors (KAB) Of Internal
Florida, Morsani College of Medicine, Tampa, FL, 2James A. Haley Medicine, Pediatric, and Emergency Medicine Residents
Veterans Affairs Hospital, Tampa, FL Dr. Artemio M. Jongco III, MD, PhD MPH, Feinstein Institute
67 Unusual Timing For The Ragweed Ambrosia Pollen Peak In for Medical Research, Manhasset, NY; Cohen Childrens Medical
Vinnitsa, Ukraine Center of New York, Great Neck, NY, Dr. Sheila Bina, MD, Stony
Ms. Viktoria Rodinkova1, Ms. I Motruk1, Ms. L. Slobodianiuk1, Brook University Hospital, Stony Brook, NY, Dr. Robert Sporter,
Ms. O. Mazur1, Ms. O. Palamarchuk1 and Prof. Lawrence M. Du- MD, Division of Allergy/Immunology, Departments of Medicine
Buske, MD, FAAAAI2, 1Vinnitsa National Pirogov Memorial Med- and Pediatrics, Hofstra North Shore-LIJ School of Medicine, Dr.
ical University, Ukraine, 2George Washington University School of Marie A. Cavuoto Petrizzo, MD, FAAAAI, ProHealth Care Asso-
Medicine, DC ciates LLP, Lake Success, NY, Dr. Blanka M. Kaplan, MD,
FAAAAI, Department of Pediatrics, Division of Allergy & Im-
munology, Hofstra-North Shore-LIJ School of Medicine, Great
Neck, NY and Dr. Susan Schuval, MD, FAAAAI, Stony Brook
U Medical Cente, Stony Brook University Medical Center, Stony
Insect Hypersensitivity/Anaphylaxis Brook, NY
75 Anaphylaxis Management Before and After Implementation Of
2206 Guidelines In The Pediatric Emergency Department
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM Dr. Shilpa Desai1, Dr. Rhett Lieberman1, Stephen Wisniewski,
68 Safety and Efficacy Of a 12-Week Maintenance Interval In Pa- PhD2 and Dr. Todd David Green, MD, FAAAAI1, 1Childrens Hos-
tients Treated With Imported Fire Ant Immunotherapy pital of Pittsburgh of UPMC, Pittsburgh, PA, 2University of
Dr. Karla E. Adams, MD1, Dr. Shayne Stokes, MD2, Dr. Kevin M. Pittsburgh
White, MD1, Dr. Kirk H. Waibel, MD, FAAAAI3 and Dr. 76 Managing Anaphylaxis In Adults: A Review Of All Cases Pre-
Michael S. Tankersley, MD, FAAAAI4, 1Wilford Hall Ambulatory senting In A Single Year At An Emergency Department
Surgical Center, Joint Base San Antonio, Lackland AFB, TX, Dr. Yarden Yanishevsky, MD1, Dr. Ann Elaine Clarke, MD, MSc2,3,
2
Luke AFB, Glendale, AZ, 3Landstuhl RMC, 4Wilford Dr. Sebastian La Vieille, MD4, Dr. Scott Delaney, MD5, Dr. Reza Ali-
Hall Ambulatory Surgical Center, Joint Base San Antonio, San zadehfar, MD1, Mr. Christopher Mill, BSc3, Dr. Lawrence Joseph,
Antonio, TX PhD3, Dr. Judy Morris, MD, MSc6, Dr. Yuka Asai, MD3,7 and Dr.
69 Epidemiology and Clinical Predictors Of Biphasic Reactions In Moshe Ben-Shoshan, MD, MSc1, 1Division of Paediatric Allergy
Children With Anaphylaxis Waleed and Clinical Immunology, Department of Paediatrics, McGill Uni-
D. Alqurashi1, Ian Stiell2, Kevin Chan3, Gina Neto1 and George versity Health Center, Montreal, QC, Canada, 2Division of Allergy
Wells4, 1Childrens Hospital of Eastern Ontario, Ottawa, ON, Can- and Clinical Immunology, Department of Medicine, McGill Univer-
ada, 2Ottawa Hospital Research Institute, Ottawa, ON, Canada, sity Health Centre, Montreal, QC, Canada, 3Division of Clinical Ep-
3
Hospital for Sick Children, Toronto, ON, Canada, 4University of idemiology, Department of Medicine, McGill University Health
Ottawa Heart Institute, Ottawa, ON, Canada Centre, Montreal, QC, Canada, 4Food Directorate, Health Canada,
70 Age As a Risk Factor For Fatal Food-Induced Anaphylaxis: An Ottawa, ON, Canada, 5Department of Emergency Medicine, McGill
Analysis Of UK and Australian Fatal Food Anaphylaxis Data University Health Center, Montreal, QC, Canada, 6Department of
Dr. Paul J. Turner, FRACP PhD1,2, Dr. Vibha Sharma, FRCPCH3, Emergency Medicine, H^ opital du Sacre-Cur, Montreal, QC, Can-
Prof. Mimi L. K. Tang, MD, PhD, FAAAAI4, Ms. M. Hazel Gow- ada, 7Division of Dermatology, Department of Medicine, McGill
land, BA5, Dr. Nigel Harper, MBChB FRCA3, Dr. Tomaz Garcez, University Health Centre, Montreal, QC, Canada
MRCP FRCPath3, Dr. Richard Pumphrey, FRCPath3 and Dr. Robert 77 Anaphylaxis Cases Presenting To Primary Care Paramedics In
J. Boyle, MBChB PhD1, 1Imperial College London, United King- Quebec
dom, 2University of Sydney, Australia, 3Central Manchester Uni- Ms. Nofar Kimchi1, Dr. Ann Elaine Clarke, MD, MSc2,3, Jocelyn
versity Hospitals NHS Foundation Trust, United Kingdom, 4The Moisan4, Colette Lachaine5, Dr. Sebastian La Vieille, MD6, Dr.
University of Melbourne, Melbourne, Australia, 5Allergy Action, Yuka Asai, MD3,7, Dr. Lawrence Joseph, PhD3,8, Mr. Christopher
United Kingdom Mill, BSc3 and Dr. Moshe Ben-Shoshan, MD, MSc9,10, 1Technion
71 Dying From Allergies: A Profile Of Fatal Anaphylaxis In The American Medical Students Program, Israel, 2McGill University
United States: 1999-2010 Health Centre, Montreal, Canada, 3Division of Clinical Epidemiol-
Dr. Elina Jerschow, MD, M.Sc.1, Dr. Robert Yao-Wen Lin, ogy, Department of Medicine, McGill University Health Centre,
FAAAAI2,3, Ms. Moira Scaperotti, Medical Student4 and Dr. Montreal, QC, Canada, 4Services prehospitaliers durgence de
Aileen McGinn, PhD4, 1Albert Einstein College of Medicine/Mon- lOutaouais, Quebec, Canada, QC, Canada, 5Direction adjointe
tefiore Medical Center, Bronx, NY, 2New York Downtown Hospi- de services prehospitaliers durgence, MSSS, Quebec, Canada,
tal, New York, NY, 3New York Medical College, Valhalla, NY, QC, Canada, 6Food Directorate, Health Canada, Ottawa, ON, Can-
4
Albert Einstein College of Medicine, Bronx, NY ada, 7Division of Dermatology, Department of Medicine, McGill
72 Prospective Study To Determine Risk Factors and Severity Of University Health Centre, Montreal, QC, Canada, 8Departments
Food-Induced Allergic Reactions In Children of Epidemiology and Biostatistics, McGill University, Montreal,
Dr. Angela Tsuang, MD1, Mr. Nikhil Menon, Medical student1, Canada, 9Division of Paediatric Allergy and Clinical Immunology,
Ms. Natasha Setia, Medical student1, Mr. Larry Geyman, Medical Department of Paediatrics, McGill University Health Center, Mon-
student1, Ms. Christina Cherny2 and Dr. Anna H. Nowak-Wegrzyn, treal, QC, Canada, 10Montreal Childrens Hospital, Montreal,
MD, FAAAAI3, 1Mount Sinai School of Medicine, New York, NY, Canada
87
AB298 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
78 Anaphylaxis Management In A Pediatric Emergency Depart- 86 Ten Years Experience Of Anaphylaxis In a Single University
ment Hospital In Korea
Natasha Sidhu, MD1,2, Stacie M. Jones, MD3,4, Elizabeth Storm, Dr. Cheol-Woo Kim, Inha University Hospital, Incheon, South Ko-
MD1,2, Maria Melguizo castro1,5, Todd Nick1,2 and Tonya Thomp- rea and Jae Hwa Cho, Inha University Hospital, South Korea
son, MD1,2, 1University of Arkansas for Medical Sciences, Little 87 Incidence Of Anaphylaxis In a Vilnius Lithuania Hospital Ap-
Rock, AR, 2Arkansas Childrens Hospital, 3University of Arkansas plying WAO Criteria
for Medical Sciences and Arkansas Childrens Hospital, Little Prof. Audra Blaziene1, Dr. Neringa Buterleviciute1, Viktorija Pal-
Rock, AR, 4Arkansas Childrens Hospital Research Institute, Little tarackiene2 and Prof. Lawrence M. DuBuske, MD, FAAAAI3, 1Vil-
Rock, AR, 5Arkansas Childrens Hospital, Little Rock, AR nius University Medical School, Lithuania, 2Vilnius university
79 Characteristics Of Anaphylaxis In a Pediatric Emergency Unit Medical School, Lithuania, 3George Washington University School
Beatriz Ameiro, M.D.1, Blanca Noguerado, M.D.1, Gabriela Zam- of Medicine, Washington, DC
brano, M.D.1, Cristina Morales, M.D.1, Miguel Guzman, M.D.1, 88 Factors Associated With a Lower Probability Of Refilling An
Mara L. Baeza, MD, PhD2 and Alberto Alvarez-Perea, MD3, Epipen Auto-Injector In a Timely Manner
1
Hospital General Universitario Gregorio Mara~non, Allergy De- Erin Buysman, MS1, Dr. Ray A. Wolf, PharmD2, Paul Cavanaugh,
partmen, Madrid, Spain, 2Hospital General Universitario Gregorio Jr, PhD3, Aylin Altan Riedel, PhD1 and Tim Bancroft, PhD1, 1OP-
Mara~ on, Allergy Department, Madrid, Spain, 3Hospital Materno
n TUM, Prairie Eden, MN, 2Mylan Specialty L.P., New Hope, PA,
3
Infantil Gregorio Mara~non, Pediatric Allergy Department, Madrid, Mylan Specialty, Basking Ridge, NJ
Spain 89 Food-Induced Anaphylaxis: Recognition and Response In Ohio
80 Characteristics Of Anaphylaxis and Angioedema In Pediatric Schools
Emergency Center Dr. Erica Glancy, MD1, Dr. Peter J. Mustillo, MD, FAAAAI2, Dr.
Dr. Jung Hyun Kwon, Departments of Pediatrics Ewha Womans Christine B. Cho, MD3, Dr. Rekha Raveendran, MD4 and Dr. Dan-
University School of Medicine, Korea, Seoul, South Korea and iel Scherzer, MD2, 1Cleveland Clinic, Cleveland, OH, 2Nationwide
Dr. Hyun Sup Keum, Departments of Pediatrics Ewha Womans Childrens Hospital, Columbus, OH, 3National Jewish Health, Den-
University School of Medicine, Korea, South Korea ver, CO, 4Asthma and Allergy Center LLC, Washington, DC
81 Anaphylaxis: Epidemiology and Treatment In The Emergency 90 Availability and Utilization Of Epinephrine In Utah Schools
Department For The Management Of Anaphylaxis
Dr. Judy Morris, MD, MSc1,2, Dr. Julie Lapointe1, Dr. Sebastien Benjamin L. Wright, MD1, Michelle Fogg, BS2, Catherine
La Vieille, MD3, Dr. Harley Eisman, MD4,5, Dr. Reza Alizadeh- Sparks, MSN, RN, NCSN3, Brian P. Vickery, MD, FAAAAI4, Dr.
far, MD6, Ms. Emma Perkins, BSc7, Mr. Christopher Mill, BSc7, Joseph L. Roberts, MD, PhD5, Yamini Virkud, MD, MA1 and
Dr. Lawrence Joseph, PhD5,7, Dr. Ann Elaine Clarke, MD, MSc7,8 Mandy Allison, MD, MSPH, M.Ed.6, 1Duke University, Durham,
and Dr. Moshe Ben-Shoshan, MD, MSc5,6, 1Department of Emer- NC, 2Utah Food Allergy Network, Salt Lake City, UT, 3Utah De-
gency Medicine, H^opital du Sacre-Cur, Montreal, QC, Canada, partment of Health, Salt Lake City, UT, 4University of North Car-
2
University of Montreal, Montreal, QC, Canada, 3Food Director- olina, Chapel Hill, NC, 5Duke University Medical Center, Durham,
ate, Health Canada, Ottawa, ON, Canada, 4Montreal Childrens NC, 6University of Colorado Denver, Denver, CO
Hospital, Montreal, QC, Canada, 5McGill University, Montreal, 91 Induction Of Remission Of Frequent Idiopathic Anaphylaxis
QC, Canada, 6Division of Paediatric Allergy and Clinical Immu- With Rituximab
nology, Department of Paediatrics, McGill University Health Dr. Arturo Borzutzky, MD, Division of Pediatrics, School of Med-
Center, Montreal, QC, Canada, 7Division of Clinical Epidemiol- icine, Pontificia Universidad Catolica de Chile, Santiago, Chile, Dr.
ogy, Department of Medicine, McGill University Health Centre, Pamela S. Morales, MD, Pediatric Rheumatology, Allergy and Im-
Montreal, QC, Canada, 8Division of Allergy and Clinical Immu- munology Unit, Division of Pediatrics, School of Medicine, Pontifi-
nology, Department of Medicine, McGill University Health Cen- cia Universidad Catolica de Chile, Santiago, Chile, Dr. Veronica
tre, Montreal, QC, Canada Mezzano, MD, Department of Rheumatology and
82 Anaphylaxis In An Upstate New York Emergency Department: Clinical Immunology, School of Medicine, Pontificia Universidad
Triggers and Treatments Catolica de Chile, Santiago, Chile, Ms. Sofia Nussbaum,
Dr. Britta Sundquist, Dr. Jaison Jose, Dr. John Paige, Keith Swee- Universidad de San Sebastian, Santiago, Chile and A. Wesley Burks,
ney, Michael Lavelle, Dr. Daniel Pauze, Dr. Denis Pauze and Dr. MD, FAAAAI, University of North Carolina, Chapel Hill, NC
Kirsi M. Jarvinen, Albany Medical College, Albany, NY 92 Evaluation Of a Diagnostic Protocol For Perioperative Anaphy-
83 The Clinical Characteristics Of Children and Adolescents With laxis Due To Isosulfan Blue Dye Allergy
Anaphylaxis Who Visited 139 ERs In Korea In 2012 Ms. Mary Grace Baker, University of Virginia School of Medicine,
Dr. Mi-Hee Lee, Department of Pediatrics, Seoul Womens Hospi- Charlottesville, VA, Julia A. Cronin, MD, University of Virginia, Di-
tal, Incheon, South Korea, Dr. Eun-Hee Chung, Department of Pe- vision of Asthma, Allergy and Immunology, Charlottesville, VA, Dr.
diatrics,National Medical Center, Seoul, South Korea and Dr. Larry Borish, MD, FAAAAI, Asthma and Allergic Diseases Center,
Young-Shil Lim, Division of Chronic Disease Surveillance, Korea Carter Center for Immunology Research, University of Virginia,
Centers for Disease Control and Prevention, Osong, South Korea Charlottesville, VA and Dr. Monica G. Lawrence, MD, University
84 Pattern Of Epinephrine Use and Referral Of Emergency De- of Virginia Department of Medicine, Division of Asthma, Allergy
partment Personnel In A Korean Hospital and Immunology, Charlottesville, VA
Dr. Jae Won Jeong, Inje University Ilsan PAIK Hospital, Goyang- 93 Acute Serum Tryptase Elevation In ALTE - An Atypical Man-
si, South Korea, Dr. Chansun PARK, Haeunda PAIK Hospital, ifestation Of Bullous Mastocytosis
South Korea and Mi Young KIM, Busan PAIK Hospital, South Dr. Alexander Alvarez, MD, Virginia Commonwealth University,
Korea Dr. Anne-Marie A. Irani, MD, FAAAAI, Virginia Commonwealth
85 Characterisation Of Anaphylaxis In a Large UK City With An University Health Systems, Richmond, VA and Dr. Lawrence B.
Ethnically Diverse Population Schwartz, MD, PhD, FAAAAI, Virginia Commonwealth Univer-
Richard J. Buka1, Richard J. Crossman2, Cathryn Derbridge1, sity, Richmond, VA
Aarnoud P. Huissoon1, Scott Hackett1, Matthew W. Cooke1,2, Susan 94 Methodology For Identifying Patients Presenting With Anaphy-
Dorrian1 and Mamidipudi T. Krishna1, 1Birmingham Heartlands laxis Using Administrative Claims Data
Hospital, Birmingham, United Kingdom, 2University of Warwick, Jerald Seare, MD1, Erin Buysman, MS1, Dr. Ray A. Wolf,
United Kingdom PharmD2, Paul Cavanaugh, Jr, PhD3, Aylin Altan Riedel, PhD1
88
J ALLERGY CLIN IMMUNOL Abstracts AB299
VOLUME 133, NUMBER 2
SATURDAY
and Tim Bancroft, PhD1, 1OPTUM, Prairie Eden, MN, 2Mylan Spe- National Institutes of Health, Bethesda, MD, 2Unitat dAl.lergia. Ser-
cialty L.P., New Hope, PA, 3Mylan Specialty, Basking Ridge, NJ vei de Neumologia i Al.lergia Respiratoria. Hospital Clinic. Barce-
95 Epicare (Epinephrine Pen Investigation: Compliance and Rec- lona. Institut dInvestigacions Biomediques August Pi i Sunyer
ommendations) (IDIBAPS)., Barcelona, Spain, 3Servei dImmunologia, Centre de Di-
Dr. Nisha S. Patel, MD, Thomas Jefferson University, Philadel- agnostic Biomedic. Hospital Clinic., Barcelona, Spain
phia, PA, Dr. Christopher Chang, MD, PhD, FAAAAI, Alfred I du- 106 Recurrence Rates Of Anaphylaxis In Children
Pont Hospital for Children, Wilmington, DE and Dr. Gang Ye, PhD, Dr. Andrew OKeefe, MD1,2, Dr. Yuka Asai, MD3,4, Mr. Christo-
Nemours, Orlando, FL pher Mill, BSc3, Dr. Harley Eisman, MD5, Dr. Sebastian La Vieille,
96 Confusion With Substituting Epinephrine Auto-Injectors: A MD6, Dr. Reza Alizadehfar, MD5,7, Ms. Emma Perkins, BSc3, Dr.
Focus On Medication Counseling, Dispensing, and Patient Ed- Lawrence Joseph, PhD3, Dr. Ann Elaine Clarke, MD, MSc3,8 and
ucation Dr. Moshe Ben-Shoshan, MD, MSc5,9, 1McGill University, Mon-
Sonia Dhanjal, PharmD and Stacie Lampkin, PharmD, BCACP, treal, Canada, QC, Canada, 2Division of Pediatric Allergy and Clin-
AE-C, DYouville College School of Pharmacy, Buffalo, NY ical Immunology, Montreal Childrens Hospital, Canada, 3Division
97 Omalizumab For a Case Of Monoclonal Mast Cell Activation of Clinical Epidemiology, Department of Medicine, McGill Univer-
Syndrome With Recurrent Anaphylaxis sity Health Centre, Montreal, QC, Canada, 4Division of Dermatol-
Dr. Amanda Jagdis, University of Toronto, Faculty of Medicine, ogy, Department of Medicine, McGill University Health Centre,
Toronto, ON, Canada and Dr. Peter Vadas, MD, PhD, St. Michaels Montreal, QC, Canada, 5McGill University, Montreal, QC, Canada,
6
Hospital, Toronto, ON, Canada Food Directorate, Health Canada, Ottawa, ON, Canada, 7Division
98 Chlorhexidine Impregnated Central Venous Lines: A Poten- of Paediatric Allergy and Clinical Immunology, Department of Pae-
tially Avoidable Cause Of Severe Perioperative Anaphylaxis diatrics, McGill University Health Center, Montreal, QC, Canada,
8
Dr. Aisha Ahmed, MD and Dr. Katherine E. Gundling, MD, Montreal General Hospital, 9Montreal Childrens Hospital, Mon-
UCSF, San Francisco, CA treal, Canada
99 Food Dependent Exercise Induced Anaphylaxis Treatment 107 Sensitization To Recombinant Allergens Of Hevea Brasilensis
With Specific Oral Tolerance Induction Using IFN-Gamma In Patients With Latex Anaphylaxis
Dr. Jae Ho Lee, MD, PhD, Department of Pediatrics, Chungnam Dr. J.M. Escobar Montalvo, MD1, Ms. A. G omez Infante, MD1,
National University, Taejeon, South Korea, Dr. Sun Young Dr. Silvia Martnez Blanco, MD2 and Dr. R. Vives Conesa, MD1,
1
You, MD, Department of Pediatrics, Taejeon, South Korea Hospital Universitario 12 de Octubre, Madrid, Spain, 2Hospital
and Dr. Hye Young Han, MD, Department of Pediatrics, Universitario 12 de Octubre, Spain
School of Medicine, Chungnam National University, Taejeon, 108 Patients Monosensitised To Hev b 8 Performs Surgery Without
South Korea Avoidance The Latex and Without Complications
100 Food Associated Exercise Induced Anaphylaxis Associated Dr. Adriano Sa, MD, Federal University of S~ao Paulo, S~ao Paulo,
With Late Phase Skin Test Reactivity To Shrimp Brazil, Dr. Leila Borges, MD, UNIFESP, Brazil, Dr. Nathalia Bar-
Dr. Marisol Nardi, New York Downtown Hospital, New York and roso, Federal University of Sao Paulo, Dr. Luis Felipe C. Ensina,
Dr. Robert Yao-Wen Lin, FAAAAI, New York Downtown Hospital, MD, Universidade Federal de S~ao Paulo, S~ao Paulo, Brazil, Ines
New York, NY; Weill Cornell Medical College, New York, NY Nunes, Federal University of S~ao P~aulo and Prof. Dirceu Sole,
101 Idiopathic Capillary Leak Syndrome MD, PhD, Federal University of Sao Paulo, Sao Paulo, Brazil
Dr. Carl B. Lauter, MD, FAAAAI, William Beaumont Hospital
102 Comprehensive Metabolomic Analysis Identifies Uric Acid As a
Critical Mediator Of Peanut Sensitization
Mr. Joshua Kong1, Dr. Kenneth Chalcraft, PhD2, Dr. Rodrigo Ji-
menez-Saiz, PhD1, Mrs. Tina Walker-Fattouh2, Dr. Susanna Gon-
HAE and Angioedema
charova, MD, PhD2, Dr. Brian McCarry, PhD2 and Dr. Manel
Jordana, MD, PhD1, 1McMaster Immunology Research Centre 2207
(MIRC), McMaster University, Hamilton, ON, Canada, 2McMaster Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
University, Hamilton, ON, Canada 109 Home Treatment With Conestat Alfa In Attacks Of Hereditary
103 Pharmacokinetics Of Berberine, a Bioactive Compound In Bu- Angioedema Due To C1-Inhibitor Deficiency
tanol Purified Food Allergy Herbal Formula-2 Henriette Farkas, MD, PhD DSc1, Dr. Erika Szabo1, Dr. Dorottya
Dr. Nan Yang, PhD, MS1, Dr. Ying Song, MD1, Dr. Changda Liu, Csuka, PhD2, Dr. Kinga, Vikt
oria Kohalmi1, Dr. Zsuzsanna Zotter1
PhD1, Sool Yeon Cho, PhD2 and Dr. Xiu-Min Li, MD1, 1Pediatrics, and Dr. Lilian Varga, PhD1, 1Semmelweis University, Budapest,
Icahn School of Medicine at Mount Sinai, New York, NY, 2Hema- Hungary, 2Hungarian HAE Center, 3rd Department of Internal
tology, Icahn School of Medicine at Mount Sinai, New York Medicine, Semmelweis University, Budapest, Hungary
City, NY 110 Comparison Of Plasma Kallikrein Inhibition By The Monoclo-
104 Anaphylaxis After Bitten By Domestic Hamster: A Case Report nal Antibody Inhibitor DX-2930 To Endogenous C1-INH
Dr. Leila Borges, MD1, Dr. Danielle Bichueti Silva, MD2, Dr. Tessa Daniel Sexton, Jon Kenniston, Ryan Faucette, Andrew Nixon,
Rachel Tranquilini Goncalves, MD3, Dr. Rafael Rota, MD3, Camila Christopher TenHoor, Yung H. Chyung and Burt Adelman, Dyax
Gonzaga da Silva4, Dr. Danieli Hirari, MD4, Dr. Marcia Mallozi, Corp.
MD5 and Prof. Dirceu Sole, MD, PhD3, 1UNIFESP, Brazil, 2Univer- 111 The Prophylactic Use Of C1 Esterase Inhibitor (Berinert) In
sidade Federal de S~ao Paulo, S~ao Paulo, Brazil, 3Federal University HAE Patients Undergoing Invasive Procedures
of Sao Paulo, Sao Paulo, Brazil, 4Federal University of S~ao Paulo, Rachel Harrison, BSc1, Stephanie Santucci, RN1, Genevieve Gav-
S~ao Paulo, Brazil, 5Federal University of S~ao Paulo, Brazil igan, MASc, MD2 and William H. Yang, MD1,2, 1Allergy and
105 Gene Expression Profiling Of Food-Induced Anaphylaxis Asso- Asthma Research Corp., Ottawa, ON, Canada, 2University of Ot-
ciated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) tawa Medical School, Ottawa, ON, Canada
Dr. Rosa M. Munoz-Cano, MD, PhD1,2, Dr. Joan Bartra, MD, PhD2, 112 Self-Administration Of a Novel Subcutaneous Bradykinin B2 Re-
Dr. Jorg Scheffel, PhD1, Dr. Mariona Pascal, PhD3, Dr. Barbara Dema, ceptor Antagonist, Icatibant (Firazyr), As An Effective Treat-
PhD1, Dr. Antonio Valero, MD, PhD2, Dr. Ana Olivera, PhD1, Prof. ment Option In Patients With Hereditary Angioedema (HAE)
Cesar Picado, MD, PhD2 and Dr. Juan Rivera, PhD1, 1National Insti- Stephanie Santucci, RN1, Hoang Pham, MD 2016, BSc, BA2, Ra-
tute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), chel Harrison, BSc1 and William H. Yang, MD1,2, 1Allergy and
89
AB300 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
Asthma Research Corp., Ottawa, ON, Canada, 2University of Ottawa Vesna Grivcheva- Panovska, MD, PhD13, Dr. Marcel Levi, MD14,
Medical School, Ottawa, ON, Canada Dr. Hilary Longhurst, MD15, Dr. Alejandro Malbran, MD16, Dr.
113 Current Medical Management Of Hereditary Angioedema Dumitru Moldovan, MD, PhD17, Dr. Gregor Porebski, MD18, Dr.
(HAE): Follow-Up To a Large Survey Of US Physicians Avner Reshef, MD19, Dr. Petra Staubach, MD20, Dr. Andrea Zani-
Dr. Marc A. Riedl, MD, MS, University of California, San Diego, chelli, MD21, Dr. Yu-xiang Zhi, MD22 and Dr. Teresa Caballero,
La Jolla, CA, Dr. Richard G. Gower, MD, FAAAAI, Marycliff Al- MD, PhD4,23, 1Hospital Universitario Severo Ochoa, Madrid,
lergy Specialists, Spokane, WA and Dr. Aleena Banerji, MD, Divi- Spain, 2Psychology Faculty, Universidad Autonoma, Madrid,
sion of Rheumatology, Allergy, and Immunology, Department of Spain, 3Hospital Universitario Fundacion Alcorcon, Madrid, Spain,
4
Medicine, Massachusetts General Hospital, Harvard Medical Allergy Department, Hospital La Paz Institute for Health Research
School, Boston, MA (IdiPaz), Madrid, Spain, 5Research Unit, Hospital La Paz Institute
114 HAE In a Southern Louisiana Kindred: Novel Gene Mutations for Health Research (IdiPaz), Madrid, Spain, 6Department of Der-
Dr. Adrian Casillas, MD, FAAAAI, Baylor College of Medicine, matology and Venereology, Medical University of Graz, Graz, Aus-
Houston, TX tria, 7Institute of Pneumology and Allergy. San Fernandos
115 Hereditary Angioedema Without C1 Inhibitor Deficiency: Ob- Hospital, Panama City, Panama, 8University of Toronto, Division
servation Of Patients Homozygous For FXII GENE Mutation of Clinical Immunology and Allergy, Toronto, ON, Canada, 9Na-
Christiane Stieber1, Camila Veronez2, Nathalia Cagini2, Elisabete tional Reference Centre for Angioedema, Internal Medicine De-
Cordeiro3, Dr. Anete S. Grumach3, Rosemeire Constantino-Silva3, partment, Grenoble University Hospital, Grenoble, France,
Joao Bosco Pesquero2 and Sven Cichon4, 1Life & Brain Center 10
Denmark HAE Centre, Department of Dermatology and Allergy
and Institute of Human Genetics, University of Bonn, Germany, Centre, Odense University Hospital, Odense, Denmark, 11Hungar-
2
Federal University of S~ao Paulo, Brazil, 3Faculty of Medicine ian HAE Center, 3rd Department of Internal Medicine, Semmel-
ABC, Brazil, 4Division of Medical Genetics, Department of Bio- weis University, Budapest, Hungary, 12Department of
medicine, University of Basel, Switzerland Dermatology, School of Medicine, University of Sao Paulo, Sao
116 Hereditary Angioedema Without C1 Inhibitor Deficiency: Clin- Paulo, Brazil, 13Unit of Allergology and Clinical Immunology. De-
ical Evaluation Of 67 Brazilian Patients partment of Dermatology. Medicine School University Sts Cyril
Elisabete Cordeiro1, Camila Veronez2, Christiane Stieber3, Natha- and Methodius, Skopje, Macedonia, 14Department of Internal Med-
lia Cagini2, Rosemeire Constantino-Silva1, Rozana Goncalves4, icine,Academic Medical Center,University of Amsterdam., Amster-
Gustavo Fusaro4, Neusa Wandalsen1, Sven Cichon5, Joao Bosco dam, Netherlands, 15Barts Health NHS Trust, London, United
Pesquero2 and Dr. Anete S. Grumach1, 1Faculty of Medicine Kingdom, 16British Hospital of Buenos Aires, Buenos Aires, Ar-
ABC, Brazil, 2Federal University of S~ao Paulo, Brazil, 3Life & gentina, 17Department of AllergologyImmunology, Mures County
Brain Center and Institute of Human Genetics, University of Hospital, Tirgu-Mures, Romania, 18Department of Clinical and En-
Bonn, Germany, 4Federal University of Minas Gerais, Brazil, 5Di- vironmental Allergology, Jagiellonian University,, Krakow, Poland,
19
vision of Medical Genetics, Department of Biomedicine, University Allergy, Clinical Immunology & Angioedema Unit, Chaim Sheba
of Basel, Switzerland Medical Center, Tel Hashomer, Israel, 20Department of Dermatol-
117 Circulating Extracellular Micrornas In Hereditary Angioe- ogy, University Medical Center, University of Mainz, Mainz, Ger-
dema many, 21Internal Medicine Department, Luigi Sacco Hospital,
Peisong Gao, MD, PhD1, Kenneth Witwer, PhD2, Melissa McA- Milan, Italy, 22Peking Union Medical College Hospital, Beijing,
lexander2, Priya Tripathi, PhD1, Tamara Johnson3 and Dr. Huamin China, 23Biomedical Research Network on Rare Diseases (CI-
Henry Li, MD, PhD, FAAAAI3, 1Division of Allergy & Clinical BERER, U754), Madrid, Spain
Immunology, Johns Hopkins University School of Medicine, 122 Relationship Between Angioedema Attacks and Health-Related
Baltimore, MD, 2Johns Hopkins Institute for NanoBioTechnol- Quality Of Life Outcomes In Patients With Hereditary Angio-
ogy, Baltimore, MD, 3Institute for Asthma and Allergy, Chevy edema (HAE)
Chase, MD Dr. Jeff Dayno, MD1, Dave P. Miller2, Ms. Emily Hautamaki,
118 Hereditary Angioedema In The Pediatric Patient MPH3, Scott Newcomer1, David Fitts1 and Dr. William R. Lumry,
Dr. Gregory H. Bennett, DO, Penn State Childrens Hospital, Her- MD, FAAAAI4,5, 1ViroPharma Incorporated, 2ICON Clinical Re-
shey, PA and Dr. Timothy J. Craig, DO, FAAAAI, Penn State Uni- search, 3Oxford Outcomes, an ICON plc company, 4AARA Re-
versity College of Medicine, Hershey, PA search Center, Dallas, TX, 5Allergy and Asthma Specialists,
119 Clinical Features Of Pediatric Hereditary Angioedema Dallas, TX
Shelby N. Elenburg, MD1, Amal H. Assaad, MD, FAAAAI2, Dr. 123 Health-Related Quality Of Life (HRQoL) In Adult Patients
Jonathan A. Bernstein, MD, FAAAAI3 and Maya Nanda, MD2, With Hereditary Angioedema Due To C1 Inhibitor Deficiency
1
University of Tennessee Health Science Center, Memphis, TN, (HAE-C1-INH) Assessed By SF-36v2
2
Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, Dr. Teresa Caballero, MD, PhD1,2, Dr. Magdalena Julia Cami-
3
Division of Immunology Allergy & Rheumatology, University of noa, MD1, Elia Perez-Fernandez, MSc3, Dr. Carmen Gomez-Tra-
Cincinnati Medical Center, Cincinnati, OH seira, MD1, Dr. Anne Aabom, MD4, Prof. Werner Aberer, MD5,
120 A Case Series Of Seven Pediatric Patients Successfully Treated Dr. Stephen D. Betschel, MD6, Prof. Anette Bygum, MD4, Dr.
With Ecallantide and Icatibant For Hereditary Angioedema Dorottya Csuka, PhD7, Henriette Farkas, MD, PhD DSc7, Dr. Ma-
Heather Minto, MD1,2 and Kelly M. Maples, MD1,2, 1Eastern Vir- ria Gomide, MD8, Dr. Adriane Groffik, MD9, Dr. Anete S. Grum-
ginia Medical School, Norfolk, VA, 2Childrens Hospital of The ach8, Mrs. Iris Leivobich10, Dr. Alejandro Malbran, MD11, Dr.
Kings Daughters, Norfolk, VA Eniko Mihaly, MD12, Dr. Dumitru Moldovan, MD, PhD13, Dr.
121 IHAE-Qol: Specific Health-Related Quality Of Life (HRQoL) Krystyna Obtulowicz, MD14, Dr. Gregor Porebski, MD15, Mrs.
Questionnaire In Hereditary Angioedema Due To C1 Inhibitor Celina Rayonne16, Dr. Avner Reshef, MD10, Dr. Petra Staubach,
Deficiency (HAE-C1INH) MD9, Dr. Michaela Wiednig, MD5, Maria Joao Forjaz17,18 and
Dr. Nieves Prior, MD1, Prof. Eduardo Remor2, Elia Perez-Fernan- Dr. Nieves Prior, MD19, 1Allergy Department, Hospital La Paz In-
dez, MSc3, Dr. Carmen G omez-Traseira, MD4, Dr. Magdalena Julia stitute for Health Research (IdiPaz), Madrid, Spain, 2Biomedical
Caminoa, MD4, Francisco Gaya5, Prof. Werner Aberer, MD6, Dr. Research Network on Rare Diseases (CIBERER, U754), Madrid,
Olga Melcina Barrera, MD7, Dr. Stephen D. Betschel, MD8, Spain, 3Hospital Universitario Fundacion Alcorcon, Madrid,
Prof. Laurence Bouillet, MD, PhD9, Prof. Anette Bygum, MD10, Spain, 4Denmark HAE Centre, Department of Dermatology and
Henriette Farkas, MD, PhD DSc11, Dr. Anete S. Grumach12, Dr. Allergy Centre, Odense University Hospital, Odense, Denmark,
90
J ALLERGY CLIN IMMUNOL Abstracts AB301
VOLUME 133, NUMBER 2
SATURDAY
5
Department of Dermatology and Venereology, Medical Univer- Milan, Italy, 8Allergy Department, Hospital La Paz Institute for
sity of Graz, Graz, Austria, 6University of Toronto, Division of Health Research (IdiPaz), Madrid, Spain
Clinical Immunology and Allergy, Toronto, ON, Canada, 7Hun- 127 Most Hereditary Angioedema (HAE) Attacks Resolved After
garian HAE Center, 3rd Department of Internal Medicine, Sem- One Icatibant Injection: Analysis Of FAST-3 Open-Label Ex-
melweis University, Budapest, Hungary, 8Department of tension Study
Dermatology, School of Medicine, University of Sao Paulo, Sao Dr. William R. Lumry, MD, FAAAAI, Allergy and Asthma Spe-
Paulo, Brazil, 9Department of Dermatology, University Medical cialists, Dallas, TX, Jovanna Baptista, MS, Shire, Lexington, MA,
Center, University of Mainz, Mainz, Germany, 10Allergy, Clinical Dr. Marc A. Riedl, MD, MS, University of California, San Diego,
Immunology & Angioedema Unit, Chaim Sheba Medical Center, La Jolla, CA and Dr. Timothy J. Craig, DO, FAAAAI, Penn State
Tel Hashomer, Israel, 11British Hospital of Buenos Aires, Buenos University College of Medicine, Hershey, PA
Aires, Argentina, 12Department of AllergologyImmunology, 128 Evaluation Of Icatibant Reinjection Of Laryngeal Hereditary
Mures County Hospital, Trgu-Mures, Romania, 13Department Angioedema Attacks: A Pooled Analysis Of Three Phase III
of AllergologyImmunology, Mures County Hospital, Tirgu- Open-Label Extension Studies
Mures, Romania, Tirgu-Mures, Romania, 14Department of Clini- Jovanna Baptista, MS, Shire, Lexington, MA, Dr. Jonathan A.
cal and Enviromental Medicine, Jagiellonian University, Krakow, Bernstein, MD, FAAAAI, Division of Immunology Allergy &
Poland, 15Department of Clinical and Environmental Allergology, Rheumatology, University of Cincinnati Medical Center, Cincin-
Jagiellonian University, Krakow, Poland, 16ReSolve Research So- nati, OH, Dr. William R. Lumry, MD, FAAAAI, Allergy and
lutions Inc., Whitby, Ontario, Canada, 17National School of Pub- Asthma Specialists, Dallas, TX and Dr. Marc A. Riedl, MD, MS,
lic Health, Carlos III Institute of Public Health, Madrid, Spain, University of California, San Diego, La Jolla, CA
18
REDISSEC, Madrid, Spain, 19Hospital Universitario Severo 129 Successful and Safe Use Of Icatibant For Life-Threatening An-
Ochoa, Madrid, Spain gioedema Attack During Pregnancy In a Patient With Heredi-
124 The Icatibant Outcome Survey: Characteristics Of Patients tary Angioedema Type I
With Hereditary Angioedema Requiring Reinjection Dr. Karine Boufleur, MD1, Ms. Luana Delcaro1, Dr. Daniel L.
Dr. Hilary Longhurst, MD, Barts Health NHS Trust, London, Cordeiro, MD1, Dr. Priscila B. Botelho Palhas, MD1, Dr. Janaina
United Kingdom, Prof. Marcus Maurer, MD, Department of Der- Fernandes de Melo Sousa, MD1, Dr. Thas Mendonca, MD1, Dr. Ja-
matology and Allergy, Charite Universitatsmedizin, Berlin, Ger- naina Michele de Lima Melo, MD1, Dr. Gustavo Neppelenbroek,
many, Dr. Vincent Fabien, PhD, Shire, Eysins, Switzerland, Prof. MD1, Prof. Wlly Sarti1, Dr. Adriana S. Moreno, PhD1 and Dr. Luisa
Werner Aberer, MD, Department of Dermatology and Venereology, Karla P. Arruda, MD, PhD, FAAAAI2, 1Ribeirao Preto Medical
Medical University of Graz, Graz, Austria, Prof. Laurence Bouillet, School, University of Sao Paulo, Ribeirao Preto, Brazil, 2School
MD, PhD, National Reference Centre for Angioedema, Internal of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil
Medicine Department, Grenoble University Hospital, Grenoble, 130 Recombinant Human C1 Inhibitor Treatment Does Not Affect
France, Dr. Andrea Zanichelli, MD, Dipartimento di Scienze Bio- D-Dimer Levels and Is Not Associated With Thromboembolic
mediche e Cliniche, Ospedale Luigi Sacco, Universita degli Studi Events In HAE Patients
di Milano, Milan, Italy and Dr. Teresa Caballero, MD, PhD, Allergy Dr. Avner Reshef, MD, Allergy, Clinical Immunology & Angioe-
Department, Hospital La Paz Institute for Health Research (IdiPaz), dema Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel, Dr.
Madrid, Spain Andrea Zanichelli, MD, Dipartimento di Scienze Biomediche e
125 The Icatibant Outcome Survey: Characterizing Breakthrough Cliniche, Ospedale Luigi Sacco, Universita degli Studi di Milano,
Hereditary Angioedema Attacks In Patients Receiving Long- Milan, Italy, Dr. Hilary Longhurst, MD, Barts Health NHS Trust,
Term Prophylaxis London, United Kingdom, Yun Hardiman, MS, Santarus Inc., San
Prof. Werner Aberer, MD, Department of Dermatology and Vene- Diego, CA, Anurag Relan, MD, Pharming Technologies BV, Lei-
reology, Medical University of Graz, Graz, Austria, Prof. Marcus den, Netherlands and C. Erik Hack, MD, University Medical Center
Maurer, MD, Department of Dermatology and Allergy, Charite Utrecht, Utrecht, Netherlands
Universitatsmedizin, Berlin, Germany, Prof. Laurence Bouillet, 131 C1-Esterase Inhibitor Concentrate For Acute Attacks Of La-
MD, PhD, National Reference Centre for Angioedema, Internal ryngeal Edema In Hereditary Angioedema (HAE): Fixed Dos-
Medicine Department, Grenoble University Hospital, Grenoble, ing Vs Body Weight-Adjusted Dosing
France, Amandine Perrin, Shire, Eysins, Switzerland, Dr. Andrea Konrad Bork, MD1, Dr. Jonathan A. Bernstein, MD, FAAAAI2,
Zanichelli, MD, Dipartimento di Scienze Biomediche e Cliniche, Henrike Feuersenger3, Thomas Machnig3 and Dr. Timothy J. Craig,
Ospedale Luigi Sacco, Universita degli Studi di Milano, Milan, DO, FAAAAI4, 1University of Mainz, Mainz, Germany, 2Division
Italy, Dr. Teresa Caballero, MD, PhD, Allergy Department, Hospi- of Immunology Allergy & Rheumatology, University of Cincinnati
tal La Paz Institute for Health Research (IdiPaz), Madrid, Spain and Medical Center, Cincinnati, OH, 3CSL Behring GmbH, Marburg,
Dr. Hilary Longhurst, MD, Barts Health NHS Trust, London, Germany, 4Penn State University College of Medicine, Hershey, PA
United Kingdom 132 Sustained Response Following Acute Treatment Of Hereditary
126 The Icatibant Outcome Survey: Rate and Impact Of Treatment Angioedema Attacks With Recombinant Human C1 Esterase
By Self-Administration Inhibitor
Dr. Dolores Hernandez Fernandez de Rojas, MD1, Dr. Ethel H.Henry Li, MD, PhD, Institute for Asthma and Allergy, Chevy
nez, MD1, Dr. Hilary Longhurst, MD2, Prof. Marcus Maurer,
Iba~ Chase, MD, Dr. Marc A. Riedl, MD, MS, University of California,
MD3, Dr. Vincent Fabien, PhD4, Prof. Werner Aberer, MD5, Prof. San Diego, La Jolla, CA, Dr. Jonathan A. Bernstein, MD, FAAAAI,
Laurence Bouillet, MD, PhD6, Dr. Andrea Zanichelli, MD7 and Division of Immunology Allergy & Rheumatology, University of
Dr. Teresa Caballero, MD, PhD8, 1IIS Hospital Universitario La Cincinnati Medical Center, Cincinnati, OH, Dr. William R. Lumry,
Fe, Valencia, Spain, 2Barts Health NHS Trust, London, United MD, FAAAAI, AARA Research Center, Dallas, TX, Dr. Avner Re-
Kingdom, 3Department of Dermatology and Allergy, Charite Uni- shef, MD, Allergy, Clinical Immunology & Angioedema Unit,
versitatsmedizin, Berlin, Germany, 4Shire, Eysins, Switzerland, Chaim Sheba Medical Center, Tel Hashomer, Israel, Dr. Dumitru
5
Department of Dermatology and Venereology, Medical University Moldovan, MD, PhD, Department of AllergologyImmunology,
of Graz, Graz, Austria, 6National Reference Centre for Angioe- Mures County Hospital, Tirgu-Mures, Romania, Tirgu-Mures, Ro-
dema, Internal Medicine Department, Grenoble University Hospi- mania, Henriette Farkas, MD, PhD DSc, Semmelweis University,
tal, Grenoble, France, 7Dipartimento di Scienze Biomediche e Budapest, Hungary, Dr. Gregor Porebski, MD, Department of Clin-
Cliniche, Ospedale Luigi Sacco, Universita degli Studi di Milano, ical and Environmental Allergology, Jagiellonian University,
91
AB302 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
1
Krakow, Poland, Marcin Stobiecki, MD, Jagiellonian University BioCryst Pharmaceuticals, Inc, Birmingham, AL, 2BioCryst Phar-
College, Krakow, Poland, Yun Hardiman, MS, Santarus Inc., San maceuticals, Durham, NC
Diego, CA, Anurag Relan, MD, Pharming Technologies BV, Lei- 144 Incidence and Treatment Of Angioedema In a Third Level
den, Netherlands and Prof. Marco Cicardi, MD, PhD, Department Spanish Hospital
of Internal Medicine, Luigi Sacco Hospital, Milan, Italy, Milan, Marta Seoane, MD, Maria Elisa Caralli, MD, Sarah Micozzi, MD,
Italy Marta Elena Rodriguez-Mazariego, MD and Mara L. Baeza, MD,
133 Efficacy Of C1Inhibitor Concentrate (Berinert) For Severe An- PhD, Hospital General Universitario Gregorio Mara~non, Allergy
gioedema Attacks Induced By Drugs Targeting The Renin-An- Department, Madrid, Spain
giotensin Aldosterone System 145 Seasonal Increase In Angioedema In An Inner City Hospital
Prof. Laurence Bouillet, Grenoble university hospital, Grenoble, Center
France, Dr. Bernard Floccard, Lyon university hospital, Lyon, Helen Zhou, BS, Dr. Ashlei Mathew, MD and Dr. Rauno Joks, MD,
France, Dr. Isabelle Boccon-Gibod, Grenoble University Hospital, Center for Allergy and Asthma Research, State University of New
Grenoble, France, Dr. Sebastien Trouiller, Centre hospitalierd York Downstate Medical Center, Brooklyn, NY
Aurillac, Aurillac, France, Dr. Anne Du-Than, Montpellier univer- 146 Seeming Tongue Swelling Responding To Nebulized Ipratro-
sity hospital, Montpellier, France and Prof. Olivier Fain, Jean Ver- pium In An Individual With A Diagnosis Of Type III HAE (He-
dier universty hospital, Bondy, France reditary Angioedema)
134 Professional Administration Costs In The US For On-Demand Ms. Jennifer Vegh1, Dr. Arthur B. Vegh, MD, FAAAAI2 and Ms.
Therapy Of Hereditary Angioedema Nicholette Butler1, 1none, Tacoma, WA, 2University of Washington,
Thomas Machnig, CSL Behring GmbH, Marburg, Germany and Tacoma, WA
Mr. Art Zbrozek, RPh, MSc, MBA, CSL Behring LLC, King of 147 Cytokine Expression In a Case Of Cutaneous Mastocytosis
Prussia, PA With An Unusual Presentation
135 Successful Administration Of C1Esterase Inhibitor (C1inh) In Prof. Young Min Ahn, MD, Department of Pediatrics, South Ko-
An Individual Anaphylactic To It rea, Prof. sang-Hoon Kim, Department of Internal Medicine, South
Dr. Arthur B. Vegh, MD, FAAAAI1, Ms. Marni Sellers2, Ms. Korea, Prof. Ho-jung Lee, Department of Pathology,Eulji Univer-
Nancy Boyden2 and Ms. Jennifer Vegh2, 1University of Washing- sity School of Medicine, South Korea and Prof. Jai Youl Ro,
ton, Tacoma, WA, 2none, Tacoma, WA PhD, Sungkyunkwan University School of Medicine, South
136 Evaluation Of DX-88 (Ecallantide) For Treatment Of Angioten- Korea
sin Enzyme Inhibitor Induced Angioedema In The Emergency
Department
Dr. Joseph Moellman, MD1, Dr. Jonathan A. Bernstein, MD,
FAAAAI2, Ms. Kimberly Hart1, Dr. Sean Collins3 and Dr. Christo-
pher Lindsell1, 1University of Cincinnati, Cincinnati, OH, 2Division
of Immunology Allergy & Rheumatology, University of Cincinnati
Population, Health in Asthma
Medical Center, Cincinnati, OH, 3Vanderbilt University, Nashville,
TN 2208
137 Ecallantide In Treatment Of Type III Hereditary Angioedema Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
Dr. Anil Nanda, MD, Asthma and Allergy Center, Lewisville, TX; 148 Aerochambers and Asthmatics: Do No Harm?
UT Southwestern Medical Center, Dallas, TX and Dr. Anita N. Wa- Dr. Jack Leon-Max Mutnick, MD, Stevens Community Medical
san, MD, Allergy and Asthma Center, Lansdowne, VA Center, Morris, MN
138 BCX4161, An Oral Kallikrein Inhibitor: Safety and Pharmaco- 149 Characterizing The Severe Asthma Population In The United
kinetic Results Of a Phase 1 Study In Healthy Volunteers States: Claims-Based Analysis Of Three Treatment Cohorts
Dr. Phil Collis1, Dr. Melanie Cornpropst1, Dr. Jo Collier2 and Dr. In The Year Prior To Treatment Escalation
William Sheridan1, 1BioCryst Pharmaceuticals, Durham, NC, Dr. Patrick W. Sullivan, PhD1, Dr. Jon Campbell, PhD2, Dr. Vah-
2
Quotient Clinical, Nottingham, United Kingdom ram Ghushchyan, PhD2, Dr. Gary Globe, PhD3, Dr. Jeff Lange,
139 Treatment Of Hereditary Angioedema At The Time Of Prodro- PhD3 and Dr. J Michael Woolley, PhD3, 1Regis University, 2Univer-
mal Symptoms: International Survey Of Physicians sity of Colorado Denver, 3Amgen, Inc., Thousand Oaks, CA
Dr. Neelu Kalra, MD, Penn State Hershey Medical Center, Her- 150 Impact Of Asthma On Child and Family Activities Among a
shey, PA and Dr. Timothy J. Craig, DO, FAAAAI, Penn State Uni- Rural Cohort
versity College of Medicine, Hershey, PA Dr. Allison J. Burbank1,2, Mallikarjuna Rettiganti, PhD1,2, Paige
141 Structural and Molecular Changes Caused By Mutations Fisher, BA3 and Tamara T. Perry, MD1,2, 1University of Arkansas
Thr328Lys and Thr328Arg In FXII Associated With Hereditary for Medical Sciences, Little Rock, AR, 2Arkansas Childrens Hos-
Angioedema With Normal C1 Inhibitor pital, Little Rock, AR, 3Drexel University School of Public Health,
Dr. Adriana S. Moreno, PhD, Ribeirao Preto Medical School, Philadelphia, PA
University of Sao Paulo, Ribeirao Preto, Brazil, Dr. Helen Arcuri, 151 Inhaled Asthma Medications: Highlighting The Differences In
PhD, Institute of Investigation in Immunology iii, School of Medi- Formulations and Use
cine of the University of Sao Paulo, S~ao Paulo, Brazil, Prof. Mario Dr. Lachara Lvingston Livingston, University of South Florida
Palma, PhD, Biosciences Institute, State University of S~ao Paulo, Morsoni College of Medicine, Dr. Gregory Michael Cowan, MD,
Rio Claro, Brazil and Dr. Luisa Karla P. Arruda, MD, PhD, University of South Florida Morsani College of Medicine and Dr.
FAAAAI, School of Medicine of Ribeirao Preto, Ribeirao Preto, Richard F. Lockey, MD, Division of Allergy and Immunology, De-
Brazil partment of Internal Medicine, University of South Florida Morsani
142 Ludwigs Angina Masquerading As Angioedema College of Medicine and James A. Haley Veterans Affairs Hospi-
Dr. Lynn A. Wiens, MD, FAAAAI, Warren Clinic, Tulsa, OK tal, Tampa, FL
143 A Simple, Sensitive and Selective Fluorogenic Assay To Monitor 152 Rhinitis and Asthma Exacerbation Revealing Large Pulmonary
Plasma Kallikrein Inhibitory Activity Of BCX4161 In Activated Effusion and Pelvic Mass
Plasma Dr. Jennifer Olivier, MD, Tulane University School of Medicine,
Dr. YS Babu1, Ms. Ramanda Wilson1, Dr. Jianwen Zhang1, Dr. New Orleans, LA and Dr. Laurianne G. Wild, MD, FAAAAI, Tu-
Melanie Cornpropst2, Dr. Phil Collis2 and Dr. William Sheridan2, lane University, New Orleans, LA
92
J ALLERGY CLIN IMMUNOL Abstracts AB303
VOLUME 133, NUMBER 2
SATURDAY
153 Deprivation Is Longitudinally Associated With Incident Child- Diagnostics
hood Asthma
Dr. Elinor Simons, MD, MS, FAAAAI1,2, Dr. Sharon Dell, MD2,3, 2210
Dr. Rahim Moineddin, PhD4,5 and Dr. Teresa To, PhD1,5, 1Child Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
Health Evaluative Sciences, Hospital for Sick Children, Toronto,
ON, Canada, 2Clinical Epidemiology, Department of Health Policy, 160 Phadiatop - An Atopy Test With Optimal Allergen Composition
Management and Evaluation, University of Toronto, Toronto, ON, Relevant For Most Geographical Regions
Canada, 3Respiratory Medicine and Child Health Evaluative Sci- Kerstin M. Wall1, Monica Noren1 and Dr. Cathy Van Rooyen2,
1
ences, Hospital for Sick Children, Toronto, ON, Canada, 4Depart- Thermo Fisher Scientific, ImmunoDiagnostics, Uppsala, Sweden,
2
ment of Family and Community Medicine, University of Toronto, Ampath National Reference Laboratory, Immunology, Pretoria,
Toronto, ON, Canada, 5Institute for Clinical Evaluative Sciences, South Africa
Toronto, ON, Canada 161 Histamine Skin Reactivity Increased With Body Mass Index In
154 Use Of Asthma Control Indicators In Measuring Efficacy Of In- Korean Children
haled Corticosteroids In Asthmatic Smokers: A Systematic Re- Dr. Jeon Mi Lee, Dr. Ju Wan Kang and Dr. Hyung Ju Cho, Yonsei
view University College of Medicine
Ms. Claire E. Hayes, MPH, CHES, AE-C and Mr. Henry Nuss, 162 The Impact Of Component Resolved Diagnosis On Allergen-
PhD, Louisiana State University Health Sciences Center School Specific Immunotherapy Prescription In Children With Pol-
of Public Health, New Orleans, LA len-Related Allergic Rhinitis
155 Evaluation Of a Medication Adherence Estimator Survey Com- Dr. Paolo Matricardi, MD1, Dr. Giovanna Stringari2, Prof. Carlo
pared To Exhaled Nitric Oxide (FeNO) Levels and Asthma Con- Caffarelli2, Dr. Riccardo Asero, MD3, Dr. Arianna Dondi4, Dr. Sal-
trol Test In Difficult-To-Treat/Severe Pediatric Asthma Patients vatore Tripodi5 and The Italian Pediatric Allergy Network6,
1
Jigar Patel1, Vanessa Y. Cavero, MD2, Amy Perkins, MS2, Charite, Berlin, Germany, 2Pediatric Department, University of
Heather Minto, MD2 and Maripaz B. Morales, MD2, Parma, Parma, Italy, 3Clinica San Carlo, Paderno Dugnano, Italy,
4
1
Department of Pediatrics, Eastern Virginia Medical School, Department of Pediatrics, University of Bologna, Bologna, Italy,
5
Norfolk, VA, 2Childrens Hospital of The Kings Daughters, Pediatric Department, Ospedale Sandro Pertini, Roma, Italy, 6.
Norfolk, VA 163 Randomized Evaluation Of Ten Allergy Skin Prick Test Devices
Dr. Yohalakshmi Chelladurai, MD, MPH1, Prof. Robert G. Ham-
ilton, PhD D.ABMLI FAAAAI2 and Dr. Jody R. Tversky, MD2,
1
Johns Hopkins University Bloomberg School of Public Health,
2
Johns Hopkins University School of Medicine, Baltimore, MD
Healthcare Delivery in Primary 164 Phenotypic Classification Of Allergen Polysensitization In Ger-
iatric Adults
Immunodeficiency Dr. Rohit Divekar, MBBS, PhD1, Dr. John B. Hagan, MD,
FAAAAI2 and Hirohito Kita, MD2, 1Division of Allergic Diseases,
2209 Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM 165 Analysis Of The Discordance Between Immunocap and Skin
156 An Assessment Of Infection Rates and Health Resource Use Prick Test For Common Allergens In Patients With Allergic
Among Primary Immunodeficiency Disorder (PIDD) Patients Rhinitis Symptoms
Prior To Diagnosis Dr. Do Yang Park1, Prof. Hyun Jun Kim1, Dr. Ju Wan Kang2, Prof.
Dr. Chris Rabbat, PhD, Ms. Diane Ito, MA, Ms. Yan Xiong, MS Yoo Suk Kim1 and Prof. Chang-Hoon Kim3, 1Ajou University
and Dr. Josephine Li-McLeod, PhD, Baxter Healthcare Corpora- School of Medicine, 2Yonsei University College of Medicine, 3De-
tion, Westlake Village, CA partment of Otorhinolaryngology, Yonsei University College of
157 A Comparison Of Costs Between Outpatient Hospital, Clinic and Medicine, Seoul, South Korea
Home Settings For Intravenous Immunoglobulin (IVIG) Infusions 166 Role Of House Dust Mites In Allergic and Non Allergic Nasal
Dr. Xiaolan Ye, PhD, Ms. Diane Ito, MA, Ms. Yan Xiong, MS and Dr. Diseases
Josephine Li-McLeod, PhD, Baxter Healthcare Corporation, Westlake Prof. Maged Refaat, MD1, Prof. Tarek Mansour1, Prof. Talaat
Village, CA Samny2, Prof. Ahmed Zaki3, Prof. Eman Osman1, Dr. Eman Ez-
158 Differences In Infection Rates Between Outpatient Hospital, zat1 and Dr. Eman Ahmed1, 1Department of Allergy and
Clinic and Home Infusion Settings For Patients With Primary Clinical immunology,Ain Shams university, Cairo, Egypt, 2De-
Immunodeficiency Disorder (PIDD) partment of ear,nose and throat diseases,Ain Shams university,
Ms. Diane Ito, MA, Ms. Yan Xiong, MS, Dr. Xiaolan Ye, PhD and Cairo, Egypt, 3Department of pathology,Ain Shams university,
Dr. Josephine Li-McLeod, PhD, Baxter Healthcare Corporation, Cairo, Egypt
Westlake Village, CA 167 Immunogenicity and IgE Blocking Capacity Of a Mixture Of
159 Assessment Of The Quality Of Life and Health Resource Utili- Depigmented and Chemically Modified Allergens From Differ-
zation Burden Among Patients With Primary Immunodefi- ent Homologous Groups
ciency Disorder (PIDD) Prior To Treatment Dr. Victor Miguel Iraola, Mr. Jose Ramon Leonor, Dr. Mara Mo-
Dr. John M. Routes, MD, FAAAAI1, Dr. Beatriz Tavares Costa- rales, Dr. Raquel Moya, Dr. M. Angeles Lopez Matas, Dr. Ma Ter-
Carvalho, MD2, Prof. Bodo Grimbacher, MD3, Dr. Kenneth Paris, esa Gallego and Dr. Jeronimo Carnes, Laboratorios LETI, Tres
MD, MPH4, Dr. Hans D. Ochs, MD5, Ms. Diane Ito, MA6, Ms. Cantos, Spain
Yan Xiong, MS6, Dr. Josephine Li-McLeod, PhD6 and Dr. Ri- 168 Modified Shuffled Blo t 5 Recombinant Allergen From Blomia
chard I. Schiff, MD, PhD7, 1Medical College of Wisconsin, Mil- Tropicalis Produces a Shift Of Antigenicity For Binding To
waukee, WI, 2Federal University of Sao Paulo, Brazil, 3Royal IgG4 Isotype
Free Hospital & University College, London, United Kingdom, Dr. Ernesto Taketomi, MD, PhD1, Mrs. Barbara Avila, MSc1,
4 1 1
LSU Health Sciences Center, New Orleans, New Orleans, LA, Mrs. Karine Almeida, PhD , Mrs. Deise Silva, PhD , Prof. Odonrio
5
University of Washington, Seattle, WA, 6Baxter Healthcare Cor- Abrah~ao Junior, PhD2 and Prof. Jair Cunha-Junior, PhD1, 1Federal
poration, Westlake Village, CA, 7Baxter BioScience, Westlake University of Uberl^andia, Uberlandia, Brazil, 2Federal University of
Village, CA Triangulo Mineiro, Uberaba, Brazil
93
AB304 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
94
J ALLERGY CLIN IMMUNOL Abstracts AB305
VOLUME 133, NUMBER 2
SATURDAY
tre for Allergic Mechanisms of Asthma, UK, 4Imperial College 192 Differential Promoter Usage and Regulation Of The Human In-
London, United Kingdom, 5Imperial College London, London, terleukin-5 Receptor a (IL-5Ra) Gene In Developing Eosino-
United Kingdom phil Progenitors
183 Th2 Cytokines Inhibit Toll-Like Receptor 2 Mediated Epider- Kimberly G. Laffey, BSc, Dr. Jian Du, MD and Dr. Steven J. Ac-
mal Barrier Repair kerman, PhD, University of Illinois at Chicago, Chicago, IL
Takeshi Yoshida, PhD1, I-Hsin Kuo, PhD1, Anna De Benedetto, 193 Multiplex Cytokine Analysis Of Cord Blood Non-Adherent
MD, FAAAAI1, Donald Y.M. Leung, MD, PhD, FAAAAI2 and Mononuclear Cells From Infants With Attributable Atopic
Lisa A. Beck, MD, FAAAAI1, 1University of Rochester Medical Risk Following Il-5 Stimulation
Center, Rochester, NY, 2National Jewish Health, Denver, CO Mrs. Jenny Thiele, MSc, Queens University, Kingston, ON, Can-
184 Epicutaneous Sensitization To Food Allergens Induce IL-4-Pro- ada, Ms. Vanessa N. Omana, MSc, Queens University, ON, Canada
ducing Cells and T Follicular Helper (Tfh) Cells In An IL-6 and and Dr. Anne K. Ellis, MD, MSc FAAAAI, Allergy Research Unit,
IL-1-Dependent Manner Kingston General Hospital, Kingston, ON, Canada; Departments of
Ritobrata Goswami, PhD, Leticia Tordesillas, PhD and M. Cecilia Medicine and Biomedical & Molecular Science, Queens Univer-
Berin, PhD, Icahn School of Medicine at Mount Sinai, New York, NY sity, Kingston, ON, Canada
185 Enhanced Thymic Stromal Lymphopoietin-Induced Eosinophil- 194 Association Of IL-33 With Atherogenic Cytokines: A Link Be-
Basophil Lineage Commitment In Atopic Individuals tween Allergic Disease and Atherosclerosis
Claudia C.K. Hui, MSc1, Sina Rusta-Sallehy, BSc1, Dr. Ilan Dr. Misu Paul, MD1, Dr. Allison B. Reiss, MD2, Dr. Steven Carsons,
Asher, MD1, Delia Heroux, BSC1 and Judah Aryeh Denburg, MD3, Dr. Luz S. Fonacier, MD, FAAAAI4 and Dr. Iryna Voloshyna,
MD, FRCPC, FAAAAI2, 1McMaster University, Hamilton, ON, PhD2, 1Section of Allergy and Clinical Immunology, Department of
Canada, 2Division of Clinical Immunology and Allergy, Depart- Medicine, Winthrop University Hospital, mineola, NY, 2Winthrop Re-
ment of Medicine, McMaster University, ON, Canada search Institute, Department of Medicine, Winthrop University Hospi-
186 CMRF35-Like Molecule 1 (CLM-1) Is Required For IL-33-In- tal, Mineola, NY, 3Division of Rheumatology, Allergy and
duced Eosinophil Activation Immunology, Department of Medicine, Winthrop University Hospital,
Dr. Ariel Munitz, PhD1, Mrs. Dana Shik1, Mr. Itay Moshkovits2 Mineola, NY, 4Section of Allergy and Clinical Immunology, Depart-
and Mrs. Danielle Karo-Atar1, 1Department of Clinical Microbiol- ment of Medicine, Winthrop University Hospital, Mineola, NY
ogy and Immunology, The Sackler School of Medicine, Tel-Aviv 195 Modulation Of Human Basophil Degranulation By Geranylger-
University, Tel Aviv, Israel, 2Tel-Aviv University, Israel anyl Compounds
187 Role Of Interleukine-33 In Rhinovirus-Induced Allergic Dr. Yuko Nakase1, Dr. Masao Yamaguchi1, Dr. Naoya Sugimoto1,
Asthma Exacerbation Dr. Maho Suzukawa, MD2, Dr. Hiroyuki Tamiya1, Dr. Yasuhiro Ko-
Dr. Marie Toussaint, DMV, PhD, Dr. Aran Singanayagam, MD, jima1, Dr. Hisanao Yoshihara1, Dr. Michio Kuramochi1, Dr. Hide-
Prof. Sebastian L. Johnston, MD, PhD and Dr. Nathan Bartlett, nori Arai1, Dr. Hiroyuki Nagase1 and Dr. Ken Ohta1,2, 1Teikyo
PhD, Imperial College London, London, United Kingdom University School of Medicine, Tokyo, Japan, 2National Hospital
188 TGF-beta1 Mobilizes Mesenchymal Stem Cells In Allergic Organization Tokyo National Hospital, Tokyo, Japan
Asthma 196 Variation In mRNA Expresion Of GATA1 and PRG2 In Umbil-
Ting Xu, MD1,2, Ling-Ling Xian, MD, PhD3, Yufeng Zhou, MD, ical Cord Blood Following IL-5 Stimulation
PhD1, Beverly Plunkett, MS1, Xu Cao, PhD3, Mei Wan, MD, Ms. Vanessa N. Omana, MSc, Queens University, ON, Canada,
PhD3 and Peisong Gao, MD, PhD1, 1Division of Allergy & Clinical Mrs. Jenny Thiele, MSc, Queens University, Kingston, ON, Canada
Immunology, Johns Hopkins University School of Medicine, Balti- and Dr. Anne K. Ellis, MD, MSc FAAAAI, Departments of Medi-
more, MD, 2Department of Respiratory Medicine, Southern Medi- cine and Biomedical & Molecular Science, Queens University,
cal University, Guangzhou, China, 3Department of Orthopedics Kingston, ON, Canada
Surgery, Johns Hopkins University School of Medicine, Baltimore, 197 Mast Cells Drive Tissue Inflammation By Producing IL-33 That
MD Orchestrates a Unique Basophil Phenotype
189 IL-10-Producing B Cells Are Increased After Grass Pollen Im- Dr. Chia-Lin Hsu, PhD and Dr. Paul Bryce, PhD, Division of Al-
munotherapy Compared To Untreated Grass Pollen Allergic lergy-Immunology, Department of Medicine, Feinberg School of
Controls: A Blinded Cross-Sectional Study Medicine, Northwestern University, Chicago, IL
Mr. James E G Charlesworth1,2, Dr. Guy W Scadding, MD1,2, Dr. 198 Differential Regulation Of Pro-Inflammatory Cytokine Expres-
Aarif Eifan, MD2, Ms. Rachel Yan, RN2, Ms. Andrea Goldstone, sion Of Airway Smooth Muscle Cells (ASM) By Insulin, Glu-
RN2, Dr. Moises A. Calderon, MD, PhD1,2, Prof. Stephen R. Durham, cose, and Rosiglitazone
MA MD FRCP3,4 and Dr. Mohamed H. Shamji, BSc MSc PhD5, Dr. Qura-Tul-Ain Rashid, MD, Allergy and Immunology, Univer-
1
Medical Research Council and Asthma UK Centre for Allergic Mech- sity of Texas Medical Branch, Dr. Lata Kaphalia, PhD, University
anisms of Asthma, United Kingdom, 2Imperial College London, of Texas Medical Branch, Galveston and Dr. William J. Calhoun,
United Kingdom, 3Imperial College London, London, United King- MD, FAAAAI, Allergy And Immunology, University of Texas
dom, 4Medical Research Council and Asthma UK Centre for Allergic Medical Branch, Galveston, TX
Mechanisms of Asthma, London, United Kingdom, 5Imperial College
London, South Kensington, United Kingdom
190 Respiratory Syncytial Virus Induces IL-25 and IL-33 Produc-
tion In The Lungs Role of Granulocytes and Mast Cells in
Matthew T. Stier1, Kasia Goleniewska2 and R. Stokes Peebles1,2,
1
Department of Pathology, Microbiology, and Immunology, Van-
Mechanisms of Allergic Disease
derbilt University School of Medicine, Nashville, TN, 2Allergy,
Pulmonary, and Critical Care Medicine, Department of Medicine, 2213
Vanderbilt University School of Medicine, Nashville, TN Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
191 Small-Molecule Inhibition Of Stat3 Prevents House-Dust-Mite 199 An Association Between Disease Severity and Levels Of Low-
(HDM)-Induced Airway Inflammation By Blocking Lung Pro- Density Granulocytes In The Peripheral Blood Mononuclear
duction Of Th17 and Th2 Cytokines Cell Fraction Of Asthma Subjects
Dr. Aries C. Gavino, MD and Dr. David J. Tweardy, MD, Baylor Dr. Mary C. Tobin, M.D.1,2, Dr. Jun Fu, PhD1, Ms. Paige Adeli,
College of Medicine, Houston, TX RN1 and Dr. Larry L. Thomas, PhD1, 1Rush University Medical
95
AB306 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
Center, Chicago, IL, 2University Consultants in Asthma and Al- 209 Regulation Of Reactive Oxygen Species Production Involving
lergy, Chicago, IL Src Family Kinase In Siglec-8 Induced Eosinophil Cell Death
200 Asthma Severity and Expression Of CLC3 On Human Periph- Dr. Gen Kano, MD, PhD, Kyoto Prefectural University of Medi-
eral Blood and Nasal Lavage Eosinophils cine, Kyoto, Japan, Bruce S. Bochner, MD, FAAAAI, Division of
Devendra K. Agrawal, Rohit Gaurav and Againdra K. Bewtra, De- Allergy and Clinical Immunology, Northwestern University School
partments of Biomedical Sciences and Internal Medicine, and Cen- of Medicine, Chicago, IL and Dr. Nives Zimmermann, MD,
ter for Clinical and Translational Science, Creighton University FAAAAI, Childrens Hospital Medical Center, Cincinnati, OH
School of Medicine, Omaha, NE 210 Ragweed Pollen Extract (RWPE)-Induces TLR4-Dependent
201 The Interaction Of Bifidobacteria With Human Blood Leuko- Neutrophil Recruitment That Augments Allergic Airway In-
cytes flammation
Dr. Leonid P. Titov, MD, PhD1, Dr. A.S. Murashko2, Dr. Andrei Dr. Koa Hosoki, MD, PhD, Dr. Leopoldo Aguilera-Aguirre, PhD,
Y. Hancharou3, Dr. N.A. Golovnyova3, Dr. E.I. Kolomiets3 and Prof. Istvan Boldogh, PhD, Dr. Qian Sun, PhD and Prof. Sanjiv Sur,
Prof. Lawrence M. DuBuske, MD, FAAAAI4, 1Republican Scien- MD, University of Texas Medical Branch, Galveston, TX
tific and Practical Center for Epidemiology and Microbiology, 211 LAMP1 and CD63 Expression In Mouse Mast Cells and Human
Minsk, Belarus, 2Republican Scientific And Practical Center for Basophils Rendered Hyporesponsive By Antigen/IgE-Mediated
Epidemiology and Microbiology, Minsk, Belarus, 3Republican Sci- Activation and Desensitization
entific and Practical Center for Epidemiology and Microbiology,- Prof. Pedro Giavina-Bianchi, MD, PhD, FAAAAI1, Dr. Matthieu
Minsk, Belarus, 4George Washington University School of Picard, MD2, Dr. Joana Caiado, MD2, Dr. Veronica Mezzano, MD2
Medicine, DC and Dr. Mariana C. Castells, MD, PhD, FAAAAI2, 1Clinical Imun-
202 Worldwide Impact Of LAD2 Mast Cell Line On Mast Cell Bi- nology and Allergy Division, University of Sao Paulo, Boston, MA,
2
ology Research Division of Rheumatology, Allergy and Immunology, Department
Arnold S. Kirshenbaum, MD, FAAAAI1, Amy Petrik, PhD2, of Medicine, Brigham and Womens Hospital, Harvard Medical
Rosemary Walsh, PhD2, Sury Vepa, PhD JD3 and Dean D. Met- School, Boston, MA
calfe, MD, FAAAAI1, 1Laboratory of Allergic Diseases, NIAID, 212 Vectorial Exposure and Fusion Of Secretory Granule Content
NIH, Bethesda, MD, 2Technology Transfer and Intellectual Prop- At The Mast Cell Degranulatory Synapse
erty Office, NIAID, NIH, Bethesda, MD, 3Office of Technology Dr. Nicolas Gaudenzio1, Mr. Regis Joulia2, Prof. Salvatore Vali-
Transfer, NIH, Rockville, MD tutti2 and Dr. Eric Espinosa2, 1Stanford University, Stanford, CA,
2
203 Non c-Kit Tyrosine Kinase Expression In Mast Cell Leukemia INSERM U1043, Toulouse, France
Dr. Joseph H. Butterfield, MD, FAAAAI, Mayo Clinic, Roches- 213 Airway Tissue, But Not Luminal, Eosinophilia Is Related To
ter, MN The Magnitude Of Airway Hyperresponsiveness In a Trans-
204 Characterization Of Systemic Mastocytosis Patients Based genic Murine Model Of Cat Allergy
Solely On The Minor Criteria Mr. Daniel M. Moldaver1, Dr. Mantej S. Bharhani1, Ms. Jennifer
Dr. Anupama Ravi, MD and Dr. Joseph H. Butterfield, MD, Wattie1, Ms. Tarandeep Singh1, Ms. Melissa Babra1, Dr. Marianne
FAAAAI, Mayo Clinic, Rochester, MN van Hage, MD2, Dr. Mark D. Inman, MD, PhD1 and Dr. Mark
205 Basophil Activation Is a Reliable Biomarker Of Allergic Bron- Larche, PhD1, 1McMaster University, Hamilton, ON, Canada, 2Kar-
chopulmonary Aspergillosis (ABPA) In CF: One Year Results olinska Institutet, Department of Medicina Solna, Clinical Immu-
Of a Longitudinal Cohort Study nology and Allergy Unit, Stockholm, Sweden
Dr. Yael Gernez, MD, PhD1,2, Mr. Jeffrey Waters2, Mrs. Colleen 214 IgEMediated Mast Cell Responses Are Inhibited By Thymol-
Dunn2, Zoe Davies2, Dr. Rabindra Tirouvanziam3, Mrs. Cassie Mediated Activation-Induced Cell Death
Everson2, Dr. John Tamaresis2, Prof. Leonore Herzenberg4 and Dr. Joshua B. Wechsler, MD1, Dr. Chia-Lin Hsu, PhD2 and Dr.
Dr. Richard B. Moss, MD5, 1Highland Hospital, San Francisco, Paul Bryce, PhD2, 1Ann & Robert H. Lurie Childrens Hospital
2
Stanford University School of Medicine, Stanford, CA, 3Emory of Chicago, Chicago, IL, 2Division of Allergy-Immunology, De-
University School of Medicine, Department of Pediatrics, Atlanta, partment of Medicine, Feinberg School of Medicine, Northwestern
GA, 4stanford, School of Medicine, stanford, 5Stanford University University, Chicago, IL
School of Medicine, Palo Alto, CA 215 Mechanisms Of Non-IgE-Mediated Uptake Of Antigen By Hu-
206 Exosomes Secretion By Eosinophils: A Possible Role In Asthma man Mast Cells
Pathogenesis Dr. Brant Ward, MD, PhD, Ms. Sahar Lotfi-Emran and Dr. Law-
Victoria Del Pozo, PhD1, Carla Mazzeo1, Ainara Rodriguez rence B. Schwartz, MD, PhD, FAAAAI, Virginia Commonwealth
Marco2, Mar Del Mar fERNANDEZ-NIETO3, Maria Paz Zafra4, University, Richmond, VA
Veronica Sanz1 and Prof. Joaquin Sastre, MD, PhD, FAAAAI3, 216 Human EMR1, An Eosinophil-Specific Surface Receptor Of
1
IIS-FJD and CIBERES, 2IIS-FJD, 3Fundacion Jimenez Diaz, Ma- Unknown Function, Is Modulated In Vivo and In Vitro
drid, Spain, 4IIS-Fundaci
on Jimenez Daz Dr. Fanny Legrand1, Dr. Nenad Tomasevic2, Mrs. Michelle Ma-
207 CD49d-Expressing Neutrophils Are Found In The Nasal Lavage kiya1, Dr. Christopher Bebbington2 and Dr. Amy D. Klion, MD1,
1
During An Acute Upper Respiratory Illness National Institutes of Health, Bethesda, MD, 2Allakos
Dr. Jerome Sigua, MD, Dr. Mitchell H. Grayson, MD, FAAAAI, 217 Cyclo-Oxygenase Inhibition Increases The Frequency Of
Dr. Pippa Simpson, PhD, Ms. Erika Buell, Mrs. Desire Hunter CD49d+ Neutrophils In The Bronchoalveolar Lavage (BAL)
and Dr. Dorothy S. Cheung, MD, FAAAAI, Medical College of During a Respiratory Viral Infection
Wisconsin, Milwaukee, WI Ms. Jennifer A. Hass, Ms. Erika Buell, Mrs. Desire Hunter, Dr.
208 Estradiol Has a Negative Impact On The Anaphylactic Re- Dorothy S. Cheung, MD, FAAAAI and Dr. Mitchell H. Grayson,
sponse In Mice, Independent From Mast Cell Degranulation MD, FAAAAI, Medical College of Wisconsin, Milwaukee, WI
Valerie Hox, MD, PhD1,2, Avanti Desai1, Geethani Bandara, PhD1, 218 High Blood Eosinophils Predict Reductions In Sputum Mast
Alasdair M. Gilfillan, PhD1, Dr. Michael Beaven, PhD3, Dr. Ana Cells and Lung Function In Response To Triamcinolone In
Olivera, PhD1 and Dean D. Metcalfe, MD, FAAAAI1, 1Laboratory Asthma
of Allergic Diseases, NIAID, NIH, Bethesda, MD, 2Laboratory of Dr. Merritt L. Fajt, MD1, Ms. Crystal Uvalle, BS1, Mr. John Tru-
Clinical Immunology, Department of Microbiology and Immunol- deau, BA1 and Sally E. Wenzel, MD, FAAAAI2, 1The University of
ogy, KULeuven, Leuven, Belgium, 3Laboratory of Molecular Im- Pittsburgh Asthma Institute at UPMC and the University of Pitts-
munology, NHLBI, NIH, Bethesda, MD burgh School of Medicine, Department of Pulmonary, Allergy
96
J ALLERGY CLIN IMMUNOL Abstracts AB307
VOLUME 133, NUMBER 2
SATURDAY
and Critical Care Medicine, 2The University of Pittsburgh Asthma Hospital of Chicago, Chicago, IL; Division of Allergy & Immunol-
Institute at UPMC and the University of Pittsburgh School of Med- ogy, Department of Pediatrics, Northwestern University Feinberg
icine, Department of Pulmonary, Allergy and Critical Care Medi- School of Medicine, Chicago, IL
cine, Pittsburgh, PA 227 Epinephrine Use In Positive Oral Food Challenges Performed
219 Analyses Of IL-33-Producing Cells During Multiple Antigen As Screening For Food Allergy Therapeutic Trials
Challenges In Murine Asthma Ms. Sally A. Noone, RN MSN CCRC1, Jaime Ross, RN2, Hugh A.
Dr. Takeshi Nabe1, Mr. Hiroki Wakamori1, Ms. Anna Takiguchi1, Mrs. Sampson, MD, FAAAAI3 and Dr. Julie Wang, MD, FAAAAI2,
Haruka Kida1, Prof. Susumu Ohya1, Dr. Nobuaki Mizutani2, Prof. Shin 1
Icahn School of Medicine at Mount Sinai, New York, NY, 2The
Yoshino2 and Prof. David Chaplin3, 1Kyoto Pharmaceutical University, Icahn School of Medicine at Mount Sinai, New York, NY, 3Pediat-
Kyoto, Japan, 2Kobe Pharmaceutical University, Kobe, Japan, 3Univer- rics, Icahn School of Medicine at Mount Sinai, New York, NY
sity of Alabama at Birmingham, Birmingham, AL 228 School Experience With Food Allergy Reactions Highlight The
220 Repeat Lipopolysaccharide Exposure Is Sufficient To Impair Need For Training and Availability Of Epinephrine
Viral Induced Pro-Atopic, CD49d Expressing Neutrophil Re- Mrs. Katherine A. Schmeissing, MS, R.N.1, Christine Szychlin-
cruitment To The Lung ski, APN, CPNP2, Dr. Jacqueline Pongracic, MD, FAAAAI1,3 and
Dr. Wei An, MD1,2, Ms. Jennifer A. Hass2, Ms. Erika Buell2, Mrs. Dr. Anne Marie Singh, MD4, 1Ann & Robert H. Lurie Childrens
Desire Hunter2, Dr. Dorothy S. Cheung, MD, FAAAAI2 and Dr. Hospital of Chicago, Chicago, IL, 2Division of Allergy & Immunol-
Mitchell H. Grayson, MD, FAAAAI2, 1Froedtert Hospital, Milwau- ogy, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi-
kee, WI, 2Medical College of Wisconsin, Milwaukee, WI cago, IL, 3Division of Allergy & Immunology, Department of
221 Important Role For Mast Cells But Not Basophils In An Adju- Pediatrics,Northwestern University Feinberg School of Medicine,
4
vant-Free Model Of Active Anaphylaxis In Mice Division of Allergy & Immunology, Department of Pediatrics,
Dr. Laurent L. Reber, PhD1, Dr. Hajime Karasuyama, MD, PhD2, Northwestern University Feinberg School of Medicine, Ann & Rob-
Dr. Mindy Tsai, DMSc1 and Dr. Stephen J. Galli, MD1, 1Stanford ert H. Lurie Childrens Hospital of Chicago, Chicago, IL
University School of Medicine, Stanford, CA, 2Tokyo Medical 229 Early and Significant Improvement In The Intensity Of Allergic
and Dentistry Graduate School, Tokyo, Japan Rhinitis Symptoms After Treatment With Intranasal Cicleso-
222 Functional Phenotype Of CD49d-Expressing Neutrophils Dif- nide 200 Mcg Qd: Open Trial In Mexican Population
fers Between Viral Infection and TLR Stimulation Francisco Javier Saynes-Marin1, Araceli Arellano-Plancarte2,
Dr. Dorothy S. Cheung, MD, FAAAAI, Erika Buell, Mrs. Desire Jazmin Chiu-Ugalde2, Estefania Torres-Medina2, Jose Antonio Var-
Hunter and Dr. Mitchell H. Grayson, MD, FAAAAI, Medical Col- gas-Romero2 and Juan Carlos Lopez-Alvarenga2,3, 1Hospital An-
lege of Wisconsin, Milwaukee, WI geles Metropolitano, Mexico City, Mexico, 2Medical Department,
223 Mast Cells Preferentially Migrate To Denatured Collagens Takeda Mexico S.A. de C.V., Edo. de Mex., Mexico, 3Direccion
Compared To Native Collagens de Investigacion, Hospital General de Mexico Eduardo Liceaga,
Thomas Kaido1, Robert T. Reid1, Anthony Montgomery2 and Ri- Mexico City, Mexico
chard Reid1, 1The Banck Center, San Diego, CA, 2University of 230 Viral Induced Ibuprofen Sensitivity Leading To Anaphylaxis In
California San Diego, San Diego, CA Preschool Aged Children
224 Expression Of The Transcription Factor E4BP4 In Human Ba- Mrs. Jodi A. Shroba, RN MSN CPNP and Ms. Kathryn Choj-
sophils nacki, Childrens Mercy Hospital
Dr. Bettina M. Jensen, Mrs. Maria Gohr and Prof. Lars K. Poulsen, 231 Anthropomorphic Variations According To Clinical Pattern In
PhD FAAAAI, Allergy Clinic, Copenhagen University Hospital - Cows Milk Allergic Children
Gentofte, Hellerup, Denmark Ms. Diana Colson1, Prof. Nicolas Kalach, MD, Ph D2, Ms. Pascale
225 Cross-Talk Between Human Mast Cells and Bronchial Epithe- Soulaines3 and Prof. Christophe Dupont, MD, PhD3,4, 1Nutricia
lial Cells In The Production Of Plasminogen Activator Inhibi- Nutrition Clinique, Saint Ouen, France, 2H^opital Saint Vincent de
tor-1 Via TGF-b1 Paul, Groupement des Hospitaux de lInstitut Catholique de Lille
Dr. Seong Ho Cho, MD1, Dr. Sun Hye Lee, PhD1, Dr. Atsushi (GH-ICL), Lille, France, 3Hopital Necker Enfants Malades, Paris,
Kato, PhD2, Dr. Tetsuji Takabayashi, MD1, Dr. Soon Shin1 and France, 4DBV Technologies, Paris, France
Dr. Robert P. Schleimer, PhD FAAAAI1, 1Division of Allergy-Im- 232 Development and Piloting Of a Food Allergy Education Pro-
munology, Department of Medicine, Northwestern University Fein- gram For Parents Of Young Children
berg School of Medicine, Chicago, IL, 2Department of Medicine, Ms. Catherine Gillespie, RN MN CAE1, Ms. Nancy Ross, RN
Division of Allergy-Immunology, Northwestern University Fein- CAE1, Dr. Nestor F. Cisneros, MD FRCPC2 and Dr. Allan Becker,
berg School of Medicine, Chicago, IL MD FRCPC3, 1Childrens Hospital, Winnipeg, MB, Canada, 2Uni-
versity of Manitoba, Winnipeg, MB, Canada, 3University Of Man-
itoba, Winnipeg, MB, Canada
233 The Proficiency Status In The Use Of Inhaler and The Effect Of
Education On Inhaler Technique
Allied Health Saturday Poster Session Eun-Jung Jo, MD1, Jung-Ha Mok, MD1, Seung-Eun Lee, MD2,
Mi-Hyun Kim, MD1, Kwangha Lee, MD, PhD1, Ki-Uk Kim,
2214 MD, PhD1, Min-Ki Lee, MD, PhD1 and Hye-Kyung Park, MD,
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM PhD1, 1Department of Internal Medicine, Pusan National University
226 Tolerability Of Two Different Immunoglobulin Intravenous School of Medicine, Busan, South Korea, 2Department of Internal
Product In Patients With Primary Immunodeficiency Disease Medicine, Pusan National University Yangsan Hospital, Yangsan,
Amanda Skoskiewicz, MSN, CPNP, Ann & Robert H. Lurie Chil- South Korea
drens Hospital of Chicago, Chicago, IL, Melanie M. Makhija, MD, 234 The Natural History Of Wheat Hypersensitivity In Thai Chil-
Division of Allergy & Immunology, Department of Pediatrics,- dren
Northwestern University Feinberg School of Medicine, Chicago, Dr. Nunthana Siripipattanamongkol, MD, Mahidol university,
IL; Ann and Robert H. Lurie Childrens Hospital of Chicago, Chi- Bangkok, Thailand
cago, IL and Ramsay L. Fuleihan, MD, Division of Allergy & Im- 235 Development Of a Multidisciplinary Clinic To Improve Care Of
munology, Department of Pediatrics, Northwestern University Adolescent Asthmatic Patients Ms. Lila C. Kertz, MSN RN
Feinberg School of Medicine, Ann & Robert H. Lurie Childrens CPNP AE-C, Washington University, St. Louis, MO
97
AB308 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
236 Food Allergy Herbal Formula-2 (FAHF-2) Adherence To L.K. Znamenska1 and Prof. Lawrence M. DuBuske, MD,
Treatment FAAAAI2, 1Crimean State Medical University, Ukraine, 2George
Jaime Ross, RN1, Suzanne K. Carlisle, RN BSN CCRP2, Maripaz Washington University School of Medicine, DC
Vazquez, RN, BSN, CDE3, Stacie M. Jones, MD4, Dr. Jacqueline Pon-
gracic, MD, FAAAAI5 and Dr. Julie Wang, MD, FAAAAI1, 1The
Icahn School of Medicine at Mount Sinai, New York, NY, 2University
of Arkansas for Medical Sciences, Little Rock, AR, 3Division of Al- Mechanisms and Immunotherapy
lergy and Immunology, Ann & Robert H. Lurie Childrens Hospital
of Chicago, Chicago, IL, Chicago, IL, 4Slot 512-13, University of Ar- 2602
kansas for Medical Sciences, Little Rock, AR, 5Ann & Robert H. Lurie Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
Childrens Hospital of Chicago, Chicago, IL 244 The Utility Of Anti-Pneumococcal Antibody Measurement In Pa-
237 Adapting Waiting-List For Allergy By Health Care On-Line: Co- tients With Primary Immunodeficiency Receiving Immunoglobulin
ordination Between Providers and Allergist In The Public System Dr. Stephen Jolles, Dr. Adrian Heaps, Dr. Mo Moody and Dr. Rachel
Dr. Inmaculada S anchez-Machn, MD1, Dr. Paloma Poza Guedes2, Jones, University Hospital of Wales, Cardiff, United Kingdom
Dr. Ruperto gonzalez Perez1, Dr. Yvelise Barrios, MD, PhD3 and Dr. 245 Diagnostic Immunization With Bacteriophage FX 174 In Pa-
Victor Matheu, MD1, 1Hospital del T orax-Ofra, Sta Cruz de Tenerife, tients With Common Variable Immunodeficiency/Hypogamma-
Spain, 2Hospital Ofra-Torax, santa cruz de tenerife, Spain, 3Hospital globulinemia
Universitario de Canarias, Tenerife, Spain Dr. Lauren Smith, MD1, Dr. Rebecca H. Buckley, MD, FAAAAI1
238 Aerobiology Of Texas Panhandle and Efficiency Of AHPCO and Dr. Patricia L. Lugar, MD, MS2, 1Department of Pediatrics,
Technology As Air Purifier, Surface Sterilizer In Food Processing Duke University Medical Center, Durham, NC, 2Duke University
Dr. Nabarun K. Ghosh, PhD1, Dr. Constantine K. Saadeh, MD, Medical Center, Durham, NC
FAAAAI2, Dr. Jeff Bennert, PhD CTN3 and Ms. Griselda Estrada, 246 Immunochip Study Reveals Regions On Chromosomes 2 and 6
BS1, 1West Texas A&M University, Canyon, TX, 2Allergy ARTS May Contribute To The Spectrum Of CVID
ACCR, Amarillo, TX, 3AIR OASIS, Amarillo, TX Dr. Tracy Hwangpo, MD/PhD1, Ewa Szymanksa, PhD1, Mrs.
Marsha Brand1, Dr. Peter Gregerson, MD2, Dr. Peter Burrows, PhD3,
Dr. Elizabeth Brown, PhD4, Dr. Richard Reynolds, PhD5 and Dr. Harry
Schroeder, MD/PhD6, 1UAB, 2The Feinstein Institute for Medical Re-
Novel Genetic Factors in Asthma search, 3UAB, Department of Microbiology, 4UAB,Department of Ep-
idemiology, 5UAB, Department of Medicine, 6UAB, Department of
Medicine and Department of Microbiology, AL
2601 247 Rule Of Different Memory Cells In Common Variable Immuno-
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM deficiency and Specific Antibody Deficiency
239 IL-33 and IL1RL1 Single Nucleotide Polymorphisms and Their Amer M. Khojah, MD, Umm Al Qura Univirsity, Makkah, Saudi
Association With Asthma Among Puerto Ricans Arabia; Inova Fairfax Hospital for children, Fall Church, VA, Oral
Dr. Javier A. Mendez, MD, Dr. Sylvette Nazario, MD, Dr. Angel Alpan, MD, Amerimmune, LLC, VA; O&O ALPAN, LLC and
Laureano, MD, Dr. Adriana Baez, PhD and Ms. Bianca Rivera, Ameera Bukhari, MS, Taif University, Saudi Arabia
PhDc, University of Puerto Rico School of Medicine, San Juan, PR 248 Evaluation of a Novel Missense Activation-Induced Deaminase
240 Genetic Effect Of Single-Nucleotide Polymorphisms In The AID Mutation in a Child with Hyper IgM Syndrome: Is it a
PPARGC1B Gene On Airway Hyperreactivity In Asthmatic Pa- Pathogenic Mutation?
tients Dr. Ottavia M. Delmonte, M.D., Pediatric Residency Program, Boston
Dr. Jong-Sook Park, MD, Dr. Myung-Sin Kim, Dr. Sung-Woo Childrens Hospital, Harvard Medical School, Boston, MA, Dr. Feilong
Park, Dr. An-Soo Jang and Dr. Choon-Sik Park, MD, Soonchun- Meng, PhD, Howard Hughes Medical Institute, Program in Cellular and
hyang University Bucheon Hospital, Bucheon, South Korea Molecular Medicine and Immune Disease Institute, Boston Childrens
241 Polymorphisms In IL10, TGFB, TLR4, TLR8 and ADBR2 Genes Hospital, Department of Genetcis, Harvard Medical School, Boston,
Resulted Associated To Asthma In Brazilian Family Trio Study MA, Dr. Frederick Alt, PhD, Howard Hughes Medical Institute, Pro-
Mrs. Isabel Rugu^e Genov, MD, Federal University of S~ao Paulo, gram in Cellular and Molecular Medicine and Immune Disease Insti-
S~ao Paulo, Brazil, Mrs. Angela Falcai, PhD, ICB USP, S~ao Paulo, tute, Boston Childrens Hospital, Department of Genetics, Harvard
Brazil, Dr. Lucila Camargo, MD, UNIFESP, S~ao Paulo, Brazil, Dr. Medical School, Boston, MA, Dr. Luigi D. Notarangelo, MD, Division
Marcia Mallozi, MD, Federal University of S~ao Paulo, Brazil, Dr. of Immunology, Boston Childrens Hospital, Harvard Medical School,
Virginia Ferriani, MD, PhD, School of Medicine of Ribeirao Preto- Boston, MA; The Manton Center for Orphan Disease Research, Boston
University of Sao Paulo, Brazil, Prof. Alessandra Pontillo, PhD, Uni- Childrens Hospital, Boston, MA and Dr. Jolan E. Walter, MD, PhD, Di-
versity of S~ao Paulo, Brazil, Prof. Antonio Condino-Neto, MD, PhD, vision of Allergy/Immunology, Massachusetts General Hospital for
Institute of Biomedical Sciences, Department of Immunology, Uni- Children, Harvard Medical School, Boston, MA
versity of S~ao Paulo, Sao Paulo, Brazil and Prof. Dirceu Sole, MD,
PhD, Federal University of Sao Paulo, Sao Paulo, Brazil
242 Genetic Variation Along The Histamine Pathway In Children
With Allergic Vs. Non-Allergic Asthma Asthma Environmental Risk Factors and
Dr. Sara Anvari, MD1, Dr. Carrie A. Vyhlidal, PhD2, Mo Rezaie-
khaligh, MS2, Dr. Hongying Dai, PhD2 and Dr. Bridgette L. Jones,
Infections
MD, FAAAAI1,2, 1Childrens Mercy Hospital & Clinics, Division
of Allergy, Asthma and Immunology, Kansas City, MO, 2Childrens 2603
Mercy Hospital & Clinics, Division of Pediatric Clinical Pharma- Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
cology, Kansas City, MO 249 Surfactant Protein A (SP-A) Reduces Human Rhinovirus 16
243 Association Of Polymorphism At The CD14 Promoter (CD14- (RV16)-Induced Inflammatory Responses In Bronchial Epithe-
C159T) With Atopic and Non-Atopic Asthma In Adults From lial Cells and Inhibits Viral Replication In H1-HeLa Cells
Crimea, Ukraine Sasipa Tanyaratsrisakul, PhD1, Ying Wang, MD2, Monica Kraft,
Dr. Yuri Bisyuk1, Prof. V.A. Beloglazov1, Dr. A.I. Dubovyi1, Dr. MD2, Mari Nakamura, MD1 and Prof. Dennis R. Voelker, PhD1,
98
J ALLERGY CLIN IMMUNOL Abstracts AB309
VOLUME 133, NUMBER 2
SATURDAY
1
Department of medicine, National Jewish Health, Denver, CO, 2De- PhD, FAAAAI4, Prof. Anne-Louise Ponsonby, PhD1, Dr. Melanie
partment of Medicine, Duke University Medical Center, Durham, NC Matheson, PhD3, Dr. David Hill, MBBD, FRACP1 and Prof. Katrina
250 The Home Microbiome and Childhood Asthma Jane Allen, MD, PhD, FAAAAI1,5, 1Murdoch Childrens Research
Dr. Christina E. Ciaccio, MD, FAAAAI, Mr. Kevin Kennedy, Institute, Victoria, Australia, 3University of Melbourne, Victoria, Aus-
MPH CIEC, Prof. Charles S. Barnes, PhD, Dr. Jay M. Portnoy, tralia, 4The University of Melbourne, Melbourne, Australia, 5Royal
MD, FAAAAI and Dr. Lanny J. Rosenwasser, MD, FAAAAI, Chil- Childrens Hospital, Victoria, Australia
drens Mercy Hospital, Kansas City, MO 256 Exome Chip Genotyping Reveals Association With PDE4C and
251 Effect Of Prenatal Antioxidant Intake On Infants Respiratory Atopic Dermatitis In Populations Of European and African De-
Infection scent
Dr. Eun Lee1, Seo Ah Hong2, Dr. Song I Yang, MD1, Prof. Kyung Nicholas M. Rafaels1, Lili Huang, MPH1, Donald Y.M. Leung, MD,
Won Kim, MD, PhD3, Prof. Youn Ho Shin4, Kang Mo Ahn5, Dr. PhD, FAAAAI2, Lisa A. Beck, MD, FAAAAI3, Dr. Candelaria I. Ver-
Soo-Jong Hong, MD, PhD1 and And the COCOA study group, 1De- gara, MD, PhD1, Dr. Mark Boguniewicz, MD, FAAAAI2, Dr. Tissa
partment of Pediatrics, Childhood Asthma Atopy Center, Research Hata, MD4, Dr. Lynda C. Schneider, MD, FAAAAI5, Dr. Jon M. Ha-
Center for Standization of Allergic Diseases, Asan Medical Center, nifin, MD, FAAAAI6, Dr. Richard Gallo, MD, PhD7, Dr. Li Gao, MD,
University of Ulsan College of Medicine, Seoul, Korea, 2Asan Insti- PhD1, Dr. Ingo Ruczinski, PhD8, Dr. Rasika A. Mathias, ScD1 and Dr.
tute for Life Sciences, University of Ulsan College of Medicine, Kathleen C. Barnes, PhD FAAAAI1, 1Division of Allergy and Clini-
Seoul, Korea, 3Department of Pediatrics, Severance Childrens Hos- cal Immunology, Department of Medicine, Johns Hopkins Univer-
pital, College of Medicine, Yonsei University, Seoul, Korea, Seoul, sity, Baltimore, MD, 2National Jewish Health, Denver, CO,
South Korea, 4Department of Pediatrics, CHA Medical Center, 3
University of Rochester Medical Center, Rochester, NY, 4University
CHA University School of Medicine, Seoul, Korea, South Korea, of California, San Diego, San Diego, CA, 5Boston Childrens Hospi-
5
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan tal, Boston, MA, 6Oregon Health & Science University, Portland,
University School of Medicine, Seoul, Korea, South Korea OR, 7Division of Dermatology, University of California, San Diego,
252 Epidermal Growth Factor Receptor (EGFR) Mediates Cell Fu- San Diego, CA, 8Johns Hopkins University School of Public Health,
sion and Infectivity Of Respiratory Syncytial Virus (RSV) Baltimore, MD
Sujin Lee1,2, Michael G. Currier1,2, Anne L. Hotard1,2, Jia Meng1,2, 257 Exploring a Role for Laminin Proteins in the Pathogenesis of
Carla Pretto1,2, Ultan F. Power3, Remi Villenave3, Michael D. Atopic Dermatitis
Shields3,4, Michael H. Chi5, R. Stokes Peebles6 and Martin L. Erin J. Klaffky, MD, PhD, Rachana Agrawal, PhD and Judith A.
Moore1,2, 1Department of Pediatrics, Emory University, GA, 2Chil- Woodfolk, MBChB, PhD, FAAAAI, University of Virginia, Char-
drens Healthcare of Atlanta, GA, 3Centre for Infection and Immu- lottesville, VA
nity, School of Medicine, Dentistry and Biomedical Science, 258 Thymic Stromal Lymphopoietin and Interleukin-33 Promote
Queens University Belfast, Northern Ireland, 4The Royal Belfast Skin Inflammation and Containment Of Vaccinia Virus In A
Hospital for Sick Children, Northern Ireland, 5Allergy, Pulmonary, Mouse Model Of Atopic Dermatitis
and Critical Care Medicine; Department of Medicine; Vanderbilt Dr. Michiko K. Oyoshi, PhD, MSc, Ms. Jacqueline Beaupre, Mr. Nich-
University School of Medicine, TN, 6Allergy, Pulmonary, and Crit- olas Venturelli and Raif S. Geha, MD, Division of Immunology, Boston
ical Care Medicine, Department of Medicine, Vanderbilt University Childrens Hospital, Harvard Medical School, Boston, MA
School of Medicine, Nashville, TN
253 Cluster Analysis Of An Inner-City Cohort Of Infant Wheezers
Dr. Monica B. Reddy, MD1, Andrew H. Liu, MD2, Allison
Schiltz1,2, Mrs. Anna Forssen, MS2 and Dr. Mary D. Klinnert,
PhD1,2, 1University of Colorado School of Medicine, 2National
Health Disparities
Jewish Health, Denver, CO
2605
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
259 What Really Happens In The Home: The Medication Environ-
ment Of Urban, Minority Youth
Atopic Dermatitis Dr. Molly Martin, MD, MAPP and Andrea A Pappalardo, MD,
Rush University Medical Center, Chicago, IL
2604 260 Young, African American Adults With Asthma: What Matters
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM To Them?
254 A Randomized, Multi-Center, NIH/NIAID Funded Study To As- Dr. Aimee L. Speck, M.D.1, Dr. Belinda Nelson, PhD2, Mrs. S. Olivia
sess The Immunogenicity Of Fluzone Intradermal and Intra- Jefferson, MSW3 and Dr. Alan P. Baptist, MD, MPH FAAAAI1, 1Uni-
muscular Vaccines In Atopic Dermatitis versity of Michigan, Division of Allergy and Clinical Immunology,
Donald Y.M. Leung, MD, PhD, FAAAAI1, Lisa A. Beck, MD, Ann Arbor, MI, 2University of Michigan, Health Behavior and Health
FAAAAI2, Dr. Jon M. Hanifin, MD, FAAAAI3, Dr. Lynda C. Education, School of Public Health, Ann Arbor, MI, 3University of
Schneider, MD, FAAAAI4, Dr. Amy Paller, MD5, Dr. Gloria David, Michigan, Department of Health Behavior and Health Education,
PhD6, Ms. Katherine Monti6, Mr. Brett Jepson6 and Dr. Adriana School of Public Health, Ann Arbor, MI
Weinberg, MD7, 1National Jewish Health, Denver, CO, 2University 261 Language Disparities Among Minority Patients with Poor
of Rochester Medical Center, Rochester, NY, 3Oregon Health & Asthma Control
Science University, Portland, OR, 4Boston Childrens Hospital, Dr. Jose R. Zaragoza-Buxo, MD, Penn State University College of
Boston, MA, 5Northwestern University Feinberg School of Medi- Medicine, Hershey, PA and Dr. Efren L. Rael, MD, FAAAAI, Al-
cine, Chicago, IL, 6Rho, Inc., Chapel Hill, NC, 7University of Col- lergy/Immunology, Penn State University College of Medicine,
orado Heath Sci Ctr., Denver, CO Hershey, PA
255 Which Infants With Eczema Are At Risk Of Food Allergy? Re- 262 Race/Ethnicity and SES Are Predictors Of Allergic Sensitiza-
sults From A Population Based Study tion To Environmental and Food Allergens
Dr. Jana K. Eckert, PhD1, Dr. Pamela Martin, PhD1, Dr. Adrian Dr. Amina Abdeldaim, MD1, Dr. Supinda Bunyavanich, MD,
Lowe, PhD1,3, Dr. Jennifer Koplin, PhD1, Prof. Shyamali Dharmage, MPH2, Ms. Sheryl Rifas-Shiman, MPH3, Thomas A.E. Platts-Mills,
MD, PhD1,3, Prof. Lyle Gurrin, PhD1,3, Prof. Mimi L. K. Tang, MD, MD, PhD, FAAAAI4, Dr. Diane R. Gold, MD, MPH5, Dr. Carlos
99
AB310 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY
Camargo Jr., MD, DrPH6, Dr. Emily Oken, MD7, Dr. Matthew Gill- 267 Role Of Basophil Activation Test For Identifying Subjects With
man, MD, SM3 and Dr. Augusto A. Litonjua, MD, MPH8, 1Channing Local Allergic Rhinitis
Division of Network Medicine, Brigham and Womens Hospital, Dr. Paloma Campo, MD, PhD1, Dr. Carmen Rondon, MD, PhD1,
MA, 2Division of Pediatric Allergy & Immunology, Department of Dr. Enrique Gomez, PhD2, Dr. Esther Barrionuevo Sanchez1, Mrs.
Pediatrics, Icahn School of Medicine at Mount Sinai, New York, Luisa Galindo, RN1, Mr. JA Huertas1, Dr. Cristobalina Mayorga,
NY, 3Harvard Medical School, Boston, MA, 4Division of Asthma, Al- PhD2 and Dr. Miguel Blanca, MD, PhD1, 1Allergy Service, Carlos
lergy & Immunology, University of Virginia Health System, Charlot- Haya Hospital, Malaga, Spain, 2Research Laboratory for Allergic
tesville, VA, 5Channing Laboratory, Brigham and Womens Hospital, Diseases, Hospital Regional Universitario de Malaga - IBIMA,
Boston, MA, 6Department of Emergency Medicine, Massachusetts Malaga, Spain
General Hospital, Harvard Medical School, Boston, MA, 7Harvard 268 Does Serum Leptin Differ Between Patients With Rhinitis Of
Medical School, 8Channing Division of Network Medicine, Brigham Allergic Vs Nonallergic Aetiology?
and Womens Hospital, Boston, MA Prof. Ayse Fusun Kalpaklioglu, MD and Dr. Ayse Baccioglu, MD,
263 Unrecognized Allergic Rhinoconjunctivitis and Allergic Sensiti- Kirikkale University Faculty of Medicine Department of Allergic
zation Among Latino Youth (GALA II Study) Diseases
Ulysses Burley, MPH1, Dr. Joy Hsu, MD, MSCI2, Duanny Alva,
MD-IMG, MPH1, Ms. Elizabeth Nguyen, BS3, Ms. Lindsey Roth,
MA4, Dr. Joshua Galanter, MD4, Dr. Sam Oh, PhD, MPH4, Ms. Ce-
leste Eng, BS4, Mr. Fred Lurmann, MS5, Dr. Rajesh Kumar, MD, Mechanisms of Steroid and Arachidonic Acid
MS, FAAAAI6, Dr. Harold J. Farber, MD, MSPH7, Dr. Denise Ser-
ebrisky, MD8, Dr. Luisa Borrell, DDS, PhD9, Dr. Saunak Sen,
Pathways in Allergic Disease
PhD10, Dr. William Rodriguez-Cintron, MD11, Dr. Jose Rodriguez-
Santana, MD12, Dr. Esteban Gonza Burchard, MD, MPH4 and Prof. 2607
Pedro C. Avila, MD, FAAAAI1, 1Feinberg School of Medicine, Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
Northwestern University, Chicago, IL, 2Department of Medicine, Di- 269 LTC4, But Not LTD4 Or LTE4, Activates Platelets Through a
vision of Allergy-Immunology, Northwestern University Feinberg CysLT2R and P2Y12 Receptor-Dependent Pathway
School of Medicine, Chicago, IL, 3Department of Medicine, Univer- Dr. Joshua A. Boyce, MD, FAAAAI1,2, Dr. Tao Liu, PhD1,2 and
sity of California, San Francisco, California, San Francisco, CA, 4De- Dr. Hannah Cummings, PhD1,2, 1Harvard Medical School, Boston,
partment of Medicine, University of California, San Francisco, San MA, 2Brigham and Womens Hospital, Division of Rheumatology,
Francisco, CA, 5Sonoma Technology, Inc., Petaluma, CA, 6Pediatric Immunology and Allergy, Boston, MA
allergy, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi- 270 Predictors Of Response To Glucocorticoids In Hypereosino-
cago, IL, 7Baylor College of Medicine and Texas Childrens Hospital, philic Syndromes
Houston, TX, 8Pediatric Pulmonary Division, Jacobi Medical Center, Paneez Khoury, MD1, Annalise Abiodun, RN1, Kelli Williams,
Bronx, NY, 9Department of Health Sciences, Graduate Program in MD, M.P.H.1, JeanAnne Ware, CRNP1, Nicole Holland-Thomas,
Public Health, Lehman College, City University of New York, Bronx, MSN, RN2 and Dr. Amy D. Klion, MD1, 1National Institutes of
NY, 10Department of Epidemiology and Biostatistics, University of Health, Bethesda, MD, 2SAIC-Frederick Inc., Bethesda, MD
California, San Francisco, San Francisco, CA, 11Veterans Caribbean 271 Differential Proteomic Analysis Of Eosinophils From Patients
Health Care System, San Juan, PR, 12Centro de Neumologia Pedia- With Glucocorticoid Responsive Or Resistant Hypereosino-
trica, San Juan, PR philic Syndrome
Konrad Pazdrak, MD, PhD1, Paneez Khoury, MD2, Kizhake V.
Soman, PhD1, Nicole Holland-Thomas, MSN, RN3, Mrs. Michelle
Makiya2, Christof Straub, PhD1, Zheng Wu, PhD1, Dr. Amy D.
Klion, MD2 and Alexander Kurosky, PhD1, 1University of Texas
Local Allergic Rhinitis and Non-Allergic Rhinitis Medical Branch, Galveston, TX, 2National Institutes of Health, Be-
thesda, MD, 3SAIC-Frederick Inc., Bethesda, MD
2606 272 Glucocorticoid Receptor-^a Up-Regulation In C57BL/6 Diet-In-
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM duced Obese Mice With House Dust Mite-Mediated Asthma
264 The Nasal NO Response To External Acoustic Energy: A Pilot Dr. Jennifer Diaz, MD1,2, Dr. Malvika Solanki, MBBS, MPH3, Dr.
Study Xiangying Xue, MD3, Prodyot Chatterjee, PhD3, Dr. Madhu Gupta,
Dennis Shusterman, MD, MPH, University of California, San MBBS3, Dr. Vincent R. Bonagura, MD, FAAAAI4 and Christine
Francisco, Richmond, CA Metz, PhD3, 1Feinstein Institute for Medical Research, Manhasset,
265 Flagellin/Toll-Like Receptor 5 Induces Interleukin-17C In Hu- NY, 2Allergy and Immunology, North Shore-LIJ Health System,
man Nasal Epithelia Great Neck, NY, 3Feinstein Institute for Medical Research, NY,
Dr. Hyun Jin Min1, Dr. Tae-Hoon Kim2, Su-Yeon Choi2, Prof. Joo- 4
Division of Allergy/Immunology, Departments of Medicine and
Heon Yoon1,2 and Prof. Chang-Hoon Kim1,3, 1Department of Oto- Pediatrics, Hofstra North Shore-LIJ School of Medicine, Great
rhinolaryngology, Yonsei University College of Medicine, Seoul, Neck, NY
South Korea, 2Research Center for Human Natural Defense System, 273 Reduced EP2 Receptor Expression Accounts For Prostaglandin
Yonsei University College of Medicine, Seoul, South Korea, 3The E2 Resistance In Nasal Polyp Fibroblasts From Patients With
Airway Mucus Institute, Yonsei University College of Medicine, Aspirin Exacerbated Respiratory Disease; Possible Role For
Seoul, South Korea Histone Acetylation In Control Of EP2 Receptor Expression
266 Phenotyping Non-Allergic and Local Allergic Rhinitis Dr. Katherine N. Cahill, MD1,2, Mr. Derek Thibault3, Dr. Benja-
Dr. Carmen Rondon, MD, PhD1, Dr. Paloma Campo, MD, PhD1, min A. Raby, MD, MPH3, Dr. Andrea Baccarelli, MD, MPH
Dr. Esther Barrionuevo Sanchez, MD1, Ms. Cristina De Leiva Mo- PhD4, Dr. Neil Bhattacharyya, MD2,3, Dr. Joshua A. Boyce, MD,
lina1, Dr. Leticia Herrero Lifona, MD, PhD1, Ms. Maria Auxiliadora FAAAAI1,2 and Dr. Tanya M. Laidlaw, MD, FAAAAI1,2, 1Brigham
Guerrero1, Dr. Francisca Gomez, MD, PhD1, Dr. Natalia Blanca- and Womens Hospital, Division of Rheumatology, Immunology
Lopez, MD, PhD2, Dr. Gabriela Canto, MD, PhD2 and Dr. Miguel and Allergy, Boston, MA, 2Harvard Medical School, Boston, MA,
Blanca, MD, PhD1, 1Allergy Service, Carlos Haya Hospital, Malaga, 3
Brigham and Womens Hospital, Boston, MA, 4Harvard School
Spain, 2Allergy Service, Infanta Leonor Hospital, Madrid, Spain of Public Health, Boston, MA
100
J ALLERGY CLIN IMMUNOL Abstracts AB311
VOLUME 133, NUMBER 2
SUNDAY
and St. Louis Childrens Hospital, Saint Louis, MO
276 A Seven Minute High Intensity Workout Is Well Tolerated In rea, South Korea, 2Childhood Asthma Atopy Center, Department of
Adults With Asthma and Results In Decreased Salivary Leuko- Pediatrics, Asan Medical Center, University of Ulsan College of
trienes Medicine, Seoul, South Korea, 3Department of Pediatrics, Kosin
Dr. Katherine G. Conner, MD1, Dr. Meaghan Misiasz, M.D.1, Dr. University Gospel Hospital, Kosin University College of Medicine,
Maria Talamo2, Ms. Caitlin Campion1, Julie McDaniel1, Dr. Jun Fu, Seoul, South Korea, 4Department of Pediatrics, Korea Cancer Cen-
PhD1 and James N Moy, MD1,2, 1Rush University Medical Center, Chi- ter Hospital, Seoul, South Korea, 5Department of Pediatrics, Hae-
cago, IL, 2John H. Stroger Hospital of Cook County, Chicago, IL undae Paik Hospital, Inje University College of Medicine, Busan,
277 Obesity and Depression Affecting Asthma Morbidity: An Anal- South Korea, 6Department of Pediatrics,Inje University Sanggye
ysis Of Montefiore Asthma Centers Poorly Controlled Asth- Paik Hospital, Seoul, South Korea, 7Department of Pediatrics, Hal-
matics lym University College of Medicine, Seoul, South Korea, 8Depart-
Dr. Sunit Jariwala, MD1, Dr. Jennifer Toh, MD1 and Dr. Sumita Si- ment of Pediatrics, Korea University Guro Hospital, Seoul, South
nha, MD2, 1Albert Einstein/Montefiore Medical Center, New York, Korea, 9Department of Pediatrics, Seoul Paik Hospital, Inje Univer-
NY, 2Albert Einstein/Montefiore Medical Center, Bronx, NY sity College of Medicine, Seoul, South Korea, 10Department of Pe-
278 Psycho Social Stresses and Asthma Morbidity In Children diatrics, National Health Insurance Corporation Ilsan Hospital,
Dr. Ejaz Yousef, MD FAAAI, Marshfield Clinic, Marshfield, WI; Seoul, South Korea, 11Department of Pediatrics, Kangbuk Samsung
Marshfield Clinic, Marshfield, WI Hospital, Sungkyunkwan University College of Medicine, Seoul,
279 Does The Sinusitis Affect Bronchial Hyperresponsiveness In South Korea, 12Research Center for Standardization of Allergic
Asthmatic Children ? Disease, University of Ulsan College of Medicine, Seoul, Korea,
13
Chikako Motomura, Dr. Hiroshi Odajima, Yuko Amimoto, Rin- Department of Pediatrics, Seoul National University Bundang
taro Ono, Keisuke Watanuki, Yoko Murakami, Naohiko Taba, Sa- Hospital, Seoul National University College of Medicine, Seong-
toshi Honjho and Sankei Nishima, Fukuoka National Hospital, nam, South Korea
Fukuoka, Japan 286 Nasal Provocation Test In The Diagnosis Of Mite Allergic Rhi-
280 Allergic Bronchopulmonary Mycosis. Are We Overdiagnosing nitis : Standard Or Rapid ?
In Cape Town, South Africa? Prof. Frederic de BLAY, Dr. Celine Lutz, Dr. Mael Bellier, Prof.
Dr. Tamara Kerbelker, MBChB, Red Cross War Memorial Chil- Jean Jacques Braun and Mrs. Brigitte Sbinne, CHRU Strasbourg,
drens Hospital, Cape Town, South Africa France
281 Risk Factors For Postoperative Pulmonary Complications After 287 Nocturnal Asthma In Latino Children Is Associated With Se-
Noncardiothoracic Surgery In Adult Asthma Patients vere Disease and Allergenic Triggers (GALA II Study)
Seung-Eun Lee, MD1,2, Eun-Jung Jo, MD2, Hye-Kyung Park, MD2, Dr. Geeta Bhargave, MD1, Dr. Joy Hsu, MD, MSCI1, Ms. Eliza-
Woo-Hyeon Cho, MD1,2, Doo-Soo Jeon, MD1,2 and Prof. Yun-Seong beth Nguyen, BS2, Ms. Lindsey Roth, MA3, Dr. Joshua Galanter,
Kim, MD1,2, 1Respiratory and allergy clinic, Pusan National University MD3, Dr. Sam Oh, PhD, MPH3, Ms. Celeste Eng, BS3, Mr. Fred
Yangsan Hospital, South Korea, 2Department of Internal Medicine, Pu- Lurmann, MS4, Dr. Harold J. Farber, MD, MSPH5, Dr. Denise Ser-
san National University School of Medicine, South Korea ebrisky, MD6, Dr. Luisa Borrell, DDS, PhD7, Dr. Saunak Sen,
282 Rates Of Comorbidities Are Related To Level Of Asthma Con- PhD8, Dr. William Rodriguez-Cintron, MD9, Dr. Jose Rodriguez-
trol Santana, MD10, Dr. Esteban Gonza Burchard, MD, MPH3 and
Dr. Mark Stevens, MD1, Dr. Jeffrey R. Stokes, MD, FAAAAI1, Prof. Pedro C. Avila, MD, FAAAAI1, 1Feinberg School of Medi-
Ryan Walters, M.S.2, Dr. Michael Schatz, MD, MS, FAAAAI3 cine, Northwestern University, Chicago, IL, 2Department of Medi-
and Dr. Thomas B. Casale, MD, FAAAAI4, 1Creighton University cine, University of California, San Francisco, California, San
Medical Center, Omaha, NE, 2Creighton University, 3Kaiser Perma- Francisco, CA, 3Department of Medicine, University of California,
nente Southern California, San Diego, CA, 4Univeristy Of South San Francisco, San Francisco, CA, 4Sonoma Technology, Inc., Pet-
Florida Morsani College Of Medicine, Tampa, FL aluma, CA, 5Baylor College of Medicine and Texas Childrens Hos-
283 Rates Of Co-Morbidities Are Related To Asthma Severity pital, Houston, TX, 6Pediatric Pulmonary Division, Jacobi Medical
Dr. Jeffrey R. Stokes, MD, FAAAAI1, Dr. Mark Stevens, MD1, Center, Bronx, NY, 7Department of Health Sciences, Graduate Pro-
Ryan Walters, M.S.2, Dr. Michael Schatz, MD, MS, FAAAAI3 gram in Public Health, Lehman College, City University of New
and Dr. Thomas B. Casale, MD, FAAAAI4, 1Creighton University York, Bronx, NY, 8Department of Epidemiology and Biostatistics,
Medical Center, Omaha, NE, 2Creighton University, 3Kaiser Perma- University of California, San Francisco, San Francisco, CA, 9Vet-
nente Southern California, San Diego, CA, 4Univeristy Of South erans Caribbean Health Care System, San Juan, PR, 10Centro de
Florida Morsani College Of Medicine, Tampa, FL Neumologia Pediatrica, San Juan, PR
101
AB312 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
8
Biomarkers and Asthma Control I Department of Pediatrics, Seoul National University Bundang
Hospital, Seoul National University College of Medicine, Seong-
nam, South Korea, 9Department of Pediatrics, Hae-undae Paik Hos-
3202 pital, Inje University College of Medicine, Busan, South Korea,
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM 10
Department of Pediatrics, Hae-undae Paik Hospital, Inje Univer-
288 Nasal Challenge With 50mgs Of L-Aspirin For Diagnosis Of sity College of Medicine, 11Department of Pediatrics,Inje Univer-
ASA Exacerbated Respiratory Disease sity Sanggye Paik Hospital, Seoul, South Korea, 12Research
Dr. Jose Manuel Reyna Guerra, MD, National Institute Of Respi- Center for Standardization of Allergic Diseases, Seoul, South Ko-
ratory Diseases, Distrito Federal, Mexico rea, South Korea, 13Department of Pediatrics, Hallym University
289 Clinical Usefulness Of Bronchial Mannitol Provocation Test In College of Medicine, Seoul, South Korea, 14Department of Pediat-
Children With Asthma Symptoms rics, Korea University Guro Hospital, Seoul, South Korea, 15Depart-
Dr. Young A. Park, MD1, Hyun Bin Park, MD1, Dr. Yoon Hee Kim, ment of Pediatrics, Seoul Paik Hospital, Inje University College of
MD1, Dr. Hee Seon Lee, MD1, Dr. Yoon Ki Han, MD1, Dr. Min Jung Medicine, Seoul, South Korea, 16Department of Pediatrics, National
Kim, MD1, Hye Mi Jee, MD2, Prof. Kyung Won Kim, MD, PhD1, Health Insurance Corporation Ilsan Hospital, Seoul, South Korea,
17
Prof. Myung Hyun Sohn, MD, PhD1 and Prof. Kyu-Earn Kim, MD, Department of Pediatrics, Kangbuk Samsung Hospital, Sung-
PhD1, 1Department of Pediatrics, Severance Children s Hospital, kyunkwan University College of Medicine, Seoul, South Korea
College of Medicine, Yonsei University, Seoul, Korea, Seoul, South 293 Metabolomic Profiles Of Exhaled Breath Condensate In Asth-
Korea, 2Department of Pediatrics, CHA University School of Medi- matics
SUNDAY
cine, Seongnam, Korea, South Korea Dr. Sandra Ho, MD1, Dr. Bruce Luxon, PhD1, Dr. Wendy Baker,
290 Salivary Alpha Amylase Activity Is a Potential Surrogate Bio- PhD1, Dr. Heidi Spratt, PhD1, Dr. Rohit Divekar, MBBS, PhD2,
marker For Inhaled Beta-2 Agonist Responsiveness Emily Aaron1 and Dr. William J. Calhoun, MD, FAAAAI1, 1Insti-
Andrea A Pappalardo, MD1,2, Jamie H Kiehm, MD1, Caitlin M tute of Translational Sciences, University of Texas Medical Branch,
Campion1, Dr. Larry L. Thomas, PhD1 and James N Moy, MD1,2, Galveston, TX, 2Division of Allergic Diseases, Mayo Clinic, Ro-
1
Rush University Medical Center, Chicago, IL, 2John H. Stroger chester, MN
Hospital of Cook County, Chicago, IL 294 Extended Nitric Oxide Analysis and Bronchial Hyperrespon-
291 Feno Decreases Significantly During Improved Symptom Con- siveness In Children With Asthma According To Atopy
trol In Pediatric Patients After Acute Asthma Exacerbations Dr. Yoon Hee Kim, MD, Dr. Min Jung Kim, MD, Dr. Hee Seon
Necessitating Emergency Department Care Lee, MD, Dr. Yoon Ki Han, MD, Dr. Young A. Park, MD, Prof.
Dr. Eric M. Karlin, MD, Division of Allergy, Pulmonary, and Crit- Kyu-Earn Kim, MD, PhD, Prof. Kyung Won Kim, MD, PhD and
ical Care Medicine, Department of Medicine, Vanderbilt University Prof. Myung Hyun Sohn, MD, PhD, Department of Pediatrics, Sev-
School of Medicine, Nashville, TN, Tebeb Gebretsadik, MPH, De- erance Childrens Hospital, College of Medicine, Yonsei University,
partment of Biostatistics, Vanderbilt University School of Medi- Seoul, Korea, Seoul, South Korea
cine, Nashville, TN; Division of Allergy, Pulmonary, and Critical 295 Reference Values and Determinants Of Fractional Concentra-
Care Medicine, Department of Medicine, and Center for Asthma tion Of Exhaled Nitric Oxide (FeNO) In Healthy Children
and Environmental Sciences Research, Vanderbilt University Dr. Young Ho Jung, MD1,2, Dr. Hyun Ju Cho, MD1, Dr. Ji-Won
School of Medicine, Nashville, TN, Dr. Emily W. Langley, MD, Di- Kwon, MD2,3, Dr. Song I Yang, MD1,2, Dr. Eun Lee, MD1,4, Dr.
vision of Allergy, Pulmonary, and Critical Care Medicine, Depart- Hyung Young Kim, MD2,5, Dr. Ju-Hee Seo, MD6,7, Dr. Byoung-
ment of Medicine, Vanderbilt University School of Medicine, Ju Kim, MD, PhD8,9, Dr. Hyo-Bin Kim, MD, PhD9,10, Prof. So
Nashville, Tennessee, Dr. Tina V. Hartert, MD, MPH, Vanderbilt Yeon Lee, MD, PhD9,11, Prof. Dae Jin Song, MD, PhD2,12, Prof.
University School of Medicine, Nashville, TN, Dr. R. Stokes Pee- Woo Kyung Kim, MD, PhD2,13, Dr. Gwang Cheon Jang, MD,
bles Jr., MD, FAAAAI, Division of Allergy, Pulmonary and Critical PhD2,14, Prof. Jung Yeon Shim, MD, PhD2,15 and Prof. Soo-Jong
Care Medicine, Vanderbilt University School of Medicine, Nash- Hong, MD. PhD2,16, 1Childhood Asthma Atopy Center, Department
ville, TN and Dr. Donald H. Arnold, MD, MPH, Center for Asthma of Pediatrics, Asan Medical Center, University of Ulsan College of
and Environmental Health Sciences Research, Vanderbilt Univer- Medicine, Seoul, South Korea, 2Research Center for Standardiza-
sity School of Medicine, Nashville, TN; Departments of Pediatrics tion of Allergic Diseases, Seoul, South Korea, 3Seoul National Uni-
and Emergency Medicine, Vanderbilt University School of Medi- versity Bundang Hospital, Seoul National University College of
cine, Nashville, Tennessee Medicine, 4childhood Asthma atopy center , asan medical center,
292 Risk Factors Of High Feno Levels & Cut-Off Value Of Feno In University of Ulsan College of Medicine, South Korea, 5Depart-
Elementary School Children With Asthma ment of Pediatrics, Kosin University Gospel Hospital, Kosin Uni-
Dr. Hyun Ju Cho, MD1, Dr. Young-Ho Ho Jung, MD1,2, Dr. Eun versity College of Medicine, Seoul, South Korea, 6Department of
Lee, MD1,3, Dr. Song I Yang, MD1,4, Dr. Hyung Young Kim, Pediatrics, Korea Cancer Center Hospital, Seoul, South Korea, 7De-
MD4,5, Dr. Ju-Hee Seo, MD6,7, Dr. Ji-Won Kwon, MD4,8, Dr. By- partment of pediatrics, Korea Cancer Center Hospital, South Korea,
8
oung-Ju Kim, MD, PhD9,10, Dr. Hyo-Bin Kim, MD, PhD11,12, Department of Pediatrics, Hae-undae Paik Hospital, Inje Univer-
Prof. So Yeon Lee, MD, PhD12,13, Prof. Dae Jin Song, MD, sity College of Medicine, Busan, South Korea, 9Research Center
PhD4,14, Prof. Woo-Kyung Kim, MD, PhD2,15, Dr. Gwang Cheon for Standardization of Allergic Diseases, Seoul, South Korea, South
Jang, MD, PhD4,16, Prof. Jung Yeon Shim, MD, PhD4,17 and Dr. Korea, 10Department of Pediatrics,Inje University Sanggye Paik
Soo-Jong Hong, MD, PhD1,2, 1Childhood Asthma Atopy Center, Hospital, Seoul, South Korea, 11Department of Pediatrics, Hallym
Department of Pediatrics, Asan Medical Center, University of Ul- University College of Medicine, Seoul, South Korea, 12Department
san College of Medicine, Seoul, South Korea, 2Research Center of Pediatrics, Korea University Guro Hospital, Seoul, South Korea,
13
for Standardization of Allergic Disease, Seoul, South Korea, 3child- Department of Pediatrics, Seoul Paik Hospital, Inje University
hood Asthma atopy center , asan medical center, University of Ul- College of Medicine, Seoul, South Korea, 14Department of Pediat-
san College of Medicine, South Korea, 4Research Center for rics, National Health Insurance Corporation Ilsan Hospital, Seoul,
Standardization of Allergic Diseases, Seoul, South Korea, 5Depart- South Korea, 15Department of Pediatrics, Kangbuk Samsung Hospi-
ment of Pediatrics, Kosin University Gospel Hospital, Kosin Uni- tal, Sungkyunkwan University College of Medicine, Seoul, South
versity College of Medicine, Seoul, South Korea, 6Department of Korea, 16Childhood Asthma Atopy Center, Department of Pediat-
Pediatrics, Korea Cancer Center Hospital, Seoul, South Korea, 7De- rics, Asan Medical Center, University of Ulsan College of Medi-
partment of pediatrics, Korea Cancer Center Hospital, South Korea, cine, South Korea
102
J ALLERGY CLIN IMMUNOL Abstracts AB313
VOLUME 133, NUMBER 2
296 Improvement Of FENO In Youth With Asthma After Attending MD1 and Dr. Osamu Kaminuma, PhD2, 1National Hospital Organi-
An Asthma Summer Camp zation, Sagamihara National Hospital, Sagamihara, Japan, 2Tokyo
Dr. Jonathan A. Olsen, DO1, Dr. Mark Stevens, MD1, Mr. Patrick Metropolitan Institute of Medical Science, Tokyo, Japan
Foster, B.S.2 and Dr. Russell Hopp, DO, FAAAAI3, 1Creighton 303 CD4+ T Cells From Nasal Polyp Explants Contain Abundant
University Medical Center, Omaha, NE, 2American Lung Associa- Th2 Cells Expressing Functional Interleukin-25 Receptors To-
tion, Omaha, NE, 3Creighton University School Medicine, Omaha, gether With Th17 Cells
NE Mrs. Emily Lam, MSc1, Dr. Harsha H. Kariyawasam, MD, PhD2,
297 Exhaled Nitric Oxide (FeNO) and T-Helper 2 Cell Biomarkers: Prof. Stephen R. Durham, MA MD FRCP3, Ms. Joanne Rimmer,
Can They Predict Treatment Response To Dupilumab, An IL- FRCS(ORL-HNS)2, Dr. Valerie J. Lund, MD2, Dr. David Cousins,
4Ra Antibody, In An Eosinophilic Asthma Population? PhD1 and Dr. Stephen Till, MD, PhD1, 1Kings College London,
Brian N. Swanson, PhD1, Lin Wang, PhD1, Jeffrey Ming, MD1, London, United Kingdom, 2Royal National Throat, Nose & Ear
Jennifer D. Hamilton, PhD2, Ariel Teper, MD1, Thomas Dicioccio, Hospital London, University College London, London, United
PhD2, Yongtao Li, PhD1, Dr. Neil Graham, MD2, Dr. Gianluca Pir- Kingdom, 3Imperial College London, London, United Kingdom
ozzi, MD, PhD1 and Sally E. Wenzel, MD, FAAAAI3, 1Sanofi, 304 Successful Desensitization To Paclitaxel For Stage 4 Ovarian
Bridgewater, NJ, 2Regeneron Pharmaceuticals, Inc., Tarrytown, Cancer
NY, 3University of Pittsburgh Medical Center NW, Pittsburgh, PA Dr. Erica T. Gastelum, MD, UCSF Fresno, Madera, CA, Kush
298 Asthma Management Costs With Feno In Addition To Standard Das, Baz Allergy, Asthma & Sinus Center, Fresno, CA, Dr. Praveen
Guidelines Buddiga, MD, FAAAAI, University of California San Francisco-
SUNDAY
Dr. Glenn Crater, MD1, Dr. Craig F. LaForce, MD, FAAAAI2, Ms. Fresno, Fresno, CA; Baz Allergy Asthma & Sinus Center, Fresno,
Nancy Herje, BSN, RN, MBA1, Dr. Elizabeth Brooks, PhD3 and Dr. CA and Dr. Malik N. Baz, MD, UCSF-Fresno, Fresno, CA; Baz Al-
Kathy Rickard, M.D.1, 1Aerocrine, Inc., Morrisville, NC, 2North lergy Asthma and Sinus Center, Fresno, CA
Carolina Clinical Research, Raleigh, NC, 3Reimbursement Princi- 305 IL-17 Plays a Major Role In Driving The Recruitment Of B
ples, Highlands Ranch, CO Cells Into Bronchial Tissue Of Asthmatic Patients
299 Developmental Assessment Of Serum Periostin As An Asthma Dr. S Al-Muhsen, MD, King Saud University, College of Medi-
Biomarker In Children cine, Riyadh, Saudi Arabia, Mrs. Mary -Angeline Pureza, King
Dr. Halie M. Anderson1, Dr. Robert F. Lemanske Jr., MD, Saud University, Riyadh, Saudi Arabia, Dr. Qutayba Hamid, MD,
FAAAAI2, Joseph R. Arron3, Cecile Holweg4, Ms. Victoria Raja- PhD, FAAAAI, McGill University Health Centre, Montreal, QC,
manickam5, Dr. James E. Gern, MD, FAAAAI2 and Dr. Daniel J. Canada and Dr. Rabih Halwani, PhD, King Saud University, college
Jackson, MD6, 1University of Wisconsin, Madison, WI, 2University of Medicine, Riyadh, Saudi Arabia
of Wisconsin School of Medicine and Public Health, Madison, WI, 306 A Comparison Of Asthma Prevalence and Severity Among Ur-
3
Genentech, Inc., South San Francisco, CA, 4Genentech, Inc, South ban and Rural African American Teenage Youth
San Francisco, CA, 5University of Wisconsin Hospitals and Clinics, Dr. Dennis Ownby, M.D. FAAAAI1, Dr. Martha Tingen, PhD2,
6
Pediatrics, University of Wisconsin School of Medicine and Public Ms. Suzanne Havstad, M.A.3, Dr. Jennifer Waller, PhD2, Dr. Chris-
Health, Madison, WI tine Cole Johnson, PhD MPH FAAAAI3 and Dr. Christine L.M. Jo-
seph, PhD3, 1Division of Allergy-Immunology and Rheumatology,
Georgia Health Sciences University, Augusta, GA, 2Georgia Re-
gents University, Augusta, GA, 3Department of Public Health Sci-
ences, Henry Ford Hospital, Detroit, MI
Atopic Disease Basic Science 307 Interleukin-4 and Transforming Growth Factor-Beta Single Nu-
cleotide Genes Polymorphisms Confer Susceptibility To Atopic
3203 Dermatitis
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM Dr. Nima Rezaei, MD, PhD1,2, Ms. Zahra Aryan2,3, Dr. Nasrin
300 T-Cell Profiles In Bronchoalveolar Lavage (BAL) Of Wheezing Behniafard, MD4, Ms. Elham Farhadi, MSc5, Dr. Soheila Sotoudeh,
Children With and Without A History Of Respiratory Syncytial MD4, Dr. Mojdeh Khaledi, MD6, Dr. Maryam Mahmoudi, MD7,
Virus (RSV) Lower Respiratory Tract Infection Prof. Asghar Aghamohammadi8, Prof. Ali Akbar Amirzargar,
Dr. Chang-Kuen Kim, MD, FAAAAI, Asthma & Allergy Center, PhD2 and Dr. Mohammad Gharagozlou, MD4, 1Research Center
Inje University Sanggye Paik Hospital, Seoul, South Korea, Dr. Jin- for Immunodeficiencies, Childrens Medical Center, Tehran Univer-
Tack Kim, MD, PhD, Department of Pediatrics, Uijeongbu St. sity of Medical Sciences, Tehran, Tehran, Iran, 2Molecular Immu-
Marys Hospital, The Catholic University of Korea, College of nology Research Center; and Department of Immunology, School
Medicine, Uijeongbu, Gyeonggi-Do, South Korea, Sally E. Wenzel, of Medicine, Tehran University of Medical Sciences, Tehran,
MD, FAAAAI, University of Pittsburgh Medical Center NW, Pitts- Iran, 3Student Scientific Research Center (SSRC), School of Med-
burgh, PA and Dr. Marzena E. Krawiec, MD, National Jewish Med- icine, Tehran University of Medical Sciences, Tehran, Iran, 4Chil-
ical and Research Center, Denver, CO drens Medical Center, Tehran University of Medical Sciences,
301 Increased Blood Th2-Like Invariant Natural Killer T Cells In Tehran, Tehran, Iran, 5Hematology Department, School of Allied
Patients With Asthma Medical Science, Tehran University of Medical Sciences, Tehran,
Prof. Young-Il Koh, MD and Jae-Uoong Shim, Chonnam National Tehran, Iran, 6Growth and Development Research Center, Tehran
University Medical School University of Medical Sciences, Tehran, Tehran, Iran, 7School of
302 Establishment and Treatment Of a Steroid Resistant Asthma Nutrition and Dietetics, Tehran University of Medical Sciences,
Model By Adoptive Transfer Of Helper T Cell Clones Tehran, Tehran, Iran, 8Research Center for Immunodeficiencies,
Dr. Akio Mori, MD, PhD1, Mr. Satoshi Kouyama, MSc1, Ms. Childrens Medical Center, Tehran University of Medical Sciences,
Miyako Yamaguchi1, Ms. Yo Iijima1, Dr. Jun Itoh, MD1, Dr. Hir- Tehran, Iran
oaki Hayashi, MD1, Dr. Takafumi Minami, MD1, Dr. Kentaro Wa- 308 A Comparison Of Regulatory T-Cell Receptor Vb (3,5) Expres-
tarai, MD1, Dr. Chihiro Mitsui, MD1, Dr. Chiyako Oshikata, MD1, sion In Patients With Food Allergy and Atopic Dermatitis
Dr. Hidenori Tanimoto, MD1, Dr. Yuma Fukutomi, MD1, Dr. Benjamin Prince, MD1,2, Kristin A. Erickson1, Christine Szychlin-
Kiyoshi Sekiya, MD1, Dr. Takahiro Tsuburai, MD, PhD1, Dr. Ma- ski, APN, CPNP2, Miao Cai, MS2 and Dr. Anne Marie Singh,
sami Taniguchi, MD, PhD1, Dr. Yuji Maeda, MD1, Dr. Mamoru Oh- MD1,3, 1Northwestern University Feinberg School of Medicine,
tomo, MD1, Dr. Maki Hasegawa, MD, PhD1, Dr. Kazuo Akiyama, Chicago, IL, 2Division of Allergy & Immunology, Ann & Robert
103
AB314 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
H. Lurie Childrens Hospital of Chicago, Chicago, IL, 3Division of 317 17b-Estradiol Increases IL-17A Protein Expression From
Allergy & Immunology, Department of Pediatrics, Northwestern Mouse CD4+ Th17 Differentiated Cells
University Feinberg School of Medicine, Ann & Robert H. Lurie Jacqueline-Yvonne Cephus, BS1, Dr. Dawn C. Newcomb Baker,
Childrens Hospital of Chicago, Chicago, IL PhD2, Madison Boswell1, Kasia Goleniewska3 and Dr. Ray Peebles,
309 Correlation Between Fractional Exhaled Nitric Oxide and MD1, 1Allergy, Pulmonary, and Critical Care Medicine; Depart-
Asthma Exacerbation ment of Medicine; Vanderbilt University School of Medicine, Nash-
Dr. Nawinda Mahawichit, MD, Mahidol University, Bangkok, ville, TN, 2Division of Allergy, Pulmonary and Critical Care
Thailand Medicine, Vanderbilt University School of Medicine, Nashville,
310 IL17RB+ Granulocytes In Asthma Patients TN, Nashville, TN, 3Allergy, Pulmonary, and Critical Care Medi-
Dr. Lin Li, MD1, Dr. Matthew A. Schaller, PhD2, Dr. Alan P. Bap- cine, Department of Medicine, Vanderbilt University School of
tist, MD, MPH FAAAAI1 and Dr. Nicholas W. Lukacs, PhD3, 1Uni- Medicine, Nashville, TN
versity of Michigan, Division of Allergy and Clinical Immunology, 318 17-b Estradiol Positively Correlates With IL-17A+ CCR6+
Ann Arbor, MI, 2University of Michigan, Department of Pathology, Memory CD4+ T Cells In Patients With Severe Asthma
Ann Arbor, MI, 3University of Michigan, Ann Arbor, MI Dr. Dawn C. Newcomb Baker, PhD1,2, Jacqueline-Yvonne Ce-
311 Pollen From Genetically Modified Bt Maize Does Not Promote phus, BS3, Dr. Emily W. Langley, MD4, Amy S. Feldman, MD5,
Allergic Responses In Mice Mrs. Nanalene Frey6, Ms. Kristen Cooper6, Dr. John M. Fahren-
Mrs. Monica Andreassen1,2, Dr. Elena Rocca3, Dr. Thomas holz, MD, FAAAAI7 and R. Stokes Peebles8, 1Vanderbilt Univer-
Bhn3,4, Dr. Odd-Gunnar Wikmark3, Prof. Johnnie Van den sity School of Medicine, Nashville, TN, 2Medicine, Vanderbilt
SUNDAY
Berg5, Prof. Martinus Lovik2, Prof. Terje Traavik3,4 and Dr. Unni University Medical Center, Nashville, TN, 3Allergy, Pulmonary,
C. Nygaard2, 1Genk - Centre for Biosafety, Tromso, Norway, and Critical Care Medicine; Department of Medicine; Vanderbilt
2
Norwegian Institute of Public Health, Oslo, Norway, 3Genk - University School of Medicine, Nashville, TN, 4Division of Al-
Centre for Biosafety, Norway, 4University of Troms, Norway, lergy, Pulmonary, and Critical Care Medicine, Department of Med-
5
North-West University, Potchefstroom, South Africa icine, Vanderbilt University School of Medicine, Nashville,
312 Effects Of rs3744262 On DNA Methylation and Symptoms In Tennessee, 5Division of Allergy, Pulmonary, and Critical Care Med-
Participants With Allergic Rhinitis During Grass Pollen Expo- icine, Department of Medicine, and Center for Asthma and Envi-
sure In The Environmental Exposure Unit (EEU) ronmental Sciences Research, Vanderbilt University School of
Dr. Michelle North, PhD1, Ms. Sarah Mah, BSc.2, Mr. Andrew G. Medicine, Nashville, TN, 6Vanderbilt University Medical Center,
Day, MSc3, Dr. Michael Kobor, PhD2,4 and Dr. Anne K. Ellis, MD, 7
Vanderbilt University Medical Center, Nashville, TN, 8Allergy,
MSc FAAAAI1,5, 1Departments of Medicine and Biomedical & Pulmonary, and Critical Care Medicine, Department of Medicine,
Molecular Science, Queens University, Kingston, ON, Canada, Vanderbilt University School of Medicine, Nashville, TN
2
Centre for Molecular Medicine & Therapeutics, Child & Family 319 Allergic Sensitization and Determination Of Serum Eosinophil
Research Institute, Vancouver, BC, Canada, 3Clinical Research Cationic Protein and Triptase In Preschool Population In Her-
Centre, Kingston General Hospital, Kingston, ON, Canada, 4Uni- mosillo, Sonora, Mexico
versity of British Columbia, Vancouver, BC, Canada, 5Allergy Re- Dr. Claudia Gallego-Corella1, Dr. Guadalupe Corella2, Ms. An-
search Unit, Kingston General Hospital, Kingston, ON, Canada drea Romo3, Prof. Antonio Rascon4 and Mr. Pablo Martnez3,
1
313 Chronic Spontaneous Urticaria An Evaluation Of An Indirect Medicine Faculty, Xochicalco University, Tijuana, Mexico,
2
Immunofluorescence Method For Detecting Anti-Mast Cell IgG Health, Nutrition and Environment, Department of Chemical and
Antibodies Biological Sciences, University of Sonora, Mexico, Hermosillo,
Bahar Bahrani, Natasha Gattey and Peter Hull, University of Sas- Mexico, 3Department of Chemical and Biological Sciences, Univer-
katchewan, Canada sity of Sonora, Mexico, Hermosillo, Mexico, 4Health, Nutrition and
314 Protease Activity Of Per a 10 Causes CD 40 Cleavage On Den- Environment, Department of Chemical and Biological Sciences,U-
dritic Cells and Th2 Polarization niversity of Sonora, Mexico, Hermosillo, Mexico
Ms. Komal Agrawal, MSc, CSIR-IGIB, DELHI, India and Dr. 320 Fungal Cross-Allergenicity In Specific Ige Testing
Naveen Arora, Ph.D, CSIR Institute of Genomics and Integrative Dr. Mercedes C. Amado, MD, FAAAAI1, Dr. Jay M. Portnoy,
Biology, New Delhi, India MD, FAAAAI2 and Dr. Charles Barnes, PhD2, 1Childrens Mercy
315 Type 2 Immunity Can Have a Protective Role In Host Defense Hospital, Shawnee Mission, KS, 2Childrens Mercy Hospital, Kan-
Against Venoms In Mice sas City, MO
Dr. Thomas Marichal, DVM PhD1, Dr. Philipp Starkl, PhD1, Dr. 321 Monocytes From Peanut-Allergic Patients Express Higher
Laurent Reber, PhD1, Dr. Janet Kalesnikoff, PhD1, Dr. Hans C. Levels Of RALDH2 In Response To Peanut Protein Than Mon-
Oettgen, MD, PhD, FAAAAI2, Dr. Mindy Tsai, DMSc1, Dr. Martin ocytes From Tolerant Subjects
Metz, MD, PhD3 and Dr. Stephen J. Galli, MD1, 1Stanford Univer- Elizabeth Fleming, BS1, Bert Ruiter, PhD1, Barry K. Hurlburt,
sity School of Medicine, Stanford, CA, 2Boston Childrens Hospi- PhD2, Soheila J. Maleki, PhD2 and Wayne G. Shreffler, MD,
tal, Boston, MA, 3Charite Campus Mitte, Berlin, Germany PhD, FAAAAI1, 1Massachusetts General Hospital, Boston, MA,
2
316 CD4+ and CD8+ T Cells Bearing Nave and Memory Markers USDA-ARS-SRRC, New Orleans, LA
In Blood Of Immigrants To Brooklyn Who Develop Asthma and 322 Peanut Protein Induces Expression Of RALDH2 In Human
Allergic Disease Dendritic Cells In a TLR2-Dependent Manner
Dr. Ashlei Mathew, MD1,2, Dr. Irina Katayeva, MD1,3, Seto Chice, Bert Ruiter, PhD1, Elizabeth Fleming, BS1, Barry K. Hurlburt,
MS1,4, Dr. Stephan Kohlhoff, MD1,5, Dr. Rauno O. Joks, MD, PhD2, Soheila J. Maleki, PhD2 and Wayne G. Shreffler, MD,
FAAAAI1,2, Dr. Helen G. Durkin, PhD1,4 and Dr. Maria-Anna Vast- PhD, FAAAAI1, 1Massachusetts General Hospital, Boston, MA,
ardi, MD1,3, 1Center for Allergy and Asthma Research, State Uni- 2
USDA-ARS-SRRC, New Orleans, LA
versity of New York Downstate Medical Center, Brooklyn, NY, 323 IL-4 Receptor Alpha and STAT6 Single Nucleotide Polymor-
2
Department of Medicine, State University of New York Downstate phisms Are Associated With Increased Risk Of Asthma In a
Medical Center, Brooklyn, NY, 3Lutheran Medical Center, Brook- Saudi Arabian Population
lyn, NY, 4Department of Pathology, State University of New York Dr. Rabih Halwani, PhD1, Dr. Alejandro Vazquez-Tello2, Mr. Amer
Downstate Medical Center, Brooklyn, NY, 5Department of Pediat- Jamhawi2, Dr. Hamdan Jahdali3 and Dr. Saleh Al-Muhsen, MD4,
1
rics, State University of New York Downstate Medical Center, King Saud University, college of Medicine, Riyadh, Saudi Arabia,
2
Brooklyn, NY King Saud University, Riyadh, Saudi Arabia, 3King Saud University
104
J ALLERGY CLIN IMMUNOL Abstracts AB315
VOLUME 133, NUMBER 2
for Health Sciences, Riyadh, Saudi Arabia, 4King Saud University, Immunology, Department of Pediatrics, David Geffen School of
College of Medicine, Riyadh, Saudi Arabia Medicine at UCLA, Los Angeles, CA, 3UCLA, CA
332 Studies On Cohort Of Infants With Di-George Syndrome De-
tected By New York State Newborn Screening For Severe Com-
bined Immunodeficiency (SCID)
Dr. Doerthe A. Andreae, MD1, Dr. Stephanie Albin, MD1, Dr.
T Cell Mediated Immunity Harshna Mehta, MD1 and Dr. Charlotte Cunningham-Rundles,
MD, PhD, FAAAAI2, 1The Icahn School of Medicine at Mount Si-
3204 nai, New York, NY, 2Mt. Sinai Medical Center, New York, NY
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM 333 Immunologic Profile Of Single Ventricle Survivorship Partici-
324 Infants With Idiopathic T Cell Lymphopenia Identified On New pants: Risk Factors For Clinically Significant Immunologic
York State Newborn Screen: A Follow Up Report Dysfunction
Dr. Stephanie Albin, MD1, Dr. Harshna Mehta, MD1 and Dr. Char- Dr. Megan Morsheimer, MD, MPH, Dr. Jack Rychik, MD, FACC,
lotte Cunningham-Rundles, MD, PhD, FAAAAI2, 1The Icahn Ms. Katie Dodds, RN, MSN, CRNP and Dr. Jennifer Heimall, MD,
School of Medicine at Mount Sinai, New York, NY, 2Mt. Sinai Childrens Hospital of Philadelphia, Philadelphia, PA
Medical Center, New York, NY 334 Chronic Non-Iatrogenic Lymphatic Loss Syndromes Identified
325 Frequency Of Cellular and Humoral Immunodeficiencies In Di- Though Abnormal TREC Analysis From The Texas Newborn
george Syndrome Patients Seen At New York Presbyterian Co- Screening Program (NBS)
SUNDAY
lumbia Between 2006-2012 Dr. Qurat U. Kamili, MD1, Niti Y. Chokshi, MD2, Dr. Jordan Or-
Dr. Collette Spalding, MD1, Dr. Kyung Hwa Jung, PhD1, Dr. Ra- ange, MD, PhD, FAAAAI3, Dr. I. Celine Hanson, MD, FAAAAI4
chel L. Miller, MD, FAAAAI1 and Dr. Yesim Demirdag, MD2, 1Di- and Dr. Lisa R. Forbes, MD4, 1Baylor College of Medicine and Texas
vision of Pulmonary, Allergy and Critical Care Medicine, Columbia Childrens Hospital, Section of Immunology, Allergy and Rheuma-
University, New York, NY, 2Department of Pediatric Allergy/Im- tology, Houston, TX, 2Baylor College of Medicine and Texas Chil-
munology, Columbia University, New York, NY drens Hospital, Section of Immunology, Allergy and
326 A Novel ORAI1 Mutation Resulting In T+B+NK+ SCID With Rheumatology, Houston, TX, 3Baylor College of Medicine and Texas
Normal Lymphocyte Proliferation Childrens Hospital, Section of Immunology, Allergy and Rheuma-
Janet S. Chou, MD1, Christina S.K. Yee, MD, PhD1, Mr. Wayne tology, 4Baylor College of Medicine-Texas Childrens Hospital, Sec-
Bainter, BS1, Dr. Luigi D. Notarangelo, M.D.2, Dr. Suleiman M. tion of Immunology, Allergy, and Rheumatology, Houston, TX
S. E. Al-Hammadi, MD, FAAAAI3 and Raif S. Geha, MD1, 1Divi- 335 An Adult With Disseminated Herpes Zoster Infection Found To
sion of Immunology, Boston Childrens Hospital, Harvard Medical Have Rare Combined CD4, CD8 T-Cell and NK-Cell Deficiency
School, Boston, MA, 2Stem Cell Institute, Boston, MA, 3FMHS, Neil Parikh, MD, UCLA-VA Greater Los Angeles Healthcare Sys-
UAE University, Al-Ain, United Arab Emirates tem, Los Angeles, CA and Joseph S. Yusin, MD, FAAAAI, VA
327 Coronin-1A Oligomerization Is Critical For Host Defense Greater Los Angeles Health Care System, Los Angeles, CA
Against Viral Pathogens 336 Clinical and Virological Characteristics Of HIV-Associated
Christina S.K. Yee, MD, PhD1, Ozden Sanal, MD2, Janet S. Chou, Lymphomas In Patients With Perinatally-Acquired HIV In
MD1, Raif S. Geha, MD1, Deniz Ayvaz, MD3, Caner Aytekin, MD3 The Era Of Antiretroviral Therapy
and A. Nurten Akarsu, MD, PhD4, 1Division of Immunology, Boston Dr. Jasmeen S. Dara, MD, Montefiore Medical Center/Albert Ein-
Childrens Hospital, Harvard Medical School, Boston, MA, 2Depart- stein College of Medicine, Dr. Stefan Barta, Montefiore Medical
ment of Pediatrics, Hacettepe University Ihsan Dogramaci Childrens Center and Dr. Jenny Shliozberg, MD, FAAAAI, Montefiore Med-
Hospital, Ankara, Turkey, 3Department of Pediatric Immunology, Dr ical Center, Bronx, NY
Sami Ulus Maternity and Childrens Research and Educational Hos-
pital, Ankara, Turkey, 4Department of Medical Genetics, Hacettepe
University Ihsan Dogramaci Childrens Hospital, Ankara, Turkey
328 Newborn Screening For Severe Combined Immunodeficiency In Asthma Epidemiology, Risk Factors and Public
Iowa: TREC Assay Results and Characteristics Of SCID and T-
Cell Lymphopenic Patients
Health II
Farheen Mirza, MD1, Emily Phillips, RN BSN CCRC1, Travis
Henry, PhD1 and Dr. Mary Beth Fasano, MD, FAAAAI2, 1Univer- 3205
sity of Iowa, 2C42-E6 GH, University of Iowa College Medicine, Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
Iowa City, IA 337 Study On Air Pollution and Respiratory Health Of Children In
329 Thymus Graft Factors Critical For Negative Selection Of Direct Delhi, India
Allospecific T Cells Ms. Jincy Mathew, M.Tech, CSIR- Institute of Genomics and In-
Dr. Ivan K. Chinn, MD, Dr. Ivo D. Shterev, PhD, Kristina J. Riebe tegrative Biology, Delhi, India, Dr. Radha Goyal, Ph.D, CSIR- Na-
and Dr. Douglas C. Rouse, DVM, Duke University Medical Center, tional Environmental Engineering Research Institute, Delhi, India,
Durham, NC Dr. Krinshna K Taneja, Ph.D, CSIR- Istitute of Genomics and Inte-
330 Successful Hematopoietic Stem Cell Transplant For CD40 Defi- grative Biology,, Delhi, India and Dr. Naveen Arora, Ph.D, CSIR
ciency Manifesting As Hyper-IgM Syndrome With Absent Institute of Genomics and Integrative Biology, New Delhi, India
CD40 Expression and Marked Lymphocytosis 338 Trans-Generational Transmission Of Ozone Induced Airway
Dr. Joyce Hsu, MD, Medicine, Boston Childrens Hospital, Boston, Dysfunction
MA, Dr. Michel Massaad, PhD, Boston Childrens Hospital and Dr. Prof. Park Choon Sik, Mr. Bae Da-Jeong, Dr. Park Jong-Sook and
Luigi D. Notarangelo, MD, Stem Cell Institute, Boston, MA Dr. Jang An Soo, Soonchunhyang University Bucheon Hospital,
331 IL-2 Receptor Gamma-Chain(IL2RG) Defect Can Present With Gyeonggi-Do, South Korea
Features Other Than Increased Susceptibility To Infection 339 Dust Mite Allergen In Bed Dust Predicts Rhinitis Symptom Per-
Dr. Bob Geng, MD1, Dr. Maria Garcia-Lloret, MD, FAAAAI2, Dr. sistence In Urban Pre-Adolescent Children With Higher Ele-
Yen Tun Wang, MD3, Dr. Ki-Young Yoo, MD3, Dr. Raymond Barn- mental Carbon Particulate Matter Exposure
hill, MD3, Dr. Derek Wong, MD3 and Dr. E. Richard Stiehm, MD, Dr. Young Yoo, MD, PhD1,2, Dr. Luis M. Acosta, MD1, Prof. Inge
FAAAAI2, 1UCLA, Los Angeles, CA, 2Division of Allergy and Goldstein, DrPH3, Prof. Andrew Rundle, DrPH4, Omar Olmedo1,
105
AB316 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Adnan Divjan1, Dr. Beihzhan Yan5, Prof. Judith Jacobson, DrPH4, 347 IgE Antibodies To Cat and Cat Components In Relation To
Dr. Rachel L. Miller, MD, FAAAAI6, Dr. Steven Chillrud5 and Asthma In a Population Study Of 963 18 Year Olds From Six
Prof. Matthew S. Perzanowski, PhD1, 1Department of Environmen- Schools In Northern Sweden
tal Health Sciences, Mailman School of Public Health, Columbia Ms. Hayley James, BS1, Prof. Matthew S. Perzanowski, PhD2, Eva
University, New York, NY, 2Department of Pediatrics, College of Ronmark, PhD3, Bo Lundback, MD, PhD3, Jillian Roper1 and
Medicine, Korea University, Seoul, South Korea, 3Department of Thomas A.E. Platts-Mills, MD, PhD, FAAAAI4, 1University of Vir-
Epidemiology, Mailman School of Public Health, Columbia Uni- ginia, Charlottesville, VA, 2Department of Environmental Health
versity, New York, NY, 4Department of Epidemiology, Mailman Sciences, Mailman School of Public Health, Columbia University,
School of Public Health, Columbia University, New York, NY, 5La- New York, NY, 3Karolinska Institutet, Stockholm, Sweden, 4Divi-
mont-Doherty Earth Observatory, Columbia University, Palisades, sion of Asthma, Allergy & Immunology, University of Virginia
NY, 6Division of Pulmonary, Allergy and Critical Care Medicine, Health System, Charlottesville, VA
Columbia University, New York, NY 348 Epitope Mapping Of An Anti-Bla g 1 ScFv Used For Cockroach
340 Associations Between Outdoor Of PM2.5 With Cough and Allergen Quantitation
Wheeze Symptoms In Asthmatic Children In Korea Dr. Geoffrey Mueller, PhD1, Mr. John Ankney2, Dr. Lars Peder-
Prof. Woo Kyung Kim, MD, PhD1,2, Mrs. Young Wook Lee1 and sen1, Dr. Taruna Khurana, PhD3, Dr. Jay E. Slater, MD4, Ms. Jill
Dr. Hae-Sun Yoon1, 1Allergy & respiratory research laboratory, Inje Glesner5, Dr. Anna Pomes, PhD FAAAAI5 and Dr. Robert London1,
University College of Medicine, Seoul, South Korea, 2Department 1
National Institute of Environmental Health Sciences, NIH, Re-
of Pediatrics, Seoul Paik Hospital, Inje University College of Med- search Triangle Park, NC, 2National Intstitute of Environmental
SUNDAY
icine, Seoul, South Korea Health Sciences, NIH, 3FDA Center for Biologics Evaluation and
341 Effect Of Duration Of Residence In Brooklyn On IgE Re- Research, 4FDA/CBER/OVRR/DBPAP, Rockville, MD, 5Indoor Bi-
sponses Of Immigrants otechnologies, Inc., Charlottesville, VA
Dr. Edward Kleiman, MD1, Dr. Maria-Anna Vastardi, MD2,3, Dr. 349 Antigenic Analysis Of The Major Cockroach Allergen Bla g 5
Irina Katayeva, MD2,3, Dr. Helen G. Durkin, PhD2 and Dr. Rauno and Its Dust Mite Homolog Der p 8
O. Joks, MD, FAAAAI1, 1SUNY Downstate Medical Center, Center Ms. Jill Glesner1, Dr. Geoffrey Mueller, PhD2, Dr. Lars Pedersen2,
for Allergy and Asthma Research, Brooklyn, NY, 2Center for Allergy Dr. Martin D. Chapman, PhD FAAAAI1 and Dr. Anna Pomes, PhD
and Asthma Research, State University of New York Downstate Med- FAAAAI1, 1Indoor Biotechnologies, Inc., Charlottesville, VA, 2Na-
ical Center, Brooklyn, NY, 3Lutheran Medical Center, Brooklyn, NY tional Institute of Environmental Health Sciences, NIH, Research
342 Impact Of Energy Expenditure On Ozone-Induced Inflamma- Triangle Park, NC
tion 350 Immunomodulatory Effects Of Rye Grass Pollen Allergen Lol p
Dr. Krista Todoric, MD1, Dr. Michelle L. Hernandez, MD1, Dr. 5 On The Prostaglandin E2 Pathway and Kallikrein-Kinin Sys-
Haibo Zhou, PhD2 and Dr. David B. Peden, MD, MS, FAAAAI1, tem Of Respiratory Epithelial Cells
1
University of North Carolina at Chapel Hill School of Medicine, Cecilia Tong, Alice Vrielink, Martha Ludwig and Geoffrey Stew-
Chapel Hill, NC, 2University of North Carolina at Chapel Hill, art, University of Western Australia
School of Public Health 351 Development and Characterization Of a Murine Model Of Re-
343 Exposure Of Mice To Silica Crystals and Poly I:C Synergisti- peated Dry Exposure To Aerosolized Fungal Conidia
cally Enhances Neutrophil Infiltration and Epithelial Damage Dr. Ajay Nayak, PhD1, Dr. Amanda Buskirk, PhD1,2, Mr. W.Travis
In The Airway Goldsmith3, Ms. Angela Lemons1, Dr. Justin Hettick, PhD1, Dr. Mi-
Dr. Hirotoshi Unno, M.D., Dr. Hideaki Morita, MD., PhD., Dr. Hir- chael Kashon, PhD4, Ms. Amy Cumpston3, Mr. Jared Cumpston3,
ohisa Saito, MD., PhD., Dr. Kenji Matsumoto, MD, PhD and Dr. Akio Mr. Howard Leonard3, Mr. Walter McKinney3, Dr. David Frazer,
Matsuda, PhD, Department of Allergy and Immunology, National PhD3, Dr. Donald H. Beezhold, PhD FAAAAI1 and Dr. Brett J.
Research Institute for Child Health and Development, Tokyo, Japan Green, PhD1, 1CDC/NIOSH/ACIB, Morgantown, WV, 2West Vir-
344 Modest Effects Of Bisphenol A Exposure In Mouse Models Of ginia University, Morgantown, WV, 3CDC/NIOSH/PPRB, Morgan-
Respiratory Allergy and Food Allergy town, WV, 4CDC/NIOSH/BEB, Morgantown, WV
Dr. Unni C. Nygaard1, Dr. Mari Samuelsen1, Dr. Nina Vinje1, Mrs. 352 Cross-Reactivity Between Recombinant Tropomyosin From
Monica Andreassen1,2, Prof. Martinus Lovik1 and Dr. Johanna Chortoglyphus and Natural Tropomyosin Of Other Extracts
Bodin1, 1Norwegian Institute of Public Health, Oslo, Norway, Dr. Jer onimo Carnes1, Dr. M. Angeles Lopez Matas1, Dr. Manuel
2
Genk - Centre for Biosafety, Tromso, Norway Boquete, MD2, Dr. Raquel Moya1 and Dr. Victor Miguel Iraola1,
1
Laboratorios LETI, Tres Cantos, Spain, 2Hospital Xeral de Calde,
Lugo, Spain
353 Identification Of The Cysteine Protease Amb a x As A Novel
Major Allergen From Short Ragweed Pollen (Ambrosia artemi-
Aerobiology II siifolia)
Dr. Philippe Moingeon, PhD1, Julien Bouley, PhD2, Maxime Le
3206 Mignon, PhD2, Veronique Baron-Bodo, PhD2, Veronique Bordas,
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM PhD2, Laetitia Bussieres2, Marie-Noelle Couret3, Aurelie Lautr-
345 In Vitro Allergy Testing: Relationship Patterns Between Aller- ette, PhD2, Thierry Batard, PhD4, Rachel Groeme2, Henri Chabre,
gen Pairs PhD2 and Emmanuel Nony2, 1Stallergenes SA, Antony, France,
2
Dr. John S. Kaptein, PhD1, C.K. Lin, PhD1 and Dr. Bruce J. Gold- Stallergenes, France, 3Stallergenes, 4Stallergenes, Antony,
berg, MD, PhD, FAAAAI2, 1Southern California Permanente France
Medical Group, Los Angeles, CA, 2Kaiser Permanente, Los An- 354 Characterization Of The Allergenic Activity Of Tropomyosin
geles, CA From Aedes Aegypti
346 Comparison Of Total Protein Profile Of Alternaria Alternata Mr. Jose F. Cantillo, Complutense University of Madrid, Spain; In-
Extract Obtained From Various U.S. Allergenic Extract Manu- munotek S.L., Alcala de Henares, Spain, Prof. Leonardo Puerta, In-
facturers stitute for Immunological Research/University of Cartagena,
Dr. Jay E. Slater, MD1, Ms. Allison Zoch2, Ms. Shoshana New- Cartagena, Colombia, Dr. Enrique Fernandez-Caldas, Inmunotek,
man-Gerhardt2 and Dr. Taruna Khurana, PhD3, 1FDA/CBER/ S.L, Spain and Dr. Sylvie Lafosse-Marin, Cabinet de Inmunoaller-
OVRR/DBPAP, Rockville, MD, 2FDA/CBER, 3CBER FDA gology, Fort de France, Martinique
106
J ALLERGY CLIN IMMUNOL Abstracts AB317
VOLUME 133, NUMBER 2
355 Allergy To Ferret Kamilaris, RN3, Michael D. Kulis Jr., PhD1, Jelena Berglund, PhD,
Mr. Ignacio Esteban Gorgojo1, Javier Cuesta Herranz1, Carlos RAC2 and A. Wesley Burks, MD, FAAAAI1, 1University of North
Pastor2, Aroa Sanz Maroto2, Mr. David Gonzalez3 and Dr. Manuel Carolina, Chapel Hill, NC, 2Duke University, Durham, NC, 3Caro-
De Las Heras1, 1Department of Allergy, Fundacion Jimenez Daz, linas Health Care System, Charlotte, NC
Madrid, Spain, 2Department of Immunology, Fundaci on Jimenez 364 Single Practice Five-Year Experience Treating Food Allergy
Daz, Spain, 3Allergy unit, Hospital de Fuenlabrada, Spain With Oral Immunotherapy: Efficacy and Epinephrine Treated
356 Do Residual Wheal Skin Prick Test Responses To Perennial and Reactions
Seasonal Allergens Correlate With Their Specific IgE Levels In Mrs. Angela R. Hague, PA-C, Dr. Richard L. Wasserman, MD,
Allergic Subjects? PhD, FAAAAI, Dr. Stacy K. Silvers, MD and Dr. Robert W. Suger-
Dr. AnneMarie Salapatek, PhD, Victoria Nelson, M.Sc and Dr. man, MD, FAAAAI, DallasAllergyImmunology, Dallas, TX
Piyush Patel, MD, FRCP, Inflamax Research, Mississauga, ON, 365 Single Practice, Five-Year Experience Treating Food Allergy
Canada With Oral Immunotherapy (FOIT): Successes and Failures
Ms. Dena M. Pence, RT, Mrs. Angela R. Hague, PA-C, Dr. Ri-
chard L. Wasserman, MD, PhD, FAAAAI, Dr. Robert W. Suger-
Food Allergy I man, MD, FAAAAI and Dr. Stacy K. Silvers, MD,
DallasAllergyImmunology, Dallas, TX
3207 366 Single Practice Five Year Experience Treating Food Allergy
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM With Oral Immunotherapy (FOIT): Effect On Antigen Specific
SUNDAY
357 Peanut Epicutaneous Immunotherapy (EPIT) In Peanut-Aller- IgE (asIgE)
gic Children: 18 Months Treatment In The Arachild Study Dr. Stacy K. Silvers, MD, Mrs. Angela R. Hague, PA-C, Ms. Dena
Prof. Christophe Dupont, MD, PhD1, Dr. Thierry Bourrier2, Prof. M. Pence, RT, Dr. Robert W. Sugerman, MD, FAAAAI and Dr. Ri-
Frederic de BLAY3, Dr. Lydie Guenard-Bilbault3, Dr. Christine chard L. Wasserman, MD, PhD, FAAAAI, DallasAllergyImmunol-
Sauvage4, Dr. Marie-Odile Cousin4, Dr. Gisele Kanny, MD, ogy, Dallas, TX
PhD5, Dr. Sophie Jarlot5 and Dr. Chantal Karila, MD6, 1Hopital 367 Secondary Eosinophilic Reactions During ORAL Immunother-
Necker Enfants Malades, Paris, France, 2Lenval Hospital, Nice, apy
France, 3CHRU Strasbourg, France, 4Saint Vincent de Paul Hospi- Prof. Yitzhak Katz, MD, FAAAAI1,2, Dr. Michael Goldberg, MD,
tal, Lille, France, 5CHU Nancy Hopital Central, Nancy, France, PhD2, Dr. Liat Nachshon, MD2, Dr. Marc E. Rothenberg, MD,
6
Hopital Necker, Paris, France PhD, FAAAAI3,4, Dr. Miguel Leon Stein, MD, FAAAAI5, Dr. Efrat
358 Predictors For Allergic Symptoms During Build-Up and Main- Broide6,7, Dr. Gratiana Hermann6, Dr. Arnon Elizur, MD1,2 and Dr.
tenance Phases Of Oral Immunotherapy To Peanut Michael B. Levy, MD, FAAAAI2, 1Tel Aviv University, Tel Aviv, Is-
Dr. Marie M. de Alwis, MD1,2, Dr. Jason Lee, MD, FAAAAI1, Dr. rael, 2Assaf Harofeh, Zerifin, Israel, 3Cincinnati Childrens Hospital
Mitchell R. Lester, MD, FAAAAI1, Dr. Louis M. Mendelson, MD, Medical Center, Cincinnati, OH, 4Childrens Hospital Medical Cen-
FAAAAI1, Dr. Glenda Nouman, MD1 and Dr. Jeffrey M. Factor, ter, Cincinnati, OH, 5Assaf Harofeh Medical Center, Rehovot, Israel,
6
FAAAAI1, 1New England Food Allergy Treatment Center, West Hart- Assaf Hrofeh Meducal center, Israel, 7Tel-Aviv university
ford, CT, 2Connecticut Childrens Medical Center, Hartford, CT 368 Rate Of Anaphylaxis Caused By Oral Immunotherapy In Chil-
359 Quality Of Life With Sublingual Immunotherapy For Peanut dren With Cows Milk Allergy
Nicole Leung1, Yamini Virkud, MD, MA2, Pamela H. Steele, MSN Prof. Giovanni B. Pajno, MD, FAAAAI1, Dr. Giuseppe Crisa-
CPNP AE-C3, Janet S. Kamilaris, RN4, Edwin Kim, MD, MS5, Brian fulli1,2, Dr. Giuseppina Salzano1,2, Dr. Roberta Vadala1,2, Dr. Stefa-
P. Vickery, MD, FAAAAI3, Dr. Audrey Dunn Galvin6 and A. Wesley nia Arasi1,2, Dr. Salvatore Barberi3 and Dr. Lucia Caminiti1,2,
1
Burks, MD, FAAAAI3, 1Duke University, 2Duke University, Durham, University of Messina, Messina, Italy, 2Dept of Pediatrics, Allergy
NC, 3University of North Carolina, Chapel Hill, NC, 4Carolinas Health Unit, University of Messina, 3Pediatric Clinic, San Paolo Hospital,
Care System, Charlotte, NC, 5University of North Carolina at Chapel University of Milan, Milan, Italy
Hill, Chapel Hill, NC, 6University College Cork, Cork, Ireland 369 Long-Term Follow Up In Cows Milk Anaphylaxis After Suc-
360 Low Dose Maintenance Peanut Oral Immunotherapy Can Pro- cessful Rush Oral Immunotherapy
duce Sustained Unresponsiveness Mrs. Paloma Poza-Guedes, Dr. Ruperto Gonzalez-Perez, Dr. In-
Julia A. Cronin, MD, University of Virginia, Division of Asthma, maculada Sanchez-Machn, MD and Dr. Victor Matheu, MD, Hos-
Allergy and Immunology, Charlottesville, VA, Julia Wisniewski, pital del Torax-Ofra, Sta Cruz de Tenerife, Spain
MD, University of Virginia, Division of Pediatric Respiratory Med- 370 Milk Oral Immunotherapy. Standard Versus Personalized Pro-
icine and Allergy, Charlottesville, VA and Scott P. Commins, MD, tocols: Efficiency and Safety
PhD, University of Virginia Health System, Charlottesville, VA Alberto Alvarez-Perea, MD, Dr. Elena Alonso-Lebrero, PhD, Fer-
361 Increases In Peanut-Specific IgA1 and IgA2 During Peanut Im- nanda Freire, MD, Dr. Sonsoles Infante, MD, Victoria Fuentes-
munotherapy Do Not Correlate With Clinical Tolerance Aparicio, MD and Lydia Zapatero, MD, Hospital Materno Infantil
Adrienne L. Yancey1, Michael D. Kulis Jr., PhD1, Pamela H. Gregorio Mara~non, Pediatric Allergy Department, Madrid, Spain
Steele, MSN CPNP AE-C1, Edwin Kim, MD, MS1, Brian P. Vick- 371 Cross-Desensitization To Goat and Sheep Milk Protein In Cows
ery, MD, FAAAAI2 and A. Wesley Burks, MD, FAAAAI1, 1Univer- Milk Protein Desensitized Patients
sity of North Carolina School of Medicine, Chapel Hill, NC, Dr. Michael Levy, MD, FAAAAI1, Dr. Liat Nachshon, MD1, Dr.
2
University of North Carolina, Chapel Hill, NC Michael Goldberg, MD, PhD1, Dr. Arnon Elizur, MD1,2 and Prof.
362 Peanut OIT-Induced IgG Suppresses Ex Vivo Activation Of Al- Yitzhak Katz, MD, FAAAAI1,2, 1Assaf Harofeh, Zerifin, Israel,
2
lergic Donor Basophils Via a Combination Of Antigen Intercep- Tel Aviv University, Tel Aviv, Israel
tion and Receptor-Bound Inhibition 372 Long Term Follow Up Of Children Who Incorporated Exten-
Caitlin Burk, Michael D. Kulis Jr., PhD, Edwin Kim, MD, MS, Brian sively Heated (baked milk) In The Diet
P. Vickery, MD, FAAAAI and A. Wesley Burks, MD, FAAAAI, Uni- Dr. Anna H. Nowak-Wegrzyn, MD, FAAAAI1, Mrs. Beth D.
versity of North Carolina at Chapel Hill, Chapel Hill, NC Strong, RN CCRC2, Ms. Diane Ananos1 and Hugh A. Sampson,
363 Omalizumab Pretreatment Does Not Protect Against Peanut MD, FAAAAI3, 1Icahn School of Medicine at Mount Sinai, New
Oral Immunotherapy-Related Adverse Gastrointestinal Events York, NY, 2Icahn School of medicine at Mount Sinia, New York,
Uyenphuong Le, MD1, Yamini Virkud, MD, MA2, Brian P. Vick- NY, 3Pediatrics, Icahn School of Medicine at Mount Sinai, New
ery, MD, FAAAAI1, Pamela H. Steele, MSN CPNP AE-C1, Janet S. York, NY
107
AB318 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
373 Baked Milk Oral Immunotherapy For Severe IgE-Mediated 383 The Use Of The ISAC Mircroarray Platform In Food Allergic
Cows Milk Protein (CMP) Allergic Patients: Interim Results Patients
Dr. Michael Goldberg, MD, PhD1, Dr. Liat Nachshon, MD1, Dr. Jacob Daniel Kattan, MD1, Gustavo Gimenez, BA1, Jay A. Lie-
Arnon Elizur, MD2, Dr. Moshe Appel3, Dr. Michael B. Levy, berman, MD2 and Hugh A. Sampson, MD, FAAAAI3, 1Icahn
MD, FAAAAI1 and Prof. Yitzhak Katz, MD, FAAAAI1,2, 1Assaf School of Medicine at Mount Sinai, New York, NY, 2University
Harofeh, Zerifin, Israel, 2Department of Pediatrics, Sackler School of Tennessee, Memphis, TN, 3Pediatrics, Icahn School of Medicine
of Medicine, Tel Aviv, Israel, 3Assaf Harofeh, Israel at Mount Sinai, New York, NY
374 Progression Towards Increasing Tolerance To Less Extensively 384 IgE Antibodies To Ara h 2 and Ara h 6 By Immunocap ISAC
Heat-Denatured Milk Products Distinguish Peanut Anaphylaxis Children From Asymptomatic
Hugh A. Sampson, MD, FAAAAI1, Dr. George N. Konstantinou, Peanut Sensitization
MD, PhD, MSc2,3, Jacob Daniel Kattan, MD4, Madhan Masilamani, Dr. Rumiko Shibata, MD, PhD1, Dr. Youko Murakami, MD1 and
PhD4, Mrs. Beth D. Strong, RN CCRC5, Mr. Tee Bahnson, BS, Dr. Hiroshi Odajima2, 1Department of Pediatrics, Fukuoka National
MPH6, Ms. Kaitie Fernandez7 and Dr. Anna H. Nowak-Wegrzyn, Hospital, Fukuoka, Japan, 2Fukuoka National Hospital, Fukuoka,
MD, FAAAAI4, 1Pediatrics, Icahn School of Medicine at Mount Si- Japan
nai, New York, NY, 2424 General Military Training Hospital, The- 385 Molecular Component Testing For Peanut Allergy Reactivity
ssaloniki, Greece, 3First Pediatric Department, Aristotle University Differs Based On Age
of Thessaloniki, Hippokration General Hospital, Thessaloniki, Dr. Michelle L. Altrich, PhD, Viracor-IBT Laboratories, Lees
Greece, 4Icahn School of Medicine at Mount Sinai, New York, Summitt, MO
SUNDAY
NY, 5Icahn School of medicine at Mount Sinia, New York, NY, 386 CD-Sens and Component Resolved Diagnostics In Diagnosing
6
Rho Federal Systems Division, Inc., Chapel Hill, NC, 7Rho Fed- Hazelnut Allergy
eral Systems Division, Inc., Chapel Hill, NC, Chapel Hill, NC Dr. Josef Brandstrom, MD1, Prof. Magnus Borres, Md, Phd,
375 Cows Milk Allergen Specific CD4+ T Cell Responses In Pa- FAAAAI2, Prof. S. G. O. Johansson, MD, PhD, FAAAAI3, Ms. Ag-
tients With Persistent Cows Milk Allergy neta Jansson Roth1, Ms. Ann-Charlotte Sundqvist1, Dr. Gunnar
Dr. Fatima S. Khan, MD, Altru, Grand Forks, ND, Nupur Bhatna- Lilja, MD, PhD1, Dr. Anna Nopp, PhD3 and Dr. Caroline Nilsson,
gar, PhD, Benaroya Research Institute, Seattle, WA, Dr. David Rob- MD, PhD1, 1Department of Clinical Science and Education,
inson, Virginia Mason Medical Center and William W. Kwok, PhD, Sodersjukhuset, Karolinska Institutet and SachsChildrens Hospital,
Benaroya Research Institute at Virginia Mason, Seattle, WA Sodersjukhuset, Stockholm, Sweden, 2Department of Womens and
376 The Role Of Skin Prick Testing and Specific IgE To Boiled Ver- Childrens Health, Uppsala Univerisity, and Thermo Fisher Scien-
sus Unheated Cow Milk In Cow Milk Allergic Children tific, Uppsala, Sweden, 3Department of Medicine, Clinical Immu-
Dr. Anilkumar Katta, MD, Saint Louis University, Saint Louis, nology and Allergy Unit, Karolinska Institutet, Stockholm, Sweden
MO, Dr. Julie Hong, MD, St. Louis University, Portland, OR and 387 Effect Of Oleic Acid On The Allergenic Properties Of Peanut
Dr. Alan Knutsen, MD, FAAAAI, Saint Louis University School and Cashew Allergens
of Medicine, Saint Louis, MO Si-Yin Chung, PhD1, Christopher P. Mattison, PhD1, Shawndrika
378 Comparing The Utility Of Skin Prick Testing Using Commer- Reed1, Dr. Richard L. Wasserman, MD, PhD, FAAAAI2 and Wendy
cial Extracts and Fresh Food In Diagnosing Peanut Allergy A. Desormeaux1, 1USDA-ARS-SRRC, New Orleans, LA, 2Allergy/
Dr. Carah Santos, MD, Dr. Matthew Strand, PhD, Pearlanne Zelar- Immunology Research Center of North Texas, Dallas, TX
ney, MS and David Mark Fleischer, MD, FAAAAI, National Jewish 388 Identification Of Conformational IgE Epitopes Of Ara h 2 and
Health, Denver, CO Ara h 6
379 Variability Of Major Allergens In Commercially Available Pea- Dr. Xueni Chen, University of Colorado, Aurora, CO and Dr. Ste-
nut Extracts For Skin Prick Testing phen C. Dreskin, MD, PhD, FAAAAI, University of Colorado Den-
Dr. Yong Luo, MD, PhD, Dr. Vincent R. Bonagura, MD, FAAAAI ver, Aurora, CO
and Dr. David Rosenthal, DO, Division of Allergy/Immunology, 389 Basophil Response To Storage Proteins and Oleosins From Sun-
Departments of Medicine and Pediatrics, Hofstra North Shore-LIJ flower Seed
School of Medicine, Great Neck, NY Maria Luisa Macias1, Dr. Francisca Gomez, MD, PhD2, Araceli
380 Ara h 2 and The Relative Risk Of Other Sensitizations Diaz3, Dr. Cristobalina Mayorga, PhD1, Dr. Ana Aranda, PhD1, Mi-
Dr. James Thompson, Fellow-In-Training, ., Evans, GA, Dr. Dan- guel Gonzalez1, Dr. Natalia Blanca-Lopez, MD, PhD4, Dr. Gabriela
iel Duquette, PhD, UW La Crosse, La Crosse, WI and Dr. Brock Canto, MD, PhD4, Ms. Miriam Osorio1, Dr. Maria Garrido, PhD3,
Williams, PhD, U. of Missouri Medical School, Olathe, KS Dr. Maria J Torres, MD, PhD2 and Dr. Miguel Blanca, MD,
381 Variability Of Repeat Peanut Serum IgE Levels PhD2, 1Research Laboratory, Carlos Haya Hospital-FIMABIS,
Tricia D. Lee, MD, Icahn School of Medicine at Mount Sinai, Ja- Malaga, Spain, 2Allergy Service, Carlos Haya Hospital, Malaga,
cob Daniel Kattan, MD, Icahn School of Medicine at Mount Sinai, Spain, 3Plant Biotechnology Institute (UPM-INIA), Madrid, Spain,
4
New York, NY, Dr. Manish Ramesh, MD, PhD, Mount Sinai School Allergy Service, Infanta Leonor Hospital, Madrid, Spain
of Medicine, New York, NY and Dr. Julie Wang, MD, FAAAAI, 390 Utility Of Ovomucoid Specific IgE In Predicting Unheated Egg
The Icahn School of Medicine at Mount Sinai, New York, NY Food Challenge Outcomes
382 Does Peanut Allergen Conjunctival Provocation Test Reflect Dr. Katherine S. Larabee, MD1, Dr. William J. Sheehan, MD2,3,
Specific IgE Levels To Peanut? Dr. Lisa M. Bartnikas, MD2,3, Mr. Carter Petty, MA3, Dr. Lynda
Helene Lindvik, MD1, Petter Mowinckel, M.Sc.2, Jesintha Navar- C. Schneider, MD, FAAAAI2,3 and Dr. Wanda Phipatanakul, MD,
atnam, MD3, Prof. Karin Cecilie Ldrup Carlsen, MD, PhD1,4, Prof. MS, FAAAAI2,3, 1Massachusetts General Hospital for Children,
Magnus Borres, Md, Phd, FAAAAI5, Dr. Bente Kvenshagen, MD2 Boston, MA, 2Harvard Medical School, Boston, MA, 3Boston Chil-
and Prof. Kai Hakon Carlsen, MD, PhD1,4, 1Department of Paedi- drens Hospital, Boston, MA
atrics, Oslo University Hospital, Oslo, Norway, 2Oslo University 391 Allergy Testing In Childhood: Agreement Between Skin Prick
Hospital, Oslo, Norway, 3Department of Ophthalmology, Oslo Uni- Test and Specific IgE In Preschool Children
versity Hospital, Oslo, Norway, 4The Faculty of Medicine, Univer- Ann-Marie M. Schoos, MD, Bo Chawes, MD, Nilofar Flsgaard,
sity of Oslo, Oslo, Norway, 5Department of Womens and Childrens MD, Nasim Samandari, MD, Klaus Bnnelykke, MD and Dr. Hans
Health, Uppsala Univerisity, and Thermo Fisher Scientific, Uppsala, Bisgaard, MD DMSci, Danish Pediatric Asthma Center, Gentofte,
Sweden Denmark
108
J ALLERGY CLIN IMMUNOL Abstracts AB319
VOLUME 133, NUMBER 2
392 Measurement Of Allergenic Components For Predicting Clin- 400 The Relationship Between Mitochondrial Haplogroups Variant
ically Relevant Shrimp Allergy In House Dust Mite Sensitized on Children with Cow Milk Allergy Expressed As Atopic Der-
Children Prof. Man-Yong Han, MD, PhD, Department of Pedi- matitis and Gastrointestinal Disease
atrics, CHA University School of Medicine, Seongnam, Dr. Juan Carlos Muino, MD, PhD, FAAAAI1, Dr. Raul Boudet1,
South Korea, Prof. Heysung Baek, MD, PhD, Department of Pe- Dr. Maria Chaig1, Dr. Roberto Chaig1, Prof. Nelida Gerez2 and
diatrics, Hallym University College of Medicine, Seoul, South Prof. Juan Carlos Copioli1, 1FAC CS MED UNC, Cordoba, Argen-
Korea and Prof. Ha-Baik Lee, MD, PhD, Department of tina, 2FAC CS MED UNC, Cordoba, Argentina
Pediatrics, Hanyang University School of Medicine, Seoul, South 401 Detection Of Peanut Allergens In Breast Milk and Saliva
Korea Dr. Kelli M. Rose, MD1, Christian Plaisance2, Casey C. Grimm,
393 Cross Reactivity Of Alpha Gal Allergy With An Extended Red PhD2, Hsiaopo Cheng, M.S.2, Tysheena Charles, MS2, Saeed A.
Meat Panel Jortani3 and Soheila J. Maleki, PhD2, 1Tulane University, New Or-
Dr. Linda Flebbe-Rehwaldt, PhD, Viracor-IBT Laboratories, leans, LA, 2USDA-ARS-SRRC, New Orleans, LA, 3University of
Lees Summit, MO and Dr. Michelle L. Altrich, PhD, Viracor- Louisville, Louisville, KY
IBT Laboratories, Lees Summitt, MO 402 Importance Of High Molecular Weight Proteins In Walnut Al-
394 Prediction Of Tolerance To Food Allergens By The Allergen- lergy
Specific IgE/Total IgE Ratio Melanie L. Downs, M.S.1,2, Dr. Aida Semic-Jusufagic, MD2, Dr.
Ms. Claudia Lau1, Dr. Ruchi Gupta, MD, MPH1,2, Dr. Aaron Don- Angela Simpson, MD2, Prof. Adnan Custovic, MD, PhD,
nell, MD3, Prof. Robert G. Hamilton, PhD D.ABMLI FAAAAI4 FAAAAI2, Dr. Savas Savatianos, MD3, Dr. Nikolaos G. Papadopou-
SUNDAY
and Dr. Kelly Newhall, MD3, 1Ann and Robert H. Lurie Childrens los, MD, FAAAAI3, Dr. Joan Bartra, MD, PhD4, Dr. Montserrat
Hospital of Chicago, Chicago, IL, 2Northwestern University Fein- Fernandez-Rivas5, Joe L. Baumert1, Steve L. Taylor, PhD1 and
berg School of Medicine, Chicago, IL, 3Chicago Family Asthma Prof. E.N. Clare Mills, BSc PhD2, 1Food Allergy Research and Re-
& Allergy, Chicago, IL, 4Johns Hopkins University School of Med- source Program, University of Nebraska-Lincoln, Lincoln, NE, 2In-
icine, Baltimore, MD stitute of Inflammation and Repair, University of Manchester,
395 T Regulatory Cells and Food Specific Responses In Peanut and Manchester, United Kingdom, 3Allergy Department, 2nd Pediatric
Egg Allergic Children Clinic, University of Athens, Athens, Greece, 4Allergy Unit, Ser-
Nashmia Qamar, DO, Anna B. Fishbein, Kristin A. Erickson, vice of Pneumology and Respiratory Allergy, Hospital Clinic
Miao Cai, MS, Christine Szychlinski, MS, APN, CPNP, Ramsay (ICT), Barcelona, Spain, 5Allergy Department, Hospital Clinico
L. Fuleihan, MD and Dr. Anne Marie Singh, MD, Division of Al- San Carlos, IdISSC, Madrid, Spain
lergy & Immunology, Department of Pediatrics, Northwestern Uni- 403 Characterizing The Effect Of Sodium Sulfite On Cashew Aller-
versity Feinberg School of Medicine, Ann & Robert H. Lurie gens
Childrens Hospital of Chicago, Chicago, IL Christopher P. Mattison, PhD1, Wendy A. Desormeaux1, Dr. Ri-
396 Surveillance Of Persistent Nut Allergy Including The Use Of chard L. Wasserman, MD, PhD, FAAAAI2 and Casey C. Grimm,
Basophil Activation Test In Pediatric Patients PhD1, 1USDA-ARS-SRRC, New Orleans, LA, 2Allergy/Immunol-
Dr. Ashleigh A. Olson, MD1, Kristin A. Erickson2, Miao Cai, MS2, ogy Research Center of North Texas, Dallas, TX
Ms. Christine Szychlinski, APN, CPNP3 and Dr. Anne Marie Singh, 404 Cross-Sensitization To Rosaceae Fruits and Their Molecular
MD2, 1Department of Pediatrics, Northwestern University Feinberg Components In Japanese School Children
School of Medicine, Ann & Robert H. Lurie Childrens Hospital of Dr. Junya Hirayama1, Dr. Atsushi Yamashita1, Dr. Mizuho Nagao,
Chicago, Chicago, IL, 2Division of Allergy & Immunology, Depart- MD1, Dr. Reiko Tokuda1,2, Dr. Keigo Kainuma, MD1 and Dr. Takao
ment of Pediatrics, Northwestern University Feinberg School of Fujisawa, MD, FAAAAI1, 1Institute for Clinical Research, Mie Na-
Medicine, Ann & Robert H. Lurie Childrens Hospital of Chicago, tional Hospital, 2Tokuda Family Clinic
Chicago, IL, 3Northwestern University Feinberg School of Medi- 405 Food-Specific IgE Panel Testing Commonly Results In Misdiag-
cine, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi- nosis and Inappropriate Dietary Exclusion
cago, IL Dr. Maryam Saifi, MD, University of Texas Southwestern Medical
397 Assessment Of a Modified Basophil Activation Test In The Di- Center, Dallas, Mrs. Maria G. Crain, CPNP AE-C, Childrens Medical
agnosis Of Peanut Allergy Center Dallas, Dallas, TX, Dr. Pooja Varshney, MD, Dell Childrens
Dr. Monika Saeedian, MD, University of California, Los Angeles Medical Center, Specially for Children, Austin, TX and Dr. J. Andrew
and Dr. Maria Garcia-Lloret, MD, UCLA Bird, MD, FAAAAI, UT Southwestern Medical Center, Dallas, TX
398 Utility Of Probability Curves Using 3gAllergy For Diagnosis Of 406 Epitope Mapping The Peanut Panallergen Ara h 8
Wheat Allergy Barry K. Hurlburt, PhD1, Hsiaopo Cheng, M.S.1, Dr. Lesa Offer-
Sakura Sato1, Kiyotake Ogura1, Yasunori Sato2 and Motohiro Ebi- mann2, Dr. Maksymilian Chruszcz, PhD3, Dr. Alexandra F. Santos,
sawa, MD, PhD, FAAAAI1, 1Clinical Research Center for Allergy MD, MSc4, Prof. Gideon Lack, MD FRCPCH5 and Soheila J. Mal-
and Rheumatology, Sagamihara National Hospital, Kanagawa, Ja- eki, PhD1, 1USDA-ARS-SRRC, New Orleans, LA, 2university of
pan, 2Department of Biostatistics, Clinical Research Center Chiba south carolina, columbia, SC, 3University of South Carolina, Co-
University lumbia, SC, 4Kings College London, London, United Kingdom,
5
399 Skin Prick Test and Specific IgE To Purified Peanut Allergens St Thomas Hospital, St Thomas Hospital, London, United
Are Related To The Age Of Onset Of Sympstons Kingdom
Dr. Maria Salas, MD, PhD1, Dr. Francisca Gomez, MD, PhD2, Dr. 407 Simulated Roasting Affects Patient IgE Binding To Ara h 2
Ana Aranda, PhD3, Dr. Carmen Rondon, MD, PhD1, Dr. Natalia Tysheena Charles, MS1,2, Casey C. Grimm, PhD2, Jane McBride2,
Blanca-L opez, MD, PhD4, Dr. Gabriela Canto, MD, PhD4, Dr. Ma- Samuel Landry, PhD1 and Soheila J. Maleki, PhD2, 1Tulane Univer-
ria J Torres, MD, PhD1, Dr. Cristobalina Mayorga, PhD3, Dr. Mi- sity Health Sciences Center, New Orleans, LA, 2USDA-ARS-
guel Blanca, MD, PhD1 and Maria Isabel Sanchez Rivas5, SRRC, New Orleans, LA
1
Allergy Service, Carlos Haya Hospital, Malaga, Spain, 2Allergy 408 Transfer Of Peanut IgE Sensitization Following Kidney and
Service, Carlos Haya Hospital, Spain, 3Research Laboratory, Carlos Pancreas Transplant
Haya Hospital-FIMABIS, Malaga, Spain, 4Allergy Service, Infanta Alalia Berry, M.D., University of Utah, Department of Medicine,
Leonor Hospital, Madrid, Spain, 5Allergy Service Carlos Haya Salt Lake City, UT, Dr. Rafael Firszt, MD, MBA, Pediatrics, Uni-
Hospital, Malaga, Spain versity of Utah, Salt Lake City, UT, Dr. Fuad Shihab, MD,
109
AB320 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
2
University of Utah,Division of Nephrology, Salt Lake City, UT, Dr. Neuropsychiatric Research Institute, Fargo, 3Genentech, Inc.,
Jeffrey Campsen, M.D. FACS, University of Utah, Division of South San Francisco, CA
Transplant Surgery, Salt Lake City, UT and Craig Myrick, R.N., In- 415 Treatment With Off-Label Omalizumab In Chronic Idiopathic
termountain Donor Services, Salt Lake City, UT Histaminergic Urticaria - Angioedema Resistant To Conven-
tional Treatment
Dr. Y. V. Rijo, MD1, Dr. P. Palao, MD1, Dr. N. Prior, MD2, Dr. A.
Fiandor, MD1, Dr. M.C. Lopez-serrano, MD, PhD1, Dr. S. Olalde,
Urticaria MD1, Mrs. M.C. Torres1, Dr. S. Quirce, MD, PhD1 and Dr. T. Ca-
ballero, MD, PhD1, 1Hospital La Paz Institute for Health Research
3208 (IdiPaz), Allergy department., Madrid, Spain, 2Hospital Severo
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM Ochoa, Madrid, Spain
409 Outcome Measures Of Challenge Testing In Patients With 416 Real-Life Experiences With Omalizumab For The Treatment
Physically Induced-Urticaria Of Severe Refractory Chronic Urticaria (SRCIU)
Dr. Dean D. Metcalfe, MD1, Sarah Arceo, RN1, Michael L. Young, Carly Barron1, Dr. Gordon L. Sussman, FAAAAI1,2, Dr. Jacques
RN MPH2, Celeste Nelson, NP1 and Dr. Hirsh D. Komarow, MD3, Hebert, MD3,4, Jiayi Bian1, Rose-Marie Caron-Guay4, Stephanie
1
NIH/NIAID/Laboratory of Allergic Diseases, Bethesda, MD, Laflamme4 and Simon Stern1, 1Gordon Sussman Clinical Research
2
2Clinical Research Directorate/CMRP, SAIC-Frederick Inc, Fred- Inc., Toronto, ON, Canada, 2University of Toronto, Faculty of Med-
erick National Laboratory for Clinic Research, Frederick, MD, icine, Toronto, ON, Canada, 3University Laval Center Hospital,
SUNDAY
3
Laboratory of Allergic Diseases, NIAID/NIH, Bethesda, MD Quebec City, QC, Canada, 4Centre de Recherche Appliquee en Al-
410 Whole Blood Histamine Concentration Response To Omalizu- lergie de Quebec, Quebec City, QC, Canada
mab In Patients With Chronic Idiopathic/Spontaneous Urti- 417 Outcomes Of Chronic Urticaria Patients Treated With Hydrox-
caria: Post Hoc Analysis Of Asteria I, Asteria II and Glacial ychloroquine
Studies Dr. Jacqueline Eastman, Dr. Nicole Wilde and Dr. Maya R. Jerath,
Dr. Sarbjit S. Saini, MD, FAAAAI1, Dr. Karin Rosen, MD, PhD2, MD, PhD, University of North Carolina, Chapel Hill, NC
Dr. Hsin-Ju Hsieh, PhD2, Ms. Patricia M. Sterba, MS1, Mr. John- 418 Polymorphisms Of Genes Encoding Interleukin-4 and Its Re-
Paul Courneya, MS1, Dr. Henry Hulter2 and Dr. Hubert Chen2, ceptor Are Associated With Chronic Idiopathic Urticaria
1
Johns Hopkins University, Baltimore, MD, 2Genentech, Inc., South Ms. Zahra Aryan1,2, Dr. Marzieh Tavakol3,4, Prof. Ali Akbar
San Francisco, CA Amirzargar, PhD1, Prof. Masoud Movahedi3, Dr. Alireza Zare bi-
411 Efficacy Of Omalizumab In Patients With Chronic Idiopathic/ doki3, Dr. Mohammad Gharagozlou, MD3, Prof. Asghar Aghamo-
Spontaneous Urticaria With Different Background Therapy: hammadi5, Dr. Mohammad Nabavi6, Mr. Alireza Ahmadvand3,
Post Hoc Analysis Of Asteria I, Asteria II, and Glacial Studies Dr. Nasrin Behniafard, MD3, Ms. Kimia Heidari3, Ms. Samaneh
Dr. Jonathan A. Bernstein, MD, FAAAAI1, Dr. Sarbjit S. Saini, Soltani3 and Dr. Nima Rezaei, MD, PhD1, 1Molecular Immunology
MD, FAAAAI2, Prof. Marcus Maurer, MD3, Dr. Hsin-Ju Hsieh, Research Center; and Department of Immunology, School of Med-
PhD4, Dr. Hubert Chen4, Dr. Janice Canvin, MD, FRCPC5, Dr. icine, Tehran University of Medical Sciences, Tehran, Iran, 2Na-
Thomas B. Casale, MD, FAAAAI6, Dr. Allen P. Kaplan, MD, tional elites foundation, Iran., 3Molecular Immunology Research
FAAAAI7 and Dr. Karin Rosen, MD, PhD4, 1Division of Immunol- Center; and Department of Immunology, School of Medicine, Teh-
ogy Allergy & Rheumatology, University of Cincinnati Medical ran University of Medical Sciences, Tehran, Iran, Iran, 4Student
Center, Cincinnati, OH, 2Johns Hopkins University, Baltimore, Scientific Research Center (SSRC), School of Medicine, Tehran
MD, 3Department of Dermatology and Allergy, Charite Univer- University of Medical Sciences, Tehran, Iran, 5Research Center
sitatsmedizin, Berlin, Germany, 4Genentech, Inc., South San Fran- for Immunodeficiencies, Childrens Medical Center, Tehran Univer-
cisco, CA, 5Novartis Pharmaceuticals UK Limited, Horsham, West sity of Medical Sciences, Tehran, Iran, 6Department of Allergy and
Sussex, United Kingdom, 6Univeristy Of South Florida Morsani Immunology, Rasool-e-Akram Hospital, Tehran University of Med-
College Of Medicine, Tampa, FL, 7Medical University of South ical Sciences, Tehran, Iran, Iran
Carolina, Charleston, SC 419 Chronic Idiopathic Urticaria Index (CIUI) As a Tool For Pre-
412 Angioedema and Angioedema Management From Asteria I and dicting Response To Cyclosporine In Pediatric Patients With
Asteria II: Phase III Studies To Evaluate The Efficacy and Refractory Autoimmune Urticaria
Safety Of Omalizumab In Patients With Chronic Idiopathic/ Dr. Moira E. Breslin, MD, MSc, Pediatrics, UCLA Medical Cen-
Spontaneous Urticaria Who Remain Symptomatic Despite H1 ter, Los Angeles, CA, Dr. Bob Geng, MD, UCLA, Los Angeles, CA
Antihistamine Treatment and Dr. Robert Roberts, MD, PhD, UCLA
Dr. James Zazzali, PhD, Dr. Karin Rosen, MD, PhD, Mary S. 420 Cholinergic Urticaria: Case Report Of Urticaria Induced By
Bradley, MS and Karina Raimundo, BPharm, MS, Genentech, Acquired Seasonal Hypohidrosis
Inc., South San Francisco, CA Dr. Yuriy Zgherea, MD, Dr. Muhammad Imran, MD, Dr. Jaron T.
413 Improvements In Health-Related Quality Of Life From Asteria Abbott, MD, Dr. Aaron K. Pinion, DO, Dr. Selina Gierer, DO and
I & II: Phase III Studies To Evaluate The Efficacy and Safety Dr. John D. Martinez, MD, University of Kansas Medical Center
Of Omalizumab In Patients With Chronic Idiopathic/Spontane- 421 Relation Between Environmental Allergen Exposure and
ous Urticaria Who Remain Symptomatic Despite H1 Antihista- Chronic Urticaria
mine Treatment Dr. Denisa Ferastraoaru, MD, MSc, Allergy - Immunology, Al-
Karina Raimundo, BPharm, MS, Dr. James Zazzali, PhD, Benja- bert Einstein College of Medicine / Montefiore Medical Center,
min Trzaskoma and Dr. Karin Rosen, MD, PhD, Genentech, Inc., Bronx, NY, Dr. Sunit Jariwala, MD, Albert Einstein/Montefiore
South San Francisco, CA Medical Center, New York, NY, Dr. Golda Hudes, MD, PhD, Albert
414 Estimating The Minimal Important Difference (MID) Of The Einstein/ Montefiore Medical Center, New York, NY and Dr. David
Measures In The Urticaria Patient Daily Diary (UPDD): Up- L. Rosenstreich, MD, FAAAAI, Albert Einstein/Montefiore Medi-
dated Findings Using Data From The Asteria I, Asteria II, cal Center, Bronx, NY
and Glacial Studies Of Omalizumab In Chronic Idiopathic/ 422 Relationship Of Clinical Characteristics Of Chronic Urticaria
Spontaneous Urticaria In Children To Treatment Outcome
Susan Mathias1, Dr. Ross D. Crosby2, Dr. Karin Rosen, MD, PhD3 Lisa Neverman, B.S. and Prof. Miles M. Weinberger, MD,
and Dr. James Zazzali, PhD3, 1Health Outcomes Solutions, FAAAAI, University of Iowa, Iowa City, IA
110
J ALLERGY CLIN IMMUNOL Abstracts AB321
VOLUME 133, NUMBER 2
423 Clinical Characteristics Of Elderly Chronic Urticaria 434 Acute Urticaria Caused By Infection In 72 Chinese Patients
Dr. Ga Young Ban, MD1, Ji Hye Kim, MD2, Mi-Yea Kim, MD1, Prof. Ting Xiao, The First Affiliated Hospital, China Medical Uni-
Dr. Hye-Soo Yoo, MD1, Dong-Ho Nahm, MD, PhD1, Dr. Young versity, Shenyang, China and Dr. Lin Zhu, The First Affiliated Hos-
Min Min Ye, MD1, Yoo Seob Shin, MD, PhD1 and Prof. Hae- pital, China Medical University
Sim Park, MD, PhD1, 1Department of Allergy & Clinical Immunol- 435 Assessment Of Acute Urticaria In Pediatric Emergency Depart-
ogy, Ajou University School of Medicine, Suwon, South Korea, ment
2
Department of Internal medicine, Konyang University College of Dr. Raquel Reis Pitchon, Clinical Research1, Mr. Daniel Reis,
Medicine, Daejeon, South Korea Medical Student2, Ms. Adriana Reis, Medical Student3, Mr. Andre
424 Decreased Serum Vitamin D Level In Patients With Chronic Chuster, Medical Student3, Prof. Teresa Mohallen, Professor2, Dr.
Spontaneous Urticaria Jose Ribeiro, Pediatrician4, Dr. Nvea Claret, Pediatrician4, Dr.
Dr. Tadech Boonpiyathad, MD, Dr. Panitan Pradappongsa and Dr. Giane Chaves, Pediatrician4, Dr. Virgilio Aleixo, Pediatrician4,
Atik Sangasapaviriya, Phramonkutklao Hospital, Bangkok, Thailand Dr. Maria do Socorro Fernandes, Pediatrician4 and Dr. Fausto Pa-
425 Supplementation With Vitamin D In a Cohort Of Patients With checo, Pediatrician4, 1Mater Dei Hospital, BELO HORIZONTE,
Chronic Urticaria Results In Clinical Improvement Brazil, 2Universidade Federal de Minas Gerais, BELO HORI-
Dr. Anastasiya Kleva, MD, Dr. Sherry Farzan, MD and Dr. Blanka ZONTE, Brazil, 3Faculdade de Ciencias Medicas, BELO HORI-
M. Kaplan, MD, FAAAAI, Department of Pediatrics, Division of ZONTE, Brazil, 4Hospital Mater Dei, BELO HORIZONTE, Brazil
Allergy & Immunology, Hofstra-North Shore-LIJ School of Medi- 436 OTC Pills and Severe Urticaria
cine, Great Neck, NY Ivan Cherrez1, Enrique Loayza2, Leonardo Greiding3, Jose M. Vi-
SUNDAY
426 Clinical and Laboratory Features Of Chronic Urticaria lema4, Juan Calderon4, Erick Calero4 and Gabriela Martinetti4,
1
Dr. Koji Masuda, Kyoto Prefectural University of Medicine, Respiralab - Hospital Kennedy, Guayaquil, Ecuador, 2Respiralab
Kyoto, Japan - Hospital Luis Vernaza, Guayaquil, Ecuador, 3Instituto Argentino
427 Serum Specific IgE Response To Thyroid Autoantigens In Aspi- de Alergia e Inmunologia, Buenos Aires, Argentina, 4Respiralab,
rin Intolerant Urticaria Patients Guayaquil, Ecuador
Dr. Yoo Seob Seob Shin, MD, PhD, Dr. Hye-Soo Yoo, MD, Dr. 437 Hypocomplementemic Urticarial Vasculitis With Elevated Im-
Ga Young Ban, MD, Dr. Young Min Min Ye, MD and Prof. Hae- mune Complexes and Nasal Polyposis
Sim Park, MD, PhD, Department of Allergy & Clinical Immu- Dr. Khrystyna Lishchuk-Yakymovych, MD, Medical University,
nology, Ajou University School of Medicine, Suwon, South Lviv, Ukraine, Dr. Roman Pukalyak, Danylo Halytskyy Lviv Na-
Korea tional Medical University, Ukraine and Prof. Lawrence M. Du-
428 Basophil Receptor Profiles In Chronic Idiopathic Urticaria Buske, MD, FAAAAI, George Washington University School of
Dr. Eric Oliver, MD, Ms. Patricia M. Sterba, MS and Dr. Sarbjit S. Medicine, DC
Saini, MD, FAAAAI, Department of Medicine, Division of Allergy
and Clinical Immunology, Johns Hopkins University School of
Medicine, Baltimore, MD
429 Altered Systemic Adipokine Levels In Patients With Chronic
Pediatric Population Health
Idiopathic Urticaria
Dr. Young Min Ye, MD, Dr. Ga Young Ban, MD, Eun-Mi Yang, 3209
Dr. Hye-Soo Yoo, MD, Yoo Seob Shin, MD, PhD and Prof. Hae- Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
Sim Park, MD, PhD, Department of Allergy & Clinical Immu- 438 Nannies Knowledge, Attitude and Management Of Food Aller-
nology, Ajou University School of Medicine, Suwon, South gies In Children; An Online Survey
Korea Dr. Justin C. Greiwe, MD1, Dr. Lisanne P. Newton, MD2, Dr. Fou-
430 Predicting Clinical Responsiveness To Dapsone In The Treat- seena Pazheri, MD3 and Dr. Brian C. Schroer, MD2, 1Cleveland
ment Of Chronic Idiopathic Urticaria (CIU) Clinic, Cleveland, OH, 2Cleveland Clinic Foundation, Cleveland,
Dr. Ryan A. Steele, DO, MS1, Dr. Janelle Sher, MD2, Dr. Mark OH, 3Cleveland Clinic
Davis-Lorton, MD, FAAAAI2, Dr. Marcella R. Aquino, MD, 439 Does Omega-3 Fatty Acid Supplementation During Pregnancy
FAAAAI2 and Dr. Luz S. Fonacier, MD, FAAAAI3, 1Allergy & Im- Prevent Childhood Atopic Disease?
munology, Winthrop University Hospital, Mineola, NY, 2Winthrop Dr. Manika Girdhar, DO, Childrens Mercy Hospital & Clinics,
University Hospital, Allergy & Immunology, Mineola, NY, 3Section Kansas City, MO and Dr. Christina E. Ciaccio, MD, FAAAAI, Chil-
of Allergy and Clinical Immunology, Department of Medicine, drens Mercy Hospital, Kansas City, MO
Winthrop University Hospital, Mineola, NY 440 Helping Children Cope With Discomfort Associated With Skin
431 Chronic Urticaria/Angioedema and Auto-Immunity: Diagnostic Prick Testing In a Pediatric Setting: A Quality Improvement
Profile Among Patients Attending a Reference Clinic In Brazil Report
Dr. Daniel L. Cordeiro, MD1, Dr. Janaina Fernandes de Melo Ms. Amanda Troger, BSN, RN1, Ms. Humaira Robinson, BSN
Sousa, MD1, Dr. Karine Boufleur, MD1, Dr. Priscila Botelho Palhas, RN1, Ms. Sonia C. Mancia, RN2, Dr. Hemant P. Sharma, MD
MD1, Dr. Thas Mendonca, MD1, Dr. Janaina Michele de Lima MHS FAAAAI3 and Dr. Katherine Kelly, PhD, RN1, 1Childrens
Melo, MD1 and Dr. Luisa Karla P. Arruda, MD, PhD, FAAAAI2, National Medical Center, Washington, DC, 2Childrens National
1
Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Medical Center, Fairfax, VA, 3Childrens National Medical Center
Preto, Brazil, 2School of Medicine of Ribeirao Preto, Ribeirao 441 Are Total Serum IgE Levels Good Predictors Of Allergies In
Preto, Brazil Children?
432 Chronic Spontaneous Urticaria-The Saskatchewan Experience Dr. Stephanie Barnes-Mercado1, Dr. Vylma Velazquez, MD2 and
and Questionnaire Survey Dr. Annette Pietri-Ramirez1, 1Hospital Episcopal San Lucas-Ponce,
2
Ms. Natasha Gattey, University of Saskatchewan, Saskatoon, SK, Hospital Episcopal San Lucas, Ponce, PR
Canada 442 Relationship Between Maternal Fat During Pregnancy and
433 A Case Of Incontinentia Pigmenti Masquerading As Urticaria Risks Of Allergic and Respiratory Diseases In Early Childhood:
Pigmentosa The Mothers and Childrens Environmental Health Study
Dr. Erin C. Donahue, MD and Dr. Sonal R. Patel, MD, White Me- Prof. Ja Hyeong Kim, MD1, Prof. Eun-Hee Ha, MD2, Prof. Hye
morial Medical Center, Los Angeles, CA sook Park, MD2, Prof. Mina Ha, MD3, Prof. Yun-Chul Hong,
111
AB322 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
MD4, Prof. Yangho Kim, MD5, Mr. Min-ho Kim, PhD6, Prof. Jin-A 450 Experience In The Development Of a Mobile Diagnosis Support
Jung, MD7 and Prof. NamSoo Chang, PhD8, 1Ulsan University System For Asthma: Intelimed
Hospital, Ulsan, South Korea, 2Department of Preventive Medicine, Prof. Silvia Wanick Sarinho Sr., Prof.Dr.1, Prof. Julio Ven^ancio
School of Medicine, Ewha Womans University, South Korea, 3De- Menezes Junior1, Prof. Cristine Gusm~ao1 and Nilza R S Lyra,
partment of Preventive Medicine, Dankook University College of MD2, 1Universidade Federal de Pernambuco, 2Universidade Federal
Medicine, 4Department of Preventive Medicine, Seoul National de Pernambuco, Recife PE, Brazil
University College of Medicine, South Korea, 5Department of Oc- 451 An Assessment Of Food Allergy Knowledge Among Parents Of
cupational and Environmental Medicine, University of Ulsan, Col- Children With Food Allergy and The Role Of An Educational
lage of Medicine, Ulsan University Hospital, South Korea, 6Ulsan Website
University Hospital, South Korea, 7Dong-A University College of Jamee Castillo, MD1, Neha Mehrotra, MD1, Raoul L. Wolf, MD,
Medicine, Busan, 8Department of Nutritional Science and Food FAAAAI2 and Ves Dimov, MD3, 1Internal Medicine Residency Pro-
Management, Ewha Womans University, Seoul, Korea, South gram, Department of Medicine, University of Chicago, Chicago, IL,
2
Korea Section of Allergy, Asthma and Immunology, Department of Pedi-
443 The Efficacy Of Training School and Nursery Personnel On Ep- atrics, Department of Medicine, University of Chicago, Chicago,
inephrine Autoinjector Use IL, 3University of Chicago Medicine, Chicago, IL
Dr. Mari Sasaki, MD, Dr. Mayumi Furukawa, MD, Dr. Koichi
Yoshida, MD and Dr. Akira Akasawa, MD, PhD, Division of Al-
lergy, Tokyo Metropolitan Childrens Medical Center, Tokyo, Japan
SUNDAY
112
J ALLERGY CLIN IMMUNOL Abstracts AB323
VOLUME 133, NUMBER 2
MD, FAAAAI1, Dr. Bruce K. Tan, MD3, Dr. Rakesh Chandra, MD, FAAAAI1, Dr. Joy Hsu, MD, MSCI1, Prof. Pedro C. Avila,
MD2, Dr. David Conley, MD3, Dr. Juan Jaen, PhD4, Dr. Thomas MD, FAAAAI1, Mr. James Norton, MS1, Ms. Lydia Suh, BSc1,
Schall, PhD4, Dr. Robert C. Kern, MD1,3 and Dr. Robert P. Dr. Rakesh Chandra, MD2, Dr. David Conley, MD3, Dr. Robert
Schleimer, PhD FAAAAI5, 1Department of Medicine, Division of C. Kern, MD3, Dr. Bruce K. Tan, MD3 and Dr. Robert P. Schleimer,
Allergy-Immunology, Northwestern University Feinberg School PhD FAAAAI4, 1Department of Medicine, Division of Allergy-Im-
of Medicine, Chicago, IL, 2Northwestern University, Chicago, IL, munology, Northwestern University Feinberg School of Medicine,
3
Department of Otolaryngology, Northwestern University Feinberg Chicago, IL, 2Northwestern University, Chicago, IL, 3Department
School of Medicine, Chicago, IL, 4Chemocentryx Inc, Mountain of Otolaryngology, Northwestern University Feinberg School of
View, CA, 5Division of Allergy-Immunology, Department of Med- Medicine, Chicago, IL, 4Division of Allergy-Immunology, Depart-
icine, Northwestern University Feinberg School of Medicine, Chi- ment of Medicine, Northwestern University Feinberg School of
cago, IL Medicine, Chicago, IL
458 Sinusitis In Latino Children Is Associated With Allergic Respi- 462 Expression Of Hypoxia-Inducible Factor 1alpha In Regulatory
ratory Diseases and Inversely Related To Native American An- T Cells Is Associated With Nasal Polypogenesis
cestry (GALA II Study) Prof. Yong Min Kim1, Dr. Jun Jin2, Dr. Dong-Yeop Chang3, Sung
Dr. Jennifer A. Regan, MD, PhD1, Dr. Joy Hsu, MD, MSCI2, Ms. Ha Kim4 and Ki-Sang Rha4, 1Chungnam National University
Elizabeth Nguyen, BS3, Ms. Lindsey Roth, MA4, Dr. Joshua Gal- School of Medicine, Daejeon, South Korea, 2Chungnam National
anter, MD4, Dr. Sam Oh, PhD, MPH4, Ms. Celeste Eng, BS4, Mr. University School of Medicine, 3Laboratory of Immunology and In-
Fred Lurmann, MS5, Dr. Rajesh Kumar, MD, MS, FAAAAI6, Dr. fectious Diseases, Graduate School of Medical Science and Engi-
SUNDAY
Harold J. Farber, MD, MSPH7, Dr. Denise Serebrisky, MD8, Dr. neering, KAIST, Daejeon, South Korea, 4Chungnam National
Luisa Borrell, DDS, PhD9, Dr. Saunak Sen, PhD10, Dr. William Ro- University School of Medicine, South Korea
driguez-Cintron, MD11, Dr. Jose Rodriguez-Santana, MD12, Dr. Es- 463 Prognoistic Factors For Olfaction After Endoscopic Sinus Sur-
teban Gonza Burchard, MD, MPH4 and Prof. Pedro C. Avila, MD, gery In Chronic Sinusitis With Or Without Allergy
FAAAAI1, 1Feinberg School of Medicine, Northwestern University, Dr. Byung Guk KIM1, Jihyun SHIN2, Chan Soon PARK2, Dr. Soo
Chicago, IL, 2Department of Medicine, Division of Allergy-Immu- Whan Kim3, JUN Myung Kang2 and So Young PARK2, 1The Catholic
nology, Northwestern University Feinberg School of Medicine, University Of Korea, Seoul, Korea, South Korea, 2The Catholic Univer-
Chicago, IL, 3Department of Medicine, University of California, sity Of Korea, Seoul, Korea, 3The Catholic University of Korea
San Francisco, California, San Francisco, CA, 4Department of
Medicine, University of California, San Francisco, San Francisco,
CA, 5Sonoma Technology, Inc., Petaluma, CA, 6Pediatric allergy,
Ann & Robert H. Lurie Childrens Hospital of Chicago, Chicago,
IL, 7Baylor College of Medicine and Texas Childrens Hospital,
Rhinitis
Houston, TX, 8Pediatric Pulmonary Division, Jacobi Medical Cen-
ter, Bronx, NY, 9Department of Health Sciences, Graduate Program 3212
in Public Health, Lehman College, City University of New York, Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
Bronx, NY, 10Department of Epidemiology and Biostatistics, Uni- 464 The Association Between Two SNPs GATA3 (rs1269486,
versity of California, San Francisco, San Francisco, CA, 11Veterans rs2229360) Gene and Allergic Rhinitis
Caribbean Health Care System, San Juan, PR, 12Centro de Neumo- Prof. Reza Farid, MD, FAAAAI, Allergy Research Center, Mash-
logia Pediatrica, San Juan, PR had University of Medical Sciences, Iran, Prof. mohammad Raza
459 Evaluation Of Olfactory Function In Patients With Chronic Abbaszadegan, 1. Genetic Research Center,Mashhsd University of
Rhinitis Medical Science, mashhad, Iran, Prof. Farahzad Jabbari, Allergy re-
Dr. Idalia V. Yanez-Perez, MD, Dr. Sandra N. Gonzalez-Diaz, search center, Mashhsd University of Medical Science, Mashhad,
MD, PhD, FAAAAI, Dr. Alejandra Macias-Weinmann, Dr. Alfredo Iran, Prof. Mehran Gholamin, Immunology Research Center,1.
Arias-Cruz, Dr. Lorena Rangel-Garza, Dr. Hilda Hernandez-San- Mashhsd University of Medical Science, mashhad, Iran, Dr. Afshin
chez, MD, Dr. Rafael Perez-Vanzzini and Dr. Karla Mejia-Salas, Shirkani, MD, Bushehr University of Medical Science, Mashhad,
Regional Center of Allergy and Clinical Immunology. University Iran, Mrs. Hadis Yousefzadeh, allergy Research Center. Mashhsd
Hospital Dr. Jose Eleuterio Gonzalez., Monterrey, Mexico University of Medical Science, mashhad, Iran and Ms. Atena Man-
460 A Method For Assessing Regional Determinants Of Eosino- souri, buoshar university, Iran
philia In Chronic Rhinosinusitis 465 Impacts Of Adolescents Allergic Rhinitis On School Achieve-
Dr. Bruce K. Tan, MD1, Ms. Erin Rocci, BS2, Dr. Kent Lam, MD1, ment and Quality Of Life
Ms. He Huang, MS1, Ms. Lydia Suh, BSc3, Mr. Avesh Thuluvath, Prof. Sun-Hee Choi, MD, PhD1, Dr. Kyung Suk Lee, MD, PhD2
BA4, Ms. Alcina K. Lidder, BA1, Dr. Rakesh Chandra, MD5, Dr. and Prof. Yeong-Ho Rha, MD, PhD2, 1Gangdong Kyung Hee Uni-
David Conley, MD1, Dr. Stephanie Shintani-Smith, MD1, Dr. Ka- versity Hospital, Seoul, South Korea, 2Kyung Hee University
thryn E. Hulse, PhD5, Dr. Atsushi Kato, PhD3, Dr. Anju T. Peters, Hospital
MD, FAAAAI3, Dr. Leslie C. Grammer, MD, FAAAAI3, Dr. Robert 466 Allergic Rhinitis (AR) Is Sub-Optimally Controlled: The Need
C. Kern, MD1 and Dr. Robert P. Schleimer, PhD FAAAAI6, 1De- For a More Effective Treatment Option
partment of Otolaryngology, Northwestern University Feinberg Dr. Phillip L. Lieberman, MD, FAAAAI, Allergy and Asthma As-
School of Medicine, Chicago, IL, 2Loyola University Stritch School sociates, Germantown, TN and Prof. David Price, FRCGP, MRCGP,
of Medicine, Chicago, IL, 3Department of Medicine, Division of DRCOG, Research In Real Life, Cambridge, United Kingdom
Allergy-Immunology, Northwestern University Feinberg School 467 Short and Long-Term Safety Of MP29-02 In The Treatment Of
of Medicine, Chicago, IL, 4Northwestern University- Feinberg Allergic Rhinitis
School of Medicine, Chicago, IL, 5Northwestern University, Chi- Dr. William Berger, MD, Allergy & Asthma Associates of South-
cago, IL, 6Division of Allergy-Immunology, Department of Medi- ern California, Mission Viejo, CA, Dr. Jonathan A. Bernstein, MD,
cine, Northwestern University Feinberg School of Medicine, FAAAAI, Division of Immunology Allergy & Rheumatology, Uni-
Chicago, IL versity of Cincinnati Medical Center, Cincinnati, OH, Dr. Nancy
461 The Prevalence Of AERD In a Tertiary Care Center Ruiz, MD, MEDA Pharmaceuticals, Somerset, NJ and Dr. Warner
Dr. Whitney Wyatt Stevens, MD, PhD1, Dr. Anju T. Peters, MD, W. Carr, MD, FAAAAI, Allergy and Asthma Associates of SCs,
FAAAAI1, Dr. Kathryn E. Hulse, PhD2, Dr. Leslie C. Grammer, Mission Viejo, CA
113
AB324 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
468 Anti-Allergic Effect Of Intranasal 1,25-Dihydroxyvitamin D3 MD4, Dr. Kelly Bethel5, Ms. Rachel Baum, B.S.4, Mr. Sean
Treatment In Allergic Rhinitis Mouse Model Lund, B.S.6, Naseem Khorram, M.S.6, Dr. David R. Scott, M.D.7,
Dr. Dong-Young Kim, Division of Allergy-Immunology, Depart- Dr. David H. Broide, MB ChB FAAAAI8 and Dr. Taylor A. Doh-
ment of Medicine, Northwestern University Feinberg School of erty, MD, FAAAAI9, 1University of California, San Diego, San
Medicine, Chicago, IL; Department of otorhinolaryngology, Seoul Diego, CA, 2Scripps Clinic Medical Group, San Diego, CA,
3
national university college of medicine, Seoul, Korea and Dr. Jae- Scripps Clinic, San Diego, CA, 4University of California, San
Min Shin, Department of Otorhinolaryngology-Head and Neck Sur- Diego, 5Scripps Green Hospital, 6University of California, San
gery, Soon Chun Hyang University Hospital, Seoul, South Korea Diego, La Jolla, CA, 7Allergy and Asthma Center of Western Col-
469 B-Cells In Allergic Airways Disease: Inhibition Of Epsilon orado, 8Department of Medicine, San Diego, CA, 9Medicine, Uni-
Transcription By Omalizumab versity of California, San Diego, San Diego, CA
Dr. Marylin Desjardins, MD1,2, Dr. Jean-Philippe Drolet, MD3, 477 Innate and Adaptive Lymphocyte Responses In a Mouse Model
Ms. Marianne Beland2, Dr. Sam Daniel, MD1 and Dr. Bruce D. Ma- Of Rhinovirus-Induced Asthma Exacerbation
zer, MD, FAAAAI1,4, 1Montreal Childrens Hospital, Montreal, Dr. Annabelle Jayaraman, PhD, Dr. Nathan Bartlett, PhD and
QC, Canada, 2Meakins-Christie Laboratories, Montreal, QC, Can- Prof. Sebastian L. Johnston, MD, PhD, Imperial College London,
ada, 3Centre Hospitalier Universitaire de Quebec, Quebec, QC, London, United Kingdom
Canada, 4Meakins-Christie Laboratories, Research Institute - 478 Aspergillus Fumigatus May Promote Th2 Activation By Sup-
McGill University Health Centre, Montreal, QC, Canada pression Of Interferon Signaling
470 Early Childhood Allergic Phenotypes Are Associated With In- Dr. Tetsuya Homma, MD1,2, Mr. Bharat Bhushan1,3, Dr. Atsushi
SUNDAY
ternalizing Disorders Kato, PhD1, Mr. James Norton, MS1, Ms. Lydia Suh, BSc1, Dr.
Maya Nanda, MD1, Linda Levin, PhD2, Grace K. LeMasters, PhD2, Quan Sha, MD, PhD4, Dr. Dave S. Gupta, MD5 and Dr. Robert P.
Amal H. Assaad, MD, FAAAAI1, Nicholas Newman, DO, MS1 and Schleimer, PhD FAAAAI6, 1Department of Medicine, Division of
Patrick Ryan, PhD1, 1Cincinnati Childrens Hospital Medical Center, Allergy-Immunology, Northwestern University Feinberg School
Cincinnati, OH, 2University of Cincinnati, Cincinnati, OH of Medicine, Chicago, IL, 2Department of Internal Medicine, Divi-
471 Allergic Rhinitis In Puerto Rican Children: Under-Diagnosis sion of Respiratory Medicine and Allergology, Showa University
and Risk Factors School of Medicine, Tokyo, Japan, 3Division of Otolaryngology-
Dr. Tammy S. Jacobs, MD, MA, Dr. Erick Forno, MD, MPH, Dr. Head and Neck Surgery, Ann & Robert H. Lurie Childrens Hospi-
John M. Brehm, MD, MPH, Dr. Yueh-Ying Han, PhD, MS and Dr. tal of Chicago, 4Allergy and Immunology research center, Anhui
Juan C. Celedon, MD, DrPH, FAAAAI, Childrens Hospital of Medical University, China, 5Department of Allergy Immunology,
Pittsburgh of UPMC, Pittsburgh, PA National Jewish Health, Denver, CO, 6Division of Allergy-Immu-
472 Hematopoietic Prostaglandin D Synthase Is a Useful Target For nology, Department of Medicine, Northwestern University Feinberg
Treating Nasal Obstruction In Guinea Pigs With Allergic Rhi- School of Medicine, Chicago, IL
nitis 479 Heterogeneity Of Specific CD4+ T Cell Responses To Peanut Al-
Daisuke Kajiwara, Hiroki Aoyagi, Kazuhiko Shigeno, Katsunao lergic Components: Prospects For Specific Immunotherapy
Tanaka, Eiji Sasaki and Teruhiro Utsugi, Tsukuba Research Center, Dr. Erik R. Wambre, PhD, Benaroya Research Institute, Seattle,
TAIHO PHARMACEUTICAL CO.,LTD. WA, William W. Kwok, PhD, Benaroya Research Institute at Vir-
473 Efficacy Of MP29-02 In The Treatment Of Nasal and Ocular ginia Mason, Seattle, WA and Dr. David Robinson, Virginia Mason
Symptoms Of Seasonal Allergic Rhinitis (SAR) Medical Center
Dr. Paul H. Ratner, MD, FAAAAI, Sylvana Research, San Antonio, 480 Vitamin D Supplementation Reduces Th17 Cells In The Lung
TX, Dr. Frank Hampel, MD, Central Texas Health Research, Dr. Julius and Spleen Of CRA-Sensitized and Challenged Mice
Van Bavel, MD, Allergy and Asthma Research Associates, Austin, TX Ankita Aggarwal1, Greg Perry1, Vikash Kansal2, Min-Jung Kim1
and Dr. Nancy Ruiz, MD, MEDA Pharmaceuticals, Somerset, NJ and Devendra K. Agrawal1, 1Department of Medical Microbiology
474 Atypical Symptoms Of Chronic Rhinitis and The Impact On & Immunology and Center for Clinical & Translational Science,
Quality Of Life Creighton University School of Medicine, Omaha, NE, 2Center
Jettanong Klaewsongkram, Chulalongkorn University, Bangkok, for Clinical and Translational Science and Department of Biomed-
Thailand and Pungjai Mongkolpathumrat, King Chulalongkorn Me- ical Sciences, Creighton University School of Medicine, Omaha,
morial Hospital, Bangkok, Thailand NE
475 Clinical Characteristics Of Allergic and Nonallergic Rhinitis In 481 Distinct Patterns and Magnitude Of T Cell Responses Are Asso-
Children ciated With Seasonal Exposure To Timothy Grass Allergens
Dr. Yong Ju Lee, MD1, Prof. Kyung Won Kim, MD, PhD2, Prof. Dr. Pearl Bakhru1, Carla Oseroff1, Dr. Veronique M. Schulten1,
Myung Hyun Sohn, MD, PhD2, Prof. Kyu-Earn Kim, MD, PhD2 Dr. Denise Hinz1, Victoria Tripple1, Rafeul Alam, MD, PhD,
and Prof. Hae-Ran Lee, MD, PhD3, 1Hallym University Kangnam FAAAAI2, Dr. David H. Broide, MB ChB FAAAAI3, Dr. April
Sacred Heart Hospital, Seoul, South Korea, 2Department of Pediat- Frazier1, John Sidney1, Dr. Bjoern Peters1, Dr. Howard Grey1 and
rics, Severance Childrens Hospital, College of Medicine, Yonsei Dr. Alessandro Sette, Dr. Biol. Sci.1, 1La Jolla Institute for Allergy
University, Seoul, Korea, Seoul, South Korea, 3Hallym University and Immunology, La Jolla, CA, 2National Jewish Health, Denver,
Sacred Heart Hospital, Anyang-si, Gyeonggi-do, South Korea CO, 3Department of Medicine, San Diego, CA
482 IgE Production In B Cells Through Up-Regulating CD40L Ex-
pression and Mediator Release Via CD1d Expressed In Surface
Of Mast Cells Related To Allergic Asthma In Mice
Jai Youl Ro1, Gwan Ui Hong1, Nam Goo Kim1 and Young Min
Mechanisms of Lymphocyte Function Ahn2, 1Sungkyunkwan University School of Medicine, 2Eulji Uni-
versity School of Medicine
3213 483 FOXP3 Epigenetic Signature To Distinguish Between Thymic-
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM and Peripherally-Derived Regulatory T Cells During In Vivo
476 GATA3-Expressing ILC2 Are Selectively Enriched In Allergic Induction Of Immune Tolerance
Eosinophilic Nasal Polyposis Dr. Philippe Begin, MD, MSc FRCPC1,2, Dr. Udo Baron, PhD3,
Dr. Hannah H. Walford, MD1, Dr. Andrew A. White, MD, Dr. Sven Olek, PhD3, Dr. Rosa Bacchetta, MD, PhD1,4 and Dr.
FAAAAI2, Dr. Christopher Bergeron, MD3, Dr. Jacob Husseman, Kari C. Nadeau, MD, PhD, FAAAAI5, 1Stanford University,
114
J ALLERGY CLIN IMMUNOL Abstracts AB325
VOLUME 133, NUMBER 2
Pediatric Allergy and Immunology, 2Centre Hospitalier Universi- Baker, PhD3 and Dr. Ray Peebles, MD4, 1Infectious Diseases; De-
taire Ste-Justine, Montreal, QC, Canada, 3Epiontis GmbH, Berlin, partment of Medicine; Vanderbilt University School of Medicine,
Germany, 4San Raffaele Telethon Institute for Gene Therapy Nashville, TN, 2Accredited Asthma and Allergy Care, PCS, Louis-
(HSR-TIGET), Milan, Italy, 5Pediatric Allergy Immunology, Stan- ville, KY, 3Division of Allergy, Pulmonary and Critical Care Med-
ford University, Stanford, CA icine, Vanderbilt University School of Medicine, Nashville, TN,
484 CD4+ and CD8+ T Cells Of Allergic Humans Express Increased Nashville, TN, 4Allergy, Pulmonary, and Critical Care Medicine;
Phosphorylated p38 MAP Kinase (p38MAPK), Substance P Department of Medicine; Vanderbilt University School of Medi-
Suppresses T Cell Expression Of p38MAPK and Memory IgE cine, Nashville, TN
Responses 491 Anti-Viral Innate Immunity Varies Across Different Asthma In-
Bryan McCarthy, BS1, Jonathan I Silverberg, MD, PhD, MPH1, Seto flammatory Phenotypes
M Chice, MS1, Ankuri Desai, BS1, Dr. Tamar A. Smith-Norowitz, PhD1, Prof. John W. Upham, MD, PhD, FAAAAI1, Mrs. Melanie Car-
Mark Stewart, MD, PhD1, Dr. Rauno Joks, MD2 and Helen G Durkin, roll, BSc1, Prof. Peter Gibson, MD/PhD2,3, Prof. Ian A. Yang,
PhD1, 1Center for Allergy and Asthma Research at SUNY Downstate, MBBS (Hons) PhD4 and Dr. Jodie Simpson, PhD2, 1University of
Brooklyn, NY, 2Center for Allergy and Asthma Research, State Univer- Queensland, Brisbane, Australia, 2University of Newcastle, New-
sity of New York Downstate Medical Center, Brooklyn, NY castle, Australia, 3John Hunter Hospital, Newcastle, Australia,
4
485 Novel Mechanisms Of Immune Modulation By Alpha-1-Anti- The University of Queensland
trypsin 492 Effect Of siRNA Inhibition Of Sialyltransferases and Fucosyl-
Louise V. Rice1, Sarah Dimeloe1, Mun Peak Nyon2, Imran Haq3, transferases On Siglec-F Ligand Expression By Epithelial Cells
SUNDAY
James Irving3, James McDonnell4, Bibek Gooptu2,5, Claudia Kem- In Vitro
per6 and Catherine M. Hawrylowicz4, 1MRC and Asthma UK Centre Dr. Maho Suzukawa, MD, National Hospital Oranization, Tokyo
for Allergic Mechanisms of Asthma, Kings College London, Lon- Hospital, Dr. Ken Ohta, National Hospital Organization Tokyo Na-
don, United Kingdom, 2Institute of Structural and Molecular Biol- tional Hospital, Tokyo, Japan and David Broide, MB ChB, Univer-
ogy/Crystallography, London, United Kingdom, 3Cambridge sity of California San Diego, Department of Medicine, Division of
Institute for Medical Research, University of Cambridge, Cambridge, Allergy and Immunology
United Kingdom, 4MRC and Asthma UK Centre for Allergic Mech- 493 Allergic Airway Inflammation Can Be Regulated By Sema-
anisms of Asthma, Kings College London, London, United King- phorin 4C Through Controlling B-Cell Migration
dom, 5Division of Asthma, Allergy and Lung Biology, Kings Ms. Di Xue, Mcgill university, Montreal, QC, Canada, Dr. Mar-
College London, London, United Kingdom, 6MRC Centre for Trans- ylin Desjardins, MD, Division of Allergy and Clinical Immunol-
plantation, Division of Transplantation Immunology and Mucosal Bi- ogy, Department of Paediatrics, McGill University Health Centre,
ology, Kings College London, london, United Kingdom Montreal, QC, Canada, Dr. Bruce D. Mazer, MD, FAAAAI, Mon-
486 Prevalence Of Allergic Diseases and/Or Allergic Sensitization treal Childrens Hospital, Montreal, QC, Canada, Dr. Amir Hos-
In Children and Adolescents With Type 1 Diabetes Mellitus sein Massoud, PhD, McGill University Health Centre, Montreal,
Dr. Hadley Vila-Nova, MD1, Prof. Angela Spinola-Castro, MD, QC, Canada and Ms. Marianne Beland, MUHC, Montreal, QC,
PhD1, Dr. Fabola E. Garcia, MD2 and Prof. Dirceu Sole, MD, Canada
PhD3, 1Federal University of S~ao Paulo, S~ao Paulo, Brazil, 2Federal 494 Mouse Bone Marrow Derived Mesenchymal Stem Cells Supress
UNiversity of S~ao Paulo, S~ao Paulo, Brazil, 3Federal University of Airway Inflammation In Both Chronic and Acute Murine
Sao Paulo, Sao Paulo, Brazil Asthma Model
487 Microcytosis: A Risk Factor For Asthma and Pulmonary In- Dr. Tunc Akkoc, PhD1, Mr. Ismail Ogulur, MSc.1, Ms. Gulben
flammation? Gurhan1, Ms. Ayca Aksoy, MSc.2, Dr. Gokhan Duruksu, PhD2,
Dr. Emily Brigham, MD, Dr. Meredith C. McCormack, MD, Dr. Dr. Deniz Filinte, MD3, Dr. Erdem Kombak3, Prof. Isil B. Barlan,
Clifford Takemoto, MD and Dr. Elizabeth Matsui, MD, The Johns MD1 and Prof. Erdal Karaoz, PhD2, 1Marmara University Division
Hopkins University School of Medicine, Baltimore, MD of Pediatric Allergy-Immunology, 2Kocaeli University Center for
488 Identification and Cloning Of Active CLC3 Promoter Stem Cell and Gene Therapies Research and Practise, 3Marmara
Rohit Gaurav and Devendra K. Agrawal, Department of Biomed- University Department of Pathology
ical Sciences and Center for Clinical and Translational Science, 495 Profiling Eicosanoids In Breath Condensates Of Asthmatic and
Creighton University School of Medicine, Omaha, NE Healthy Children
Dr. Li-chen Chen1,2, Prof. Jing-Long Huang1,2, Mrs. AI-Hsuan
Wu1, Prof. Ming-ling Kuo3 and Prof. Shau-ku Huang4,5, 1Chang-
Role of Structural Cells in Mechanisms in Health Gung Memorial Hospital, Taoyuan, Taiwan, 2Chang-Gung Univer-
sity, Taoyuan, Taiwan, 3Department of Microbiology and Immunol-
and Disease ogy, Institute of Basic Medical Science, Taoyuan, Taiwan,
4
Division of Environmental Health and Occupational Medicine,
3214 National Health Research Institutes, Miaoli, Taiwan, 5Johns Hop-
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM kins Asthma and Allergy Center, Baltimore, MD
489 Airway Epithelial Cells Exposed To Alternaria Release IL-18 496 Increased IP-10 Expressions In Nasal Fibroblasts From Patients
Independent Of NALP3/Caspase-1 Pathway By Inducing Au- With Refractory Chronic Rhinosinusitis and Asthma
tophagy and Nf-Kb Activation Dr. Mamoru Yoshikawa, MD1, Dr. Kota Wada, MD1, Dr. Tsuyoshi
Hiroki Murai, MD, PhD1, Shintaro Okazaki, MD1, Hisako Haya- Yoshimura, MD2, Dr. Daiya Asaka, MD2 and Prof. Hiroshi Mor-
shi, MD1, Akiko Kawakita, MD1, Motoko Yasutomi, MD, PhD1, iyama, MD2, 1Department of Otorhinolaryngology, Toho University
Mitsufumi Mayumi, MD, PhD1, Prof. Sanjiv Sur, MD2 and Yusei School of Medicine, Tokyo, Japan, 2Department of Otorhinolaryn-
Ohshima, MD, PhD1, 1University of Fukui, Fukui, Japan, 2Univer- gology, Jikei University School of Medicine, Tokyo, Japan
sity of Texas Medical Branch, Galveston, TX 497 Vitamin D Regulating TGF-b Induced Epithelial-Mesenchymal
490 Generation Of Human Hybridomas Secreting Naturally-Occur- Transition
ring IgE MAbs Using Memory B-Cells From Atopic and Asth- Ms. Kimberly Fischer, Creighton University, Omaha and Deven-
matic Patients dra K. Agrawal, Department of Biomedical Sciences and Center
Dr. Scott A. Smith, MD, PhD1, Dr. Dennis Horvath, PhD1, Dr. for Clinical and Translational Science, Creighton University School
Charles Steven Smith, MD, FAAAAI2, Dr. Dawn C. Newcomb of Medicine, Omaha, NE
115
AB326 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
498 Macrophage-Derived Chemokine In Nasal Washes Is Associ- Eun Lee, MD6, Dr. Song I Yang, MD7, Dr. Ji-Won Kwon, MD8,
ated With Asthma Exacerbations and Infections With Rhinovi- Dr. Hyung Young Kim, MD9, Dr. Ju-Hee Seo, MD10, Dr. By-
rus In Children oung-Ju Kim, MD, PhD11, Dr. Hyo-Bin Kim, MD, PhD12, Se-
Carolyn R. Word, MD1, Holliday T. Carper, BS1, Patricia Jorge, Young Oh4, Dr. Soo-Jong Hong, MD, PhD7 and Dr. Bong-Seong
MD1, Joshua L. Kennedy, MD2, Deborah D. Murphy, RN1, Thomas Kim, MD13, 1Johns Hopkins Bloomberg School of Public Health,
A.E. Platts-Mills, MD, PhD, FAAAAI3 and Peter W. Heymann, 2
Research Center for Standardization of Allergic Diseases, Asan
MD1, 1University of Virginia, Charlottesville, VA, 2Arkansas Chil- Institute for Life Sciences, University of ulsan College of Medi-
drens Hospital Research Institute, Little Rock, AR, 3Division of cine, 3Research Center for Standardization of Allergic Diseases,
Asthma, Allergy & Immunology, University of Virginia Health Sys- Asan Institute for Life Sciences, University of ulsan College of
tem, Charlottesville, VA Medicine, South Korea, 4Department of Food and Nutrition, Col-
499 Application Of Isoraft Single Cell Isolation For Analysis Of Pe- lege of Human Ecology, Kyung Hee University, 5Childhood
diatric Bal Macrophages Asthma Atopy Center, Department of Pediatrics, Asan Medical
Dr. Neil Alexis, PhD1, Ms. Heather Wells2, Dr. Yogesh Saini, Center, University of Ulsan College of Medicine, South Korea,
PhD3, Ms. Louisa Brighton2, Dr. Nancy Allbritton, MD, PhD4 6
Department of Pediatrics, Childhood Asthma Atopy Center,
and Dr. Marianne Muhlebach, MD2, 1Center Environmental Med. Asan Medical Center, University of Ulsan College of Medicine,
Asthma/Lung Biology, Chapel Hill, NC, 2Center for Environmental Seoul, South Korea, 7Department of Pediatrics, Childhood
Medicine Asthma and Lung Biology, Chapel Hill, NC, 3CF Center Asthma Atopy Center, Research Center for Standization of Aller-
UNC Chapel Hill, Chapel Hill, NC, 4Department of Chemistry gic Diseases, Asan Medical Center, University of Ulsan College
SUNDAY
UNC Chapel Hill, Chapel Hill, NC of Medicine, Seoul, Korea, 8Department of Pediatrics, Seoul Na-
500 7, 4-Dihydroxyflavone Isolated From Glycyrrhiza Uralensis a tional University Bundang Hospital, Seoul National University
Constituent Of ASHMITM Prevents Dexamethasone Enhance- College of Medicine, Seongnam, South Korea, 9Department of
ment Of Eotaxin-1 Secretion By Human Lung Fibroblasts Pediatrics, Kosin University Gospel Hospital, Kosin University
Dr. Changda Liu, PhD1, Dr. Nan Yang, PhD, MS1, Mr. Ryan P. College of Medicine, Seoul, South Korea, 10Department of Pedi-
Robalino2, Dana Greene2, Janaki Patel2, Jiachen Zi3, Shuwei atrics, Korea Cancer Center Hospital, 11Department of Pediatrics,
Zhang3, Dr. Joseph Goldfarb2, Hugh A. Sampson, MD, FAAAAI1, Hae-undae Paik Hospital, Inje University College of Medicine,
Dr. Jixun Zhan3 and Dr. Xiu-Min Li, MD1, 1Pediatrics, Icahn Busan, South Korea, 12Department of Pediatrics,Inje University
School of Medicine at Mount Sinai, New York, NY, 2Icahn School Sanggye Paik Hospital, Seoul, South Korea, 13Department of Pe-
of Medicine at Mount Sinai, New York, NY, 3Utah State University diatrics, Gangneung Asan Hospital, University of Ulsan College
501 Allergen Sensitivities and Obstruction Indices Among Inner of Medicine
City Asthmatic Patients with High IgE (30-700 IU/ml) Vs Ul- 506 Longitudinal Trends Of Food and Environmental Allergen-Spe-
tra-High IgE Levels (>700 IU/ml) cific IgE In Asthmatic Inner-City Children < 4 Years Of Age
Jamie Zacharias, MD1, Dr. Edward S. Schulman, MD, FAAAAI2, Dr. Keshav Achar, M.B.B.S1, Yikania Pichardo2, Margaret A.
Rebanta Chakraborty, MD2, Rozina Ali, DO1 and Natasha Mehta, Chin, NP3, Dr. Ramin Nazari, MD4, Dr. Andrew A. Wiznia,
MD1, 1Division of Internal Medicine, Drexel University College MD4 and Dr. Gabriele De Vos, MD5, 1Albert Einstein
of Medicine, Philadelphia, PA, 2Division of Pulmonary, Critical College of Medicine, NY, 2Jacobi Medical Center, New York,
Care and Sleep Medicine, Drexel University College of Medicine, NY, 3Jacobi Medical Center, NY, 4Albert Einstein College of
Philadelphia, PA Medicine, 5Albert Einstein College of Medicine, Bronx, NY
502 Alcohol Exposure and Airway Hyperresponsiveness 507 The Effect Of Human Placental Extract In a Mouse Model Of
Dr. Christina Cruz, MD1, Dr. Thomas B. Casale, MD, FAAAAI2 Allergic Rhinitis
and Peter Oldenburg, PhD1, 1Creighton University School of Med- Dr. Soo Whan Kim and Dr. Suk-Woo Yang, The Catholic Univer-
icine, Omaha, NE, 2Univeristy Of South Florida Morsani College sity of Korea
Of Medicine, Tampa, FL 508 Induced Long-Lived Mucosal Mast Cells In The Airways Arise
503 Ragweed Or Dust Mite Antigen-Stimulated Human Primary From Circulating Mast Cell Progenitors
Bronchial Epithelial Cells Differentially Express Cytokines In Dr. Lora Georgieva Bankova, Rheumatology/Immunology/Al-
Response To Formoterol Or Mometasone Or Their Combina- lergy, Brigham and Womens Hospital, Boston, MA, Daniel Dwyer,
tion Brigham and Womens Hospital, Dr. Anne Y. Liu, MD, Stanford
Dr. Anthony Szema, MD, FAAAAI, SUNY Stony Brook School University School of Medicine, Palo Alto, CA, Dr. Tatiana Jones,
of Medicine, East Setauket, NY; Stony Brook University, Stony College of Health Science University of Massachusetts, Lowell,
Brook, NY, Dr. Sayyed Hamidi, Stony Brook University School MA, Dr. K. Frank Austen, MD, FAAAAI, Brigham and Womens
of Medicine, Stony Brook, NY, Dr. Ken-Ichi Takemaru, State Uni- Hospital, Harvard Medical School, Boston, MA and Dr. Michael
veristy of New York @ Stony Brook, Stony Brook, NY and Ma- Gurish, Brigham and Womens Hospital/Harvard Medical School,
rianne Frieri, MD, PhD, FAAAAI, Medicine and Pediatrics, Boston, MA
Nassau University Medical Center, East Meadow, NY; State Uni- 509 Despite Inflammation, No Structural Upper Airway Remodel-
versity of NY @ Stony brook, Stony Brook, NY ling In Severe Allergic Rhinitis
504 Release Kinetics Of Soluble ST2 and Proinflammatory Cyto- Dr. Aarif Eifan, MD1, Dr. Nara Orban, MD2, Dr. Mikila Jacobson,
kines In Allergic Rhinits PhD2 and Prof. Stephen R. Durham, MA MD FRCP2, 1Imperial
Mr. Igor Stenin1, Mr. Ralf Baumann1, Mr. Matthaeus Rabaszow- College London, United Kingdom, 2Imperial College London, Lon-
ski1, Dr. Kathrin I. M. Scheckenbach, MD1, Mr. Pascal Werming- don, United Kingdom
haus1 and Dr. Martin Wagenmann, MD, FAAAAI2, 1Department 510 Ozone Inhalation Induces Epithelial IL-33 and Thymic Stromal
of Otorhinolaryngology, Head and Neck Surgery, Heinrich-Heine- Lymphopoietin (TSLP) and Leads To Eosinophilic Airway In-
University Duesseldorf, Germany, 2Henrich Heine University, flammation
Dusseldorf, Germany Stephanie Kubala1,2, Moyar Q. Ge2, Imre Redai2, Monica Soni2,3,
505 Interaction Between Dietary Antioxidants and Passive Smoking Dr. Bei Chen, MD2, Dr. Qi Yang, PhD2, Dr. Avinash Bhandoola,
On The Risk Of Asthma Modified By GSTP1(rs1695) Polymor- MBBS PhD2, Dr. Noam A. Cohen, MD, PhD2 and Dr. Angela
phism Haczku, MD, PhD, FAAAAI2, 1Temple University School of Med-
Dr. Young-Hwa Song, MD, MPH Candidate1, Hye Lim Shin2, icine, Philadelphia, PA, 2University of Pennsylvania, Philadelphia,
Seo Ah Hong3, Sung-Ok Kwon4, Dr. Young Ho Jung, MD5, Dr. PA, 3Georgetown University
116
J ALLERGY CLIN IMMUNOL Abstracts AB327
VOLUME 133, NUMBER 2
Allied Health Oral Abstract Luncheon Brigham and Womens Hospital, Division of Rheumatology, Immu-
nology and Allergy, Boston, MA
3520 517 Relationships Between The New Biomarkers Induced By Inter-
Sunday, March 2nd, 2014, 12:15 PM - 1:30 PM leukin-13 and Bronchial Hyperresponsiveness In Asthmatic
Children: Periostin and Squamous Cell Carcinoma-Related An-
511 Clinical Efficacy Of Subcutaneous and Sublingual Immunother- tigens
apy In Asthma and Rhinitis Children Sensitized To House Dust Prof. Heysung Baek, MD, PhD1, Prof. Kenji Izuhara, MD, PhD2
Mite Min-Ju Kim1,2, Eun Lee1,3, Keun-Mi Park1, Keum-Hee and Dr. Jeong-Sub Yoo1, 1Department of Pediatrics, Hallym Uni-
Hwang1, Young-Ho Jung1,3, Song-Yi Yang1,4, Jae-Eun Lee2, Hee- versity College of Medicine, Seoul, South Korea, 2Saga Medical
Kyeong Kim2, Hye-yeong Lee2, Jin-ho Yu1 and Prof. Soo-Jong School, Saga, Japan
Hong, MD. PhD1,3, 1Childhood Asthma Atopy Center, Department 518 Exhaled Nitric Oxide Performance Compared To Methacholine
of Pediatrics, Asan Medical Center, University of Ulsan College of Challenge In Asthma
Medicine, South Korea, 2Department of Childrens Hospital Nurs- Andrew Nickels, MD, Dr. Kaiser G. Lim, MD, FAAAAI, Dr. Paul
ing, Asan Medical Center, South Korea, 3Research Center for Stan- Scanlon, MD and Kenneth Parker, Mayo Clinic, Rochester, MN
dardization of Allergic Disease, University of Ulsan College of 519 Serum Interleukin 13 (IL-13) and Surfactant Protein D (SP-D)
Medicine, Seoul, Korea, 4Research Center for Standardization of Expression Is Differentially Associated With Disease Status In
Allergic Disease, University of Ulsan College of Medicine, Seoul, Pediatric Asthma Patients
Korea, South Korea Dr. Vasiliki Gemou-Engesaeth, MD, PhD1, Dr. N Laliotou, MD1,
SUNDAY
512 A Patient-Reported Symptom-Based Predictor Of Objective Si- Prof. Chris J. Corrigan, MD, PhD, FAAAAI2, Prof. George P.
nus Inflammation Chrousos, MD, PhD1 and Dr. Angela Haczku, MD, PhD, FAAAAI3,
Ms. Alcina K. Lidder, BA1, Dr. Rakesh Chandra, MD2, Dr. David 1
National & Kapodistrian University of Athens, Greece, 2Kings
Conley, MD1, Dr. Stephanie Shintani-Smith, MD1, Dr. Anju T. Pe- College London School of Medicine, London, United Kingdom,
ters, MD, FAAAAI3, Dr. Leslie C. Grammer, MD, FAAAAI3, Dr. 3
University of Pennsylvania, Philadelphia, PA
Robert C. Kern, MD1, Dr. Brian Schwartz, MD4,5 and Dr. Bruce 520 Correlation Of Exhaled Breath Temperature With Age In
K. Tan, MD1, 1Department of Otolaryngology, Northwestern Uni- Chronic Respiratory Diseases
versity Feinberg School of Medicine, Chicago, IL, 2Northwestern Dr. Radoslaw Gawlik, MD1, Dr. Malgorzata Rajzer-Wrobel2, Dr.
University, Chicago, IL, 3Department of Medicine, Division of Al- Dariusz Ziora2 and Prof. Lawrence M. DuBuske, MD, FAAAAI3,
lergy-Immunology, Northwestern University Feinberg School of 1
Silesian Medical University, Katowice, Poland, 2Silesian Medical
Medicine, Chicago, IL, 4Center for Health Research, Geisinger University, Poland, 3George Washington University School of Med-
Clinic, Danville, PA, 5Johns Hopkins Bloomberg School of Public icine, Washington, DC
Health, Baltimore, MD
513 Healthcare Providers Perception Versus Reality In Patient
Concerns About Starting Subcutaneous Immunoglobulin
Ms. Carla M. Duff, CPNP MSN1, Ms. Annette R. Zampelli, NP2
and Dr. Ann Bullinger, PharmD2, 1University of South Florida, Immune Mechanisms in Atopy
Tampa, FL, 2CSL Behring, LLC, King of Prussia, PA
514 Anaphylaxis During Obstetric Surgery In Latex Allergic Pa- 3602
tients Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
Dr. Nana Jinjolava, MD1, Dr. *Mili Shum, MD2, Dr. Keshav
521 Peripherally Induced Foxp3+ Regulatory T Cells Mediates The
Achar1, Dr. Ren Zhen1 and Dr. Elina Jerschow, MD, M.Sc.3, 1Albert
Immunomodulatory Effect Of Intravenous Immunoglobulin In
Einstein College of Medicinen, 2Montefiore Medical Center, Bronx,
An Experimental Model Of Allergic Airway Disease
NY, 3Albert Einstein College of Medicine/Montefiore Medical Cen-
Dr. Amir Hossein Massoud, PhD1,2, Mr. Gabriel N. Kaufman,
ter, Bronx, NY
MSc1,2, Dr. Ciriaco Piccirillo, PhD2 and Dr. Bruce D. Mazer,
515 The Impact Of Legislation On Illinois School Nurses
MD, FAAAAI1,3, 1Meakins-Christie Laboratories, Research Insti-
Ms. Christine Szychlinski, APN, CPNP1, Mrs. Katherine A.
tute - McGill University Health Centre, Montreal, QC, Canada,
Schmeissing, MS, R.N.2, Dr. Jacqueline Pongracic, MD, FAAAAI2 2
McGill University Health Centre, Montreal, QC, Canada, 3Mon-
and Dr. Anne Marie Singh, MD3, 1Northwestern University Fein-
treal Childrens Hospital, Montreal, QC, Canada
berg School of Medicine, Ann & Robert H. Lurie Childrens Hos-
522 Differential DNA Methylation In Mothers Increases The Prev-
pital of Chicago, Chicago, IL, 2Ann & Robert H. Lurie Childrens
alence Of Atopic Dermatitis In Their Offspring
Hospital of Chicago, Chicago, IL, 3Division of Allergy & Immunol-
Dr. Pia J. Hauk, MD1, Mrs. Anna Forssen, MS1, Dr. Brent Peder-
ogy, Department of Pediatrics, Northwestern University Feinberg
sen, PhD2, Dr. Matthew Strand, PhD1, Mrs. Lindsay Munoz, BA1,
School of Medicine, Ann & Robert H. Lurie Childrens Hospital
Dr. Michaela Schedel, PhD1, Dr. Anne Lynch, MD, MSPH2, Dr.
of Chicago, Chicago, IL
Virginia Winn, MD, PhD2, David A. Schwartz, MD3 and Dr. Erwin
W. Gelfand, MD, FAAAAI1, 1National Jewish Health, Denver, CO,
2
University of Colorado Denver, Aurora, CO, 3University of Colo-
rado Denver School of Medicine, Aurora, CO
Biomarkers 523 Hypereosinophilia In Children and Adults: A Retrospective
Comparison
3601 Kelli Williams, MD, M.P.H., JeanAnne Ware, CRNP, Annalise
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM Abiodun, RN, Paneez Khoury, MD and Dr. Amy D. Klion, MD, Na-
516 Socio-Demographic and Environmental Correlates Of Exhaled tional Institutes of Health, Bethesda, MD
Nitric Oxide Levels 524 Interleukin 35 Modulates TSLP, IL-25 and IL-33 Primed Den-
Dr. Lakiea S Wright, MD MAT, Brigham and Womens Hospital dritic Cells and Inhibits Naive T Cell Differentiation and Grass
Division of Rhematology, Immunology & Allergy, Boston, MA; Pollen-Specific T Cell Proliferation
Boston Childrens Hospital Division of Allergy and Immunology, Natalia C Couto-Francisco1, Dr. Tomokazu Matsuoka2,3, Ms. Ra-
Boston, MA, Dr. Wanda Phipatanakul, MD, MS, FAAAAI, Boston chel Yan, RN3, Prof. Stephen R. Durham, MA MD FRCP1 and Dr.
Childrens Hospital, Boston, MA and Jessica Rabe Savage, MD , Mohamed H. Shamji, BSc MSc PhD4, 1Imperial College London,
117
AB328 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
London, United Kingdom, 2Medical Research Council and Asthma 530 Sensitization To Occupational Allergens and Allergic Diseases
UK Centre for Allergic Mechanisms of Asthma, UK, United King- In Workers Of 5 Havana Bakeries
dom, 3Imperial College London, United Kingdom, 4Imperial Col- Dr. Mirta Alvarez, MD1, Dr. Alexis Labrada, PhD2, Raul Lazaro
lege London, South Kensington, United Kingdom Castro Almarales, MD3, Mrs. Yaqueln Leyva1, Mr. Victor R
525 Fc-Gamma-Receptor-IIb Is Required For The Immunomodula- Meli4, Dr. Humberto Barata4 and Dr. Miguel Hinojosa5, 1Calixto
tory Actions Of Intravenous Immune Globulin In An Antigen- Garca University Hospital, Cuba, 2National Center of Bioproducts,
Driven Murine Model Of Allergic Airways Disease Havana, Cuba, 3National Center of Bioproducts, Cuba, 4Diater Lab-
Mr. Gabriel N. Kaufman, MSc1, Dr. Amir Hossein Massoud, oratories, Argentina, 5Ramon y Cajal Hospital, Spain
PhD1, Dr. Ciriaco A. Piccirillo, PhD2 and Dr. Bruce D. Mazer,
MD, FAAAAI1,3, 1Meakins-Christie Laboratories, Research Insti-
tute - McGill University Health Centre, Montreal, QC, Canada,
2
Centre for the Study of Host Resistance, Research Institute - Drug Allergy
McGill University Health Centre, Montreal, QC, Canada, 3Montreal
Childrens Hospital, Montreal, QC, Canada 3604
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
531 Safety Of Propofol Use In Patients With Food Allergies
Dr. Harshna Mehta, MD, The Icahn School of Medicine at Mount
Leonard Bernstein Session on Occupational
SUNDAY
Sinai, New York, NY and Dr. Mirna Chehade, MD, MPH, Icahn
Allergic Diseases School of Medicine at Mount Sinai, New York, NY; Mount Sinai
Center of Eosinophilic Disorders, Jaffe Food Allergy Institute,
3603 Mount Sinai School of Medicine, New York, NY
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM 532 Risk Stratification Protocol For Carboplatin and Oxaliplatin
Hypersensitivity Reactions With Repeat Skin Testing Improves
526 Endotoxin In Size-Specific Airborne Particles Induces Differen-
Care
tial Nitrative Stress In Human Bronchoepithelial Cells
Dr. Alberta L. Wang, MD1, Dr. Sarita U. Patil, MD2, Dr. Aidan
Umesh Singh1, Dr. Jonathan A. Bernstein, MD, FAAAAI1, Kristin
Long, MD, FAAAAI2 and Dr. Aleena Banerji, MD2, 1Department
Luther2, Lauren Haar2 and Dr. W. Keith Jones, PhD2, 1Division of
of Medicine, Massachusetts General Hospital, Harvard Medical
Immunology Allergy & Rheumatology, University of Cincinnati
School, Boston, MA, 2Division of Rheumatology, Allergy, and Im-
Medical Center, Cincinnati, OH, 2Department of Medicine and
munology, Department of Medicine, Massachusetts General Hospi-
Pharmacology & Cell Biophysics, University of Cincinnati Medical
tal, Harvard Medical School, Boston, MA
Center, Cincinnati, OH
533 Added Value Of Skin Testing In Hypersensitivity Reactions To
527 High Rates Of Sensitization To Selected Metals and Bone Ce-
Taxanes
ment In Joint Replacement Failure Patients and Preoperative
Dr. Matthieu Picard, MD1, Dr. Leyla Pur, MD1, Dr. Joana Caiado,
Evaluations
MD1, Prof. Pedro Giavina-Bianchi, MD, PhD, FAAAAI2, Dr. Vio-
Dr. Karin A. Pacheco, MD, MSPH FAAAAI, Dr. Annyce Mayer,
leta Galv~ao, MD1 and Dr. Mariana C. Castells, MD, PhD,
MD, MSPH, Ms. Samantha Erb, MS, Dr. Lata Shirname-More, PhD
FAAAAI1, 1Division of Rheumatology, Allergy and Immunology,
and Dr. Lisa A. Maier, MD, MSPH FCCP, National Jewish Health,
Department of Medicine, Brigham and Womens Hospital, Harvard
Denver, CO
Medical School, Boston, MA, 2Clinical Imunnology and Allergy
528 Component Resolved Diagnosis In Bakers Asthma
Division, University of Sao Paulo, Boston, MA
Ms. Cristina Gomez-Casado1, Dr. Paloma Campo, MD, PhD2, Dr.
534 Risk Stratification For Paclitaxel-Induced Hypersensitivity Re-
Maria Garrido, PhD3, Ms. C Pereira4, Dr. Arantxa Palacin, PhD1,
actions Improves Quality Of Care
Dr. La Rivas4, Dr. M Catarino5, Dr. Ana Aranda, PhD6, Maria Luisa
Dr. Timothy P. Lax, MD, Dr. Aleena Banerji, MD, Dr. Johnson T.
Macias6, Dr. Alicia Armentia, MD, PhD7, Dr. S. Quirce, MD, PhD8,
Wong, MD, FAAAAI, Dr. Michael T. Wilson, MD, PhD and Dr. Ai-
Dr. Miguel Blanca, MD, PhD2 and Araceli Diaz Perales1, 1Centre
dan Long, MD, FAAAAI, Division of Rheumatology, Allergy, and
for Plant Biotechnology and Genomics (UPM-INIA), Madrid,
Immunology, Department of Medicine, Massachusetts General
Spain, 2Allergy Service, Carlos Haya Hospital, Malaga, Spain,
3 Hospital, Harvard Medical School, Boston, MA
Plant Biotechnology Institute (UPM-INIA), Madrid, Spain, 4Mo-
535 Healthcare Utilization and Serious Infection Prevalence Associ-
lecular Evolution Laboratory, Astrobiology Centre (INTA-CSIC),
ated With Penicillin Allergy In Hospitalized Patients: A Co-
Madrid, Spain, 5Faculty of Pharmacy, University of Lisbon, Lisbon,
hort Study
Portugal, 6Research Laboratory, Carlos Haya Hospital-FIMABIS,
Dr. Eric M. Macy, MD, FAAAAI, 5th Floor, SCPMG-Kaiser Per-
Malaga, Spain, 7Valladolid University, Valladolid, Spain, 8Hospital
manente San Diego, San Diego, CA and Richard Contreras, MS,
La Paz Institute for Health Research (IdiPaz), Allergy department.,
Kaiser Permanente Health Care Program, Department of Research
Madrid, Spain
and Evaluation, Pasadena, CA
529 Endotoxin Exposure May Protect Against The Development Of
Rhinoconjunctivitis and Respiratory Symptoms In Non-Atopic
Individuals With Occupational Exposure To Mice
Dr. Sharon K. Ahluwalia, MD1,2, Dr. Roger Peng, PhD3, Mr.
Charles Aloe, MPH2, Wayne G. Shreffler, MD, PhD, FAAAAI4,5,
Oral Immunotherapy for Food Allergy
Mary Krevans, RN6, Karol A. Hagberg, BSN FNP6, Dr. Peter S.
Thorne, PhD7, Kenneth Walsh8 and Dr. Elizabeth Matsui, MD9, 3605
1
Childrens National Medical Center, Washington, DC, 2Johns Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
Hopkins University School of Medicine, Baltimore, MD, 3Johns 536 Length Of Avoidance Period Following Peanut Oral Immuno-
Hopkins School of Public Health, Baltimore, MD, 4Massachusetts therapy Influences Effector Cell Suppression and Clinical Out-
General Hospital, Boston, MA, 5Harvard Medical School, Boston, comes Michael D. Kulis Jr., PhD, Dr. Rishu Guo, PhD, Brian P.
MA, 6The Jackson Laboratory, Bar Harbor, ME, 7 University of Vickery, MD, FAAAAI, Pamela H. Steele, MSN CPNP AE-C, Ed-
Iowa, Iowa City, IA, 8The Jackson Laboratories, ME, 9The Johns win Kim, MD, MS and A. Wesley Burks, MD, FAAAAI, University
Hopkins University School of Medicine, Baltimore, MD of North Carolina at Chapel Hill, Chapel Hill, NC
118
J ALLERGY CLIN IMMUNOL Abstracts AB329
VOLUME 133, NUMBER 2
537 Basophil Hyporesponsiveness To Peanut Following Immuno- 545 Misuse Of Medical Devices Among Patients In a Tertiary Care
therapy May Be Transient and Correlates With Clinical Re- Allergy/Immunology Practice
sponse Dr. Rana S. Bonds, MD, FAAAAI, University of Texas Medical
Dr. Mark Gorelik, MD1, Dr. Satya Narisety, MD1, Kristin Chiches- Branch, Galveston, TX and Dr. Aasia I. Ghazi, MD, Allergy and
ter, MS1, Anja Bieneman, BS1, Corinne Keet, MD, MS2, Robert A. Asthma Specialists, Plano, TX
Wood, MD, FAAAAI2, Dr. John T. Schroeder, PhD1 and Pamela
Frischmeyer Guerrerio1, 1Johns Hopkins University School of Med-
icine, 2Johns Hopkins University Medical Center, Baltimore, MD
538 Safety Of Pediatric Peanut Oral Immunotherapy Is Compli-
cated By High Adverse Event Rates
Mechanisms of Immunotherapy
Yamini Virkud, MD, MA1, Brian P. Vickery, MD, FAAAAI2, Pa-
mela H. Steele, MSN CPNP AE-C2, Janet S. Kamilaris, RN3 and A. 3607
Wesley Burks, MD, FAAAAI2, 1Duke University, Durham, NC, Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
2
University of North Carolina, Chapel Hill, NC, 3Carolinas Health 546 B Cells and Plasma Cells Populations Suffer Changes Along
Care System, Charlotte, NC The Time After Dermatophagoides Pteronyssinus Specific Im-
539 Course and Outcome Of Patients With Asthma During Oral munotherapy
Immunotherapy To Cows Milk Protein Dr. Enrique Gomez, PhD1, Dr. Taha Fernandez, PhD2, Dr. Inmacu-
Dr. Arnon Elizur, MD1,2, Dr. Michael Goldberg, MD, PhD1, Dr. lada Do~na, MD, PhD3, Dr. Francisca Gomez, MD, PhD3, Mrs. Luisa
SUNDAY
Michael Levy, MD, FAAAAI1, Dr. Liat Nachshon, MD1 and Prof. Galindo, RN3, Ms. Lidia Melendez, Lab. Tech.4, Dr. Miguel Blanca,
Yitzhak Katz, MD, FAAAAI1,2, 1Assaf Harofeh, Zerifin, Israel, MD, PhD3, Dr. Cristobalina Mayorga, PhD5 and Dr. Maria Jose Jose
2
Tel Aviv University, Tel Aviv, Israel Torres, MD, PhD3, 1Research Laboratory for Allergic Diseases, Hos-
540 B-Fahf-2 Pretreatment Reduces OIT Adverse Reactions and pital Regional Universitario de Malaga - IBIMA, Malaga, Spain, 2Re-
Improves Outcomes In a Murine Model Of Multiple Nut Al- search Laboratory - FIMABIS Foundation, Malaga, Spain, 3Allergy
lergy Service, Carlos Haya Hospital, Malaga, Spain, 4Research Labora-
Dr. Xiu-Min Li, MD, Dr. Ying Song, MD, Dr. Changda Liu, PhD, tory, Carlos Haya Hospital-FIMABIS, Malaga, Spain, 5Research
Mr. Ilan Goldberg, Hugh A. Sampson, MD, FAAAAI and Dr. Ka- Laboratory, Carlos Haya Hospital-FIMABIS, Malaga, Spain
mal D. Srivastava, PhD, Pediatrics, Icahn School of Medicine at 547 A Subset Of Novel Timothy Grass Antigens Is Associated With
Mount Sinai, New York, NY Marked Th1/Th2 Shifts Following Specific Immunotherapy
Dr. Veronique M. Schulten1, Victoria Tripple1, John Sidney1, Dr.
Jason Greenbaum1, Dr. April Frazier1, Rafeul Alam, MD, PhD,
FAAAAI2, Dr. David H. Broide, MB ChB FAAAAI3, Dr. Howard
Grey1, Dr. Bjoern Peters1 and Dr. Alessandro Sette, Dr. Biol.
Adherence Sci.1, 1La Jolla Institute for Allergy and Immunology, La Jolla,
CA, 2National Jewish Health, Denver, CO, 3Department of Medi-
3606 cine, San Diego, CA
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM 548 Interleukin IL-27+ Dendritic Cells Modulate Ex-Vivo Th2 Re-
541 Adherence Documentation During Asthma Encounters At a Pe- sponses In a Pdl-1-Dependent Manner and Increase In-Vivo
diatric Tertiary Care Referral Center Following Grass Pollen Immunotherapy
Kara J. Wada, MD, Nationwide Childrens Hospital and The Ohio Dr. Tomokazu Matsuoka1, Ms. Rachel Yan, RN2, Dr. Guy W
State University, Columbus and David R. Stukus, MD, FAAAAI, Scadding, MD2, Prof. Stephen R. Durham, MA MD FRCP3 and
Nationwide Childrens Hospital, Columbus, OH Dr. Mohamed H. Shamji, BSc MSc PhD4, 1Medical Research
542 High-Risk Asthma Multidisciplinary Care Clinic Adherence Council and Asthma UK Centre for Allergic Mechanisms of
Linked To Asthma Control Test (ACT) Score Improvement Asthma, UK, United Kingdom, 2Imperial College London, United
Dr. Bradley A. Locke, DO1, Dr. Pippa Simpson, PhD1, Mrs. Tina Kingdom, 3Imperial College London, London, United Kingdom,
Bromberger, RN, BSN, AE-C2, Mrs. Melodee Nugent, MA1, Mrs. 4
Imperial College London, South Kensington, United Kingdom
Sara A. Lowe, NP1, Dr. Juan Ruiz, MD1, Dr. Patricia Marik, 549 Local Protective IgG4 Antibodies In Nasal Fluid Are Elevated
PsyD2, Dr. Jacquelyn Smith, PhD2, Dr. Joshua A. Steinberg, MD1 Following Grass Pollen Immunotherapy
and Dr. Dorothy S. Cheung, MD, FAAAAI1, 1Medical College of Jinjin Zhang1, Dr. Esther Steveling2, Ms. Rachel Yan, RN2, Dr.
Wisconsin, Milwaukee, WI, 2Childrens Hospital of Wisconsin, Aarif Eifan, MD2, Rebecca Parkin3, Dr. Guy W Scadding, MD2,
Milwaukee, WI Dr. Mohamed H. Shamji, BSc MSc PhD4 and Prof. Stephen R. Dur-
543 Understanding Asthma Medical Nonadherence In Adult and ham, MA MD FRCP1, 1Imperial College London, London, United
Pediatric Populations Kingdom, 2Imperial College London, United Kingdom, 3Imperial
Joyce Xiang Wu Lee, MD1, Henry Wojtczak, MD2, Allan M. College London, London, 4Imperial College London, South Ken-
Wachter, MD3, Martin Lee, PhD4, Lisa Burns, RN3, Diana Chen3 sington, United Kingdom
and Joseph S. Yusin, MD, FAAAAI5, 1Allergy/Immunology, VA 550 Grass Pollen Immunotherapy: Impaired Allergen-Induced Na-
Greater Los Angeles Health Care System, Los Angeles, CA, 2Naval sal and Cutaneous Responses Correlate With Overall Seasonal
Medical Center San Diego, San Diego, CA, 3Foundation for Symptom Scores and Are Associated With Suppressed Local
Asthma Research and Intervention, Phoenix, AZ, 4UCLA School Th2 Cytokines In Nasal Fluid
of Public Health, Los Angeles, CA, 5VA Greater Los Angeles Dr. Guy W Scadding, MD1, Dr. Aarif Eifan, MD1, Dr. Mongkol
Health Care System, Los Angeles, CA Lao-Araya, MD1, Dr. Martin J. Penagos Paniagua, MD1, Ms.
544 Improved Education and Self-Management In Children and Shun Yan Poon1, Dr. Esther Steveling1, Ms. Andrea Goldstone,
Adolescents With Asthma Using a Personalized Smartphone RN1, Ms. Rachel Yan, RN1, Ms. Amy Switzer1, Dr. Deborah Phip-
Application pard2, Dr. Mohamed H. Shamji, BSc MSc PhD3 and Prof. Stephen
David R. Stukus, MD, FAAAAI1,2, Gary Phillips, M.A.S.1 and Na- R. Durham, MA MD FRCP4, 1Imperial College London, United
beel Farooqui, MD1,2, 1Wexner Medical Center at The Ohio State Kingdom, 2Immune Tolerance Network, 3Imperial College London,
University, Columbus, OH, 2Nationwide Childrens Hospital, Co- South Kensington, United Kingdom, 4Imperial College London,
lumbus, OH London, United Kingdom
119
AB330 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Mechanisms of Eosinophil-Driven Disease 557 Analysis Of Severe Asthma Phenotypes By Using High-Resolu-
tion Computed Tomography: Relation To Clinical Assessment
3608 Sujeong Kim1, Kwang-Nam Jin2, Chang Hyun Lee2, Prof. So-Hee
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM Lee3, Jae-Won Jung4, Prof. Woo-Jung Song, M.D.1, Prof. Hye-
Ryun Kang1, Kyung-Up Min1 and Prof. Sang Heon Cho, MD,
551 IL-4 and IL-13 Differentially Regulate TLR-Induced Eosino- PhD3, 1Department of Allergy and Clinical Immunology, Seoul Na-
phil-Basophil Differentiation Of Cord Blood CD34+ Progenitor tional University College of Medicine, Seoul, South Korea, 2De-
Cells partment of Radiology, Seoul National University College of
Dr. Pia Reece, PhD1, Dr. Roma Sehmi, PhD FAAAAI1 and Ju- Medicine, Seoul, South Korea, 3Department of Internal Medicine,
dah Aryeh Denburg, MD, FRCPC, FAAAAI2, 1McMaster Univer- Seoul National University College of Medicine, Seoul, South Ko-
sity, Hamilton, ON, Canada, 2Division of Clinical Immunology rea, 4Inje university ilsan paik hospital, Seoul, South Korea
and Allergy, Department of Medicine, McMaster University, 558 Associations Between The Expression Of Corticosteroid Regu-
ON, Canada lated Genes By Peripheral Blood Mononuclear Cells (PBMCs)
552 Basophils Act As a Cellular Switch to Drive Eosinophilic In- In Children From The NIH/NIAID Sponsored Asthma Pheno-
flammation after IgE Activation types In The Inner City (APIC) Study
Dr. Laurence E. Cheng, MD, PhD, University of California, San Dr. Elena Goleva, PhD1, Leisa P. Jackson, BS1, Baomei Shao, BS2,
Francisco Medical Center, San Francisco, CA and Prof. Richard Zheng Hu, BS2, Dr. Michelle A. Gill, MD, PhD2, Andrew H. Liu,
M. Locksley, MD, University of California, San Francisco, MD1 and Donald Y.M. Leung, MD, PhD, FAAAAI1, 1National
SUNDAY
HHMI, San Francisco, CA Jewish Health, Denver, CO, 2UT Southwestern Medical Center,
553 The SNARE VAMP-7 Contributes To Eosinophil Degranula- Dallas, TX
tion, In Vivo 559 Bronchial Mast Cell Markers and Clinical Asthma Severity In
Dr. Paige Lacy, PhD FAAAAI1, Dr. Lian Willetts, PhD1, Dr. Eliza- Steroid Refractory Asthmatics
beth Jacobsen, PhD2, Dr. Rachel Condjella, PhD2, Ms. Katie Zellner2, Dr. Mandeep Hundal, M.D.1, Dr. Katherine N. Cahill, MD2, Rob-
Dr. Sergei Ochkur, PhD2, Mr. Hui Lou2, Mr. Will LeSuer2, Mr. John ert Pedicini1, Allison Crosby-Thompson1, Stefanie Dutile1, Usha
Kim, MSc1, Ms. Cheryl Protheroe2, Mr. Ralph Pero2, Dr. James J. Govindarajulu, PhD2, Dr. Kartik Shenoy, M.D.3, Dr. Mark Drans-
Lee, PhD3, Dr. Nancy A. Lee, PhD2 and Dr. Redwan Moqbel, PhD field4, Dr. Emily DiMango5, Dr. Serpil C. Erzurum, M.D.6, Dr.
FRCPath FAAAAI4, 1University of Alberta, Edmonton, AB, Canada, Mario Castro, MD, MPH7, Dr. Nizar N. Jarjour, MD8, Dr. Howard
2
Mayo Clinic Arizona, Scottsdale, AZ, 3Mayo Clinic of Arizona, Katz, PhD2, Dr. Joshua A. Boyce, MD, FAAAAI2 and Dr. Elliot Is-
Scottsdale, AZ, 4University of Manitoba, Winnipeg, MB, Canada rael, MD, FAAAAI1, 1Brigham and Womens Hospital, Boston,
554 Microbiota Regulates Eosinophils In The Small Intestine MA, 2Brigham and Womens Hospital, Division of Rheumatology,
Dr. Rodrigo Jimenez-Saiz, PhD1, Mrs. Tina Walker-Fattouh1, Immunology and Allergy, Boston, MA, 3Temple University School
Mrs. Melissa E. Gordon, MSc1, Mr. Waleed S. Ahmed1, Ms. of Medicine, 4University of Alabama School of Medicine, AL, 5Co-
Breanne Dale1, Mr. Talveer S. Mandur1, Mr. Joshua Kong1, lumbia University, New York, NY, 6Department of Pathobiology,
Mr. Derek K. Chu1, Dr. Roland Kolbeck, PhD2, Dr. Alison A. Cleveland Clinic, 7Washington University School of Medicine, St.
Humbles, PhD2, Dr. Elena F. Verdu, MD, PhD3 and Dr. Manel Louis, MO, 8University of Wisconsin School of Medicine and Pub-
Jordana, MD, PhD1, 1McMaster Immunology Research Centre lic Health, Madison, WI
(MIRC), McMaster University, Hamilton, ON, Canada, 2Medi- 560 Antagonistic Effects Of Ozone (O3) Exposure and Glucocorti-
mmune LCC, Gaithersburg, MD, 3Farcombe Family Digestive coid Treatment On Airway Hyperresponsiveness (AHR) and
Health Research Institute, McMaster University, Hamilton, ON, Surfactant Protein D (SP-D) Production In Mice
Canada Moyar Q. Ge1,2, Monica Soni1, Imre Redai1, Blerina Kokalari1, Dr.
555 The Airway Mucins Muc5b and Muc4 Are Endogenous Ligands Angela Haczku, MD, PhD, FAAAAI1 and Zhilong Jiang1, 1Univer-
For Siglec-F and Induce Mouse Eosinophil Death sity of Pennsylvania, Philadelphia, PA, 2National University of Sin-
Takumi Kiwamoto, MD, PhD1, Toshihiko Katoh, PhD2, Christo- gapore, Singapore, Singapore
pher Evans, PhD3, Mary E. Brummet, MS1, Sherry Hudson, MS1,
Zhou Zhu, MD, PhD1, Michael Tiemeyer, PhD2 and Bruce S. Boch-
ner, MD, FAAAAI1, 1Division of Allergy and Clinical Immunology,
Johns Hopkins University School of Medicine, Baltimore, MD,
2
Complex Carbohydrate Research Center, University of Georgia, Advances in Primary Immunodeficiencies
Athens, GA, 3Division of Pulmonary Medicine, University of Col-
orado School of Medicine, Denver, CO 3802
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
561 Impaired Glycosylation Due To Autosomal Recessive PGM3
Mutations Results In Atopy, Immune Deficiency, Autoimmu-
Featured Poster Session nity, and Neurocognitive Impairment
Dr. Joshua D. Milner, MD1, Dr. Jonathan J. Lyons, MD1, Dr. Yu
Zhang, PhD2, Dr. Xiaomin Yu, PhD1, Dr. Shrimati Datta, PhD1,
Ian T. Lamborn, BSc2, Matthew R. Biancalana, BSc3, Lynne A.
Best of ADT Wolfe, CRNP4, Thomas DiMaggio, BSN2, Helen F. Matthews,
BSN3, Dr. Sarah M. Kranick, MD5, Dr. Kelly D. Stone, MD,
3801 PhD, FAAAAI1, Dr. Steven M. Holland, MD6, Dr. Daniel S. Reich,
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM MD, PhD7, Dr. Jason D. Hughes, PhD8, Dr. Huseyin Mehmet,
556 Impact Of Asthma Exacerbations On Lung Function In a Large PhD8, Dr. Joshua McElwee, PhD8, Dr. Hudson H. Freeze, PhD9,
Cohort Of Patients With Severe Or Difficult-To-Treat Asthma Dr. Alexandra F. F. Freeman, MD6 and Dr. Helen C. Su, MD,
Dr. Theodore A. Omachi1, Dr. Tmirah Haselkorn1, Dave P. Miller2 PhD2, 1Laboratory of Allergic Diseases, NIAID/NIH, Bethesda,
and Dr. William J. Calhoun, MD, FAAAAI3, 1Genentech, Inc., South MD, 2Laboratory of Host Defenses, NIAID/NIH, Bethesda, MD,
San Francisco, CA, 2ICON Clinical Research, 3Allergy And Immunol- 3
Laboratory of Immunology, NIAID/NIH, Bethesda, MD, 4Undiag-
ogy, University of Texas Medical Branch, Galveston, TX nosed Diseases Program, NHGRI/NHI, Bethesda, MD, 5Medical
120
J ALLERGY CLIN IMMUNOL Abstracts AB331
VOLUME 133, NUMBER 2
Neurology Branch, NINDS/NIH, Bethesda, MD, 6Laboratory of Biotechnologies, Inc., Charlottesville, VA, 2University of Virginia,
Clinical Infectious Diseases, NIAID/NIH, Bethesda, MD, 7Neuro- Charlottesville, VA, 3University of South Carolina, Columbia, SC
immunology Branch, NINDS/NIH, Bethesda, MD, 8Merck Re- 569 Development Of IgE Against a Cimex Lectularius Allergen Af-
search Laboratories, Merck & Co. Inc., Boston, MA, 9Sanford ter Being Bitten By Bed Bugs Was Common Among Children In
Burnham Medical Research Institute, La Jolla, CA NYC
562 Expansion Of Circulating T Follicular Helper Cells In CVID Adnan Divjan1, Dr. Jason B. Price, MD2, Dr. Luis M. Acosta, MD1,
Patients With Autoimmune Cytopenias Prof. Andrew Rundle, DrPH3, Prof. Inge Goldstein, DrPH4, Prof. Ju-
Dr. Neil D. Romberg, MD1, Dr. Ida Hsu, MD1, Dr. Christina C. dith Jacobson, DrPH3, Prof. William R. Montfort, PhD5, Prof. Greg
Price, MD1, Dr. Charlotte Cunningham-Rundles, MD, PhD, Freyer, PhD6 and Prof. Matthew S. Perzanowski, PhD1, 1Department
FAAAAI2 and Dr. Eric Meffre, PhD1, 1Yale University School of of Environmental Health Sciences, Mailman School of Public Health,
Medicine, New Haven, CT, 2Mt. Sinai Medical Center, New Columbia University, New York, NY, 2Division of Pediatrics, Depart-
York, NY ment of Medicine, College of Physician & Surgeons, Columbia Uni-
563 Treatment Of Murine Chronic Granulomatous Disease (CGD) versity, New York, NY, 3Department of Epidemiology, Mailman
With The PPARg Agonist Pioglitazone Enhances Phagocyte Mi- School of Public Health, Columbia University, New York, NY, 4De-
tochondrial Reactive Oxygen Species (ROS) Production and partment of Epidemiology, Mailman School of Public Health, Co-
Antimicrobial Responses lumbia University, New York, NY, 5Department of Chemistry and
Dr. Donna Bratton, MD, Dr. S. Courtney Frasch, PhD, Dr. Ken- Biochemistry, University of Arizona, Tucson, Arizona, 61Depart-
neth Malcolm, PhD and Dr. Ruby Fernandez-Boyanapalli, PhD, ment of Environmental Health Sciences, Mailman School of Public
SUNDAY
National Jewish Health, Denver, CO Health, Columbia University, New York, New York
564 Patient Specific Targeted Gene Therapy In The Treatment Of 570 Divergent Effects Of Endotoxin and Mold Exposure On Asthma
X-Linked Hyper-IgM Syndrome Exacerbations In The Childhood Asthma Management Pro-
Caroline Y. Kuo, M.D., Division of Allergy and Immunology, De- gram (CAMP)
partment of Pediatrics, David Geffen School of Medicine at UCLA, Dr. Ronina A. Covar, MD1, Mrs. Anna Forssen, MS1, Dr. Stanley
Los Angeles, CA, Alok Joglekar, PhD, Department of Microbiol- J. Szefler, MD, FAAAAI2,3, David A. Schwartz, MD4 and Andrew
ogy, Immunology, and Molecular Genetics, University of Califor- H. Liu, MD1, 1National Jewish Health, Denver, CO, 2University of
nia, Los Angeles, Los Angeles, CA and Donald B. Kohn, MD, Colorado Denver School of Medicine, Denver, CO, 3Childrens
Department of Pediatrics and Department of Microbiology, Immu- Hospital Colorado, Denver, CO, 4University of Colorado Denver
nology, and Molecular GeneticsUniversity of California, Los An- School of Medicine, Aurora, CO
geles, Los Angeles, CA
565 Digeorge Syndrome Found By SCID Newborn Screening In
California
Dr. Kiran P. Patel, MD, MS1, Dr. Antonia Kwan, PhD, MRCPCH1,
Mica Muskat, MSN1, Dr. Joseph A. Church, MD, FAAAAI2, Dr.
Best of FADDA
Morna J. Dorsey, MD MMSc FAAAAI1 and Dr. Jennifer M. Puck,
MD1, 1Department of Pediatrics, University of California San Fran- 3804
cisco and UCSF Benioff Childrens Hospital, San Francisco, CA, Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
2
Department of Pediatrics, University of Southern California and 571 Inhibition Of Epidermal Tight Junction Function By Histamine
Childrens Hospital Los Angeles, Los Angeles, CA Is Mediated By H1 and H4 Receptors
Lisa A. Beck, MD, FAAAAI1, Takeshi Yoshida, PhD1, Sade
Fridy1, I-Hsin Kuo, PhD1, Donald Y.M. Leung, MD, PhD,
FAAAAI2 and Anna De Benedetto, MD, FAAAAI1, 1University
of Rochester Medical Center, Rochester, NY, 2National Jewish
Best of EORD Health, Denver, CO
572 The Natural History and Clinical Predictors Of Egg Allergy In
3803 The First 2 Years Of Life: A Prospective, Population-Based, Co-
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM hort Study
566 Urinary Levels Of Phytoestrogens Are Inversely Associated Ms. Rachel Peters, MPH1,2, Prof. Shyamali Dharmage, MD,
With Wheezing, Asthma, and Atopy PhD1,2, Prof. Lyle Gurrin, PhD2, Dr. Jennifer Koplin, PhD1, Prof.
Juan-Carlos Cardet, MD, Rheumatology, Immunology, and Al- Anne-Louise Ponsonby, PhD1, Dr. Adrian Lowe, PhD2, Prof.
lergy, Brigham and Womens Hospital, Boston, MA, Christina Mimi L. K. Tang, MD, PhD, FAAAAI3, Dr. Dean Tey, MD1,4,
Johns, BA, Brigham and Womens Hospital, Boston, MA and Jes- Dr. David Hill, MBBD, FRACP1, Dr. Marnie Robinson, MBBD,
sica Rabe Savage, MD , Brigham and Womens Hospital, Division FRACP5, Ms. Helen Czech, B.Nurs1, Ms. Leone Thiele, MNSc1,
of Rheumatology, Immunology and Allergy, Boston, MA Dr. Nicholas Osborne, PhD6 and Prof. Katrina Jane Allen, MD,
567 Vitamin D Treatment Is Protective Of Inhalant Organic Dust- PhD, FAAAAI1,4, 1Murdoch Childrens Research Institute, Victoria,
Induced Bone Loss Australia, 2University of Melbourne, Victoria, Australia, 3The Uni-
Dr. Jill A. Poole, MD, FAAAAI1, Anand Dusad1, Dr. Todd Wyatt, versity of Melbourne, Melbourne, Australia, 4Royal Childrens
PhD2, Angela Gleason, MA1, Michael Duryee1, Elizabeth Klein1, Hospital, Victoria, Australia, 5Royal Childrens Hospital, Parkville,
Christopher Bauer1, Dr. Lynell Klassen, MD1, Dr. Ted Mikuls, Australia, 6Royal Cornwall Hospital, Truro, United Kingdom
MD1, Dr. William West, MD1, Dr. Debra Romberger, MD2 and 573 Mendelian Inheritance Of Elevated Tryptase Associated With
Dr. Geoffrey Thiele, PhD1, 1University of Nebraska Medical Cen- Atopy and Connective Tissue Abnormalities
ter, Omaha, NE, 2UNMC, Omaha, NE Dr. Jonathan J. Lyons, MD1, Dr. Guangping Sun, MD1, Dr. Kelly
568 Antigenic Determinants On Der p 1 Identified By Mutagenesis D. Stone, MD, PhD, FAAAAI1, Celeste Nelson, NP1, Laura Wisch,
Analysis Based On The Structure Of Allergen-Antibody Com- MSN1, Michelle OBrien, RN, BSN1, Nina Jones, RN, BSN2, Dr.
plexes Andrew W. Lindsley, MD, PhD3, Dr. Hirsh D. Komarow, MD1,
Dr. Anna Pomes, PhD FAAAAI1, Ms. Jill Glesner1, Ms. Lisa D. Yun Bai, MS1, Linda M. Scott, MS, CRNP1, Daly Cantave,
Vailes1, Dr. Wladek Minor, PhD2, Dr. Maksymilian Chruszcz, MSN4, Dr. Irina Maric, MD5, Dr. J. Pablo Abonia, MD3, Dr.
PhD3 and Dr. Martin D. Chapman, PhD FAAAAI1, 1Indoor Marc E. Rothenberg, MD, PhD, FAAAAI3, Dr. Lawrence B.
121
AB332 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Schwartz, MD, PhD, FAAAAI6, Dr. Todd M. Wilson, DO1 and Dr. Chronic Rhinosinusitis and Polyps
Joshua D. Milner, MD1, 1Laboratory of Allergic Diseases, NIAID/
NIH, Bethesda, MD, 2Frederick National Laboratory for Clinical 3806
Research, Frederick, MD, 3Cincinnati Childrens Hospital Medical Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
Center, Cincinnati, OH, 4Clinical Center, National Institutes of
Health, Bethesda, MD, 5Department of Laboratory Medicine, Na- 581 Activation Of TLR4 Induces VEGF Expression Via Akt Path-
tional Institutes of Health, Bethesda, MD, 6Virginia Commonwealth way In Nasal Polyps
University, Richmond, VA Mrs. Jung-Sun Cho1, Mr. Ju-Hyung Kang1, Ms. In-Hye Han1,
574 Expression Of TSLP and TSLP-R In Chronic Idiopathic Urti- Mrs. Ji-Young Um1, Prof. Il-Ho Park2 and Prof. Heung-Man
caria Lee2,3, 1Department of Biomedical Sciences, Korea University
Ms. Patricia M. Sterba, MS1, Allen Myers, Ph.D2 and Dr. Sarbjit Graduate School, Seoul, South Korea, 2Department of Otorhinolar-
S. Saini, MD, FAAAAI1, 1Johns Hopkins University, Baltimore, yngology-Head and Neck Surgery, Korea University College of
MD, 2Division of Allergy & Clinical Immunology, Johns Hopkins Medicine, Seoul, South Korea, 3Medical Devices Clinical Trial
University School of Medicine, Baltimore, MD Center, Guro Hospital, Korea University, Seoul, South Korea
575 Preclinical Study Of Rapidly-Disintegrating Sublingual Tablets 582 Non-Eosinophilic Nasal Polyps In Second-Generation Asian Pa-
(RDST): Effect Of Epinephrine (E) Incorporated As Nano- tients In The U.S. With Chronic Rhinosinusitis; Evidence For
Crystals Genetic Influence On Eosinophilia
Dr. Keith Simons, PhD1, Dr. Ousama Rachid, PhD1, Dr. Mutasem Dr. Mahboobeh Mahdavinia, MD, PhD1, Ms. Lydia Suh, BSc2,
SUNDAY
Rawas-Qalaji, PhD2, Dr. Belacryst Mendez, PhD3, Ms. Annette Losada3 Mr. James Norton, MS2, Mr. Roderick Carter, BSc2, Dr. Atsushi
and Dr. F. Estelle R. Simons, MD, FAAAAI1, 1University of Manitoba, Kato, PhD2, Dr. Anju T. Peters, MD, FAAAAI2, Dr. Rakesh
Winnipeg, MB, Canada, 2Nova Southeastern University, F. Lauderdale, Chandra, MD3, Dr. Bruce K. Tan, MD4, Dr. David Conley,
FL, 3Nova Southeastern University, Ft. Lauderdale, FL MD4, Dr. Robert C. Kern, MD4, Dr. Leslie C. Grammer, MD,
FAAAAI2 and Dr. Robert P. Schleimer, PhD FAAAAI5, 1Depart-
ment of Medicine, Division of Allergy-Immunology, Northwest-
ern University Feinberg School of Medicine, chicago, IL,
2
Department of Medicine, Division of Allergy-Immunology,
Best of HEDQ Northwestern University Feinberg School of Medicine, Chicago,
IL, 3Northwestern University, Chicago, IL, 4Department of Oto-
3805 laryngology, Northwestern University Feinberg School of Medi-
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM cine, Chicago, IL, 5Division of Allergy-Immunology,
576 A 24-Month Randomized, Controlled Trial Of An Automated Department of Medicine, Northwestern University Feinberg
Speech Recognition Program To Improve Adherence In Pediat- School of Medicine, Chicago, IL
ric Asthma 583 Regulation Of Expression Of Pendrin Protein In CRS With Na-
Bruce G. Bender, PhD FAAAAI1, Peter Cvietusa2, Glenn Good- sal Polyps and In Airway Epithelial Cells
rich2, C. Ryan Lowe2, Heather Nuanes2, Susan Shetterly2, Cathy Dr. Sudarshan Seshadri, PhD1, Dr. Xiang Lu, MD, PhD1, Mr.
R. Tacinas2, Nicole Wagner2, Frederick S. Wamboldt1, Stan Xu2 Matthew Purkey, BS1, Dr. Tetsuya Homma, MD1, Mr. Andrew
and David Magid2, 1National Jewish Health, Denver, CO, 2Kaiser Choi1, Mr. Roderick Carter, BSc1, Mr. James Norton, MS1, Ms. Ly-
Permanente Colorado, Denver, CO dia Suh, BSc1, Dr. Atsushi Kato, PhD1, Prof. Pedro C. Avila, MD,
577 Asthma Carepartners: A Home-Based Asthma Intervention FAAAAI1, Dr. Anju T. Peters, MD, FAAAAI1, Dr. David Conley,
Embedded Within Medicaid Managed Care MD2, Dr. Rakesh Chandra, MD3, Dr. Bruce K. Tan, MD2, Dr. Leslie
Ms. Julie Kuhn, MSW1, Ms. Helen Margellos-Anast, MPH1, Ms. Tala C. Grammer, MD, FAAAAI1, Dr. Robert C. Kern, MD2 and Dr.
Alhajj Schwindt, MPH1, Ms. Lourdes Reyes2, Ms. Barbara Hay, M.A.2, Robert P. Schleimer, PhD FAAAAI4, 1Department of Medicine, Di-
Ms. Sheena Freeman, B.A.1 and Ms. Gloria Seals1, 1Sinai Urban Health vision of Allergy-Immunology, Northwestern University Feinberg
Institute, Chicago, IL, 2Family Health Network, Chicago, IL School of Medicine, Chicago, IL, 2Department of Otolaryngology,
578 The Osia Platform: An Extensible Tool For Improving Individ- Northwestern University Feinberg School of Medicine, Chicago,
ual Allergy and Asthma Control and Understanding Environ- IL, 3Northwestern University, Chicago, IL, 4Division of Allergy-
mental Drivers Immunology, Department of Medicine, Northwestern University
Dr. Richard W Lucas, PhD1, Mr. Josh Dees2, Mr. Rob Reynolds2, Feinberg School of Medicine, Chicago, IL
Mr. Bryn Rhodes3 and Dr. Richard W Hendershot, MD4, 1Swedish 584 Sex-Specific Differences In Disease Severity In Patients With
University of Agricultural Sciences, Ume a, Sweden, 2OSIA Medi- Chronic Rhinosinusitis With Nasal Polyps
cal, Sandy, UT, Database Consulting Group, Orem, UT, 4Inter-
3
Dr. Kathryn E. Hulse, PhD1, Dr. Whitney Wyatt Stevens, MD,
mountain Health Care, Salt Lake City, UT PhD2, Dr. Bruce K. Tan, MD3, Mr. James Norton, MS2, Ms. Ly-
579 Allergy Immunotherapy Significantly Reduces Outpatient Ser- dia Suh, BSc2, Dr. Robert C. Kern, MD3, Dr. David Conley,
vices Use For Allergy and Respiratory Conditions In Patients MD3, Dr. Rakesh Chandra, MD1, Dr. Anju T. Peters, MD,
With Newly-Diagnosed Allergic Rhinitis FAAAAI2, Dr. Leslie C. Grammer, MD, FAAAAI2, Ms. Kathleen
Dr. Cheryl S. Hankin, PhD1, Dr. Linda Cox, MD, FAAAAI2, Dr. Amy E. Harris, BSc2, Mr. Roderick Carter, BSc2, Dr. Atsushi Kato,
Bronstone, PhD1 and Ms. Zhaohui Wang, M.S.1, 1BioMedEcon, LLC, PhD2, Dr. Margrit Urbanek, PhD4 and Dr. Robert P. Schleimer,
Moss Beach, CA, 2Allergy & Asthma Center, Fort Lauderdale, FL PhD FAAAAI5, 1Northwestern University, Chicago, IL, 2Depart-
580 Real-Time Asthma Outreach Reduces Excessive Short-Acting ment of Medicine, Division of Allergy-Immunology, Northwest-
Beta-Agonist (SABA) Canister-Dispensing: A Randomized ern University Feinberg School of Medicine, Chicago, IL,
3
Study Department of Otolaryngology, Northwestern University Fein-
Dr. Robert S. Zeiger, MD, PhD, FAAAAI1, Dr. Michael Schatz, berg School of Medicine, Chicago, IL, 43Division of Endocrinol-
MD, MS, FAAAAI1, Qiaowu Li, M.S.2, Dr. James Zazzali, PhD3 ogy, Metabolism and Molecular Medicine, Northwestern
and Wansu Chen, M.S.2, 1Kaiser Permanente Southern California, University Feinberg School of Medicine, 5Division of Allergy-
San Diego, CA, 2Kaiser Permanente Southern California, Pasadena, Immunology, Department of Medicine, Northwestern University
CA, 3Genentech, Inc., South San Francisco, CA Feinberg School of Medicine, Chicago, IL
122
J ALLERGY CLIN IMMUNOL Abstracts AB333
VOLUME 133, NUMBER 2
1
585 The Role Of Innate Cytokine In Non-Asthmatic, Non-Eosino- Johns Hopkins University School of Medicine, Baltimore, MD,
2
philic Nasal Polyps: IL-25, IL-33 and TSLP Johns Hopkins University School of Medicine, 3Pediatrics, Johns
Dr. Dong-Kyu Kim1, Dr. Hyun-Woo Shin2, Dr. Jong-Wan Park2, Hopkins University School of Medicine, Baltimore, MD, 4Gei-
Dr. Min-Suk Yang3 and Dr. Dae Woo Kim3, 1Chuncheon Sacred singer Community Medical Center., Scranton, PA, 5Johns Hopkins
Heart Hospital, Hallym University College of Medicine, South Ko- University Medical Center, Baltimore, MD
rea, 2Seoul National University College of Medicine, Pharmacology
and Biomedical Science, Ischemic/Hypoxic Disease Institute, South
Korea, 3Seoul National University Hospital and Boramae Medical
Center, South Korea
Epidemiology: Asthma Control
4201
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
The Redwan Moqbel Memorial MAAI Featured
592 Asthma In The Elderly: The Role Of Vitamin D
Poster Session Dr. Michele Columbo, MD, FAAAAI, Asthma, Allergy and Im-
munology Specialists, Bryn Mawr, PA, Dr. Reynold A. Panettieri
3807 Jr., MD, University of Pennsylvania, Philadelphia, PA and Dr. Al-
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM bert S. Rohr, MD, FAAAAI, Rohr and Columbo Asthma, Allergy
SUNDAY
586 IL33 and Type 2 Innate Lymphoid Cells (ILC2) But Not Th2 and Immunology Specialists, Bryn Mawr, PA
Cells Are Essential For Persistence Of Chronic Experimental 593 A Preliminary Randomized Controlled Trial:Educational Inter-
Asthma vention For Treatment Of Hispanic and African American
Dr. Christina Christianson, PhD, Ms. Chaoyu Irvin, MS, Magda- Adults With Asthma: Allergen Triggers, Peak Flow, and Spi-
lena Gorska, MD, PhD and Rafeul Alam, MD, PhD, FAAAAI, Na- rometry
tional Jewish Health, Denver, CO Reenal Patel, MD, UMDNJ, Newark, NJ, Josha Fogel, PhD, Nas-
587 PGE2 Deficiency Causes a Phenotype Of Aspirin Sensitive sau University Medical Center, East Meadow, NY and Marianne
Asthma That Depends On Platelets and Cysteinyl Leukotrienes Frieri, MD, PhD, FAAAAI, State University of NY @ Stony brook,
Dr. Tao Liu, PhD1,2, Dr. Joshua A. Boyce, MD, FAAAAI1,2, Dr. Tanya Stony Brook, NY
M. Laidlaw, MD, FAAAAI1,2 and Dr. Howard Katz, PhD1,2, 1Brigham 594 Assessment Of Asthma Education and Teaching Practices
and Womens Hospital, Division of Rheumatology, Immunology and Among Allergists
Allergy, Boston, MA, 2Harvard Medical School, Boston, MA Natalia Vernon, M.D., Penn State Hershey Medical Center, Her-
588 CCR8 Is a Receptor For CCL18 On Human Th2 Cells shey, PA and Dr. Timothy Craig, D.O., Penn State University, Her-
Dr. Morris Ling, MD1, Dr. Sabina Islam, MD1,2, Dr. John Leung, shey, PA
MD3, Wayne G. Shreffler, MD, PhD, FAAAAI1,2 and Dr. Andrew 595 Comparison Of Asthma-Related ED Visits In Public Versus Pri-
D. Luster, MD, PhD4,5, 1Massachusetts General Hospital, Boston, vate Hospitals In The Bronx
MA, 2Harvard Medical School, Boston, MA, 3Tufts Medical Cen- Dr. Mili Shum, MD, Weill Cornell Medical College, New York,
ter, Boston, MA, 4Massachusetts General Hospital, Charlestown, NY; Montefiore Medical Center, Bronx, NY, Dr. David L. Rose-
MA, 5Harvard Medical School, Charlestown, MA nstreich, MD, FAAAAI, Albert Einstein/Montefiore Medical Cen-
589 Increased Frequency Of Dual Positive Th2/Th17 Cells In Bron- ter, Bronx, NY and Dr. Sunit Jariwala, MD, Albert Einstein/
choalveolar Lavage Characterizes a Population Of Severe Asth- Montefiore Medical Center, New York, NY
matic Patients 596 Comparison Of Pre- and Post-Pubertal Gender Differences In
Rafeul Alam, MD, PhD, FAAAAI, Ms. Chaoyu Irvin, MS, Dr. Markers Of Angiogenesis and Asthma Outcomes
James Good, MD, Dr. Donald Rollins, MD, Dr. Christina Christian- Dr. Amy Thomas, MD1, Mark DeVries2, Mr. Christopher J. Tisler,
son, PhD, Ms. Iram Zafar, MS, Magdalena Gorska, MD, PhD and MT2, Ms. Victoria Rajamanickam3, Dr. James E. Gern, MD,
Dr. Richard J. Martin, MD, National Jewish Health, Denver, CO FAAAAI2, Dr. Robert F. Lemanske Jr., MD, FAAAAI2 and Dr.
590 Cmrf-35-Like Molecule 1 (CLM-1) Is Required For IL-4-In- Daniel J. Jackson, MD4, 1University of Wisconsin Hospitals and
duced Cellular Responses and Development Of Allergic Airway Clinics, Madison, WI, 2University of Wisconsin School of Medi-
Inflammation cine and Public Health, Madison, WI, 3University of Wisconsin
Mr. Itay Moshkovits1, Mrs. Danielle Karo-Atar1, Mrs. Dana Shik1, Hospitals and Clinics, 4Pediatrics, University of Wisconsin School
Dr. Alon Hershko, MD, PhD2 and Dr. Ariel Munitz, PhD1, 1Depart- of Medicine and Public Health, Madison, WI
ment of Clinical Microbiology and Immunology, The Sackler 597 Asthma Exacerbation In U.S. Adults: Who Are The Frequent
School of Medicine, Tel-Aviv University, Tel Aviv, Israel, 2Labora- Utilizers Of The Emergency Department?
tory of Allergy and Clinical Immunology, Department of Medici- Dr. Kohei Hasegawa, MD, MPH1,2, Ashley Sullivan, MPH, MS1,
ne,The Herbert Center of Mast Cell Disorders, Meir Medical Stuart Turner, BPharm, MPH3, Susan Massaro, PharmD, MPH4 and
Center, Kfar Saba, Israel Dr. Carlos Camargo Jr., MD, DrPH1,2, 1Department of Emergency
Medicine, Massachusetts General Hospital, Boston, MA, 2Harvard
Medical School, Boston, MA, 3Novartis Pharmaceuticals Corpora-
tion, East Hanover, NJ, 4Novartis Pharmaceuticals
598 The Relationship Of The Serum Vitamin D Levels With Asth-
Allied Health Featured Poster matic Severity Responses In Asthmatic Children
Dr. Julio Orellana1, Dr. Telma Varela2, Dr. Ana Romero Boni1, Dr.
3811 Ofelia Mi~no1, Dr. Estela Pautasso1, Dr. Susana Rivolta1, Dr. Ramon
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM Pogonza3 and Dr. Juan Carlos Muino, MD, PhD, FAAAAI4, 1Nuevo
591 Quality Of Life Improves In Children Undergoing Peanut Im- Hospital de Ni~nos de la Santisima Trinidad Cordoba Argentina,
munotherapy Cordoba, Argentina, 2Nuevo Hospital de Ni~nos de la Santisima Tri-
Ms. Shannon Seopaul, BS1, Dr. Satya Narisety, MD2, Corinne nidad Cordoba Argentina, Cordoba, Argentina, 3Nuevo Hospital de
Keet, MD, MS3, Ms. Kim E. Mudd, RN MSN CCRP1, Ms. Sarah Ni~nos de la Santisima Trinidad Cordoba Argentina - CIU, Cordoba,
D. Knorr, RN MPH CCRP4 and Robert A. Wood, MD, FAAAAI5, Argentina, 4FAC CS MED UNC, Cordoba, Argentina
123
AB334 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
599 Newly Diagnosed Asthma In The Elderly: Is It Really Differ- Montefiore Medical Center, Bronx, NY, 5Albert Einstein College
ent? of Medicine, Bronx, NY
Prof. Bilun Gemicioglu, MD, PhD, Istanbul Univ. Cerrahpasa Faculty 606 Ashmi Suppresses Neutrophil Pulmonary Inflammation In a
of Medicine, Istanbul, Turkey, Prof. Oznur Abadoglu, MD, Cumhur- Ragweed Allergic Asthma Model That Is Associated With Mod-
iyet Univ. Faculty of Medicine, Sivas, Turkey, Dr. Levent Akyildiz, ulation Of Innate and Adaptive Immune Responses
MD, Mardin Medical Park Hospital, Mardin, Turkey, Prof. Hasan Dr. Kamal D. Srivastava, PhD1, Dr. David Dunkin, MD2, Dr. Nan
Bayram, MD, PhD, University of Gaziantep, Gaziantep, Turkey, Yang, PhD, MS1, Dr. Changda Liu, PhD1, Dr. Rachel L. Miller, MD,
Prof. Aykut Cilli, MD, Akdeniz Univ. Faculty of Medicine, Antalya, FAAAAI3 and Dr. Xiu-Min Li, MD1, 1Pediatrics, Icahn School of Med-
Turkey, Prof. Arif Cimrin, MD, Dokuz Eylul Univ. Faculty of Medi- icine at Mount Sinai, New York, NY, 2Icahn School of Medicine at
cine, Izmir, Turkey, Prof. Hakan Gunen, MD, Sureyyapasa Pulmonary Mount Sinai, New York, NY, 3Division of Pulmonary, Allergy and Crit-
Diseases Hospital and Research Center, Istanbul, Turkey, Prof. Zeynep ical Care Medicine, Columbia University, New York, NY
Misirligil, MD, Ankara Univ. Faculty of Medicine, Ankara, Turkey, 607 Longitudinal Characteristics Of Viral and Non-Viral Exacerba-
Prof. Tevfik Ozlu, MD, Karadeniz Teknik Univ. Faculty of Medicine, tions Of Childhood Asthma
Trabzon, Turkey, Prof. Mecit Suerdem, MD, Selcuk Univ. Faculty of Dr. Amaziah Coleman, MD1, Dr. Daniel J. Jackson, MD2, Dr. Ro-
Medicine, Konya, Turkey and Prof. Esra Uzaslan, MD, Bursa Univ. nald E. Gangnon, PhD1, Mr. Michael D. Evans, MS1, Dr. Robert F.
Faculty of Medicine, Bursa, Turkey Lemanske Jr., MD, FAAAAI1 and Dr. James E. Gern, MD,
600 Risk Factors For Acute Asthma In The City Of FAAAAI1, 1University of Wisconsin School of Medicine and Public
Esmeraldas, Ecuador Health, Madison, WI, 2Pediatrics, University of Wisconsin School
Dr. Cristina Ardura-Garcia1, Gisela Oviedo2, Maritza Vaca2, Car- of Medicine and Public Health, Madison, WI
los Sandoval2, Stefanie Menzies2, Lisa J. Workman, BA3, Prof.
Matthew S. Perzanowski, PhD4, Maria Jose Rosa5, Thomas A.E.
Platts-Mills, MD, PhD, FAAAAI3 and Dr. Phil J. Cooper2,6, 1Uni-
versity of Liverpool, Wellcome Trust PhD Fellow, Liverpool,
United Kingdom, 2Laboratorio de FEPIS, Quininde, Esmeraldas
Biomarkers and Asthma Control II
Province, Ecuador, 3Division of Asthma, Allergy & Immunology,
University of Virginia Health System, Charlottesville, VA, 4Depart- 4202
ment of Environmental Health Sciences, Mailman School of Public Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
Health, Columbia University, New York, NY, 5Columbia Univer- 608 Bronchial Epithelial Cell Gene Expression In Relation To Ex-
sity, New York, NY, 6St. Georges University, London, United haled Nitric Oxide Identifies New Molecular Asthma Pheno-
Kingdom types
601 Serum Vitamin D Levels and Clinical Features Of The Disease Dr. Brian D. Modena, MD1, Dr. John Tedrow, MD1, Dr. Jadranka
In Children With Asthma Aged 5 To 18 Years Old Milosevic, PhD1, Dr. Naftali Kaminski, MD2 and Sally E. Wenzel,
Dr. Zeynep Tamay, MD, Associate Professor of Pediatrics, Istan- MD, FAAAAI1, 1University of Pittsburgh Medical Center NW,
bul University, Istanbul School of Medicine, Department of Pediat- Pittsburgh, PA, 2Yale-New Haven Hospital, New Haven, CT
rics, Division of Pediatric Allergy, Istanbul, Turkey, Dr. Nurhan 609 How Common Is The Phenotype Reflected By The Atopic
MONDAY
Ozcan, Ege Medical Faculty, Department of Pediatrics, Prof. Fir- March? Results At Two Years Of Age In a General Risk
devs Bas, Istanbul University, Istanbul School of Medicine, Depart- Multi-Racial Birth Cohort
ment of Pediatrics; Division of Pediatric Endocrinology, Prof. Umit Dr. Christine Cole Johnson, PhD MPH FAAAAI1, Ms. Suzanne
Turkoglu, Istanbul University, Istanbul School of Medicine, Depart- Havstad, M.A.1, Dr. Dennis Ownby, M.D. FAAAAI2, Dr. Christine
ment of Pediatrics, Division of Biochemistry and Prof. Nermin Gu- L.M. Joseph, PhD1, Dr. Haejin Kim, MD3, Kimberley J. Woodcroft,
ler, MD, Istanbul University, Istanbul School of Medicine, PhD1, Dr. Edward M. Zoratti, MD, FAAAAI4 and Ganesa We-
Department of Pediatrics, Division of Pediatric Allergy, Turkey gienka, PhD1, 1Department of Public Health Sciences, Henry
602 Effectiveness Of Specific Immunotherapy Against Alternaria Ford Hospital, Detroit, MI, 2Department of Pediatrics Georgia Re-
Alternata In Patients With Asthma and Or Allergic Rhinitis gents University, Augusta, GA, 3Division of Allergy and Clinical
Dr. Silvia Martnez Blanco, MD1, Dr. Ana Anton-Laiseca, MD1, Immunology, Henry Ford Hospital, Detroit, MI, 4Henry Ford
Dr. R. Mielgo Ballesteros, MD1, Dr. Consuelo Fernandez Health System, Detroit, MI
Rodrguez, MD, PhD1, Dr. Ruth Barranco Jimenez, MD1 and Dr. 610 Is Asthma Predictive Index Feasible For A Retrospective
R. Vives Conesa, MD2, 1Hospital Universitario 12 de Octubre, Study?
Spain, 2Hospital Universitario 12 de Octubre, Madrid, Spain Dr. Chung I. Wi, MD1, Dr. Miguel A. Park, MD2 and Dr. Young J.
603 Vitamin D Levels As Related To Severity and Ethnicity In Asth- Juhn, MD, MPH1, 1Dept of Pediatric and Adolescent Medicine,
matics Mayo Clinic, Rochester, MN, 2Department of Internal Medicine:
Dr. Patricia H. Stewart, MD1, Dr. Thomas Pressley, PharmD1, Dr. Division of Allergic Diseases, Mayo Clinic, Rochester, MN
Deborah Minor, PharmD1 and Prof. Gailen D. Marshall Jr., MD, 611 Comparison Of Rates Of Prescribing Oral Corticosteroids For
PhD, FAAAAI2, 1University of Mississippi Medical Center, 2Uni- Asthma Exacerbations Between Step-Down Therapy Ap-
versity of Mississippi Medical Center, Jackson, MS proaches Among Initiators Of Inhaled Corticosteroids and
604 Real Life Study Of Safety and Efficacy Of Subcutaneous Immu- Long-Acting Beta-Agonist Combination Therapy
notherapy With Cat and Dog Extracts Ayad K. Ali, PhD1,2, Almut Winterstein, PhD2, Leslie Hendeles,
Ms. Silvia Uriarte and Prof. Joaquin Sastre, MD, PhD, FAAAAI, PharmD2, Xiaomin Lu, PhD3, Richard Segal, PhD2 and Abraham
Fundacion Jimenez Daz, Madrid, Spain Hartzema, PhD2, 1Eli Lilly and Company, Indianapolis, IN, 2Col-
605 Improvement In Quality Of Life In Parents Of Asthmatic Chil- lege of Pharmacy, University of Florida, Gainesville, FL, 3College
dren Aged < 4 Years Receiving Subcutaneous Allergy Immuno- of Public Health and Health Professions, College of Medicine, Uni-
therapy versity of Florida, Gainesville, FL
Yurydia Jorge1, Yikania Pichardo1, Paola Polanco, MD2, Xin 612 The Good, The Bad and The Ugly Of The Naepp EPR3 Guide-
Zheng, PhD3, Jose Adames, BS3, Dr. Andrew A. Wiznia, MD3, lines
Dr. David L. Rosenstreich, MD, FAAAAI4 and Dr. Gabriele De Dr. Priyanka Lall, MD, Emory University, Atlanta, Dr. Karen A.
Vos, MD5, 1Jacobi Medical Center, New York, NY, 2Jacobi Medical DeMuth, MD, FAAAAI, Emory University, Atlanta, GA and Dr.
Center, 3Albert Einstein College of Medicine, 4Albert Einstein/ Morton Galina, Emory University
124
J ALLERGY CLIN IMMUNOL Abstracts AB335
VOLUME 133, NUMBER 2
613 Fibrin Complexes From The Sputum Of Human Asthmatics Dr. Isaac Reuven Melamed, MD1, Dr. Richard L. Wasserman, MD,
Contain Viable Fungi PhD, FAAAAI2, Dr. Mark Stein, MD, FAAAAI3, Dr. Arye Rubinstein,
Dr. Rani Maskatia, MD1, Cameron Landers, B.S1, Dr. Evan Li, MD, FAAAAI4, Dr. Jennifer M. Puck, MD5, Sudhir Gupta, MD, PhD,
M.D.1, Dr. Roger Rossen, M.D.1,2, Dr. Frank M. Orson, MD, FAAAAI6, Werner Engl7, Dr. Heinz Leibl, PhD7, Dr. Leman Yel, MD,
FAAAAI1,2 and Dr. David B. Corry, MD1, 1Baylor College of Med- FAAAAI8 and Dr. Richard I. Schiff, MD, PhD8, 1IMMUNOe Health
icine, Houston, TX, 2Veterans Affairs Medical Center, Houston, TX Centers, Centennial, CO, 2DallasAllergyImmunology, Dallas, TX,
3
614 Proteomic Identification Of S100A8 As a Potential Effector Pro- Allergy Associates of the Palm Beaches, North Palm Beach, FL, 4Al-
tein Of Acupuncture In Asthma Treatment bert Einstein College of Medicine, Bronx, NY, 5Department of Pediat-
Yu-Dong Xu1,2, Yu Wang1, Ying Wei1, Lei-Miao Yin1, Jun Ran1 rics, University of California San Francisco and UCSF Benioff
and Yong-Qing Yang1,2, 1Molecular Biology Laboratory, Shanghai Childrens Hospital, San Francisco, CA, 6University of California, Ir-
Research Institute of Acupuncture and Meridian, Shanghai Univer- vine, Irvine, CA, 7Baxter BioScience, Vienna, Austria, 8Baxter BioSci-
sity of Traditional Chinese Medicine, Shanghai, China, 2Yue Yang ence, Westlake Village, CA
Hospital, Shanghai University of Traditional Chinese Medicine, 622 Health-Related Quality Of Life Of Japanese Patients With Pri-
Shanghai, China mary Immunodeficiency Diseases Receiving IgPro20, a 20%
615 Are Asthma Specialists and Non-Specialists Familiar With In- Liquid Subcutaneous Immunoglobulin (Hizentra)
haled Corticosteroid (ICS) Dosing Recommendations and Side Prof. Hirokazu Kanegane, MD, PhD1, Prof. Kohsuke Imai, MD,
Effects In Children With Asthma? PhD2, Prof. Masafumi Yamada, MD, PhD3, Prof. Hidetoshi Takada,
Dr. Jonathan Drori, West Penn Allegheny Health System, Pitts- MD, PhD4, Prof. Tadashi Ariga, MD, PhD3, Prof. Ataru Igarashi,
burgh, PA PhD5, Prof. Kiichiro Tsutani, MD, PhD5, Dr. Martin Bexon,
616 Medication Remaining In Discarded Metered Dose Inhalers Of MD6, Dr. Mikhail Rojavin, PhD7, Ms. Midori Kobayashi, BSPharm,
Asthmatic Children MBA8, Dr. John-Philip Lawo, PhD9, Mr. Art Zbrozek, RPh, MSc,
Dr. Wantida Dampanrat, MD, Prince Of Songkla University, Ha- MBA10, Prof. Shigeaki Nonoyama, MD, PhD11, Prof. Toshiro
tyai, Thailand, Dr. Pasuree Sangsupawanich, MD, Prince Songkhla- Hara, MD, PhD4 and Prof. Toshio Miyawaki, MD, PhD1, 1Depart-
nagarind hospital, Hadyai, Thailand and Dr. Araya Yuenyongviwat, ment of Pediatrics, Graduate School of Medicine and Pharmaceuti-
MD, Prince of Songkla University, Songkhla, Thailand cal Sciences, University of Toyama, Toyama, Japan, 2Department
617 Defining Severe Asthma In Childhood: A Descriptive Multicen- of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo
ter Study In Turkey Medical and Dental University, Tokyo, Japan, 3Department of Pedi-
Bulent Enis Sekerel1, Dr. Ozge Soyer2, Fatih Celmeli3, Yakup atrics, Hokkaido University Graduate School of Medicine, Sapporo,
Canitez3, Ozlem Keskin3, Demet Can3, Ferhat Catal3, Mehtap Japan, 4Department of Pediatrics, Graduate School of Medical Sci-
Kilic3, Burcin Nalbantoglu3, Nail Yologlu3, Suleyman T. Yavuz3, ences, Kyushu University, Fukuoka, Japan, 5Department of Drug
Belgin Guc3, Fadil Ozturk3, Gulbin Karakoc3, Suna Asilsoy3, Meh- Policy and Management, Graduate School of Pharmaceutical Sci-
met Kilic3, Cem Razi3, Dost Zeyrek3, Semanur Kuyucu3, Hasan ences, The University of Tokyo, Tokyo, Japan, 6Clinical Research
Yuksel3, Omer Cevit3, Aysen Bingol3, Mehtap G. Yazicioglu3 and and Development, CSL Behring AG, Berne, Switzerland, 7Clinical
Ayse Yenigun3, 1Hacettepe University, Pediatric Allergy Unit, An- Research and Development, CSL Behring LLC, King of Prussia,
kara, Turkey, 2Hacettepe University School of Medicine, Ankara, PA, 8Research and Development, CSL Behring K.K., Tokyo, Japan,
Turkey, 3TURPEDAS, Turkey 9
CSL Behring GmbH, Marburg, Germany, 10CSL Behring LLC,
MONDAY
618 The Pediatric Diagnostic Conundrum Of Chronic Respiratory King of Prussia, PA, 11Department of Pediatrics, National Defense
Symptoms Medical College, Tokorozawa, Japan
Zainab Kagen, MD, University of Tennesee College of Medicine- 623 Efficacy and Tolerability Of Privigen In Clinical Practice
Chattanooga, TN, Joel Ledbetter, MD, University of Tennessee Col- Dr. Morna J. Dorsey, MD MMSc FAAAAI1, Viet Ho2, Dr. Moh-
lege of Medicine-Chattanooga, TN, Jennifer Hamm, MD, University sen I. Mabudian, MD3, Pere Soler-Palacn4, Nerea Domnguez-Pi-
of Tennesee College of Medicine-Chattanooga and Esther Wilson, nilla5, Dr. Robert W. Hellmers, MD, FAAAAI6, Dr. Radha
MD, University of Tennessee College of Medicine-Chattanooga Gandhi Rishi, MD, FAAAAI6, Rahul Rishi7, Dr. Duane W. Wong,
MD6, Dr. Mikhail Rojavin, PhD8, Dr. Alphonse Hubsch9 and Dr.
Melvin Berger, MD, PhD, FAAAAI8, 1Department of Pediatrics,
University of California, San Francisco, San Francisco, CA, 2Mof-
IVIG and Other Therapeutics fitt Cancer Hospital, FL, 3Beaver Medical Group, Inc., Department
of Allergy and Clinical Immunology, Redlands, CA, 44Pediatric In-
4203 fectious Diseases and Immunodeficiencies Unit, Hospital Universi-
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM tari Vall dHebron, Barcelona, Spain, 55Department of Pediatrics,
619 Quantification Of The Wear-Off Effect Towards The End Of Hospital 12 de Octubre, Madrid, Spain, 6Arizona Allergy Associ-
The Intravenous Immunoglobulin Infusion Interval: Pooled ates, Chandler, AZ, 7Arizona Allergy Associates, Phoenix, AZ,
8
Data Analysis Clinical Research and Development, CSL Behring LLC, King of
Mr. John-Philip Lawo, CSL Behring GmbH, Marburg, Germany, Prussia, PA, 9CSL Behring AG, Berne, Switzerland
Dr. Alphonse Hubsch, CSL Behring AG, Berne, Switzerland and 624 Safety and Tolerability Of An Intravenously Administered Al-
Dr. Mikhail Rojavin, PhD, Clinical Research and Development, pha1-Proteinase Inhibitor (A1PI) At An Increased Infusion
CSL Behring LLC, King of Prussia, PA Rate: A Randomized, Rate Control, Placebo-Masked, Cross-
620 Safety and Efficacy Of Biweekly Hizentra Administration In over Study In Healthy Adults
Patients With Primary Immunodeficiency Diseases: A Retro- Adam Haeberle1, Leock Ngo1, Neil Inhaber1, David Gelmont1 and
spective Single-Center Study Dr. Leman Yel, MD, FAAAAI2, 1Baxter BioScience, 2Baxter Bio-
Clare Malcolmson and Dr. Alison Jones, Great Ormond Street Science, Westlake Village, CA
Hospital, London, United Kingdom 625 Pharmacokinetic Modeling Predicts Different IgG Exposures
621 Long-Term Tolerability and Safety Of Facilitated-Subcutaneous Using Different IVIG-Scig Dose Conversion Factors In Patients
Infusion Of Human Immune Globulin G (IgG), 10%, and Re- With Primary Immune Deficiency
combinant Human Hyaluronidase (rHuPH20) (IGHy): A Phase Dr. Jagdev S. Sidhu, PhD1, Dr. Mikhail Rojavin, PhD2, Dr. Melvin
3 Extension Study In Patients With Primary Immunodefi- Berger, MD, PhD, FAAAAI2, Dr. Martin Bexton3 and Dr. Jonathan
ciencies (PIs) M. Edelman, MD2, 1Clinical Pharmacology & Early Development,
125
AB336 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
CSL Ltd, Parkville, Australia, 2Clinical Research and Development, 634 Retrospective Analysis Of The Clinical Utility Of Biweekly Dos-
CSL Behring LLC, King of Prussia, PA, 3CSL Behring AG, Berne, ing With High-Concentration Subcutaneous Immunoglobulin
Switzerland In 10 Patients With Primary Immunodeficiency
626 Flexible Dosing For Hizentra: Pharmacokinetic Simulations Dr. Richard L. Wasserman, MD, PhD, FAAAAI1, Dr. Shahnaz
Of Various Subcutaneous Dosing Regimens and Compliance Fatteh2, Dr. Javaid M. Khan, DO2 and Dr. Elie Haddad, MD3,
1
In Patients With Primary Immunodeficiency Medical City Childrens Hospital, Dallas, TX, 2Larkin Community
Dr. Mikhail Rojavin, PhD1, Dr. Jagdev S. Sidhu, PhD2, Dr. Martin Hospital, South Miami, FL, 3CHU Sainte-Justine, Montreal, QC,
Bexon, MD3 and Dr. Jonathan M. Edelman, MD1, 1Clinical Re- Canada
search and Development, CSL Behring LLC, King of Prussia,
PA, 2Clinical Pharmacology & Early Development, CSL Ltd, Park-
ville, Australia, 3Clinical Research and Development, CSL Behring
AG, Berne, Switzerland
627 Effect Of Synthetic Steroids and Hydroxychloroquine On B-
Autoinflammatory Disorders
Cell IgE Production
Dr. Ahila Subramanian, MD, MPH, Yingchun Han and Dr. Fred 4204
H. Hsieh, MD, Cleveland Clinic Foundation, Cleveland, OH Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
628 Safety, Tolerability, and Efficacy Of Hizentra In Japanese Pa- 635 Concomitant FMF and TRAPS Mutation In a Periodic Fever
tients With Primary Immunodeficiency Over 48 Weeks Patient
Prof. Kohsuke Imai, MD, PhD1, Prof. Hirokazu Kanegane, MD, Dr. Adrianne C. Netterville, MD1, Dr. Victoria Dimitriades, MD1
PhD2, Prof. Masafumi Yamada, MD, PhD3, Prof. Hidetoshi Takada, and Dr. Paul D. Niolet, MD2, 1Louisiana State University Depart-
MD, PhD4, Prof. Tadashi Ariga, MD, PhD3, Ms. Midori Kobayashi, ment of Pediatrics, New Orleans, LA, 2Allergy Asthma and Immu-
BSPharm, MBA5, Dr. Mikhail Rojavin, PhD6, Dr. Martin Bexon, nology, Ocean Springs, MS
MD7, Prof. Shigeaki Nonoyama, MD, PhD8, Prof. Toshiro Hara, 636 Association Of Interleukin-23 Receptor Single Nucleotide Poly-
MD, PhD4 and Prof. Toshio Miyawaki, MD, PhD2, 1Department of morphisms With Ulcerative Colitis
Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Med- Dr. Mona Hedayat, MD, Boston Childrens Hospital, Boston, MA,
ical and Dental University, Tokyo, Japan, 2Department of Pediatrics, Dr. Nasser Ebrahimi Daryani, Department of Gastroenterology and
Graduate School of Medicine and Pharmaceutical Sciences, University Hepatology, Tehran University of Medical Sciences, Dr. Farnaz
of Toyama, Toyama, Japan, 3Department of Pediatrics, Hokkaido Uni- Najmi Varzaneh, Molecular Immunology Research Center, Depart-
versity Graduate School of Medicine, Sapporo, Japan, 4Department of ment of Immunology, Tehran University of Medical Sciences and
Pediatrics, Graduate School of Medical Sciences, Kyushu University, Dr. Nima Rezaei, MD, PhD, Research Center for Immunodefi-
Fukuoka, Japan, 5Research and Development, CSL Behring K.K., To- ciencies, Childrens Medical Center, Tehran University of Medical
kyo, Japan, 6Clinical Research and Development, CSL Behring LLC, Sciences, Tehran, Tehran, Iran
King of Prussia, PA, 7Clinical Research and Development, CSL Behr- 637 A Novel Immunoablative Regimen Utilized In The Successful
ing AG, Berne, Switzerland, 8Department of Pediatrics, National De- Remission Of Pulmonary Hemorrhage In An Adolescent Fe-
fense Medical College, Tokorozawa, Japan male With Systemic Lupus Erythematosus
MONDAY
629 In Vitro Effect Of Intravenous Immunoglobulin (IVIG) On Nat- Ms. Vivian E. Cino, MSN ARNP-BC PNP1, Alexander Constan-
ural Antibody Producing Human B1 Cells tinescu, MD2, Kristina Deeter, MD2, Faina Shenderov, PharmD2,
Kevin A. Cook, MD1, Sudhanshu Agrawal, MS1 and Sudhir Gupta, Joan Spiro, PharmD2 and Dr. Gary I. Kleiner, MD, PhD, FAAAAI2,
MD, PhD, FAAAAI2, 1University of California, Irvine, 2University 1
Joe Dimaggio Childrens Hospital, Hollywood, FL, 2Joe Dimaggio
of California, Irvine, Irvine, CA Childrens Hospital
630 Effect Of A Novel, Oral Histamine H4R Antagonist On Hista- 638 Haptoglobin Deficiency and Autoimmune Manifestations; A
mine-Induced Pruritus In Healthy Subjects Case Series
Dr. Alexa P. Kollmeier, MD1, Paul Dunford, MSc1, Xie Xu, PhD1, Dr. Anna Kochin, MD1, Dr. Jenny Shliozberg, MD, FAAAAI1 and
Andrew Greenspan, MD1, Yichuan Xia, PhD2, Bei Zhou, PhD2, Dr. Arye Rubinstein, MD, FAAAAI2, 1Montefiore Medical Center,
Klaus Francke, MD, PhD3 and Dr. Robin L. Thurmond, PhD1, Bronx, NY, 2Albert Einstein College of Medicine, Bronx, NY
1
Janssen Research & Development, LLC, La Jolla, CA, 2Janssen 639 Immunogenicity Analysis Of Two Anti-TNF (Infliximab vs Eta-
Research & Development, LLC, Spring House, PA, 3Parexel Inter- nercept) Therapies In Rheumatologic Patients
national, London, United Kingdom Dr. Yvelise Barrios, MD, PhD1, Dr. Victor Matheu, MD2, Dr. An-
631 Decreasing Risk Of Infection and Severity Of Infections Result- dres Franco, MD1, Dr. Esmeralda Delgado, MD3 and Dr. Sagrario
ing In Hospitalizations In Patients With Primary Immunodefi- Bustabad, MD3, 1Immunology, Hospital Universitario de Canarias,
ciency Disease Changing From IVIG To Scig Therapy LA LAGUNA, Spain, 2Allergy Section, Hospital Ofra, Tenerife,
Mr. Art Zbrozek, RPh, MSc, MBA1, Ms. Sonam Mehta2, Dr. Spain, 3Rheumatology, Hospital Universitario de Canarias, LA LA-
Dipen A. Patel2 and Mr. Marc Botteman, MSc2, 1CSL Behring GUNA, Spain
LLC, King of Prussia, PA, 2Pharmerit International, Bethesda, MD 640 Circulating Endothelial and Platelet Microparticles For Diag-
632 A Multicenter Non-Interventional Study On The Efficacy and nosis and Monitoring Vasculitis
Tolerability Of The Polyvalent Intravenous Immunoglobulin Prof. El-Desouki E. Fouda, MD, FAAAAI, Al-Azhar university
Privigen Allergy & Immunology Cr., Cairo, Egypt, Dr. Marwa Ahmed, Al-
Dr. Rainer Hoffmann, MD1, Dr. Peer Lotichius, PhD2 and Dr. Di- azhar Allergy&Immunology Cr., Cairo, Egypt and Prof. Mona Al-
etmar Pfruender, MD2, 11Praxis fur Neurologie und Psychiatrie, rayes, Al-Azhar Allergy& Immunology Cr.,, Cairo, Egypt
Berlin, Germany, 2CSL Behring, Hattersheim, Germany 641 Mistaken Identity: Misdiagnosis Based On Auto-Antibodies In
633 The Immunoglobulin Diagnosis, Evaluation, and Key Learnings IVIG
(IDEaL) Patient Registry: Analysis Of Ig Dosing, Infection Con- Dr. Kristyn E. Anthony, MD, Tulane University, New Orleans, LA
trol, and Quality-Of-Life Assessments In Our Primary Immu- and Dr. Jane M. El-Dahr, MD, Tulane University School of Medi-
nodeficiency Population cine, New Orleans, LA
Sean Kearns, Ph.D1, Keith Crawford1, Loretta Kristofek, RN1, Rob- 642 Th-17 Cytokines In Oral Lichen Planus
byn Kirylo1 and Dr. Luqman Seidu, MD2, 1Coram Clinical Trials, Den- Prof. G.N. Drannik1, Prof. A.I. Kurchenko1, Dr. R.A. Rehuretska1,
ver, CO, 2Allergy and Asthma of Atlanta, LLC, Atlanta, GA Dr. A.G. Drannik2 and Prof. Lawrence M. DuBuske, MD,
126
J ALLERGY CLIN IMMUNOL Abstracts AB337
VOLUME 133, NUMBER 2
FAAAAI3, 1National Medical University, Kiev, Ukraine, 2National University, Bangkok, Thailand and Dr. Wisuwat Songnuan, Depart-
medical University, Kiev, Ukraine, 3George Washington University ment of Plant Science, Faculty of Science, Mahidol University,
School of Medicine, DC Bangkok, Thailand
652 Attitudes and Behaviors Among Patients With Confirmed Pet
Allergy
Dr. Timothy J. Campbell, MD, Dr. Asaf Klein, MD, Xiaofeng
Wang, PhD, Qi Zhang, M.S. and Dr. Roxana Siles, MD, Cleveland
Airborne Allergen Exposures Clinic
653 Uniformed Distribution Of Aerosolized Dust Mite Allergen In
4205 The Allergen Biocube (ABC)
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM Keith Lane, Ora Inc., MA, Paul Gomes, Ora Inc., Endri Angjeli,
643 A Study On Allergy Sensitization Of Dense Urban Dwellers To Ora, Inc, Andover, MA and Dr. Anne K. Ellis, MD, MSc FAAAAI,
Dog and Cat Allergens Using The Skin Prick Test Allergy Research Unit, Kingston General Hospital, Kingston, ON,
Dr. Racquel Joy Y. So, Dr. Florecita Padua and Dr. Shirley Kwong, Canada; Departments of Medicine and Biomedical & Molecular
Fe Del Mundo Medical Center, Quezon City Science, Queens University, Kingston, ON, Canada
644 Rhinix Nasal Filters For The Treatment Of Allergic Rhinitis:
A Randomized, Double-Blinded Placebo-Controlled Crossover
Clinical Trial
Peter Kenney, BSc1, Ole Hilberg, MD, DMSc2, Henrik Pedersen,
PhD3, Ole Bkgaard Nielsen, PhD4 and Torben Sigsgaard, MD,
Infections, Asthma and Allergies
PhD1, 1Department of Public Health, Aarhus University, Aarhus,
Denmark, 2Department of Respiratory Diseases and Allergology, 4206
Aarhus University Hospital, Aarhus, Denmark, 3Department of Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
Engineering - Signal Processing, Aarhus University, Aarhus, Den- 654 Cytokine Profiles In Bronchoalveolar Lavage In a Mouse Model
mark, 4Department of Biomedicine, Aarhus University, Aarhus Of Bronchial Asthma During A(H1N1)pdm09 and Seasonal
645 Airborne Allergen Exposure As a Quantum Phenomenon H1N1 Infection
Dr. Gert Doekes, PhD, Institute for Risk Assessment Sciences, Dr. Shunji Hasegawa1, Dr. Seigo Okada2, Dr. Hiroyuki Wakiguchi2,
University Utrecht, NL, Utrecht, Netherlands, Dr. Peter S. Thorne, Dr. Hideki Hasegawa3, Dr. Akira Ainai4, Dr. Komei Shirabe5, Dr. Shoi-
PhD, University of Iowa, Iowa City, IA, Dr. Ingrid Sander, PhD, In- chi Toda5, Dr. Ryo Atsuta6, Dr. Akihiro Hasegawa7 and Dr. Takashi
stitute for Prevention and Occupational Medicine, Ruhr-University Ichiyama1, 1Department of Pediatrics, Yamaguchi University Graduate
Bochum, Bochum, Germany, Dr. Inge Wouters, PhD, Institute for School of Medicine, Ube, Yamaguchi, Japan, 2Department of Pediat-
Risk Assessment Sciences, University Utrecht, Utrecht, Nether- rics, Yamaguchi University Graduate School of Medicine, 3Depart-
lands, Dr. Wijnand Eduard, PhD, National Institute of Occupational ment of Pathology, National Institute of Infectious Diseases,
4
Health, Oslo, Norway and Dr. Dick Heederik, PhD, Institute for Influenza Virus Research Center, National Institute of Infectious Dis-
Risk Assessment Sciences, Utrecht, Netherlands eases, 5Yamaguchi Prefectural Institute of Public Health and Environ-
MONDAY
646 Computer-Aided Design Of An Allergen Challenge Theatre ment, 6Department of Respiratory Medicine, Juntendo University
William H. Yang, MD, Jimmy Yang, MBA, Robert Perrins, P.Eng, School of Medicine, 7Department of Microbiology and Immunology,
Suzanne Kelly, PhD and Jacob Karsh, MD, Red Maple Trials Inc., Yamaguchi University Graduate School of Medicine
Ottawa, ON, Canada 655 In Vitro Tumor Necrotic Factor Alpha Responses To Persistent
647 Evaluation Of a Compact Ionic Capture Device For Airborne Chlamydia Pneumoniae Infection From PBMC Of Asthmatic
Allergens In Inner City Schools Children
Dr. Julian Gordon, PhD1, Ms. Prasanthi Gandhi, MBA MPH1, Dr. Dr. Kobkul Chotikanatis, MD1, Dr. Diana Weaver, MD2, Danielle
Gajendra Shekhawat, PhD2, Ms. Ann Bailey, BA3 and Dr. Wanda Lent3, Eva Estrella3, Dr. Margaret R. Hammerschlag, MD3, Dr.
Phipatanakul, MD, MS, FAAAAI4, 1Inspirotec LLC, Chicago, IL, Rauno O. Joks, MD, FAAAAI1,4 and Dr. Stephan Kohlhoff, MD5,6,
2
Northwestern University, Evanston, IL, 3Channing Laboratory, 1
SUNY Downstate Medical Center, Center for Allergy and Asthma
Boston, MA, 4Boston Childrens Hospital, Boston, MA Research, Brooklyn, NY, 2Kings County Hospital Center, Brooklyn,
648 Relevance Of Sensitization To Blomia Tropicalis, Dermatopha- NY, 3SUNY Downstate Medical Center, Brooklyn, NY, 4Department
goides and Tropomyosin- Containing Antigens Among Atopics of Medicine, State University of New York Downstate Medical Cen-
Living In a Tropical Region ter, Brooklyn, NY, 5Center for Allergy and Asthma Research, State
Dr. Beverly K. Di Giorgi, MD, Dr. Sylvette Nazario, MD, Dr. Fer- University of New York Downstate Medical Center, Brooklyn, NY,
6
nando J. Lopez, MD and Dr. Javier A. Mendez, MD, University of Department of Pediatrics, State University of New York Downstate
Puerto Rico School of Medicine, San Juan, PR Medical Center, Brooklyn, NY
649 Update In The Prevalence Of Atopic Conditions, IgE Levels and 656 Human Rhinoviruses/Enteroviruses Associated Wheezing In
Skin Test Sensitization To Aeroallergens In Northern Puerto Children
Rico Anyarat Wanitchakorn, MD1, Dr. Wiparat Manuyakorn, MD1,
Dr. Rafael H. Zaragoza, MD, PhD, Doral Bank Center, San Juan, Wasu Kamchaisatian, MD1, Dr. Wasun Chantratita2, Kanjana Pre-
PR; University of Puerto Rico School of Medicine, San Juan, PR mchaiporn2 and Suwat Benjaponpitak, MD1, 1Division of Pediatric
650 Stability Of Immunoassay Analytes and Test Kits Used For Allergy/Immunology/Rheumatology, Department of Pediatrics,
Monitoring Environmental Allergen Exposure Faculty of Medicine Ramathibodi Hospital, Mahidol University,
Bryan Smith, Denise Block, Stephanie Filep, Dr. Martin D. Chap- Bangkok, Thailand, 2Department of Pathology, Faculty of Medicine
man, PhD FAAAAI and Dr. Eva-Maria King, PhD, Indoor Biotech- Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
nologies, Inc., Charlottesville, VA 657 Study Of Montelukast For The Treatment Of Acute and Post
651 Factors Affecting Pollen Rupture and Protein Release From Al- Viral-Induced Wheezing
lergenic Pollens Sirirak Kanchanateeraphong, MD, Gun Phongsamart, MD, Tas-
Ms. Umaporn Siriwattanakul, Master of Science Program in Plant salapa Dangsuwan, MD and Mukda Vangveeravong, MD, Queen
Science, Department of Plant Science, Faculty of Science and De- Sirikit National Institute of Child Health(Children Hospital), Bang-
partment of Pharmaceutical Botany, Faculty of Pharmacy, Mahidol kok, Thailand
127
AB338 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
658 Prevalence Of Toxocara Infection In Subjects With Suspected MD4, Dr. Gianluca Pirozzi, MD, PhD5, Warren Brooks, PhD4
Allergies and Dr. Marius Ardeleanu, MD4, 1Universitat zu Lubeck, Lu-
Dr. Rosanna M. Qualizza, Istituti Clinici di Perfezionamento, Mi- beck, Germany, 2Charite - Universitatsmedizin Berlin, Berlin,
lano, Italy, Dr. Cristoforo Incorvaia, Istituti Clinici di perfeziona- Germany, 3Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ,
4
mento, Milano, Italy and Dr. Anna Maraschini, IRCCS Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 5Sanofi,
Fondazione CaGranda Policlinico, Milano, Italy Bridgewater, NJ
659 The Effects Of Dexamethasone On Community-Acquired Pneu- 665 A Lipid Plant Extract From Chamaecyparis Obtusa Induces
monia In Children Filaggrin and Human Beta-Defensin -3
Prof. Youn Ho Shin, Department of Pediatrics, CHA Medical Cen- Mr. Byung Eui Kim, MD, PhD1, Mr. Gwui Cheol Kim, PhD2, Ms.
ter, CHA University School of Medicine, Seoul, Korea, South Ko- Hee Jin Kim2 and Donald Y.M. Leung, MD, PhD, FAAAAI1, 1Na-
rea, Dr. Jun Hwan Kim, Department of Pediatrics, CHA University tional Jewish Health, Denver, CO, 2Jeonnam Nano Bio Research
School of Medicine, South Korea, Dr. Jung Won Yoon, Department Center
of Pediatrics, Myongji Hospital, Gyeonggi-do, South Korea, Prof. 666 Identification Of Novel Gene Signatures In Atopic Dermatitis
Sun-Hee Choi, MD, PhD, Gangdong Kyung Hee University Hospi- Complicated By Eczema Herpeticum
tal, Seoul, South Korea, Dr. Hyeung Yoon Kim, Department of Pe- Dr. Lianghua Bin, MD, PhD1, Dr. Michael G Edwards2, Dr. Ryan
diatrics, Bundang Jaesaeng Hospital, Seongnam, South Korea, Hye Heiser, PhD1, Mrs. Joanne Streib, BA1, Ms. Brittany Richers1 and
Mi Jee, MD, Department of Pediatrics, CHA University School of Donald Y.M. Leung, MD, PhD, FAAAAI1, 1National Jewish
Medicine, Seongnam, Korea, South Korea, Prof. Man-Yong Han, Health, Denver, CO, 2University of Colorado at Denver
MD, PhD, Department of Pediatrics, CHA University School of 667 Topical Application Of Rapamycin Ointment Inhibits Dermato-
Medicine, Seongnam, South Korea and Dr. Jin-Tack Kim, MD, phagoides Farinae Body (Dfb) Extract Antigen-Induced Derma-
PhD, Department of Pediatrics, Uijeongbu St. Marys Hospital, titis In NC/Nga Mice
The Catholic University of Korea, College of Medicine, Uijeongbu, Mr. Fei Yang1, Dr. Lingli Yang1, Dr. Mari Tanaka1, Dr. Mari
Gyeonggi-Do, South Korea Wataya-Kaneda1, Ayumi Nakamura2, Shoji Matsumoto2, Dr.
660 The Association Between Strongyloides Stercoralis Infection Mostafa Attia3, Dr. Hiroyuki Murota1 and Prof. Ichiro Ka-
and Allergic Skin Diseases tayama1, 1Department of Dermatology, Course of Integrated
Dr. Lahari Rampur, MD, Albert Einstein/Jacobi medical centre, Medicine, Graduate School of Medicine, Osaka University,
Bronx, NY, Dr. Gabriele De Vos, MD, Albert Einstein College of Osaka, Japan, Osaka, Japan, 2Osaka University Hospital, Depart-
Medicine, Bronx, NY, Dr. Golda Hudes, MD, PhD, Albert Einstein/ ment of Pharmacy, Osaka, Japan, 3Dermatology, Cairo Univer-
Montefiore Medical Center, New York, NY and Dr. Sunit Jariwala, sity, Cairo, Egypt, Cairo, Egypt
MD, Albert Einstein/Montefiore Medical Center, New York, NY 668 Therapeutic Effects Of Recombinant Salmonella Typhimurium
661 Effects Of Human Rhinovirus Species On Cytokine Production Expressing TLR8 miRNA On Atopic Dermatitis
and Cellular Cytotoxicity In Differentiated Sinus Epithelial Dr. Wonsuck Yoon, Department of Life Science and Biotechnol-
Cells ogy, Seoul, South Korea, Prof. Ji Tae Choung, MD, Korea Univ.
Dr. Kazuyuki Nakagome, MD1,2, Dr. Yury Bochkov, PhD1, Dr. Medical Center, Seoul and Dr. Young Yoo, MD, PhD, Department
Shamaila Ashraf, PhD1, Ms. Rebecca Brockman-Schneider, MS1 of Pediatrics, College of Medicine, Korea University, Seoul, South
MONDAY
128
J ALLERGY CLIN IMMUNOL Abstracts AB339
VOLUME 133, NUMBER 2
673 Mycotoxin Aggravates Atopic Dermatitis Via TSLP Induced Hospital, 2Gangdong Kyung Hee University Hospital, Seoul, South
Th2 Inflammation Korea
Ms. Seung-Hwa Lee1, Ms. Ha-Jung Kim1 and Prof. Soo-Jong 682 Excellent Agreement Between Dermatology and Pediatric Re-
Hong, MD. PhD2,3, 1Asan Institute for Life Sciences, University searchers In Severity Scoring Of Atopic Dermatitis (SCORAD)
of Ulsan College of Medicine, 2Department of Pediatrics, Asan Index In Children
Medical Center, Childhood Asthma Atopy Center, South Korea, Dr. Rodrigo Hoyos Bachiloglu, MD1, Dr. Cristian Navarrete,
3
Research Center for Standardization of Allergic Disease, Univer- MD2, Dr. Cristian Vera, MD2, Dr. Sergio Silva, MD2, Dr. Lorena
sity of Ulsan College of Medicine, Seoul, Korea Cifuentes, MD1, Mrs. Carolina Iturriaga, RN1, Ms. Francisca Cristi,
674 Early Skin Care By Experienced Mothers May Prevent Sen- MSc1 and Dr. Arturo Borzutzky, MD1, 1Division of Pediatrics,
sitization In Infants With Atopic Dermatitis School of Medicine, Pontificia Universidad Catolica de Chile, San-
Dr. Atsushi Yamashita, Dr. Mizuho Nagao, MD, Ms. Kanae Fur- tiago, Chile, 2Department of Dermatology, School of Medicine,
uya, Dr. Junya Hirayama, Dr. Keigo Kainuma, MD and Dr. Takao Pontificia Universidad Catolica de Chile, Santiago, Chile
Fujisawa, MD, FAAAAI, Institute for Clinical Research, Mie Na- 683 A Case Of Recurrent Severe Poison Ivy Contact Dermatitis,
tional Hospital Treated Successfully With Seasonal Cyclosporine
675 Association Of Bathing Habits To Pruritus and Allergic Disease Dr. Jaron T. Abbott, MD, Dr. Yuriy Zgherea, MD and Dr. Selina
Dr. Kanwaljit K. Brar, MD1, Dr. Rauno O. Joks, MD, FAAAAI2 Gierer, DO, University of Kansas Medical Center
and Dr. Hamid Moallem, MD1, 1SUNY Downstate Medical Center, 684 Allergic Contact Stomatitis From Orthodontic Adhesives
Brooklyn, NY, 2Center for Allergy and Asthma Research, State Dr. Priscilla H. Wong, MD1, Dr. Scott D. Dickson, DO2 and Dr.
University of New York Downstate Medical Center, Brooklyn, NY Christopher A. Coop, MD1, 1Wilford Hall Ambulatory Surgical
676 A Molecular Mechanism Underlying Atopic Dermatitis In Hy- Center, Lackland AFB, TX, 256th Medical Group, Luke AFB, AZ
per-IgE Syndrome 685 Contact Dermatitis Due To Topical Amorolfine
Masako Saito, PhD, Division of Molecular Medicine, Institute for Dr. Ruperto Gonzalez Perez, Mrs. Paloma Poza-Guedes, Mrs. In-
Genome Research, The University of Tokushima, Tokushima, Ja- maculada Sanchez Machn and Dr. Victor Matheu, MD, Hospital
pan, Dr. Hajime Karasuyama, MD, PhD, Tokyo Medical and Den- del Torax-Ofra, Sta Cruz de Tenerife, Spain
tistry Graduate School, Tokyo, Japan and Dr. Yoshiyuki Minegishi, 686 Sweets Syndrome By A Show Of Hands
MD and PhD, Division of Molecular Medicine, Institute for Ge- Dr. Syeda Hamadani, Dr. Anita Ravi, Dr. Seth Politano, Dr. Eric
nome Research, The University of Tokushima Hsieh and Dr. Gina Rossetti, USC, Los Angeles, CA
677 Racial Differences In The Relationship Of Total and Food-Spe- 687 Mango, Pulp Fiction?
cific IgE To Atopic Dermatitis In Childhood Dr. Alexander S. Kim, MD, University of California San Diego,
Dr. Gillian Bassirpour, MD1, Dr. Edward M. Zoratti, MD, La Jolla, CA and Dr. Sandra C. Christiansen, MD, FAAAAI, South-
FAAAAI2, Ganesa Wegienka, PhD3, Ms. Suzanne Havstad, ern CA Permanente Med Grp, San Diego, CA
M.A.3, Alexandra Sitarik, M.S.3, Dr. Haejin Kim, MD1, Dr. Dennis 688 Preoperative Patch Testing In Patients Undergoing Pectus Ex-
Ownby, M.D. FAAAAI4 and Dr. Christine Cole Johnson, PhD MPH cavatum Repair
FAAAAI3, 1Division of Allergy and Clinical Immunology, Henry Dr. Laura Helfner, MD1, Dr. David Rosenthal, DO1, Dr. Blanka
Ford Hospital, Detroit, MI, 2Henry Ford Health System, Detroit, M. Kaplan, MD, FAAAAI2 and Dr. Punita Ponda, MD, FAAAAI3,
MI, 3Department of Public Health Sciences, Henry Ford Hospital, 1
MONDAY
Division of Allergy/Immunology, Departments of Medicine and
Detroit, MI, 4Department of Pediatrics Georgia Regents University, Pediatrics, Hofstra North Shore-LIJ School of Medicine, Great
Augusta, GA Neck, NY, 2Department of Pediatrics, Division of Allergy & Immu-
678 Major Culprit Allergen Sensitization Patterns According To nology, Hofstra-North Shore-LIJ School of Medicine, Great Neck,
Age In Korean Atopic Dermatitis Patients NY, 3Allergy and Immunology, North Shore LIJ Health System,
Hye Jung Park1, Jae-Hyun Lee1,2, Kyung-Yong Jeong2, Kyung- Great Neck, NY
Hee Park1,2, Yoon-Ju Kim2 and Jung-Won Park1,2, 1Division of Al-
lergy and Clinical Immunology, Department of Internal Medicine,
Yonsei University College of Medicine, Seoul, South Korea, 2Insti-
tute of Allergy, Yonsei University College of Medicine, Seoul,
South Korea
Food Allergy II
679 Protein Microarray: IgE-Profiling Of Brazilians With Atopic
Dermatitis 4208
Lucila Camargo Lopes de Oliveira1, Roberta Faria Camilo-Ara- Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
ujo1, Isabel Rugue Genov1, Dr. Renata R. Cocco2, Dr. Marcia Mal-
689 Oral Allergy Syndrome - a Spectrum Of Presentations
lozi, MD3, Prof. Nelson A. Rosario, MD, PhD, FAAAAI4 and Prof. Dr. Parwinder Gill1, Dr. Gordon L. Sussman, FAAAAI2, Jiayi
Dirceu Sole, MD, PhD5, 1UNIFESP, 2Federal University of S~ao Bian1 and Ms. Carly Barron3, 1University of Toronto, Toronto,
Paulo, 3Federal University of S~ao Paulo, Brazil, 4Federal University ON, Canada, 2University of Toronto, Faculty of Medicine, Toronto,
of Parana, Curitiba, Brazil, 5Federal University of Sao Paulo, Sao ON, Canada, 3Gordon Sussman Clinical Research Inc., Toronto,
Paulo, Brazil ON, Canada
680 Relationship Between Dietary Food and Nutrient Intakes and 690 Allergy To Sheep Milk With Or Without Allergy To Cow Milk
Bone Mineral Density In Childhood Eczema Dr. Fouseena Pazheri1, Dr. Alton Lee Melton Jr., MD2, Dr. Earl
Dr. Ting Fan Leung, MD FRCPCH FAAAAI, Ms. Flora Yin-ying Poptic1 and Dr. Belinda Willard1, 1Cleveland CLinic, Cleveland,
Kwok, MPhil, Dr. Yvonne Yi-fong Ho, MPhil, Dr. Susan Shuxin OH, 2Cleveland Clinic, Cleveland, OH
Wang, PhD, Ms. Patty Pui-pui Tse, MSc, Prof. Gary Wing-kin 691 Genome-Wide Study Of Interaction Between Season Of Birth
Wong, MD, FRCPC and Dr. Kam Lun Ellis Hon, MD, FAAP, De- and Peanut Allergy Identifies a Region On Chromosome 3 As
partment of Paediatrics, The Chinese University of Hong Kong, a Genetic Risk Factor
Hong Kong Corinne Keet, MD, MS1, Xiumei Hong, PhD2, Dr. Ingo Ruczinski,
681 Change Of Caregivers Perception Regarding Atopic Dermati- PhD2, Dr. Terri H Beaty, PhD2, Dr. Jacqueline Pongracic, MD,
tis From 2006 To 2013 FAAAAI3 and Dr. Xiaobin Wang, MD, MPH ScD4, 1Pediatrics,
Dr. Kyung Suk Lee, MD, PhD1, Prof. Yeong-Ho Rha, MD, PhD1 Johns Hopkins University School of Medicine, Baltimore, MD,
and Prof. Sun-Hee Choi, MD, PhD2, 1Kyung Hee University 2
Johns Hopkins University School of Public Health, Baltimore,
129
AB340 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
MD, 3Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi- Baltimore, MD, 4Johns Hopkins University Medical Center, Balti-
cago, IL, 4Center on Early Life Origins of Disease, Department of more, MD
Population, Family and Reproductive Health, Johns Hopkins Uni- 697 Prevalence Of IgE-Mediated Food Sensitisation and Food Al-
versity Bloomberg School of Public Health, Baltimore, MD lergy In Unselected 12-36 Month Old South African Children
692 Orofecal Infections and Risk Of Food Allergy In Children Dr. Maresa Botha, MBChB, FCPaed1 and Prof. Michael E. Levin,
Dr. Gary Wong, MD1, Dr. Jing Li, MD, MSc2, Dr. Ting Fan Leung, MBChB, FCPaed, Dip Allergology, MMed(Paeds), PhD, EAACI
MD FRCPCH FAAAAI3 and Prof. Nanshan Zhong2, 1Chinese Uni- allergy exam (UEMS), Certificate Allergology, FAAAAI1,2, 1Uni-
versity of Hong Kong, Shatin, Hong Kong, 2The First Affiliated versity of Cape Town, Cape Town, South Africa, 2Red Cross War
Hospital of Guangzhou Medical College, State Key Laboratory of Memorial Childrens Hospital, Cape Town, South Africa
Respiratory Disease, Guangzhou Institute of Respiratory Disease, 698 Evaluation Of Peanut Allergy In a Birth Cohort
Guangzhou, China, 3Department of Paediatrics, The Chinese Uni- Dr. Hiba Bashir, MD1, Mr. Christopher J. Tisler, MT1, Dr. Eliza-
versity of Hong Kong, Hong Kong beth L. Anderson1, Dr. Theresa Kang, PhD1, Lisa Salazar, BS1,
693 Peanut, Milk, and Wheat Intake During Pregnancy Is Associ- Mr. Michael D. Evans, MS1, Dr. Ronald E. Gangnon, PhD1, Dr.
ated With Reduced Allergy and Asthma In Children Daniel J. Jackson, MD2, Dr. Robert F. Lemanske Jr., MD, FAAAAI1
Dr. Supinda Bunyavanich, MD, MPH1, Ms. Sheryl Rifas-Shiman, and Dr. James E. Gern, MD, FAAAAI1, 1University of Wisconsin
MPH2, Thomas A.E. Platts-Mills, MD, PhD, FAAAAI3, Lisa J. School of Medicine and Public Health, Madison, WI, 2Pediatrics,
Workman, BA3, Dr. Joanne Sordillo, ScD4, Dr. Carlos Camargo University of Wisconsin School of Medicine and Public Health,
Jr., MD, DrPH5, Dr. Matthew Gillman, MD, SM2, Dr. Diane R. Madison, WI
Gold, MD, MPH6 and Dr. Augusto A. Litonjua, MD, MPH4, 1Divi- 699 Prevalence Of Peanut Allergy: A Systematic Review
sion of Pediatric Allergy & Immunology, Department of Pediatrics, Dr. Heather Mackenzie1, Dr. Carina Venter, PhD RD2, Dr. Sally
Icahn School of Medicine at Mount Sinai, New York, NY, 2Depart- Kilburn1, Ms. Harriet R. Moonesinghe1, Ms. Kellyn Lee1 and
ment of Population Medicine, Harvard Pilgrim Health Care Insti- Prof. Taraneh Dean1,3, 1University of Portsmouth, School of Health
tute, Harvard Medical School, Boston, MA, 3Division of Asthma, Sci, Portsmouth, United Kingdom, 2The David Hide Asthma and
Allergy & Immunology, University of Virginia Health System, Allergy Research Center, Isle of Wight, United Kingdom, 3The Da-
Charlottesville, VA, 4Channing Division of Network Medicine, vid Hide Asthma and Allergy Centre, Newport
Brigham & Womens Hospital, Harvard Medical School, Boston, 700 Prevalence Of Fish and Shellfish Allergy- A Systematic Review
MA, 5Department of Emergency Medicine, Massachusetts General Ms. Harriet R. Moonesinghe1, Dr. Sally Kilburn1, Dr. Heather
Hospital, Harvard Medical School, Boston, MA, 6Channing Labo- Mackenzie1, Dr. Paul J. Turner, FRACP PhD2, Dr. Carina Venter,
ratory, Brigham and Womens Hospital, Boston, MA PhD RD3, Ms. Kellyn Lee1 and Prof. Taraneh Dean1, 1University
694 The Prevalence Of Food Sensitization and Food Allergy In An of Portsmouth, School of Health Sci, Portsmouth, United Kingdom,
2
Inner City Birth Cohort Imperial College London, United Kingdom, 3The David Hide
Robert A. Wood, MD, FAAAAI, Johns Hopkins University Med- Asthma and Allergy Research Center, Isle of Wight, United
ical Center, Baltimore, MD, Dr. Emily C. McGowan, MD, Johns Kingdom
Hopkins University School of Medicine, Baltimore, MD, Dr. Gor- 701 Prevalence Of Food Allergy To Uncommon Foods Based On
don R. Bloomberg, MD, FAAAAI, Campus Box 8116, St. Louis Oral Food Challenges
MONDAY
Childrens Hospital, Saint Louis, MO, Dr. Peter J. Gergen, MD, Dr. Gita Ram1, Christina Gustafson1, Dr. Jonathan M. Spergel,
MPH, AAIB\DAIT\NIH, Bethesda, MD, Dr. Cynthia Visness, MD, PhD, FAAAAI2 and Dr. Antonella Cianferoni, MD, PhD3,
1
PhD, Rho Federal Systems Division, Inc., Chapel Hill, NC, Katy Childrens Hospital of Philadelphia, Philadelphia, PA, 2The Chil-
Jaffee, MS, Rho, Inc., Chapel Hill, NC, Dr. George T. OConnor, drens Hospital of Philadelphia, Philadelphia, PA, 33615 Civic Cen-
MD, Boston University School of Medicine, Boston, MA, Dr. ter Boulevard, The Childrens Hospital of Philadelphia,
Meyer Kattan, MD, NewYork-Presbyterian/Columbia, New York, Philadelphia, PA
NY and Dr. James E. Gern, MD, FAAAAI, University of Wisconsin 702 Prevalence Of Food Allergy In Patients With Irritable Bowel
School of Medicine and Public Health, Madison, WI Syndrome
695 Food Allergy Prevalence In Parents Of Food-Allergic Children Erin L. Reigh, MD, MS1, Dr. Javed Sheikh, MD, FAAAAI2 and
Based On Self-Report, Serologic Testing and Physician Diagno- Anna Kovalszki, MD1, 1Beth Israel Deaconess Medical Center,
sis Boston, MA, 2Kaiser Permanente Los Angeles Medical Center,
Melanie M. Makhija, MD1,2, Dr. Rachel Glick Robison2,3, Deanna Los Angeles, CA
Caruso, MS4, Miao Cai, MS5, Dr. Xiaobin Wang, MD, MPH ScD4 703 Clinical Characteristics Of Seafood Allergy In Canadian Chil-
and Dr. Jacqueline Pongracic, MD, FAAAAI3,6, 1Ann and Robert dren
H. Lurie Childrens Hospital of Chicago, Chicago, IL, 2Division Dr. Victoria Cook, Department of Pediatrics, University of British
of Allergy & Immunology, Department of Pediatrics,Northwestern Columbia, BC Childrens Hospital, Vancouver, BC, Canada, Dr.
University Feinberg School of Medicine, Chicago, IL, 3Ann & Rob- Edmond S. Chan, MD, FAAAAI, Department of Pediatrics, Faculty
ert H. Lurie Childrens Hospital of Chicago, Chicago, IL, 4Johns of Medicine, University of British Columbia, Dr. Ann Elaine
Hopkins University School of Public Health, Baltimore, MD, 5Di- Clarke, MD, MSc, Division of Allergy and Clinical Immunology,
vision of Allergy & Immunology, Department of Pediatrics, North- Department of Medicine, McGill University Health Centre, Mon-
western University Feinberg School of Medicine, Ann & Robert H. treal, QC, Canada; Division of Clinical Epidemiology, Department
Lurie Childrens Hospital of Chicago, Chicago, IL, 6Division of Al- of Medicine, McGill University Health Centre, Montreal, QC, Can-
lergy & Immunology, Department of Pediatrics,Northwestern Uni- ada, Mr. Greg Shand, Department of Medicine, Division of Clinical
versity Feinberg School of Medicine Epidemiology, McGill University Health Center, Montreal, QC,
696 The Effect Of Neighborhood Level Poverty and Urbanization Canada and Dr. Moshe Ben-Shoshan, MD, MSc, Division of Paedi-
On The Prevalence Of Food Allergy In The National Health In- atric Allergy and Clinical Immunology, Department of Paediatrics,
terview Survey (NHIS) McGill University Health Center, Montreal, QC, Canada
Dr. Emily C. McGowan, MD1, Dr. Meredith C. McCormack, 704 Changes In Total IgE Levels To Predic Food Challenge Test
MD2, Dr. Roger Peng, PhD3, Dr. Elizabeth Matsui, MD2 and Cor- Outcomes
inne Keet, MD, MS4, 1Johns Hopkins University School of Medi- Dr. Kenta Horimukai, Jikei University Katsushika Medical Cen-
cine, Baltimore, MD, 2The Johns Hopkins University School of ter, Tokyo, Japan, Dr. Masami Narita, MD, PhD, National Center
Medicine, Baltimore, MD, 3Johns Hopkins School of Public Health, for Child Health and Development, Tokyo, Japan, Dr. Ichiro
130
J ALLERGY CLIN IMMUNOL Abstracts AB341
VOLUME 133, NUMBER 2
Nomura, MD, PhD, National Center for Child Health and Develop- Directorate, Health Canada, Ottawa, ON, Canada, 7McGill Univer-
ment, Setagayaku, Japan, Dr. Kenji Matsumoto, MD, PhD, Depart- sity, Dorval, QC, Canada, 8Division of Clinical Epidemiology, De-
ment of Allergy and Immunology, National Research Institute for partment of Medicine, McGill University Health Centre, Montreal,
Child Health and Development, Tokyo, Japan and Dr. Yukihiro QC, Canada, 9McGill University, Montreal, QC, Canada, 10Divi-
Ohya, MD, PhD, Division of Allergy, National Center for Child sion of Clinical Epidemiology, Department of Medicine, McGill
Health and Development, Tokyo, Japan University Health Center, QC, Canada, 11Department of Geogra-
705 Situational and Environmental Factors Associated With a phy, University of Toronto, Toronto, ON, Canada, ON, Canada,
12
Childs Willingness To Use An Epinephrine Auto-Injector Applied Health Sciences, University of Waterloo, ON, Canada,
13
Amanda Tantleff, Byram Hills High School and Dr. Anna H. McGill University Health Centre, Montreal, Canada
Nowak-Wegrzyn, MD, FAAAAI, Icahn School of Medicine at 710 Differences In Empowerment and Quality Of Life Among
Mount Sinai, New York, NY Mothers and Fathers Of Children With Food Allergy
706 Possession Of Epinephrine Auto-Injectors (EAI) In a Vulnera- Mr. Christopher Warren, BA1, Dr. Ruchi Gupta, MD, MPH2, Mr.
ble Canadian Population With Food Allergies Namit Lal3, Dr. Min-Woong Sohn, PhD4, Dr. Craig Garfield, MD4,
Dr. Sabrine Cherkaoui, M.D1, Ms. Lianne Soller, MSc2, Dr. Dr. Jacqueline Pongracic, MD, FAAAAI2 and Dr. Xiaobin Wang,
Moshe Ben-Shoshan, MD, MSc3, Daniel Harrington, MA, PhD4, MD, MPH ScD5, 1University of Southern California, Los Angeles,
Dr. Sebastien La Vieille, MD5, Dr. Joseph Fragapane, MD6, Dr. CA, 2Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi-
Lawrence Joseph, PhD7, Mr. Yvan St-Pierre, MSc8, Prof. Susan El- cago, IL, 3University of Michigan, Ann Arbor, MI, 4Northwestern
liott, PhD9 and Dr. Ann Elaine Clarke, MD, MSc7,10, 1Division of University, Chicago, IL, 5Johns Hopkins, Chicago, IL
Internal Medicine, Department of Medicine, University of Mon- 711 Prevalence Of Misconceptions Regarding Egg Allergy and Mea-
treal, Montreal, QC, Canada, 2Division of Clinical Epidemiology, sles Mumos and Rubella Vaccine Contraindications
Department of Medicine, McGill University Health Center, Mon- Dr. Vylma Velazquez, MD, Dr. Carmen Rivera and Dr. Monique
treal, QC, Canada, 3Division of Paediatric Allergy and Clinical Im- Adorno, Hospital Episcopal San Lucas, Ponce, PR
munology, Department of Paediatrics, McGill University Health 712 Prenatal and Postnatal Factors Associated With IgE-Mediated
Center, Montreal, QC, Canada, 4McMaster University - School of Wheat Allergy In Infants: A Study In Asian Population
Geography, Hamilton, ON, Canada, 5Food Directorate, Health Can- Dr. Suparat Sirivimonpan, MD, Chulalongkorn University, Bang-
ada, Ottawa, ON, Canada, 6McGill University, Dorval, QC, Canada, kok, Thailand
7
Division of Clinical Epidemiology, Department of Medicine, 713 Maternal Healthy Diet and Development Of Allergic Disease
McGill University Health Centre, Montreal, QC, Canada, 8Division Dr. Carina Venter, PhD RD1, Ms. Harriet R. Moonesinghe2, Prof. Ha-
of Clinical Epidemiology, Department of Medicine, McGill Univer- san Arshad3,4, Prof. Taraneh Dean2,5, Mrs. Jane Grundy3, Mrs. Gill
sity Health Center, Canada, 9Applied Health Sciences, University of Glasbey3 and Dr. Veeresh Patil3,4, 1The David Hide Asthma and Al-
Waterloo, ON, Canada, 10Division of Allergy and Clinical Immu- lergy Research Center, Isle of Wight, United Kingdom, 2University
nology, Department of Medicine, McGill University Health Centre, of Portsmouth, School of Health Sci, Portsmouth, United Kingdom,
3
Montreal, QC, Canada The David Hide Asthma and Allergy Centre, Newport, United King-
707 Food Allergy In Daycare Centers: Prevalence, Management, dom, 4University of Southampton, Southampton, United Kingdom,
5
and Knowledge Of Directors The David Hide Asthma and Allergy Centre, Newport
MONDAY
Dr. Lisanne Newton, M.D. and Dr. Brian Schroer, MD, Cleveland 714 Effect Of Annual Income On Parental/Family Burden Of Food
Clinic, Cleveland, OH Allergy
708 Assessment Of Food Insecurity and Health Literacy In a Ter- Dr. David A. Petty, DO, University of Tennessee Allergy fellow-
tiary Care Pediatric Allergy Population ship program, Memphis, TN, Jay A. Lieberman, MD, University
Dr. Meredith A. Dilley, MD1,2, Ms. G. Lynn Christie, MS RD2, of Tennessee, Memphis, TN and Nhu Quynh Tran, PhD, University
Ms. Mary Price2, Ms. Connelly Weeks2, Mallikarjuna Rettiganti, of Tennessee Department of Preventative Medicine
PhD1,2, Maria Melguizo Castro1,2, Dr. Amy M. Scurlock, MD3,4, 715 Food Allergy and Anaphylaxis Educational Needs Assessment,
Dr. Tamara T. Perry, MD1,2, Dr. Robbie D. Pesek1,2, Dr. Matthew Training Curriculum and Assessment Of Knowledge Of Urban
C. Bell, MD1,2, Joshua L. Kennedy, MD5, Ms. Erin OBrien1,2, Child Care Center Workers
Ms. Sklar McGrath2, Mr. Jared Hogan2, Megan Patterson1, Julia Ar- Dr. Bruce J. Lanser, MD1, Dr. Ronina A. Covar, MD1, David
onson1, Dr. Patrick Casey, MD1,2 and Stacie M. Jones, MD3,5, 1Uni- Mark Fleischer, MD, FAAAAI1 and Dr. J. Andrew Bird, MD,
versity of Arkansas for Medical Sciences, Little Rock, AR, FAAAAI2, 1National Jewish Health, Denver, CO, 2UT Southwest-
2
Arkansas Childrens Hospital, Little Rock, AR, 3University of Ar- ern Medical Center, Dallas, TX
kansas for Medical Sciences and Arkansas Childrens Hospital, Lit- 716 Food Allergy Survey Among Food Service Workers
tle Rock, AR, 4University of Arkansas for Medical Sciences/ Bruce M. Prenner, MD1, John Hollingsworth, PA2, Ron Oliver3
Arkansas Childrens Hospital, Little Rock, AR, 5Arkansas Chil- and Linnet Brew, LVN1, 1Allergy Partners of San Diego, San
drens Hospital Research Institute, Little Rock, AR Diego, CA, 2Scripps Clinic, 3The Marine Room, La Jolla, CA
709 Environmental and Sociodemographic Factors Associated With 717 Bullying and Food Allergy Longitudinal Follow-Up
Food Allergy: A Nested Case-Control Study Scott H. Sicherer, MD, FAAAAI1, Melissa Rubes2, Chloe Mullar-
Dr. Moshe Ben-Shoshan, MD, MSc1,2, Ms. Lianne Soller, MSc3, key2, Mordechai Ambrose3, Noga Ravid2, Kelley Chuang3, Rachel
Daniel Harrington, MA, PhD4, Ms. Megan Knoll, MSc5, Dr. Sebas- Annunziato2 and Eyal Shemesh3, 1Mount Sinai School of Medicine,
tian La Vieille, MD6, Dr. Joseph Fragapane, MD7, Dr. Lawrence New York, NY, 2Fordham University, NY, 3Icahn School of Medi-
Joseph, PhD8,9, Mr. Yvan St. Pierre, MSc10, Dr. Kathi Wilson11, cine at Mount Sinai, NY
Prof. Susan Elliott, PhD12 and Dr. Ann Elaine Clarke, MD, 718 Prevalence and Characteristics of Consumer-Reported Food
MSc8,13, 1Division of Paediatric Allergy and Clinical Immunology, Allergic and Anaphylactic Events in CAERS, 2007-2011
Department of Paediatrics, McGill University Health Center, Mon- Ms. Taiye M Oladipo, MPH and Dr. Stefano Luccioli, MD,
treal, QC, Canada, 2Montreal Childrens Hospital, Montreal, Can- FAAAAI, Center for Food Safety and Applied Nutrition, Food
ada, 3Division of Clinical Epidemiology, Department of and Drug Administration, College Park, MD
Medicine, McGill University Health Center, Montreal, QC, Can- 719 Impact Of School Peanut-Free Guidelines On Epinephrine Ad-
ada, 4McMaster University - School of Geography, Hamilton, ministration
ON, Canada, 5Division of Clinical Epidemiology, Department of Dr. Lisa M. Bartnikas, MD1,2, Dr. Michelle F. Huffaker, MD1,3,
Medicine, McGill University Health Center, Canada, 6Food Dr. William J. Sheehan, MD1,2, Dr. Watcharoot Kanchongkittiphon,
131
AB342 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
MD, PhD1,2, Mr. Carter Petty, MA2, Ms. Anne Sheetz, RN, BSN, 728 Banana Allergy In Children Evaluated Using Double Blind Pla-
MPH4, Dr. Robert Leibowitz, PhD4, Dr. Michael C. Young, MD, cebo Controlled Food Challenge
FAAAAI1,2 and Dr. Wanda Phipatanakul, MD, MS, FAAAAI1,2, Aysen Bingol, TURPEDAS, Turkey, Dilara Kocacik Uygun, AK-
1
Harvard Medical School, Boston, MA, 2Boston Childrens Hospi- DENIZ UNIVERSITY MEDICAL FACULTY DEPT OF PEDIAT-
tal, Boston, MA, 3Brigham and Womens Hospital, Boston, MA, RIC ALLERGY IMMMUNOLOGY, Dr. Serkan Filiz, AKDENIZ
4
Massachusetts Department of Public Health, Boston, MA UNIVERSITY MEDICAL FACULTY DEPT OF PEDIATRIC AL-
720 Comparison Of Germfree and Conventional Mice For Evaluat- LERGY IMMUNOLOGY, ANTALYA, Turkey and Olcay Yegin,
ing The Potential Allergenicity Of Dietary Proteins Using AKDENIZ UNIVERSITY MEDICAL FACULTY DEPT OF PEDI-
Model Allergenic and Non-Allergenic Proteins ATRIC ALLERGY IMMUNOLOGY, Antalya, Turkey
Nathan L. Marsteller1,2, Mr. Kwame Andoh-Kumi1, Daniel A. Peter- 729 Risk Of Oral Food Challenges In Children - a Prospective Mul-
son3, Richard E. Goodman1 and Joe L. Baumert1, 1Food Allergy Re- ticenter Study -
search and Resource Program, University of Nebraska-Lincoln, Dr. Toshiko Itazawa, MD, PhD1, Dr. Motokazu Nakabayashi, MD,
Lincoln, NE, 2School of Biological Sciences, University of Ne- PhD1, Dr. Yasunori Ito, MD, PhD1, Dr. Yoshie Okabe, MD, PhD1,
braska-Lincoln, 3Johns Hopkins School of Medicine, Baltimore, MD Dr. Yoko S Adachi, MD, PhD1, Dr. Yuichi Adachi, MD, PhD1, Dr.
721 The Role Of Lipopolysaccharide In Skewing The Sensitization Komei Ito, MD, PhD2 and Motohiro Ebisawa, MD, PhD, FAAAAI3,
1
Potential Of Purified b-Lactoglobulin In a Mouse Model Department of Pediatrics, University of Toyama, Toyama, Japan,
Mr. Kwame Andoh-Kumi1, Richard E. Goodman1, Daniel A. Peter- 2
Aichi Childrens Health and Medical Center, Obu, Aichi, Japan,
son2, Joe L. Baumert1 and Nathan L. Marsteller1,3, 1Food Allergy Re- 3
Clinical Research Center for Allergy and Rheumatology, Sagami-
search and Resource Program, University of Nebraska-Lincoln, hara National Hospital, Kanagawa, Japan
Lincoln, NE, 2Johns Hopkins School of Medicine, Baltimore, MD, 730 A Double-Blind Randomized Controlled Trial Of A Thickened
3
School of Biological Sciences, University of Nebraska-Lincoln Amino-Acid-Based Formula In Children Allergic To Cows
722 Oral Co-Administration Of Peanut and Cholera Toxin Subunit Milk and To Protein Hydrolyzates
B During Pregnancy and Lactation Blocks Anaphylaxis and In- Prof. Nicolas Kalach, MD, Ph D1, Dr. Elena Bradatan2, Prof.
duces Epigenetic Modifications In Peanut Allergic Murine Alain Lachaux3, Dr. Francois Payot3, Prof. Frederic de BLAY4,
Mothers Dr. Lydie Guenard-Bilbault5,6, Dr. Riad Hatahet7, Dr. Sandra Mu-
Dr. Ying Song, MD1, Dr. ChangDa Liu1, Dr. Kamal D. Srivas- lier8 and Prof. Christophe Dupont, MD, PhD9, 1H^opital Saint Vin-
tava, PhD1, Dr. Jia Chen, ScD1,2, Dr. Rachel L. Miller, MD, cent de Paul, Groupement des Hospitaux de lInstitut Catholique de
FAAAAI3 and Dr. Xiu-Min Li, MD1, 1Pediatrics, Icahn School Lille (GH-ICL), Lille, France, 2Department of Pediatrics, Regional
of Medicine at Mount Sinai, New York, NY, 2Prevention, Icahn Hospital, Namur, Belgium, 3Gastroenterology, Hepatology and Nu-
School of Medicine at Mount Sinai, NY, 3Division of Pulmonary, trition Unit, University and Pediatric Hospital of Lyon, France,
4
Allergy and Critical Care Medicine, Columbia University, New CHRU Strasbourg, France, 5Regional University Hospital, Stras-
York, NY bourg, Strasbourg, France, 6Allergologist, Illkirch-Graffenstaden,
723 Worsened Reaction Severity In Oral Food Challenges Confirms France, 7Pediatrician Allergologist, Forbach, France, 8Queen Fa-
Need For In-Office Procedure biola Childrens, University Hospital, Brussels, Brussels, Belgium,
9
Dr. Annie Esquivel, Dr. Girish V. Vitalpur, MD, FAAAAI, Dr. Hopital Necker Enfants Malades, Paris, France
MONDAY
Kirsten Kloepfer, MD and Dr. Frederick E. Leickly, MD, MPH 731 Impact Of Formula Containing Docosahexaenoic Acid, Prebi-
FAAAAI, Riley Hospital for Children at Indiana University Health, otics, and Beta-Glucan On Allergic Manifestations In Young
Indianapolis, IN Children
724 Oral Food Challenge Outcome Among Children With a Nega- Dr. Deolinda Scalabrin, MD, PhD1, Suzanne Stolz1, Weihong
tive Skin Prick Test Result Zhuang1, Mariana Pontes2, Angela de Mattos2, Indhira Almeida2,
Dr. Wipa Jessadapakorn, MD, Division of Allergy and Immunol- Carolina Godoy2, Sara Gatto2, Vivian Leal2, Gabriela Cabral2, Ter-
ogy, Department of Pediatrics, Faculty of Medicine, Prince of eza Ribeiro2 and Hugo Ribeiro2, 1Mead Johnson Nutrition, Evans-
Songkla University, Hat-Yai, Songkhla, Thailand, Dr. Prapasri Ku- ville, IN, 2Federal University of Bahia, Brazil
lalert, MD, Prince of Songkla University, Songkla, Thailand, Dr. 732 Parents Perception Of The Likelihood Of Future Life-Threat-
Araya Yuenyongviwat, MD, Prince of Songkla University, ening Events In Their Children With Food Allergies
Songkhla, Thailand and Dr. Pasuree Sangsupawanich, MD, Prince Dr. Peter Arkwright, MD, PhD, FAAAAI1, Ms. Jennifer Ogg1,
Songkhlanagarind hospital, Hadyai, Thailand Dr. Naomi Davis2 and Dr. Ming Wan1, 1University of Manchester,
725 Abbreviated Oral Food Challenge As a Safe and Effective Alter- Manchester, United Kingdom, 2Royal Manchester Childrens Hos-
native For Diagnosing Food Allergy In a Pediatric Clinic pital, United Kingdom
April L. Goolsby, BS1, Heather Minto, MD1,2, Amy Perkins, MS1,2 733 Can Training Improve Allergists Ability To Accurately Iden-
and Kelly M. Maples, MD1,2, 1Eastern Virginia Medical School, tify Anxiety In Children With Food Allergy?
Norfolk, VA, 2Childrens Hospital of The Kings Daughters, Nor- Melissa Rubes1, Anna Podolsky2, Nicole Caso1, Rachel Annun-
folk, VA ziato1, Dr. Amanda L. Cox, MD2, Dr. Jennifer S. Kim, MD,
726 Safety Of Ungraded Oral Food Challenges In Ruling Out Pea- FAAAAI2, Dr. Anna H. Nowak-Wegrzyn, MD, FAAAAI2, Dr. Julie
nut Allergy In Children Wang, MD, FAAAAI2, Scott H. Sicherer, MD, FAAAAI3 and Eyal
Dr. Darlene Kassab Mansoor, MD, MS1, Amit Singal, BS2, Shemesh2, 1Fordham University, NY, 2Icahn School of Medicine at
Shweta Bansil, BS2 and Dr. Hemant P. Sharma, MD MHS Mount Sinai, NY, 3Mount Sinai School of Medicine, New York, NY
FAAAAI1, 1Childrens National Medical Center, 2George Washing- 734 Nutritional Status Impairment In Patients With Food Allergies
ton University School of Medicine Dr. Gesmar Segundo, Mrs. Larissa Costa and Mrs. Erica Rezende,
727 Safety Of Oral Food Challenges To Extensively Heated Egg In Universidade Federal de Uberlandia, Uberlandia, Brazil
Children 735 Everyday Life Impact On Food Allergy Spanish Children.Car-
Dr. Cindy Nguyen, MD1, Shweta Bansil, BS2, Amit Singal, BS2 egivers Perception
and Dr. Hemant P. Sharma, MD MHS FAAAAI3, 1Childrens Na- Dr. Elena Alonso-Lebrero, PhD, Hospital Materno Infantil Gre-
tional Medical Center, Division of Allergy and Immunology, Wash- gorio Mara~non Pediatric Allergy Section, Madrid, Spain, Mr. Julio
ington, DC, 2George Washington University School of Medicine, Monleon, MS, Santa Barbara, Madrid, Spain and Alberto Alvarez-
3
Childrens National Medical Center, Division of Allergy and Im- Perea, MD, Hospital Materno Infantil Gregorio Mara~non, Pediatric
munology, DC Allergy Department, Madrid, Spain
132
J ALLERGY CLIN IMMUNOL Abstracts AB343
VOLUME 133, NUMBER 2
736 The First 4 Central American Cases Of Delayed Meat Allergy 743 Variability In Measurement Of Allergen Skin Testing Results
With Galactose-Alpha-1,3-Galactose Positivity Clustered Among Allergy-Immunology Specialists
Among Field Biologists In Panama Dr. Tiffany Jean1, Dr. Kenny Y. Kwong1 and Dr. Nasser Redjal,
Dr. Paige G. Wickner, MD, Brigham and Womens Hospital, Di- MD, FAAAAI2, 1Harbor-UCLA Medical Center, 2Harbor-UCLA
vision of Rheumatology, Immunology and Allergy, Chesnut Hill, Medical Center, Torrance, CA
MA and Scott P. Commins, MD, PhD, University of Virginia Health 744 Serologic Specific IgE (sIgE) Testing In a Closed Healthcare
System, Charlottesville, VA System
737 Incidence Of New Onset Food Allergy In Renal, Cardiac, and Dr. Daniel A. Steigelman, MD and Dr. Tonya S. Rans, MD, Wil-
Hepatic Transplant Recipients and Correlation With Immuno- ford Hall Ambulatory Surgical Center, Joint Base San Antonio -
suppression Protocol Lackland AFB, TX
Francois Graham, MD, MSc1, Frederic Racicot2, Luminita Iuli- 745 Outcomes After Implementation Of An Inpatient Antibiotic
ana Jamali, MD2, Marie-Jeanne Lebel, MD2, Hugo Chapdelaine, Prescribing Pathway For Patients With Penicillin Or Cephalo-
MD2, Fernando Alvarez, MD2, Veronique Phan Cong, MD2, sporin Allergy
Marie-Josee Raboisson, MD2, Louis P. Paradis, MD FRCPC Dr. Kimberly Blumenthal, MD, Allergy and Immunology, Divi-
FAAAAI2 and Anne M. Des Roches, MD FRCPC FAAAAI2, sion of Rheumatology, Allergy, and Immunology, Department of
1
CHUM, H^ opital Notre-Dame, Montreal, QC, Canada, 2Centre Medicine, Massachusetts General Hospital, Harvard Medical
Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada School, Boston, MA, Dr. Erica Shenoy, MD, PhD, Division of In-
738 Late and Secondary Onset Food Allergy fectious Disease and Infection Control Unit, Department of Medi-
Dr. Liat Nachshon, MD1, Dr. Michael Goldberg, MD, PhD1, Dr. cine, Massachusetts General Hospital, Harvard Medical School,
Arnon Elizur, MD1,2, Dr. Michael B. Levy, MD, FAAAAI1 and Boston, MA, Ms. Christy Varughese, Pharm.D., Department of
Prof. Yitzhak Katz, MD, FAAAAI1,2, 1Assaf Harofeh, Zerifin, Is- Pharmacy, Infection Control Unit, Massachusetts General Hospital,
rael, 2Tel Aviv University, Tel Aviv, Israel Boston, MA, Dr. David Hooper, MD, PhD, Division of Infectious
739 Food Allergy Testing Practices Of Primary Care Pediatricians Disease and Infection Control Unit, Department of Medicine, Mas-
In Illinois sachusetts General Hospital, Boston, MA and Dr. Aleena Banerji,
Hector Rodriguez, MD1,2, Ms. Claudia Lau1, Dr. Ruchi Gupta, MD, Division of Rheumatology, Allergy, and Immunology, Depart-
MD, MPH1,2 and Melanie M. Makhija, MD1,3, 1Ann and Robert ment of Medicine, Massachusetts General Hospital, Harvard Med-
H. Lurie Childrens Hospital of Chicago, Chicago, IL, 2Northwest- ical School, Boston, MA
ern University Feinberg School of Medicine, Chicago, IL, 3Division 746 The Effect Of Panel Ordering On Utilization Of In Vitro Spe-
of Allergy & Immunology, Department of Pediatrics,Northwestern cific IgE Testing By Primary Care Physicians In a Large HMO
University Feinberg School of Medicine, Chicago, IL Dr. Bruce J. Goldberg, MD, PhD, FAAAAI, Kaiser Permanente,
740 Understanding The Role Of Online Resources For Childhood Los Angeles, CA and Dr. John S. Kaptein, PhD, Southern Califor-
Food Allergies nia Permanente Medical Group, Los Angeles, CA
David Goese, University of Chicago Pritzker School of Medicine, 747 Premature Discontinuation Of Allergy Immunotherapy-Inade-
Chicago, IL and Ves Dimov, MD, University of Chicago Medicine, quate Reimbursement By Health Insurers A Major Factor
Chicago, IL; Section of Allergy, Asthma and Immunology, Depart- Dr. Surender K. Vaswani, MD, FAAAAI, Allergy & Asthma
MONDAY
ment of Pediatrics, Department of Medicine, University of Chicago, Clinical Center, Columbia, MD, Ravi Vaswani, New York Univer-
Chicago, IL sity School of Medicine, Dr. Njideka Udochi, Howard County Gen-
741 Clinical Features, Diagnosis, Management and Natural History eral Hospital/Johns Hopkins, Rajiv Karani, University of Cincinnati
Of Food Protein-Induced Enterocolitis Syndrome In a National School of Medicine and Dr. Leena Parikh, St.Agnes Hospital
Cohort 748 Adherence To Labeling Guidelines Of Inhalant Allergen Immu-
Dr. Todd David Green, MD, FAAAAI1, Dr. Matthew J. Green- notherapy Practice Parameter 2011 At The University Of Mich-
hawt, MD, MBA, MSc2, Dr. Tammy S. Jacobs, MD, MA1 and Fal- igan Health Service
lon Schultz3, 1Childrens Hospital of Pittsburgh of UPMC, Dr. Marilyn Karam, MD1, Kiela Samuels2, Cynthia Hernandez,
Pittsburgh, PA, 2Department of Internal Medicine, The University RN2, Dr. Christine L. Holland, MD1 and Dr. Matthew J. Greenhawt,
of Michigan Medical School, Division of Allergy and Clinical Im- MD, MBA, MSc3, 1The University of Michigan, Division of Al-
munology, Ann Arbor, MI, 3International Association for Food Pro- lergy and Clinical Immunology, Ann Arbor, MI, 2University of
tein Enterocolitis (IAFFPE) Michigan Health System, Ann Arbor, MI, 3Department of Internal
Medicine, The University of Michigan Medical School, Division of
Allergy and Clinical Immunology, Ann Arbor, MI
749 The Prevalence Of Allergic Rhinitis Among High- School Male
Military Recruits In Jordan
Dr. Mansour Fuad Karadsheh, MD and Dr. Suleiman Soudi,
Health Care Delivery Royal Medical Services, Madaba, Jordan
750 Allergen Sensitivity Patterns Among Atopic Individuals At A
4209 Tertiary Allergy Center
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM Dr. Lukena U. Karkhanis, MD, Dr. Sarena Sawlani, MD and Dr.
742 Health Literacy Is Associated With Medication Adherence In Andrew Kau, MD, PhD, Washington University School of Medi-
Adolescents and Young Adults With HIV-1 Infection cine, St. Louis, MO
Dr. Amrita Khokhar, MD, Department of Medicine, Hofstra North 751 Assessing Quality Of Life In Patients With AERD After Aspirin
Shore-LIJ School of Medicine, Dr. Robert Sporter, MD, Division of Desensitization
Allergy/Immunology, Departments of Medicine and Pediatrics, Dr. Melissa Iammatteo, MD1, Dr. Autumn Chandler Guyer, MD2,
Hofstra North Shore-LIJ School of Medicine, Kathryn Kilkenny, Dr. Rebecca Saff, MD, PhD3, Dr. Eric Holbrook, MD4, Dr. Stacey
Division of Allergy/Immunology, Departments of Medicine and Pe- Gray, MD4, Dr. Aidan Long, MD, FAAAAI5 and Dr. Aleena Bane-
diatrics, Hofstra North Shore-LIJ School of Medicine and Dr. David rji, MD5, 1Massachusetts General Hospital, Boston, MA, 2Massa-
Rosenthal, DO, Division of Allergy/Immunology, Departments of chusetts General Hospital, Harvard Medical School, Boston, MA,
3
Medicine and Pediatrics, Hofstra North Shore-LIJ School of Med- Allergy and Clinical Immunology, Massachusetts General Hospi-
icine, Great Neck, NY tal, Boston, MA, 4Massachusetts Eye and Ear Infirmary, Boston,
133
AB344 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
MA, 5Division of Rheumatology, Allergy, and Immunology, De- AZ, Dr. David W. Hauswirth, MD, FAAAAI, Nationwide Chil-
partment of Medicine, Massachusetts General Hospital, Harvard drens Hospital, Columbus, OH, Dr. Christopher W. Calabria,
Medical School, Boston, MA MD, Dilley Allergy and Asthma Specialists, San Antonio, TX,
752 Published Findings On Dust Allergens May Be Inaccurate Due Dr. Lawrence D. Sher, MD, FAAAAI, Peninsula Research Associ-
To Improper Handling Of Values Below The Lower Limit Of ates, Rolling Hills Estates, CA and Dr. Desiree E.S. Larenas Linne-
Detection mann, MD, FAAAAI, Hospital Medica Sur, Mexico D.F., Mexico
Henry Lynn, Mr. Agustin Calatroni, MA MS, Katy Jaffee, MS, Re- 760 Venom Immunotherapy Use With Contraindicated Medication:
becca A. Zabel and Samuel J. Arbes Jr., Rho, Inc., Chapel Hill, NC A Survey Of AAAAI Members Experience
753 Patient-Reported Factors That Influence Diphenhydramine Use Dr. David W. Hauswirth, MD, FAAAAI, Buckeye Allergy, Co-
In Children and Adults In An Allergy Specialty Practice lumbus, OH; Nationwide Childrens Hospital, Columbus, OH, Dr.
Dr. Prakash Navaratnam1, Dr. Robert Anolik, MD, FAAAAI2, Dr. Matthew A. Rank, MD, FAAAAI, Mayo Clinic, Scottsdale, AZ,
Howard Friedman, MS, PhD1 and Dr. Eduardo Urdaneta, MD3, Dr. Desiree E.S. Larenas Linnemann, MD, FAAAAI, Hospital
1
DataMed Solutions LLC, New York, NY, 2Allergy and Asthma Medica Sur, Mexico D.F., Mexico, Dr. Lawrence D. Sher, MD,
Specialists, PC, Blue Bell, PA, 3McNeil Consumer Healthcare, FAAAAI, Peninsula Research Associates, Rolling Hills Estates,
Fort Washington, PA CA and Dr. Christopher W. Calabria, MD, Dilley Allergy and
Asthma Specialists, San Antonio, TX
761 Simultaneous Measurement Of Multiple Proteins In Blattella
Germanica Extract Using Antibody-Based Multiplex Assay
Dr. Taruna Khurana, PhD1, Ms. Maggie Collison1 and Dr. Jay E.
Allergen Extracts and Immunotherapy Slater, MD2, 1CBER FDA, 2FDA/CBER/OVRR/DBPAP, Rockville,
MD
4210 762 Characterization and Protein Composition Of Food Allergen
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM Extracts
754 The Efficacy and Safety Of The Short Ragweed Sublingual Im- Dr. Greg A. Plunkett, PhD and Dr. Tricia Moore, PhD, ALK-
munotherapy Tablet MK-3641 Is Similar In Asthmatic and Abello, Inc, Round Rock, TX
Nonasthmatic Subjects Treated For Allergic Rhinitis With/ 763 Stability and Compatibility Of Cat, Dog, Dust Mite, and Cock-
Without Conjunctivitis (AR/C) roach Extracts In Indoor Allergen Mixtures and Dilutions For
Dr. Jennifer Maloney, MD1, Dr. David I. Bernstein, MD, FAAAAI2, Immunotherapy
Dr. Jacques Hebert, MD3, Dr. Martha White, MD4, Dr. Robert Fisher, Dr. Silvia Huebner, MD1, Dr. Satyen Manilal Gada, MD2, Dawn
MD5, Dr. Thomas B. Casale, MD, FAAAAI6, Dr. Amarjot Kaur, Hall, BS3 and Dr. Thomas Grier, MD3, 1Evans Army Community
PhD1 and Dr. Hendrik Nolte, MD, PhD1, 1Merck, Whitehouse Sta- Hospital, Fort Carson, CO, 2Walter Reed National Military Medical
tion, NJ, 2Bernstein Allergy Group, Cincinnati, OH, 3Centre de Re- Center, Bethesda, MD, 3Greer Labs
cherche Appliquee en Allergie de Quebec, Quebec City, QC, 764 Interest Of Mass Spectrometry-Based Quantification Of Rele-
Canada, 4Institute for Asthma & Allergy, Wheaton, MD, 5Allergy vant Allergens To Improve The Standardization Of Allergen
Research & Care, Milwaukee, WI, 6Univeristy Of South Florida Extracts
MONDAY
Morsani College Of Medicine, Tampa, FL Thierry Batard, PhD1, Emmanuel Nony2, Christel Dayang, PhD2,
755 Compliance With Guidelines In The Use Of Allergen Immuno- Julien Bouley, PhD2, Maxime Le Mignon, PhD2, Christelle Ber-
therapy rouet2, Aurelie Lautrette, PhD2, Marie Naveau, PhD2, Henri Cha-
Dr. Pudupakkam K Vedanthan, MD1, Ms. Christina Cutter, MSc, bre, PhD2 and Dr. Philippe Moingeon, PhD3, 1Stallergenes,
BA2, Ms. Phuong Dinh, BS2 and Mr. Peter DeWitt, MS2, 1Univer- Antony, France, 2Stallergenes, France, 3Stallergenes SA, Antony,
sity of Colorado, Lakewood, CO, 2University of Colorado - An- France
schutz Medical Campus, Aurora, CO
756 Efficacy Of Short Ragweed Sublingual Immunotherapy Tablet
(SLIT-T) In Mono-Sensitized and Poly-Sensitized Subjects
Dr. David I. Bernstein, MD, FAAAAI1, Kevin R. Murphy, MD2, Outcome Measures and Challenge Testing with
Dr. Hendrik Nolte, MD, PhD3, Dr. Amarjot Kaur, PhD3 and Dr. Jen-
nifer Maloney, MD3, 1Bernstein Allergy Group, Cincinnati, OH,
Immunotherapy
2
Boys Town National Research Hospital, Boys Town, NE, 3Merck,
Whitehouse Station, NJ 4211
757 Trends In Prescribing Of Specific Immunotherapy For Grass Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
Pollen Allergy In Germany: 2005-2012 765 Baseline Predictors Of Symptom Severity Following Exposure
Prof. Ulrich Wahn, Prof Dr Med1, Amanda McDonnell2, Catrina To House Dust Mite In An Antigen Challenge Chamber (ACC)
Richards2, Dr. Felicia C. Allen-Ramey, PhD3, Mr. Jakob N. Andrea- Daniel Ramirez, MD1, Robert L. Jacobs, MD1, Cynthia Rather,
sen4, Charles Hawes2 and Dirk Demuth2, 1Charite, Berlin, Ger- CCRC1, Andrew Carrillo, BS2,3, Weijing He, MD2,3, Nathan
many, 2IMSHealth, United Kingdom, 3Merck & Co, Inc, West Harper, BS2,3, Charles Andrews, MD1 and Sunil K. Ahuja,
Point, PA, 4ALK, Denmark MD2,3, 1Biogenics Research Chamber, San Antonio, TX, 2Depart-
758 Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In The ment of Medicine, University of Texas Health Science Center,
Treatment Of Rhinitis Symptoms In Patients With Grass Pol- San Antonio, TX, 3Veterans Administration Center for Personalized
len-Induced Allergic Rhinoconjunctivitis Medicine, South Texas Veterans Health Care System, San Antonio,
Prof. Claus Bachert, MD, PhD1, Prof. Alain Didier, MD, PhD2, TX
Ms. Laurence Ambroisine, Msc3, Dr. Kathy Abiteboul, PharmD3 766 Validation Of Biogenics Research Chamber For Elicitation Of
and Dr. Robert K. Zeldin, MD3, 1Universitair Ziekenhuis Gent, Symptoms To Dust Mite Antigen (Der p1)
Ghent, Belgium, 2Larrey Hospital, CHU, Toulouse, France, 3Stal- Robert L. Jacobs, MD1, Cynthia Rather, CCRC1, Fabio Jimenez,
lergenes S.A., Antony, France BS2,3, Hernan Martinez, MD2,3, Weijing He, MD2,3, Daniel Ram-
759 Allergen Immunotherapy Safety While Using High Risk irez, MD1, Charles Andrews, MD1 and Sunil K. Ahuja, MD2,3, 1Bi-
Medication: A Survey Of AAAAI Members ogenics Research Chamber, San Antonio, TX, 2Department of
Dr. Matthew A. Rank, MD, FAAAAI, Mayo Clinic, Scottsdale, Medicine, University of Texas Health Science Center, San Antonio,
134
J ALLERGY CLIN IMMUNOL Abstracts AB345
VOLUME 133, NUMBER 2
TX, 3Veterans Administration Center for Personalized Medicine, Tcheurekdjian, MD, FAAAAI4, 1University Hospitals, South Eu-
South Texas Veterans Health Care System, San Antonio, TX clid, OH, 2Rainbow Babies and Childrens Hospital, Cleveland,
767 Magnitude Of Changes In Patient Symptom and Medication OH, 3Case Western Reserve University School of Medicine,
Scores In Grass Allergy Immunotherapy Trials: Dependency Cleveland, OH, 4Allergy/Immunology Associates, Inc., South Eu-
On Levels Of Pollen Exposure clid, OH
Dr. Hendrik Nolte, MD, PhD1, Prof. Stephen R. Durham, MA
MD FRCP2, Dr. Harold S. Nelson, MD, FAAAAI3, Dr. David
I. Bernstein, MD, FAAAAI4, Dr. Peter S. Creticos, MD,
FAAAAI5, Dr. Ziliang Li, PhD1 and Dr. Jens Andersen, PhD6, Mechanistic Insight into Pollens and Other
1
Merck, Whitehouse Station, NJ, 2Imperial College London, Lon-
don, United Kingdom, 3National Jewish Health, Denver, CO,
Antigens
4
Bernstein Allergy Group, Cincinnati, OH, 5Johns Hopkins Divi-
sion of Allergy & Clinical Immunology, 6ALK-Abello, 4212
Hrsholm, Denmark Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
768 Evaluation Of Acoustic Rhinometry In Histamine Nasal Provo- 775 Protease Inhibitor Reduces Airway Response and Inflammation
cation Test In Children and Adolescents In Mouse Model Of Cockroach Allergy
Dr. Fausto Y. Matsumoto, Federal University of S~ao Paulo, S~ao Mr. Sanjay Saw, M.Sc. and Dr. Naveen Arora, Ph.D, CSIR Insti-
Paulo, Brazil, Dr. Gustavo Wandalsen, MD, UNIFESP, Sao Paulo, tute of Genomics and Integrative Biology, New Delhi, India
Brazil, Dr. Aline Mendes, Federal University of S~ao Paulo, Brazil. 776 Aryl Hydrocarbon Receptor (AhR) Modulates Cockroach Al-
and Prof. Dirceu Sole, MD, PhD, Federal University of Sao Paulo, lergen Induced TGF Beta 1 Secretion In Fibroblasts
Sao Paulo, Brazil Sarah Mirza1,2, Yufeng Zhou, MD, PhD1, Priya Tripathi, PhD1,
769 EQ-5D Health Utility Values In The Treatment Of Seasonal Liang Yuan1, Beverly Plunkett, MS1, Allen Myers, Ph.D1 and Pei-
Grass Pollen Induced Rhinoconjunctivitis song Gao, MD, PhD1, 1Division of Allergy & Clinical Immunology,
Mr. Jakob N. Andreasen1, Dr. Chris Poole2, Dr. Christian Bannis- Johns Hopkins University School of Medicine, Baltimore, MD,
ter3, Dr. Jens Andersen, PhD4 and Mr. Niels Serup-Hansen1, 1ALK, 2
Sher-I-Kashmir Institute of Medical Sciences, Jammu and Kash-
Denmark, 2Cardiff University, Cardiff, Wales, 3Cardiff University, mir, India
4
ALK-Abell o, Hrsholm, Denmark 777 Effect Of Peanut Allergens On Intestinal Barrier Permeability
770 Ex-Vivo Allergen Stimulation In Whole Blood: A Novel Ap- and Tight Junction Localisation In Caco-2 Cell Cultures
proach For Evaluating Mechanisms Of Action Of Synthetic Prof. Cenk Suphioglu, PhD1, Ms. Dwan Price, BSc Hons1, Prof.
Peptide Immuno-Regulatory Epitopes Leigh Ackland, PhD2, A. Wesley Burks, MD, FAAAAI3 and Dr.
Dr. Pascal LC Hickey, BPharm PhD1, Dr. Mark Larche, PhD2, Dr. Matthew Knight, PhD4, 1Deakin University, Australia, 2Deakin
Rod Hafner, PhD3, Ms. Kristen Armstrong, M.Sc.4, Ms. Eileen Lee, Universisty, Australia, 3University of North Carolina, Chapel Hill,
BA (Hons)5, Dr. Elaine Lee, PhD5 and Dr. Stephen A. Kilfeather, NC, 4Department of Primary Industries, Australia
PhD5, 1Adiga Life Sciences, Hamilton, Canada, 2McMaster Univer- 778 Synergistic Effect Of Dermatophagoides Pteronyssinus Aller-
sity, Hamilton, ON, Canada, 3Circassia Ltd, Oxford, United King- gens and Dexamethasone On Expression Of CD163 By Periph-
dom, 4Adiga Life Sciences Inc., Hamilton, ON, Canada, 5Aeirtec
MONDAY
eral Blood Mononuclear Cells Of Allergic Asthma Patients
Limited, Newcastle upon Tyne, United Kingdom Prof. Krzysztof Kowal, MD, PhD1, Pawel Bernatowicz, MD,
771 Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In Grass PhD2, Prof. Lech Chyczewski, MD, PhD2 and Prof. Anna Bod-
Pollen-Induced Allergic Rhinoconjunctivitis: Pooled Analysis zenta-Lukaszyk, MD, PhD3, 1Medical University of Bialystok, Bia-
By Age lystok, Poland, 2Medical University of Bialystok, 3Medical
Dr. Robert K. Zeldin, MD1, Prof. Ulrich Wahn, Prof Dr Med2, University of Bialystok, Poland
Prof. Alain Didier, MD, PhD3, Mrs. Armelle Montagut1 and Dr. 779 IgE Antibodies and FceRI Are Critical For Acquired Resistance
Marie-Pierre Furrer, PhD1, 1Stallergenes S.A., Antony, France, Against Honeybee Venom In Mice
2
Charite, Berlin, Germany, 3Larrey Hospital, CHU, Toulouse, Dr. Philipp Starkl, PhD1, Dr. Thomas Marichal, DVM PhD1, Dr.
France Laurent L. Reber, PhD1, Dr. Janet Kalesnikoff, PhD1, Dr. Hans C.
772 Characterization Of Allergic Rhinitis Symptomotology Induced Oettgen, MD, PhD, FAAAAI2, Dr. Martin Metz, MD, PhD3 and
By a Nasal Allergen Challenge (NAC) Titration In a Dust Mite Dr. Stephen J. Galli, MD1, 1Stanford University School of Medi-
Sensitize Population cine, Stanford, CA, 2Boston Childrens Hospital, Boston, MA,
Mr. Paul Gomes1, Endri Angjeli2, Mr. Keith Lane2 and Dr. Paul H. 3
Charite Campus Mitte, Berlin, Germany
Ratner, MD, FAAAAI3, 1ORA. Inc, Andover, MA, 2Ora, Inc, And- 780 Ragweed Pollen Proteins Bind TLR4/MD2, and Rapidly Re-
over, MA, 3Sylvana Research, San Antonio, TX cruit MyD88 and TRAF6 To The Signaling Complex
773 Atopic and Non-Atopic Individuals Manifest Partly Concordant Dr. Qian Sun, PhD, Dr. Koa Hosoki, MD, PhD, Dr. Leopoldo
Clinical and Leukocyte Responses Following Exposure To Aguilera-Aguirre, PhD, Prof. Istvan Boldogh, PhD and Prof. Sanjiv
House Dust Mite In An Antigen Challenge Chamber (ACC) Sur, MD, University of Texas Medical Branch, Galveston, TX
Weijing He, MD1,2, Nathan Harper, BS1,2, Andrew Carrillo, 781 Sensitization To Silkworm Moth (Bombyx mori) Allergen In
BS1,2, Charles Andrews, MD3, Cynthia Rather, CCRC3, Daniel Patients With Respiratory Allergy
Ramirez, MD3, Robert L. Jacobs, MD3 and Sunil K. Ahuja, Mrs. Laura ML Araujo, Federal University of Parana, Brazil and
MD1,2, 1Department of Medicine, University of Texas Health Sci- Prof. Nelson A. Rosario, MD, PhD, FAAAAI, Federal University of
ence Center, San Antonio, TX, 2Veterans Administration Center Parana, Curitiba, Brazil
for Personalized Medicine, South Texas Veterans Health Care Sys- 782 Balsam Of Peru, a Common Contact Dermatitis Allergen, Is a
tem, San Antonio, TX, 3Biogenics Research Chamber, San Anto- CD1a Antigen
nio, TX Sarah Nicolai, MD1,2, Tan-Yun Cheng, PhD1,2, Elvire A. Bour-
774 The Effects Of Pollen Season On Reactions To Subcutaneous geois, PhD1,2, Annemieke de Jong, PhD3 and D. Branch Moody,
Immunotherapy MD1,2, 1Brigham and Womens Hospital, Division of Rheumatol-
Dr. Devi Jhaveri, DO1, Dr. Julie Abraham, M.D.2, Megan Betteley, ogy, Immunology and Allergy, Boston, MA, 2Harvard Medical
B.S.3, Dr. Mary Ann ORiordan, PhD2, Dr. Theodore H. Sher, MD, School, Boston, MA, 3Columbia University Medical Center, De-
FAAAAI4, Dr. Robert W. Hostoffer, DO4 and Dr. Haig partment of Dermatology, New York, NY
135
AB346 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
783 Cellular Infiltrate Induced By Bites From The Tick Ambly- Andrew M. Smith, MD, FAAAAI8, Dr. Peter Lenz9 and Dr. Tolly
omma Americanum In Subjects With Or Without IgE To Ga- Epstein, MD, MS10, 1University of Cincinnati Medical Center, Cin-
lactose-Alpha-1,3-Galactose (Alpha-gal) cinnati, OH, 2Bernstein Allergy Group, Cincinnati, OH, 3Bernstein
Dr. Nikhila Schroeder, MD1, Mr. Jake Eccles2, Erin J. Klaffky, Clinical Research Center, LLC, Cincinnati, OH, 4Cincinnati Chil-
MD, PhD1 and Thomas A.E. Platts-Mills, MD, PhD, FAAAAI1, drens Hospital Medical Center, Cincinnati, OH, 5Division of Im-
1
Division of Asthma, Allergy & Immunology, University of Vir- munology Allergy & Rheumatology, University of Cincinnati
ginia Health System, 2University of Virginia School of Medicine Medical Center, Cincinnati, OH, 6University of Cincinnati, 7Uni-
784 Duox2 and Mitochondria-Induced Antiviral Innate Immune versity of Cincinnati, Cincinnati, OH, 83255 Eden Ave., HPB
Response After Influenza A Virus Infection In Human Nasal 350, University of Cincinnati Medical Center, Cincinnati, OH,
9
Epithelium The University of Cincinnati Medical Center, 10Allergy Partners
Prof. Hyun Jik Kim1,2, Prof. Chang-Hoon Kim3,4, Dr. Sung-Shik of Central Indiana, Indianapolis, IN
Kim5 and Prof. Joo-Heon Yoon3,6, 1Chung-Ang University College 791 Texting Medication Reminders For Better Asthma Control In
of Medicine, Seoul, South Korea, 2Airway Mucus Institute, Seoul, Children and Teens
South Korea, 3Department of Otorhinolaryngology, Yonsei Univer- Dr. Humaa M. Bhatti, DO1, Ms. Wafa Alame, RN1, Mr. Joseph
sity College of Medicine, Seoul, South Korea, 4The Airway Mucus Adams2, Dr. Jenny M. Montejo, MD1, Dr. Milind V. Pansare,
Institute, Yonsei University College of Medicine, Seoul, South Ko- MD, FAAAAI1, Dr. Pavadee Poowuttikul, MD1 and Dr. Elizabeth
rea, 5Koenko Nose Infirmary, Seongnam, South Korea, 6Research A. Secord, MD, FAAAAI2, 1Childrens Hospital of Michigan, De-
Center for Human Natural Defense System, Yonsei University Col- troit, MI, 2Wayne State University, Detroit, MI
lege of Medicine, Seoul, South Korea 792 Adherence To Prescribed Controller Therapy and Effects On
785 Persistent Endothelial Damage After Intravenous Immunoglob- Asthma Control In The Hispanic Population Of a Pediatric Dis-
ulin Therapy In Kawasaki Disease ease Management Program
Dr. Yoshihiko Sakurai1,2, Dr. Hideo Takatsuka1, Dr. Mutsuzo Ta- Dr. Lyne G. Scott, MD1, Tricia Morphew2, Marilyn Li1 and Dr.
kada1 and Dr. Masato Nishino1, 1Nara Prefectural Mimuro Hospital, Salima A. Thobani, MD1, 1University of Southern California,
Sango, Japan, 2Matsubara Tokushukai Hospital, Matsubara, Japan 2
Morphew Consulting, LLC, CA
786 Prevalence Of Toxocariasis In General Population Based On 793 Correlation Between Emergency Department Visits For
Serologic Test Asthma Exacerbation and No Show Visits To Primary Care
Prof. Byung-Jae Lee, MD1, Dr. Jin-Young Lee, MD1, Dr. Mi-Jung Provider In a Pediatric Population
Oh, MD2 and Prof. Dong-Chull Choi, MD1, 1Samsung Medical Dr. Margaret Redmond, M.D. and David R. Stukus, MD,
Center, 2Bundang Jesaeng General Hospital FAAAAI, Nationwide Childrens Hospital, Columbus, OH
787 Vitamin D Levels and Sensitization To Indoor Inhalant Aller- 794 Choosing Wisely: Adherence By Allergists To Recommended
gens In Korea Use Of Spirometry In The Diagnosis and Management Of Adult
Dr. Kyung-Hwan Lim1,2, Dr. Min-Gyu Kang1,2, Dr. Han-Ki Park1, Asthma
Prof. So-Hee Lee1, Prof. Min-Suk Yang1,3, Prof. Woo-Jung Song, Dr. Kristin C. Sokol, MD, MPH, Dr. Gregg Wilkinson, PhD, Ms.
M.D.1, Prof. Hye-Ryun Kang1, Prof. Heung-Woo Park, MD, Karen Pierson, MA and Dr. Randall M. Goldblum, MD, University
PhD1, Prof. Sun-Sin Kim1, Prof. Yoon-Seok Chang1,2, Prof. Sang of Texas Medical Branch, Galveston, TX
MONDAY
Heon Cho, MD, PhD1, Prof. Kyung-Up Min, MD, PhD1 and Prof.
Sae-Hoon Kim1,2, 1Department of Internal Medicine, Seoul Na-
tional University College of Medicine, Seoul, South Korea, 2De-
partment of Internal Medicine, Seoul National University
Bundang Hospital, Seongnam, South Korea, 3SMG-SNU Boramae Bone Marrow Transplantation in Primary
Medical Center, Seoul, South Korea
788 Measuring Vascular Leak During Respiratory Viral Infections
Immunodeficiencies
Dr. Brian T. Kelly, MD, Mrs. Desire Hunter and Dr. Mitchell H. Gray-
son, MD, FAAAAI, Medical College of Wisconsin, Milwaukee, WI 4602
789 Effects Of Rhinovirus (RV) 39 Infection On Airway Hyper-Re- Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
activity (AHR) To Histamine and Carbachol In Human Airways 795 G Protein-Coupled Receptor Kinase-3 (GRK-3) In Bone Mar-
Joshua L. Kennedy, MD1, Stacie M. Jones, MD1,2, Ms. Megan row Niche Interactions and Transplantation
Kurten1,3, Ms. Suzanne House1,3 and Richard Kurten, PhD1,3, 1Ar- Jaime M. Brozowski1,2, Roman Timoshchenko2, Jessica Koontz3,
kansas Childrens Hospital Research Institute, Little Rock, AR, Janet Rubin3,4, Matthew Billard2 and Teresa K. Tarrant2,3, 1Depart-
2
University of Arkansas for Medical Sciences and Arkansas Chil- ment of Microbiology and Immunology, University of North Caro-
drens Hospital, Little Rock, AR, 3University of Arkansas for Med- lina School of Medicine, Chapel Hill, NC 27599, USA, 2Thurston
ical Sciences, Little Rock, AR Arthritis Research Center and Department of Medicine, Division
of Rheumatology, Allergy, and Immunology, University of North
Carolina, Chapel Hill, NC 27599, USA, 3School of Medicine, Uni-
versity of North Carolina, Chapel Hill, NC 27599, USA, 4Pediatrics
and Pharmacology and Department of Medicine, Division of Endo-
Adherence crinology and Metabolism, University of North Carolina, Chapel
Hill, NC 27599, USA
4601 796 Allogeneic Hematopoietic Stem Cell Transplantation For Im-
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM mune Dysregulation, Polyendocrinopathy, X-Linked (IPEX)
790 Poor Asthma Control In Older Adults Is Associated With Re- Syndrome Resolves Enteropathy and Autoimmunity: A Single
duced Adherence To Controller Therapies and Inability To Af- Institution Experience
ford Medications Dr. Zeynep Yesim Yesim Kucuk, MD, Dr. Jack J.H. Bleesing,
Dr. Jessica Tan, MD, MPH1, Dr. David I. Bernstein, MD, MD, PhD, Dr. Rebecca A. Marsh, MD, Dr. Kejian Zhang, MD,
FAAAAI2, Ms. Cheryl Koff Bernstein, RN BSN CCRC3, Dr. Pat- Dr. Stella Davies, MBBS, PhD and Dr. Alexandra H. Filipovich,
rick Ryan, PhD4, Dr. Jonathan A. Bernstein, MD, FAAAAI5, Ms. MD, Cincinnati Childrens Hospital Medical Center,
Banu Kesavalu6, Dr. Manuel S. Villareal, MD, FAAAAI1,7, Dr. Cincinnati, OH
136
J ALLERGY CLIN IMMUNOL Abstracts AB347
VOLUME 133, NUMBER 2
797 Natural Killer Cell Immunoglobulin Like Receptor (KIR) Ge- FAAAAI3, 1Department of Pediatric Allergy and Immunology,
netic Profile Is a Strong Predictor Of Allogeneic Hematopoietic Stanford University, Stanford, CA, 2Division of Laboratory Sci-
Cell Transplant Outcomes ences, National Center for Environmental Health, Centers for Dis-
Dr. Rehan M. Faridi, PhD1, Taylor Kemp1, Dr. Poonam Dhar- ease Control and Prevention, Atlanta, GA, 3Pediatric Allergy
mani, PhD1, Dr. Victor Lewis, MD2, Dr. Noureddine Berka, Immunology, Stanford University, Stanford, CA
PhD3, Dr. Jan Storek, MD, PhD1 and Dr. Faisal Khan, PhD1, 1Uni- 802 Impact Of BMI On Ozone-Induced IL-1b In The Airways Of
versity of Calgary, Calgary, AB, Canada, 2Alberta Childrens Hos- Human Volunteers
pital, Calgary, AB, Canada, 3Calgary Laboratory Services, Calgary, Dr. Michelle L. Hernandez, MD1, Dr. Krista Todoric, MD1, Ms.
AB, Canada Katherine Mills, BA2, Dr. Haibo Zhou, PhD3 and Dr. David B. Pe-
798 Transient Lymphopenia Of Infancy: A Previously Unrecognized den, MD, MS, FAAAAI4, 1University of North Carolina at Chapel
Entity Hill School of Medicine, Chapel Hill, NC, 2University of North
Dr. Robert Sporter, MD, Division of Allergy/Immunology, De- Carolina Chapel Hill School of Medicine, Chapel Hill, NC, 3Uni-
partments of Medicine and Pediatrics, Hofstra North Shore-LIJ versity of North Carolina at Chapel Hill, School of Public Health,
4
School of Medicine, Dr. Catherine Capo, MD, Department of Med- Office #544, Campus Box 7310, University of North Carolina at
icine, Hofstra North Shore-LIJ School of Medicine, Manhasset, NY Chapel Hill School Medicine, NC
and Dr. Vincent R. Bonagura, MD, FAAAAI, Division of Allergy/ 803 Group-2 Innate Lymphoid Cells Promote Air-Pollutant Induced
Immunology, Departments of Medicine and Pediatrics, Hofstra Airway Inflammation and Hyperresponsiveness (AHR)
North Shore-LIJ School of Medicine, Great Neck, NY Dr. Qi Yang, PhD, Moyar Q. Ge, Blerina Kokalari, Imre G Redai,
Xinxin Wang, Dr. Avinash Bhandoola, MBBS PhD and Dr. Angela
Haczku, MD, PhD, FAAAAI, University of Pennsylvania, Philadel-
phia, PA
Air Pollution/Allergens/Air Quality
4603
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM Food Allergy
799 Associations Among Volatile Organic Compounds, Allergic Sen-
sitization, and Respiratory Illness In Children With Asthma 4604
Enrolled In a Study Of Low-Income, Green Eco-Friendly Hous- Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
ing (The Green Housing Study) 804 Peanut T Cell Epitope Discovery: Ara h1 and Ara h3
Dr. Joy Hsu, MD, MSCI1, Sandra Chaves, MD, MSc2, Marika Dr. Manish Ramesh, MD, PhD1, Madhan Masilamani, PhD2, Dr.
Iwane, PhD, MPH2, Yang Qiu, ScM3, Christopher Schaffer, BS4, George N. Konstantinou, MD, PhD, MSc3,4, Jay A. Lieberman,
Marty Alvarez-Reeves, MS3, Prof. Tiina Reponen, PhD4, Dr. MD5, Hugh A. Sampson, MD, FAAAAI6, Dr. Madhundra Sivaku-
Gary Adamkiewicz, PhD3, Dr. Patrick Ryan, PhD5, Doug Brugge, mar1, Dr. Araya Yuenyongviwat, MD7 and Dr. Mariona Pascal,
PhD6, David Turcotte, ScD7, Fuyuen Yip, PhD, MPH8, Kanta Sir- PhD8, 1Mount Sinai School of Medicine, New York, NY, 2Icahn
MONDAY
car, PhD, MPH8, Benjamin Blount, PhD9, K. Udeni Alwis, PhD9, School of Medicine at Mount Sinai, New York, NY, 3424 General
Connie Sosnoff, MA9, Peter Ashley, DrPH10, Curtis Hedman, Military Training Hospital, Thessaloniki, Greece, 4First Pediatric
PhD11, Steve Strebel, BS11, Behrooz Behbod, MBChB, MSc, Department, Aristotle University of Thessaloniki, Hippokration
ScD1, Matthew Lozier, PhD, MPH1 and Dr. Ginger L. Chew, General Hospital, Thessaloniki, Greece, 5University of Tennessee,
ScD, MSPH8, 1Epidemic Intelligence Service, Centers for Disease Memphis, TN, 6Pediatrics, Icahn School of Medicine at Mount Si-
Control and Prevention, Atlanta, GA, 2National Center for Immuni- nai, New York, NY, 7Prince of Songkla University, Songkhla, Thai-
zation and Respiratory Diseases, Centers for Disease Control and land, 8Servei dImmunologia, Centre de Diagnostic Biomedic.
Prevention, Atlanta, GA, 3Harvard School of Public Health, Boston, Hospital Clinic., Barcelona, Spain
MA, 4University of Cincinnati, Cincinnati, OH, 5Cincinnati Chil- 805 Microparticles Encapsulated With Antigen Protect Against
drens Hospital Medical Center, Cincinnati, OH, 6Tufts University Sensitization and Reduce Anaphylactic Reactivity In a Food Al-
Health Sciences, Boston, MA, 7Center for Family, Work and Com- lergy Model
munity, University of Massachusetts Lowell, Lowell, MA, 8Air Pol- Dr. Karen B. Chien, PhD, Northwestern University, Chicago, IL
lution and Respiratory Health Branch, Division of Environmental and Dr. Paul Bryce, PhD, Division of Allergy-Immunology, Depart-
Hazards and Health Effects, National Center for Environmental ment of Medicine, Feinberg School of Medicine, Northwestern
Health, Centers for Disease Control and Prevention, Atlanta, GA, University, Chicago, IL
9
Division of Laboratory Sciences, National Center for Environmen- 806 Over-The-Counter Dietary Supplements Genistein and Iprifla-
tal Health, Centers for Disease Control and Prevention, Atlanta, vone Suppress Peanut Allergy Symptoms
GA, 10Office of Healthy Homes and Lead Hazard Control, U.S. De- Ms. Lisa Chang, BS1, Ms. Mohanapriya Kamalakannan, MS1, Mr.
partment of Housing and Urban Development, Washington, DC, Matthew Stadler1, Hugh A. Sampson, MD, FAAAAI2 and Madhan
11
Wisconsin State Lab of Hygiene, Madison, WI Masilamani, PhD1, 1Icahn School of Medicine at Mount Sinai, New
800 A Systematic Analysis Of Pollen Transcriptomes From Plant York, NY, 2Pediatrics, Icahn School of Medicine at Mount Sinai,
Allergens Reveals Conserved Targets Of Immune Responses New York, NY
Dr. Bjoern Peters1, Dr. Jason Greenbaum1, Dr. Veronique M. 807 Analyzing Casein-Specific IL-4 and IL-13 Secreting T-Cells: A
Schulten1, Dr. Denise Baker1, Dr. April Frazier1, Dr. Alessandro Reliable Tool For Diagnosis Of Cows Milk Allergy
Sette, Dr. Biol. Sci.1, Dr. Michael Wallner 2 and Mrs. Heidi Hofer2, Dr. Benedicte Michaud, MD, PhD1,2, Dr. Joseph Aroulandom,
1
La Jolla Institute for Allergy and Immunology, La Jolla, CA, 2Uni- MD3, Mrs. Nour Baz, PhD4, Dr. Flore Amat, MD3, Dr. Rahele
versity of Salzburg, Salzburg, Austria Gouvis-Echraghi, MD3, Dr. Sophie Candon, MD, PhD1,2, Mr.
801 Urinary Polycyclic Aromatic Hydrocarbon Metabolites and Remy Couderc, PhD PharmaD5, Prof. Jean-Francois Bach, MD,
Th2 Immunity In Children PhD1,2, Prof. Lucienne Chatenoud, MD, PhD1,2 and Prof. Jocelyne
Kinjal M. Hew, PhD1, Annett I. Walker, MD1, Arunima Kohli1, Just, MD, PhD3,4, 1Universite Paris Descartes, Sorbonne Paris Cite,
Aleena Syed1, Cameron McDonald-Hyman1, Zheng Li, PhD, France, 2Institut national de la sante et de la recherche medicale,
MPH2, Andreas Sjodin, PhD2 and Dr. Kari C. Nadeau, MD, PhD, Unite U1013, Paris, France, 3Allergology department, Trousseau
137
AB348 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
hospital AP-HPUPMC Paris 6, France, 4EPidemiology of Allergic and Dr. Anju T. Peters, MD, FAAAAI1, 1Department of Medicine,
and Respiratory diseases (EPAR) Department, UMR-S 707 IN- Division of Allergy-Immunology, Northwestern University Fein-
SERM, UPMC Paris 6, France, 5Service de Biochimie et Biologie berg School of Medicine, Chicago, IL, 2University of Chicago,
Moleculaire, Trousseau hospital AP-HP, Paris, France IL, 3Department of Medicine, Northwestern University Feinberg
808 Growth Of Children Aged 2-17 With Cows Milk, Peanut, and School of Medicine, 4Northwestern University, Chicago, IL, 5De-
Egg Allergy In NHANES partment of Otolaryngology, Northwestern University Feinberg
Dr. Karen Robbins, MD1, Robert A. Wood, MD, FAAAAI2 School of Medicine, Chicago, IL, 6Division of Allergy-Immunol-
and Corinne Keet, MD, MS2, 1Johns Hopkins University ogy, Department of Medicine, Northwestern University Feinberg
School of Medicine, 2Johns Hopkins University Medical Center, School of Medicine, Chicago, IL
Baltimore, MD 815 Meta-Analysis Of Gene Expression Microarrays Reveals Novel
Biomarkers Consistent With Altered Functionality Of Mucosal
Barrier In Patients With Chronic Rhinosinusitis
Epidemiology Dr. Sergejs Berdnikovs, PhD1, Dr. Atsushi Kato, PhD2, Mr. James
Norton, MS2, Ms. Lydia Suh, BSc2, Dr. Robert C. Kern, MD3, Dr.
4605 David Conley, MD3, Dr. Rakesh Chandra, MD4, Dr. Anju T. Peters,
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM MD, FAAAAI2, Dr. Leslie C. Grammer, MD, FAAAAI2, Ms.
Kathleen E. Harris, BSc2, Dr. Michael Platt, MD5, Dr. Ralph Met-
809 Allergic Causes Of Death In The United States son, MD6 and Dr. Robert P. Schleimer, PhD FAAAAI7, 1Division of
Dr. Susan J. Kim, MD, Kaiser Permanente Southern California, Allergy-Immunology, Northwestern University Feinberg School of
Los Angeles, CA and Dr. Jordan C. Brooks, PhD, MPH, Life Ex- Medicine, Chicago, IL, 2Department of Medicine, Division of Al-
pectancy Project, San Francisco, CA lergy-Immunology, Northwestern University Feinberg School of
810 Death From Anaphylaxis Is a Reassuringly Unusual Outcome Medicine, Chicago, IL, 3Department of Otolaryngology, Northwest-
Dr. Larry Borish, MD, FAAAAI1, Dr. Theodore Danoff, MD, ern University Feinberg School of Medicine, Chicago, IL, 4North-
PhD2 and Dr. Liyuan (Larry) Ma, PhD2, 1Asthma and Allergic western University, Chicago, IL, 5Department of Otolaryngology,
Diseases Center, Carter Center for Immunology Research, Uni- Boston Medical Center, Boston University, Boston, MA, 6Depart-
versity of Virginia, Charlottesville, VA, 2Endo Pharmaceuticals ment of Otology and Laryngology, Harvard Medical School, Bos-
Inc. ton, MA, 7Division of Allergy-Immunology, Department of
811 Allergic Rhinitis, Asthma and Cardiovascular Disease Medicine, Northwestern University Feinberg School of Medicine,
Dr. Angelina M. Crans Yoon, MD1, Dr. Anne M. Staveren, MD1, Chicago, IL
Dr. Michael S. Kaplan, MD, FAAAAI1, Dr. Javed Sheikh, MD, 816 Evidence For Immunoglobulin D In Patients With Chronic Rhi-
FAAAAI2 and Dr. Bruce J. Goldberg, MD, PhD, FAAAAI1, 1Kaiser nosinusitis
Permanente, Los Angeles, CA, 2Kaiser Permanente Los Angeles Dr. Jin Young Min, MD, PhD1, Dr. Robert C. Kern, MD1, Dr.
Medical Center, Los Angeles, CA Kathryn E. Hulse, PhD2, Dr. Rakesh Chandra, MD2, Dr. David
812 Pre-Natal and Early Life Predictors Of Atopy In Canadian Conley, MD1, Ms. Lydia Suh, BSc3, Mr. Roderick Carter,
Children: Results Of The Family Study BSc3, Mr. James Norton, MS3, Julia H. Huang1, Dr. Atsushi
Tahira Batool, MBBS, FRCPC1, Michael M. Cyr, MD, FRCPC1,
MONDAY
138
J ALLERGY CLIN IMMUNOL Abstracts AB349
VOLUME 133, NUMBER 2
Mechanisms of Asthma and Allergic Disease Cincinnati, OH and Dr. David I. Bernstein, MD, FAAAAI, Bern-
stein Allergy Group, Cincinnati, OH
4607 826 Twins Increased Risk Of Asthma Compared To Singletons Is
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM Mediated By Gestational Age
Vilhelmina Ullemar1, Cecilia Lundholm, MSc1 and Prof. Catarina
819 Allergen Challenge Increases Peripheral Blood CD84+ ILC2 In Almqvist, MD, PhD1,2, 1Department of Medical Epidemiology and
Allergic Rhinitis Biostatistics, Karolinska Institutet, Stockholm, Sweden, 2Depart-
Dr. David R. Scott, M.D.1, Dr. Taylor A. Doherty, MD, FAAAAI2, ment of Womens and Childrens Health, Astrid Lindgren Chil-
Naseem Khorram, M.S.3, Mr. Sean Lund, B.S.3, Ms. Rachel Baum, drens Hospital, Karolinska University Hospital, Stockholm,
B.S.3, Jinny Chang, M.D.4, Mr. Peter Rosenthal, B.S.3, Mr. Andrew Sweden
Beppu, B.S.3, Dr. Marina Miller, MD, PhD3 and Dr. David H. 827 Viral Etiology Of Early Life Wheezing Illnesses Differentially
Broide, MB ChB FAAAAI5, 1Allergy and Asthma Center of West- Predict Persistence Of Asthma In High-Risk Children
ern Colorado, 2Medicine, University of California, San Diego, San Dr. Frederick Rubner, MD1, Dr. Daniel J. Jackson, MD2, Mr. Mi-
Diego, CA, 3University of California San Diego, 4Sansum Clinic, chael D. Evans, MS1, Dr. James E. Gern, MD, FAAAAI1 and Dr.
Santa Barbara, 5Department of Medicine, San Diego, CA Robert F. Lemanske Jr., MD, FAAAAI1, 1University of Wisconsin
820 Asthma Susceptibility Due To Environmental Programming Of School of Medicine and Public Health, Madison, WI, 2Pediatrics,
Innate Immunity In Utero University of Wisconsin School of Medicine and Public Health,
Sarah Manners, BS1, Rafeul Alam, MD, PhD, FAAAAI1, David Madison, WI
A. Schwartz, MD2 and Magdalena M. Gorska, MD, PhD1, 1Na- 828 Prevalence and Severity Of Wheezing In The First Year Of Life
tional Jewish Health, Denver, CO, 2University of Colorado Denver Among Infants With Low Birth Weight
School of Medicine, Aurora, CO Dr. Nathalia Barroso1, Dr. Leila Borges, MD1, Dr. Gustavo Wan-
821 Rhinovirus Challenge Augments Allergen Responsiveness In dalsen, MD2, Dr. Elaine Prestes3, Prof. Herberto J. Chong Neto,
Basophils Of Atopic Asthmatics MD, PhD, FAAAAI4, Prof. Nelson A. Rosario, MD, PhD,
Rachana Agrawal, PhD, Thomas A.E. Platts-Mills, MD, PhD, FAAAAI5, Dr. Ana Carolina Dela Bianca6, Dr. Carolina Aranda7,
FAAAAI, Peter W. Heymann, MD and Judith A. Woodfolk, Dr. Decio Medeiros6, Prof. Emanuel Sarinho, Prof. PHD8, Dr. Lil-
MBChB, PhD, FAAAAI, University of Virginia, Charlottesville, lian SANCHEZ LACERDA Moraes, MD, MSc9, Dr. Javier Mal-
VA lol10 and Prof. Dirceu Sole, MD, PhD7, 1UNIFESP, Brazil,
822 Der p 3 Allergen Activated Ano-1 Channel On Afferent Airway 2
UNIFESP, Sao Paulo, Brazil, 3State University of Para, 4Federal
Nerves Regulates Th2 Cell Responses University of Parana, Brazil, 5Federal University of Parana, Curi-
Mr. Mayur Patil, MS1, Dr. Edward G. Brooks, MD2, Dr. Michael tiba, Brazil, 6Federal University of Pernambuco, 7Federal Univer-
Henry, D.D.S, PhD1 and Dr. Armen Akopian, PhD3, 1UTHSCSA, sity of Sao Paulo, Sao Paulo, Brazil, 8UFPE, Universidade
san antonio, TX, 2Univ. Texas Health Science Center San Antonio, Federal de Pernambuco, Brazil, 9Federal University of Mato
San Antonio, TX, 3UTHSCSA, San Antonio, TX Grosso, 10University of Santiago de Chile
823 Increased Serum Soluble ST2 In Asthmatic Children and Re- 829 Interactive Exploration Of Microbial Exposure, Asthma and
current Early Wheezers Allergy Using a Web-Based Tool
Prof. Hai Lee Chung, MD, PhD and Dr. Eun Joo Lee, Catholic Jeremy Wildfire1, Mr. Agustin Calatroni, MA MS1, Dr. Susan V.
University of Taegu, Taegu, South Korea Lynch, PhD2, Dr. Homer A. Boushey Jr., MD, FAAAAI3, Dr. Kei
Fujimura, PhD2, Dr. Marcus Rauch, PhD2 and Henry Lynn1,
1
Rho, Inc., Chapel Hill, NC, 2University of California San Fran-
cisco, San Francisco, CA, 3University of California, San Francisco,
The Impact of Environmental Factors on Asthma San Francisco, CA
830 Is There a Link Between Uncontrolled Asthma and Sensitiza-
5201 tion To Inhalant Allergens?
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM Dr. Majdy Qutub, MD1, Prof. Emad Abdulkader Koshak, MD1,
824 High Traffic Pollution Exposure Is Significantly Associated Dr. Moufag Tayeb2 and Dr. Mohammed Alrabea1, 1King Abdul
With Poorer Asthma-Related Quality Of Life In Older Asth- Aziz University, Jeddah, Saudi Arabia, 2King Abdul Aziz Univer-
matics sity, Rabigh, Saudi Arabia
Dr. Jennifer A. Kannan1, Dr. David I. Bernstein, MD, FAAAAI2, 831 Allergy To Cockroaches: The Need For Standardization Of Ex-
Ms. Cheryl Koff Bernstein, RN BSN CCRC3, Dr. Patrick Ryan, tracts For Clinical Practice
PhD1,4, Dr. Jonathan A. Bernstein, MD, FAAAAI5, Dr. Manuel S. Prof. Emanuel Sarinho, Prof. PHD, UFPE, Universidade Federal
Villareal, MD, FAAAAI1, Dr. Andrew M. Smith, MD, FAAAAI6, de Pernambuco, Brazil, Dr. Filipe Wanick Sarinho, Md, IMIP, Bra-
Dr. Peter Lenz1 and Dr. Tolly Epstein, MD, MS7, 1University of zil, Prof. Dirceu Sole, MD, PhD, Federal University of Sao Paulo,
Cincinnati Medical Center, Cincinnati, OH, 2Bernstein Allergy Sao Paulo, Brazil and Dr. Isabela Londres, UFPE
TUESDAY
Group, Cincinnati, OH, 3Bernstein Clinical Research Center, 832 Are Environmental Factors More Important Than Genetic Fac-
LLC, Cincinnati, OH, 4Cincinnati Childrens Hospital Medical tors In Incident Asthma?
Center, Cincinnati, OH, 5Division of Immunology Allergy & Rheu- Dr. Efren L. Rael, MD, FAAAAI, Allergy/Immunology, Penn
matology, University of Cincinnati Medical Center, Cincinnati, OH, State University College of Medicine, Hershey, PA
6
3255 Eden Ave., HPB 350, University of Cincinnati Medical Cen- 833 Sensitization In Patients With Allergic Difficult-To-Control
ter, Cincinnati, OH, 7Allergy Partners of Central Indiana, Indianap- Asthma
olis, IN Dr. Rosana C. Agondi, MD, PhD1, Dr. Bruna Saliba2, Dr. Carla
825 Effect Of Early Exposure To Traffic Related Air Pollution On Bisaccioni, MD1, Dr. Marcelo Vivolo Aun, MD1, Prof. Jorge Kalil,
The Asthma Predictive Index and Asthma At Age 7 MD, PhD1 and Prof. Pedro Giavina-Bianchi, MD, PhD,
Dr. Priyal Amin, DO, University of Cincinnati, College of Medi- FAAAAI1,3, 1Clinical Immunology and Allergy Division, Univer-
cine, Cincinnati, OH, Afghanistan, Prof. Linda Levin, PhD, Univer- sity of Sao Paulo, Sao Paulo, Brazil, 2Clinical Immunology and
sity of Cincinnati, Cincinnati, OH, Dr. Tolly Epstein, MD, MS, Allergy Division University of S^ao Paulo, Brazil, Brazil, 3Clinical
Allergy Partners of Central Indiana, Indianapolis, IN, Dr. Patrick Imunnology and Allergy Division, University of Sao Paulo,
Ryan, PhD, Cincinnati Childrens Hospital Medical Center, Boston, MA
139
AB350 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
834 Sensitization To Inhalant Allergens In Elderly Patients Of An 842 The Simplified Method For Eucapnic Voluntary Hyperventila-
Allergy Clinic In Rio De Janeiro tion (EVH) May Be Useful To Discriminate Between Hyperven-
Dr. Jose Luiz M. Rios, MD, PhD, Dr. Luiz C G Arcanjo, Fabio C tilation and Gastroesophageal Reflux Disease (GERD) Induced
Kuschnir, Joao BM Rios and Ana CS Oliveira, Policlinica Geral do Bronchospasm
Rio de Janeiro, Brazil Dr. Richard R. Rosenthal, MD1,2, Mr. Harvey Howe, BS3 and Mr.
Paul Knause, BS3, 1Allergy and Clinical Immunology, Johns Hop-
kins University School of Medicine, Baltimore, MD, 2INOVA Fair-
fax Hospital, Fairfax, VA, 3Self
843 A Young Adult With Increased Variability Of FEF25-75 Rela-
tive To FEV1 Post-Bronchial Thermoplasty
Diagnostic Modalities of Asthma Dr. Amy M. CaJacob, MD1, Dr. Mark H. Kalenian, MD,
FAAAAI2, Dr. John T. Anderson, MD1, Dr. Mark Dransfield3 and
5202 Dr. Jennifer Trevor, MD1, 1University of Alabama at Birmingham,
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM Birmingham, AL, 2Alabama Asthma and Allergy, PC, Dothan, AL,
3
835 The Evaluation Of Airway Obstruction By Lung Sound Analy- University of Alabama School of Medicine, AL
sis In The Patients With Asthma
Dr. Terufumi Shimoda, MD1, Dr. Yukio Nagasaka, MD2, Dr.
Yasushi Obase, MD3, Dr. Michiyoshi Imaoka, MD1, Dr. Tomoaki
Iwanaga, MD1 and Dr. Reiko T. Kishikawa, MD1, 1Fukuoka Na-
tional Hospital, Fukuoka, Japan, 2Kyoto Respiratory Center,
Basic and Translational Immunology
Otowa Hospital, Kyoto, Japan, 3Kawasaki Medical School, Kur-
ashiki, Japan 5203
836 IOS Is Useful In Younger Children Who Cannot Perform Spi- Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
rometry 844 Interferon-~a-Release Assay Prevents Unnecessary Tuberculosis
Dr. Shintaro Okazaki, MD, Hiroki Murai, MD, PhD, Hisako Hay- Therapy In Individuals With Positive Tuberculin Skin Test
ashi, MD, Akiko Kawakita, MD, Motoko Yasutomi, MD, PhD, Mit- Dr. Vered Schichter-konfino and Prof. Elias Toubi, Bnai-Zion
sufumi Mayumi, MD, PhD and Yusei Ohshima, MD, PhD, Medical Center, Rappaport Faculty of Medicine, Technion, Haifa-
University of Fukui, Fukui, Japan Israel, Haifa, Israel
837 The Association Of Spirometry With Asthma Control and 845 High Dimensional Single-Cell Mass Cytometry Demonstrates
Asthma Morbidity In Inner City Schoolchildren With Asthma Conserved Human Toll-Like-Receptor Activation Signatures
Dr. Watcharoot Kanchongkittiphon, MD, PhD1,2, Dr. Jonathan Dr. Elena Hsieh, MD1, Dr. William OGorman, PhD2, Ms. Erica
M. Gaffin, MD, MMSc1,3, Dr. Lianne S. Kopel, MD1,3, Dr. William Savig2, Dr. Pier Federico Gherardini, PhD2, Prof. Mark Davis,
J. Sheehan, MD1,3, Dr. Sachin N. Baxi, MD1,3, Dr. Perdita Permaul, PhD2 and Prof. Garry Nolan, PhD2, 1Allergy and Immunology,
MD3,4, Dr. Diane R. Gold, MD, MPH3,5 and Dr. Wanda Phipatana- Stanford University, Stanford, CA, 2Stanford University-Microbiol-
kul, MD, MS, FAAAAI1,3, 1Boston Childrens Hospital, Boston, ogy & Immunology, Stanford, CA
MA, 2Ramathibodi Hospital, Mahidol University, Bangkok, Thai- 846 Heterogenous Nuclear Ribonucleoprotein L Regulates The Se-
land, 3Harvard Medical School, Boston, MA, 4Division of Pediatric lective Expression Of Glucocorticoid Receptor Translational
Allergy/Immunology, Massachusetts General Hospital, Boston, Isoforms In HL-60 Cells
MA, 5Channing Laboratory, Brigham and Womens Hospital, Bos- Newton Li, MD, Ingrid Bender and Nick Lu, PhD, Division of Al-
ton, MA lergy and Immunology, Department of Medicine, Northwestern
838 Impulse Oscillometry (IOS) Is Easier Than Spirometry For University Feinberg School of Medicine, Chicago, IL
Older Asthmatic and Non-Asthmatic Subjects 847 Dendrimeric Silica Particle Composites For IgE Determination
Dr. Michael C. Balduzzi, MD1, Dr. Adam Updegraff, DO1, Dr. In Patients Allergic To Amoxicillin
Kerri Rawson, Ph.D, MS2, Dr. Brice Taylor, MD3, Dr. Monroe J. Dr. Maria Isabel Monta~ nez, PhD1,2, Dr. Yolanda Vida, PhD2,3, Dr.
King, DO, FAAAAI4 and Dr. Richard F. Lockey, MD5, 1University Adriana Ariza, PhD , Dr. Cristobalina Mayorga, PhD1, Dr. Maria
1
of South Florida, Tampa, FL, 2Washington University School of Salas, MD, PhD4, Dr. Miguel Blanca, MD, PhD4, Dr. Ezequiel
Medicine of Medicine, St. Louis,, MO, 3Morsani College of Med- Perez-Inestrosa, PhD2,3 and Dr. Mara Jose Torres, MD, PhD4, 1Re-
icine, University of South FLorida, Tampa, FL, 4University of search Laboratory for Allergic Diseases, Hospital Regional Universi-
South Florida, Largo, FL, 5Division of Allergy and Immunology, tario de Malaga - FIMABIS-IBIMA, Malaga, Spain, 2Andalusian
Department of Internal Medicine, University of South Florida Mor- Centre for Nanomedicine and Biotechnology, BIONAND, Malaga,
sani College of Medicine and James A. Haley Veterans Affairs Spain, 3Organic Chemistry, University of Malaga, Malaga, Spain,
4
Hospital, Tampa, FL Allergy Service, Carlos Haya Hospital, Malaga, Spain
839 Clinical and Spirometric Characteristics In Young Patients 848 Murine Splenocytes From Peanut-Allergic Donors Transfer
TUESDAY
With Intermittent and Mild Persistent Atopic Asthma Peanut Allergy To Nave, Irradiated Recipient Mice
Prof. Vera Tsybulkina1, Dr. N. Kurmaeva1, Dr. Nicolai Tsybulkin1 Daphne Moutsoglou, BS and Dr. Stephen C. Dreskin, MD, PhD,
and Prof. Lawrence M. DuBuske, MD, FAAAAI2, 1Kazan State FAAAAI, University of Colorado Denver, Aurora, CO
Medical University, Russia, 2George Washington University School 849 Alternaria-Induced Releases Of IL-1 Alpha and IL-1 Beta
of Medicine, DC From Airway Epithelial Cells Through Syk and PKC Signaling
840 Clinical Impact Of Molecular Diagnosis In Dog Allergy Pathways
Prof. Joaquin Sastre, MD, PhD, FAAAAI and Ms. Silvia Uriarte, Dr. Yonghan Sun, gil hospital, Incheon, South Korea and Hirohito
Fundacion Jimenez Daz, Madrid, Spain Kita, MD, Mayo Clinic Rochester, Rochester, MN
841 Asthma As An Unrecognized Risk Factor For Herpes Zoster In 850 Transmaternal Bisphenol A Exposure Accelerates Diabetes
Adults: A Population-Based Case-Control Study Type 1 Development In NOD Mice
Dr. Young J. Juhn, MD, MPH1, Dr. Hyo-Jin Kwon1, Dr. Duk Won Dr. Johanna Bodin1, Dr. Anette Kocbach Blling1, Dr. Rune
Bang1, Dr. Eun Na Kim1, Peter Wollan2 and Mr. Brian Lahr2, 1Dept Becher1, Prof. Frieke Kuper2, Prof. Martinus Lovik1 and Dr. Unni
of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, C. Nygaard1, 1Norwegian Institute of Public Health, Oslo, Norway,
MN, 2Mayo Clinic, Rochester, MN 2
TNO Nutrition and Food Research, Zeist, Netherlands
140
J ALLERGY CLIN IMMUNOL Abstracts AB351
VOLUME 133, NUMBER 2
851 Soluble Type I Interferon Receptor 2 and Soluble Type II Inter- Vanderbilt University School of Medicine, Nashville, TN, 3Allergy,
feron Receptor 1 Are Independently Regulated Pulmonary, and Critical Care Medicine, Department of Medicine, Van-
Thomas B. Lavoie, PhD, Taher Fatakdawala, Xiao-Hong Lin, Mi- derbilt University School of Medicine, Nashville, TN
chael Skawinski, Jonathan Ferriera and Tara Stauffer, PBL Assay 860 Influence Of Dietary Fiber On Cellular Immunity In Experi-
Science mental Vitamin Deficiency
852 Regulation Of Innate Immune Recognition Of Viral Infection Dr. Roman Khanferyan, MD, PhD1, Dr. E.N. Trushina2, O.K. Mus-
By Epigallocatechin Gallate tafina3, V.M. Kodentzova2 and Prof. Lawrence M. DuBuske, MD,
Dr. Christina L. Nance, PhD1,2, Melinda Mata, B.S.1, Ashley FAAAAI4, 1Insitute of Nutrition, Russian Academy of medical Sci-
McMullen, B.S.1, Sean McMaster, B.S.1 and Dr. William T. ences, Moscow, Russia, 2Insitute of Nutrition Russian Academy of Sci-
Shearer, MD, PhD, FAAAAI1,2, 1Baylor College of Medicine, ences, Russia, 3Institute of Nutrition Russian Academy of Sciences,
2
Texas Childrens Hospital Russia, 4George Washington University School of Medicine, DC
853 Prostaglandin I2 (PGI2) Inhibits IL-33-Induced Type 2 Cyto- 861 Evaluation Of Cytokine Levels In Patients With Active Pulmo-
kine Responses By Mouse CD4 T Cells nary Tuberculosis Their Household Contacts-A Follow Up
Weisong Zhou, PhD1, Jian Zhang, MS1, Kasia Goleniewska2 and Study
Dr. R. Stokes Peebles Jr., MD, FAAAAI1, 1Division of Allergy, Pul- Ms. Ramya Sivangala1, Ms. Meenakshi Ponnana1, Ms. Shruthi
monary and Critical Care Medicine, Vanderbilt University School Thada1, Mrs. Lavanya Joshi1, Dr. Vijayalakshmi Valluri1,2 and Dr.
of Medicine, Nashville, TN, 2Allergy, Pulmonary, and Critical Sumanlatha Gaddam1, 1Bhagwan mahavir medical research center,
Care Medicine, Department of Medicine, Vanderbilt University Hyderabad, India, 2LEPRA IndiaBlue Peter Public Health & Re-
School of Medicine, Nashville, TN search Centre, Hyderabad, India
854 Sequencing Of The ST2 Gene and The Identification Of Genetic 862 Semaphorin 4C Is An Intrinsic Regulator Of Cell-Cell Interac-
Determinants Of Serum Total ST2 Levels: Strong Evidence For tion In Th2 Stimulated Memory-B-Cells
Replication Across European and African American Popula- Ms. Marianne Beland1, Dr. Marylin Desjardins, MD1,2, Ms. Di
tions Xue3 and Dr. Bruce D. Mazer, MD, FAAAAI4,5, 1Meakins-Christie
Dr. Rasika A. Mathias, ScD1, Lili Huang, MPH1, Dr. Candelaria I. Laboratories, Montreal, QC, Canada, 2Division of Allergy and Clin-
Vergara, MD, PhD1, Dr. Li Gao, MD, PhD1, Nicholas M. Rafaels1, ical Immunology, Department of Paediatrics, McGill University
Joseph Potee1, Mrs. Monica Campbell1, Dr. Hironori Masuko, MD, Health Centre, Montreal, QC, Canada, 3Mcgill university, Montreal,
PhD1, Justyna Fert-Bober2, James Snider3, Dr. Margaret Taub, QC, Canada, 4Montreal Childrens Hospital, Montreal, QC, Can-
PhD4, Dr. Ingo Ruczinski, PhD4, Dr. Terri H Beaty, PhD4, Dr. Jen- ada, 5Meakins-Christie Laboratories, Research Institute - McGill
nifer E. Van Eyk, PhD2 and Dr. Kathleen C. Barnes, PhD University Health Centre, Montreal, QC, Canada
FAAAAI1, 1Division of Allergy and Clinical Immunology, Depart-
ment of Medicine, Johns Hopkins University, Baltimore, MD, 2De-
partment of Medicine, Johns Hopkins University, Baltimore, MD,
3
Critical Diagnostics, San Diego, CA, 4Johns Hopkins Bloomberg Innate Immunity and Primary
School of Public Health, Johns Hopkins University, Baltimore, MD
855 Salmonella Typhimurium Impedes Innate Immunity With a
Immunodeficiencies
Mast Cell-Suppressing Tyrosine Phosphatase Sptp
Hae Woong Choi1, Rhea Brooking, PhD1, Subham Neupane1, 5204
Chul-Jin Lee, PhD1, Dr. Edward Miao, MD, PhD2, Dr. Herman F. Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
Staats, PhD1 and Dr. Soman N. Abraham, PhD1,3, 1Duke University 863 A Patient With a Novel Leukocyte Adhesion Deficiency and Py-
Medical Center, Durham, NC, 2University of North Carolina at oderma Gangrenosum-Like Disease
Chapel Hill, Chapel Hill, 3Duke-National University of Singapore, Dr. Jared I. Darveaux, MD1, Dr. Anna Huttenlocher2, Dr. Daniel
Singapore, Singapore Bennett3, Dr. Judith Smith3, Dr. Christine M. Seroogy, MD,
856 The Role Of Semaphorin 7A In Alternatively Activation Of FAAAAI3 and Dr. James E. Gern, MD, FAAAAI4, 1University of Wi-
Macrophages soconsin, Madison, WI, 2University of Wisconsin, Madison, Madi-
Prof. Hye-Ryun Kang, MD, PhD, Dr. Hyun Seung Lee, PhD, Ms. son, WI, 3University of Wisconsin, Madison, WI, 4University of
Da Eun Park, B.A., Ms. Ji Won Lee, B.A., Prof. Woo-Jung Song, Wisconsin School of Medicine and Public Health, Madison, WI
MD, Prof. Heung-Woo Park, MD, PhD, Prof. Sang Heon Cho, 864 Reduced Macrophages IL-12 Production After Stimulation By
MD, PhD and Prof. Kyung-Up Min, MD, PhD, Department of In- BCG/INF-Gamma Suggestive Of Impaired INF-Gamma Path-
ternal Medicine, Seoul National University College of Medicine, way Signalling In a Child With Disseminated Atypical Myco-
Seoul, South Korea bacterial Infection and History Of Chemotherapy For
857 Immune Perturbation In Patients With Tgfbeta Pathway De- Langerhans Cell Histiocytosis
fects Dr. Eliska Furlong, MD, PhD, Dr. Richard K.S. Loh, MD,
Dr. Dat Q. Tran, MD1, Mrs. Ellen Regalado2 and Dr. Dianna Mile- FAAAAI, Dr. Grace Wooi Kee Gong, MD and Dr. Andrew
TUESDAY
wicz2, 1University of Texas Medical School at Houston, Houston, McLean-Tooke, MBChB, Princess Margaret Hospital for Children,
TX, 2UTHealth Perth, Australia
858 Chemokine Receptors On Regulatory T Cell Surface, Surrogate 865 Sporadic Case Of Chronic Mucocutaneous Candidiasis (CMC)
Markers For Intracellular Th1 and Th2 Cytokines Due To a Gain-Of-Function Mutation In STAT1 In a 13 Year
Mr. Satoru Watanabe1,2, Dr. Yoshiyuki Yamada1 and Prof. Hiro- Old Female
kazu Murakami2, 1Gunma Childrens Medical Center, Shibukawa, Dr. Aimee E. Baer Ellington, MD and Dr. Jennifer A. Shih, MD,
Gunma, Japan, 2Gunma University Faculty of Medicine School of Emory University, Atlanta, GA
Health Science, Maebashi, Gunma, Japan 866 A Young Boy With a Novel, Autosomal-Dominant Signal Trans-
859 IL-4 Signaling Attenuates gd T Cell IL-17A Protein Expression ducer and Activator Of Transcription 1 (STAT1) Hypermorphic
Melissa T. Harintho, BS1, Dr. Dawn C. Newcomb Baker, PhD2, Jac- Mutation Presenting With Pneumocystis Jirovecii Pneumonia
queline-Yvonne Cephus, BS2, Kasia Goleniewska3 and Dr. R. Stokes (PJP), Chronic Mucocutaneous Candidiasis (CMC), and Com-
Peebles Jr., MD, FAAAAI2, 1Department of Pathology, Microbiology, bined Immunodeficiency
and Immunology, Vanderbilt University School of Medicine, Nash- Dr. Matthew C. Altman, MD1, Dr. David Hagin, MD1, Dr. David
ville, TN, 2Division of Allergy, Pulmonary and Critical Care Medicine, Buchbinder, MD2, Dr. Suzanne Skoda-Smith, MD3, Dr. Hans D.
141
AB352 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Ochs, MD1 and Dr. Troy R. Torgerson, MD, PhD1, 1University of Goncalves, MD3, Dr. In^es Camelo Nunes2 and Prof. Dirceu Sole,
Washington, Seattle, WA, 2Childrens of Orange County, 3Seattle MD, PhD3, 1Division of Allergy and Clinical Immunology, Dept
Childrens Hospital, Seattle, WA of Pediatrics, Escola Paulista de Medicina, Federal University of
867 Infections In Mannose-Binding Lectin Deficiency Patients S~ao Paulo, S~ao Paulo, Brazil, S~ao Paulo, Brazil, 2Universidade Fed-
Dr. Mary K. Paul, MD1,2, Dr. Christopher Chang, MD, PhD, eral de S~ao Paulo, S~ao Paulo, Brazil, 3Federal University of Sao
FAAAAI2, Dr. Magee DeFelice, MD3, Dr. Gang Ye, PhD4 and Paulo, Sao Paulo, Brazil
Dr. Sam Soundar, PhD5, 1Thomas Jefferson University Hospital, 875 Atopic Associations In Asthmatic Patients Readmitted Within
Philadelphia, PA, 2Alfred I duPont Hospital for Children, Wilming- 30 Days To The Hospital
ton, DE, 3Nemours/AI duPont Hospital for Children, Philadelphia, Dr. Larisa Buyantseva, MD, MS, Dr. Melissa Rossi, Prof. Jason
PA, 4Nemours, Orlando, FL, 5Nemours Liao, PhD and Dr. Timothy Craig, D.O., Penn State University, Her-
868 LRBA Causes Immunodeficiency and Autoimmunity By Dereg- shey, PA
ulating NFkB-Mediated Multiple Immune Effectors Critical 876 Pediatric Asthma Associated With Fungal Exposure
For B Cell Activation Dr. Cecilia Nguyen, MD1, Dr. Christina E. Ciaccio, MD,
Dr. Jia-Wang Wang, PhD1, Mrs. Michelle A. Reiser, MS1, Mrs. FAAAAI2 and Dr. Charles Barnes, PhD2, 1Childrens Mercy Hospi-
Kunyu Li, BS1, Ms. Eileen Rifkin1, Ms. Bangmei Wang1, Dr. Nar- tals and Clinics, 2Childrens Mercy Hospital, Kansas City, MO
asaiah Kolliputi, PhD1 and Dr. Richard F. Lockey, MD1,2, 1Division 877 Assessment Of Factors Associated With PPV23 Vaccine Uptake
of Allergy and Immunology, Department of Internal Medicine, Uni- Among Young Adults With Asthma In Olmsted County, MN
versity of South Florida, Morsani College of Medicine, Tampa, FL, Maria J. Bachman, Medical Student1, Joshua Gauger, Medical
2
James A. Haley Veterans Affairs Hospital, Tampa, FL Student2, Dr. Chriss Derauf, MD3, Dr. Slavica Katusic, MD3, Jen
869 Giscelli Syndrome: A Case Treated With a Hematopoietic Rand-Weaver3, YuBin Choi3, Elizabeth Krusemark3 and Dr. Young
Stems Cells From a Cord Blood J. Juhn, MD, MPH3, 1Mayo Medical School, Rochester, MN,
2
Dr. Marisol Rico-Arroyo, Instituto Mexicano del Seguro Social Mayo Medical School, 3Dept of Pediatric and Adolescent Medi-
870 Fungal Granuloma and Chronic Mucocutaneous Candidiasis cine, Mayo Clinic, Rochester, MN
Due To Autosomal Dominant Gain Of Function STAT1 Mutation 878 Clinical Effectiveness In Allergic Airway Disease Of Oriton IgE
Dr. Nauman Salim, MBBS , MD, University of South Florida, Chemiphar TM: A Rapid Determination System Of Allergen-
Tampa, FL and Dr. Jennifer Leiding, MD, University of South Flor- Specific IgE
ida, St. Petersburg, FL Dr. Tomoyuki Soma, MD1,2, Dr. Ai Masumoto2, Dr. Takehito Ko-
871 Impaired T-Independent IgM Responses Due To Irak-4-, bayashi, MD2, Dr. Atsushi Kamijyo, MD2, Dr. Yoshitaka Uchida1,2,
MyD88 Deficiency Or Splenectomy Prof. Kouichi Hagiwara, MD1, Prof. Minoru Kanazawa, MD1 and
Dr. Paul J. Maglione, MD, PhD1, Lin Radigan1, Sam Black1, Jes- Prof. Makoto Nagata, MD1,2, 1Department of Respiratory Disease,
sica Overbey1, Dr. Emelia Bagiella1, Dr. Isabelle Meyts2, Prof. Saitama Medical University, Japan, 2Allergy Center, Saitama Med-
Jean-Laurent Casanova, MD, PhD3,4, Dr. Capucine Picard, MD, ical University, Japan
PhD3 and Dr. Charlotte Cunningham-Rundles, MD, PhD, 879 Gender Differentially Contributes To Airway Hyperresponsive-
FAAAAI1, 1Mount Sinai Medical Center, New York, NY, 2Univer- ness In Adult Asthmatics
sity Hospitals Leuven, Belgium, 3Hopital Necker-Enfants Malades, Dr. Jeong-Hee Choi, MD1, Dr. Cheol-Hong Kim, MD2, Prof. In-Gyu
Paris, France, 4Rockefeller University, New York, NY Hyun, MD3, Dr. Joo-Hee Kim, MD4, Dr. Tae-Rim Shin, MD5 and Dr.
872 Intestinal Perforation and Non-Tuberculous Mycobacterial Per- Sang-Myeon Park, MD5, 1Dept. of Pulmonology and Allergy, Hal-
itonitis In a Patient With Interleukin-1 Receptor Associated Ki- lym University Dongtan Sacred Heart Hospital, Hwaseong, South
nase 4 Deficiency Korea, 2Dept. of pulmonology and Allergy, Hallym University Dong-
Dr. Hana B. Niebur, MD, Dr. Nathan Tang, MD, FAAAAI and Dr. tan Sacred Heart Hospital, 3Hallym University Dongtan Sacred Heart
Jennifer Leiding, MD, University of South Florida, St. Petersburg, Hospital, 4Hallym University School of Medicine, Anyang, 5Hallym
FL University Kangnam Sacred Heart Hospital
873 Suspected Non-Infectious Prosthetic Valve Inflammatory Dehis- 880 Prevalence Of Sleep Disorders In Children With Asthma and
cence In X-Linked Chronic Granulomatous Disease Its Association With The Level Of Control Of The Disease,
Dr. Monica Bhagat, MD1, Dr. Joshua A. Steinberg, MD2, Dr. Smoking and Obesity
Frank Silvestry, MD3, Dr. Lea Surrey, MD3, Dr. Andrea J. Apter, Dr. Lorena Rangel-Garza, MD1, Prof. Sandra N. Gonzalez-Diaz,
MD MA MSc FAAAAI1, Dr. Patricia A. Takach, MD, FAAAAI1 MD, PhD, FAAAAI1, Dr. Alejandra Macias-Weinmann, MD2, Prof.
and Dr. Benjamin P. Soule, MD1, 1University of Pennsylvania, Phil- Alfredo Arias-Cruz, MD, FAAAAI1, Dr. Maria Del Carmen Zarate-
adelphia, PA, 2Medical College of Wisconsin, Milwaukee, WI, Hernandez, MD3, Dr. Idalia V. Yanez-Perez, MD4 and Dr. Hilda
3
UPENN, Philadelphia, PA Hernandez-Sanchez, MD4, 1University Hospital Dr. Jose Eleuterio
873A The Effects Of Anti-Seizure Medications On Patients With An- Gonzalez, UANL, Monterrey, Mexico, 2Hospital Universitario
tibody Deficiency Syndrome UANL, Monterrey, N.L., Mexico, 3University Hospital, Monterrey,
Dr. Tatyana Gavrilova, MD and Dr. Harumi Jyonouchi, MD, Mexico, 4Regional Center of Allergy and Clinical Immunology.
TUESDAY
Rutgers University of Medicine and Dentistry, Newark, NJ University Hospital Dr. Jose Eleuterio Gonzalez., Monterrey,
Mexico
881 Asthma and Allergic Diseases Of Preschool Children In Korea:
Findings From The Pilot Study For The Korean Surveillance
Survey For Childhood Asthma
Epidemiology and Risk Factors of Asthma Prof. Ji Tae Choung, MD, Korea Univ. Medical Center, Seoul,
Prof. Sungchul Seo, The Enviornmental Health Center for Asthma,
5205 Korea University, Seoul, Dr. YongMin Cho, The environmental
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM health center for asthma, Dr. Young Yoo, MD, PhD, Department
874 Risk Factors Associated With The Development Of Asthma of Pediatrics, College of Medicine, Korea University, Seoul, South
and Allergic Rhinitis Among Adolescents Living In S~ao Paulo Korea; Department of Environmental Health Sciences, Mailman
Brazil School of Public Health, Columbia University, New York, NY
Dr. Fernanda Patini Furlan1, Dr. Djanira Andrade2, Danielli and Dr. Wonsuck Yoon, Department of Life Science and Biotech-
Christinni Bichuete-Silva, MD3, Dr. Tessa Rachel Tranquilini nology, Seoul, South Korea
142
J ALLERGY CLIN IMMUNOL Abstracts AB353
VOLUME 133, NUMBER 2
882 Atopic Characteristics Of Patients With Paroxysmal Vocal Arai, MD3, Dr. Hirotaka Shimizu, MD3, Dr. Yoshiyuki Yamada,
Cord Dysfunction MD, PhD4, Dr. Yukihiro Ohya, MD, PhD1, Dr. Hirohisa Saito,
Casey Curtis, MD1,2, Meagan W. Shepherd, MD1,2, Gary Phillips, MD., PhD.2 and Dr. Kenji Matsumoto, MD, PhD2, 1Division of Al-
M.A.S.3 and Princess U. Ogbogu, MD, FAAAAI1,2, 1Wexner Med- lergy, National Center for Child Health and Development, Tokyo,
ical Center at the Ohio State University, Columbus, OH, 2Nation- Japan, 2Department of Allergy and Immunology, National Research
wide Childrens Hospital, Columbus, OH, 3Wexner Medical Institute for Child Health and Development, Tokyo, Japan, 3Divi-
Center at The Ohio State University, Columbus, OH sion of Gastroenterology, National Center for Child Health and De-
883 Relationship Of Allergen Sensitization and LUNG Function In velopment, Tokyo, Japan, 4Gunma Childrens Medical Center,
Adults Patients With Asthma In Allergy Clinic In Monterrey, Shibukawa, Japan
Mexico 890 Comprehensive Analysis Of Offending Milk Protein Compo-
Dr. Hilda Hernandez Sanchez, MD, Prof. Sandra N. Gonzalez- nents In Non-IgE-Mediated Gastrointestinal Food Allergies
Diaz, MD, PhD, FAAAAI, Prof. Alejandra Macias-Weinmann, By Antigen-Specific Lymphocyte Proliferation Test
MD, Prof. Alfredo Arias-Cruz, MD, FAAAAI, Dr. Idalia Vanessa Dr. Tetsuo Shoda, M.D., Dr. Ichiro Nomura, MD, PhD, Dr. Hide-
Yanez-Perez, MD and Dr. Lorena Rangel-Garza, MD, University aki Morita, MD., PhD., Dr. Akio Matsuda, PhD, Dr. Hirohisa Saito,
Hospital Dr. Jose Eleuterio Gonzalez, UANL, Monterrey, Mexico MD., PhD. and Dr. Kenji Matsumoto, MD, PhD, Department of Al-
884 Targeting Patient Eduation: Correlating Fluctuating Pollen lergy and Immunology, National Research Institute for Child
Counts With Patient Online Inquiries Into Asthma and Allergic Health and Development, Tokyo, Japan
Rhinitis 891 Milk Elimination Diet For Treatment Of Eosinophilic Esopha-
Dr. John M. Kern, D.O.1, Dr. Leonard Bielory, MD, FAAAAI2,3 gitis
and Mr. Spencer H. Luster3,4, 1Rutgers University - NJMS, ocean- Elizabeth Erwin, MD1, Patrice Kruszewski2, Dr. John Russo,
port, NJ, 2Robert Wood Johnson University Hospital, New Bruns- M.D.1 and Thomas A.E. Platts-Mills, MD, PhD, FAAAAI3, 1Na-
wick, NJ, 3STARx Allergy and Asthma Center, Springfield, NJ, tionwide Childrens Hospital, Columbus, OH, 2Nationwide Chil-
4
University of Pennsylvania, Philadelphia, PA drens Hospital, 3Division of Asthma, Allergy & Immunology,
University of Virginia Health System, Charlottesville, VA
892 Pediatric Eosinophilic Esophagitis: A 10-Year Experience At a
Canadian Tertiary Care Centre
Eosinophilic Gastrointestinal Diseases Dr. Jason A. Ohayon, MD1, Perri R. Tutelman2, Dr. Jefferson
Terry, MD, PhD3 and Dr. Mary E. Sherlock, MB BCh, BAO,
5206 PhD2, 1Department of Pediatrics, McMaster Childrens Hospital,
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM McMaster University, Hamilton, ON, Canada, 2Department of Pe-
886 Elevated Exhaled Nitric Oxide Levels In Eosinophilic Esophagi- diatric Gastroenterology and Nutrition, McMaster Childrens
tis Patients With and Without Atopy Hospital, McMaster University, Hamilton, ON, Canada, 3Depart-
Michael Kagen, M.D.1, Zainab Kagen, MD2, Prof. Steve L. Kagen, ment of Pathology and Molecular Medicine,
MD, FAAAAI3 and Joe Zondlo, M.D.3, 1University of Tennessee McMaster Childrens Hospital, McMaster University, Hamilton,
College of Medicine-Chattanooga, Chattanooga, TN, 2University ON, Canada
of Tennesee College of Medicine-Chattanooga, TN, 3Kagen Allergy 893 Clinical Characteristics Of Eosinophilic Esophagitis - a Case
Clinic, Appleton, WI Series Of 30 Patients
887 Older Mice Intranasally Sensitized with Aspergillus Fumigatus Dr. Susana D. Piedade1, Dr. Diana Silva1,2, Dr. Bruno Sim~oes1,3,
Develop Stronger Eosinophilic Esophageal Inflammation Com- ^
Dr. Angela Gaspar1, Dr. Sandra Morgado4, Dr. Filipa Santos5 and
pared to Their Younger Counterparts Dr. Mario Morais-Almeida1, 1Immunoallergy Department, Hospital
Dr. Antonella Cianferoni, MD, PhD1, Simona Barni, MD2, Cara CUF Descobertas, Lisbon, Portugal, 2Immunoallergy Department,
Smith, BS3, Valsamma Abraham, PhD4, Peng Guan, BS3, Dr. Fran- Hospital S~ao Jo~ao, Oporto, Portugal, 3Pediatrics Department, Hos-
cesca Saretta, MD5, Katie Ruyman, BS3, Hamid Bassiri, MD, PhD3, pital Faro, Faro, Portugal, 4Gastroenterology Unit, Hospital CUF
Dr. Kim E. Nichols, MD6 and Dr. Jonathan M. Spergel, MD, PhD, Descobertas, Lisbon, Portugal, 5Pediatrics Department, Hospital
FAAAAI3,7, 1The Childrens Hospital of Philadelphia, 2University of CUF Descobertas, Lisbon, Portugal
Florence Italy, Italy, 3Childrens Hospital of Philadelphia, 4University 894 Characteristics Of Eosinophilic Esophagitis Among Children
of Pennsylvania, 5Ospedale Di Palmanova, ASS 5 Bassa Friulana, Pag- Living In Rural, Southern United States
nacco, Italy, 6CChildrens Hospital of Philadelphia, Philadelphia, PA, Ms. Erin OBrien1,2, Dr. Troy Gibbons, MD1,2, Dr. Amy M. Scur-
7
The Childrens Hospital of Philadelphia, Philadelphia, PA lock, MD3, Dr. Jennifer Olivier, MD1,2, Mallikarjuna Rettiganti,
888 Cripto-1 Is Elevated In Pediatric Subjects With Eosinophilic PhD1,2, Maria Melguizo Castro1,2, Ms. Peggy L. Chandler,
Esophagitis APN1,2, Audrey Fendley, RD2, Dr. Helen Casteel, MD1,2, Dr. Mar-
Lisa Beppu, BS1, Arjun Andrew Anilkumar, BS2, Richard Kurten, yelle VonLanthen, MD1,2, Dr. Stephen Fiedorek, MD1,2, Dr. Tamara
PhD3, Ranjan Dohil, MD4, David Broide, MB ChB2 and Seema T. Perry, MD1,2, Stacie M. Jones, MD3,4 and Dr. Robbie D. Pesek1,2,
TUESDAY
1
Sharma Aceves, MD, PhD, FAAAAI5, 1University of California University of Arkansas for Medical Sciences, Little Rock, AR,
2
San Diego, Department of Pediatrics, Division of Allergy and Im- Arkansas Childrens Hospital, Little Rock, AR, 3University of Ar-
munology, 2University of California San Diego, Department of kansas for Medical Sciences and Arkansas Childrens Hospital, Lit-
Medicine, Division of Allergy and Immunology, 3University of Ar- tle Rock, AR, 4Arkansas Childrens Hospital Research Institute,
kansas for Medical Sciences, Little Rock, AR, 4University of Cal- Little Rock, AR
ifornia San Diego, Rady Childrens Hospital, Department of 895 Failure To Thrive In a Pediatric Cohort With Eosinophilic
Pediatrics, Division of Gastroenterology, 5Pediatrics, University Esophagitis
of California San Diego, La Jolla, CA Dr. Brenda Paquet, MD, FRCPC1, Dr. Philippe Begin, MD, MSc
889 Interleukin-33 and Thymic Stromal Lymphopoietin Are Prefer- FRCPC1, Louis P. Paradis, MD FRCPC FAAAAI2, Dr. Eric Drouin,
entially Elevated In The Sera Of Infants With Eosinophilic Gas- MD FRCPC1 and Anne M. Des Roches, MD FRCPC FAAAAI2,
1
troenteritis Centre Hospitalier Universitaire Ste-Justine, Montreal, QC, Can-
Dr. Ichiro Nomura, MD, PhD1,2, Dr. Akio Matsuda, PhD2, Dr. ada, 2Centre Hospitalier Universitaire Sainte-Justine, Montreal,
Tetsuo Shoda, MD2, Dr. Hideaki Morita, MD., PhD.2, Dr. Katsuhiro QC, Canada
143
AB354 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
896 Eosinophilic Esophagitis In The Puerto Rican Pediatric Popula- 905 Rituxan Hypersensitivity and Management
tion Dr. Johnson T. Wong, MD, FAAAAI1, Dr. Aleena Banerji, MD1,
Dr. Carmen M. Pimentel, MD, Dr. Angel M. Rivera, MD, Dr. Iona Dr. Timothy P. Lax, MD2, Dr. Aidan Long, MD, FAAAAI1, Dr. Mi-
K. Malinow, MD, Dr. Cristina J. Ramos, MD, Dr. Anardi Agosto- chael T. Wilson, MD, PhD1 and Dr. Caroline Sokol, MD, PhD3,
1
Mujica, MD, Dr. Rita Diaz, MD and Dr. Sylvette Nazario, MD, Division of Rheumatology, Allergy, and Immunology, Department
University of Puerto Rico School of Medicine, San Juan, PR of Medicine, Massachusetts General Hospital, Harvard Medical
897 Challenges With Measurement Of IgE Antibodies To Minor School, Boston, MA, 2Division of Rheumatology, Allergy, and Im-
Components In Food Allergy: Eosinophilic Esophagitis, Peanut munology, Department of Medicine, Massachusetts General Hospi-
Allergy, and Delayed Anaphylaxis To Mammalian Meat tal, Harvard Medical School, Boston, MA, Boston, MA,
Anubha Tripathi, MD1, Lisa J. Workman, BA1, Scott Commins, 3
Massachusetts General Hospital
MD, PhD1, Barrett Barnes, MD2, Prof. Robert G. Hamilton, PhD 906 Diagnostic Evaluation Of Hypersensitivity Reactions To Beta-
D.ABMLI FAAAAI3, Thomas A.E. Platts-Mills, MD, PhD, lactam Antibiotics In A Large Population Of Children
FAAAAI1 and Elizabeth Erwin, MD4, 1Division of Asthma, Allergy Dr. Maria J Torres, MD, PhD1, Dr. Maria Angeles Zambonino2,
& Immunology, University of Virginia Health System, Charlottes- Dr. Jose Luis Corzo, MD3, Dr. Candelaria Mu~noz3, Dr. Gloria Re-
ville, VA, 2Division of Pediatric Gastroenterology, University of quena3, Dr. Adriana Ariza, PhD4, Dr. Cristobalina Mayorga, PhD5,
Virginia Health System, Charlottesville, VA, 3Johns Hopkins Uni- Dr. Antonio Urda3 and Dr. Miguel Blanca, MD, PhD1, 1Allergy Ser-
versity School of Medicine, Baltimore, MD, 4Nationwide Chil- vice, Carlos Haya Hospital, Malaga, Spain, 2Allergy Service, Car-
drens Hospital, Columbus, OH los Haya Hospital, Malaga, Spain, Malaga, Spain, 3Pediatric
898 Serum IgE To Allergen Components In Patients With Eosino- Service, Carlos Haya Hospital, Malaga, Spain, 4Research Labora-
philic Esophagitis tory for Allergic Diseases, Hospital Regional Universitario de Ma-
Maria Slack, MD1, Princess U. Ogbogu, MD, FAAAAI2, Anubha laga - FIMABIS-IBIMA, Malaga, Spain, 5Research Laboratory for
Tripathi, MD3, Lisa J. Workman, BA3, Thomas A.E. Platts-Mills, Allergic Diseases, Hospital Regional Universitario de Malaga -
MD, PhD, FAAAAI3 and Elizabeth Erwin, MD4, 1Nationwide Chil- IBIMA, Malaga, Spain
drens Hospital, Columbus, OH, 2Wexner Medical Center at the 907 Clinical Presentation and Outcomes Of Children Undergoing
Ohio State University, Columbus, OH, 3Division of Asthma, Al- Evaluation For Drug Allergy
lergy & Immunology, University of Virginia Health System, Char- Dara Mairiang, MD, Dr. Wiparat Manuyakorn, MD, Wasu Kam-
lottesville, VA, 4Nationwide Childrens Hospital chaisatian, MD, Soamarat Vilaiyuk, MD and Suwat Benjaponpitak,
899 Eosinophilic Gastroenteritis Due To Egg Allergy Presenting As MD, Division of Pediatric Allergy/Immunology/Rheumatology,
Acute Pancreatitis Department of Pediatrics, Faculty of Medicine Ramathibodi Hospi-
Dr. Kevin Tse, MD, UCSD and Dr. Sandra C. Christiansen, MD, tal, Mahidol University, Bangkok, Thailand
FAAAAI, Southern CA Permanente Med Grp, San Diego, CA 908 Analysis Of Drug Hypersensitivity Reactions In A Large Serie
900 Patient Ratings Of Various Eosinophilic Esophagitis Treatment Of Children
Options Dr. Maria Angeles Zambonino1, Dr. Candelaria Mu~noz2, Dr. Jose
Dr. Samantha K. Lin, MD, Dr. Neelu Kalra, MD and Dr. Gisoo Ghaf- Luis Corzo, MD2, Dr. Gloria Requena2, Dr. Adriana Ariza, PhD3,
fari, MD, FAAAAI, Penn State Hershey Medical Center, Hershey, PA Dr. Cristobalina Mayorga, PhD3, Dr. Antonio Urda2, Dr. Miguel
901 Eosinophilic Esophagitis and Serum Eotaxin-3 Levels: A Non- Blanca, MD, PhD1 and Dr. Maria J Torres, MD, PhD1, 1Allergy Ser-
Invasive Method To Monitor Disease Activity vice, Carlos Haya Hospital, Malaga, Spain, 2Pediatric Service, Car-
Dr. Cristina Jimenez-Aponte1, Dr. Jose Torres-Silva1, Dr. Eric los Haya Hospital, Malaga, Spain, 3Research Laboratory for
Gonzalez-Hernandez1, Dr. Liza Gonzalez-Benitez1, Dr. Mairim Allergic Diseases, Hospital Regional Universitario de Malaga - FI-
Wiscovich-Torres1, Dr. Carlos Camacho1 and Dr. Vylma Velaz- MABIS-IBIMA, Malaga, Spain
quez, MD2, 1Hospital Episcopal San Lucas-Ponce, 2Hospital Epis- 909 Assessing IgE-Mediated Reactions In Children Presenting To
copal San Lucas, Ponce, PR An Allergy Clinic With a Suspected Antibiotic Allergy
902 Evaluation Of Antigenic Triggers and Etiologies In Eosinophilic Mr. Christopher Mill, BSc1, Dr. Marie-Noel Primeau, MD2, Dr.
Esophagitis: A Single Center Experience Christine Lejtenyi, MD3, Dr. Elaine J. Medoff3, Ms. Nofar Kimchi4
Dr. Tanvi Patel, University of Florida, Gainesville, FL and Dr. Sa- and Dr. Moshe Ben-Shoshan, MD, MSc5,6, 1Division of Clinical
rah Glover, University of Florida at Gainesville, Gainesville, FL Epidemiology, Department of Medicine, McGill University Health
903 Eosinophilic Esophagitis and Selective IgA Deficiency. A New Centre, Montreal, QC, Canada, 2McGill University Health Center,
Combined Disorder Montreal, QC, Canada, 3Montreal Childrens Hospital, Montreal,
Dr. Eric Gonzalez Hernandez1, Dr. Vylma Velazquez, MD2, Dr. QC, Canada, 4Technion American Medical Students Program, Is-
Carlos Camacho3 and Dr. Sheila Capre1, 1Hospital Episcopal San rael, 5Division of Paediatric Allergy and Clinical Immunology, De-
Lucas, 2Hospital Episcopal San Lucas, Ponce, PR, 3Hospital Epis- partment of Paediatrics, McGill University Health Center,
copal San Lucas-Ponce Montreal, QC, Canada, 6Montreal Childrens Hospital, Montreal,
Canada
TUESDAY
144
J ALLERGY CLIN IMMUNOL Abstracts AB355
VOLUME 133, NUMBER 2
consultorio 803, Caracas., Caracas, Venezuela, 6Hospital Universi- FIMABIS-IBIMA, Malaga, Spain, 4Allergy Service, Carlos Haya
tario, Monterrey, Mexico, 7Fundacion Valle del Lili, Cali, Colom- Hospital, Malaga, Spain
bia, 8Consultorios San Juan, San Juan, Argentina, 9Respiralab - 915 Aspirin Allergy In a High Risk VA Population and Potential
Hospital Kennedy, Guayaquil, Ecuador, 10Nuevo Hospital San Ro- Benefit From Aspirin Desensitization
que, C ordoba, Argentina, 11Universidad Nacional de La Plata, La Bhavisha Patel, MD1,2, Joseph Karls2, Sandra Tompkins2, Dawn
Plata, Argentina, 12Fundair, San Luis, Argentina, 13Hospital Mocel, Nyland2, Jo Ann Clough2, Jane Ludwig2 and Sameer K. Mathur,
Mexico City, Mexico, 14Clnica Las Condes, Santiago, Chile, MD, PhD, FAAAAI1,2, 1University of Wisconsin School of Medi-
15
British Hospital, Montevideo, Uruguay cine and Public Health, Madison, WI, 2William S. Middleton Vet-
911 Copy Number Variations In ALOX5 and PTGER1 Genes Are erans Hospital, Madison, WI
Associated With Susceptibility To AERD and Mnsaid-UA 916 Novel Protocol For Successful Aspirin Desensitization In a Pa-
Mrs. Maria Del Carmen Plaza Seron, Bsc.1, Dr. Pedro Ayuso Par- tient With Laryngeal Angioedema To Aspirin
ejo, PhD1, Dr. Natalia Blanca-Lopez, MD, PhD1, Dr. Inmaculada Dr. Nikki Garg, MD, Dr. Pratik Patel, MD and Dr. Sindhura Bandi,
Do~ na, MD, PhD2, Dr. Jose A Cornejo-Garcia, PhD3, Dr. Mara MD, Rush University Medical Center, Chicago, IL
Jose Torres, MD, PhD2, Dr. Javier Fernandez4, Dr. Jose Julio La- 917 Allergy To Beta-Lactams In Patients Consulting Allergology
guna, MD, PhD5, Veronique Godineau3, Ms. Miriam Osorio6, Center Of The Antioquia University, Colombia
Mrs. Luisa Galindo, RN2, Dr. Gabriela Canto, MD, PhD1 and Dr. Dr. Elizabeth Lopez1, Dr. Kaddy Juliana Beltran1, Dr. Jorge San-
Miguel Blanca, MD, PhD2, 1Allergy Service, Infanta Leonor Hos- chez1 and Dr. Ricardo Cardona-Villa, MD2, 1Universidad de Anti-
pital, Madrid, Spain, 2Allergy Service, Carlos Haya Hospital, oquia, Colombia, 2Universidad de Antioquia, Medellin, Colombia
Malaga, Spain, 3Research Laboratory, Carlos Haya Hospital, Ma- 918 Effect Of Penicillin Allergy On Outpatient Antibiotic Prescrip-
laga, Spain, 4UMH Alicante G.University Hospital - Allergy tions At VA Hospital
Sect., Alicante, Spain, 5De La Cruz Roja Hospital, Madrid, Spain, Mark Biagtan, MD1,2, Bryan Babler, BS Pharm RPh2, Sujani Ka-
6
Research Laboratory, Carlos Haya Hospital-FIMABIS, Malaga, kumanu, MD1,2 and Sameer K. Mathur, MD, PhD, FAAAAI1,2,
1
Spain University of Wisconsin School of Medicine and Public Health,
912 Association Study Of Genes Involved In Mast Cell Activation Madison, WI, 2William S. Middleton Veterans Hospital, Madison,
and Mnsaid-UA WI
Dr. Pedro Ayuso Parejo, PhD1, Mrs. Maria del Carmen Plaza- 919 Value Of Clavulanic Acid In Basophil Activation Test For Eval-
Seron, Bsc1, Dr. Inmaculada Do~na, MD, PhD2, Dr. Natalia uating Immediate Reactions To The Combination Amoxicillin-
Blanca-L opez, MD, PhD1, Dr. Jose A Cornejo-Garcia, PhD3, Dr. Clavulanic Acid
Maria J Torres, MD, PhD2, Dr. Javier Fernandez4, Dr. Jose Julio La- Dr. Cristobalina Mayorga, PhD1, Dr. Adriana Ariza, PhD2, Dr. In-
guna, MD, PhD5, Ms. Miriam Osorio6, Veronique Godineau3, Mrs. maculada Do~na, MD, PhD3, Dr. Maria Angeles Zambonino3, Dr.
Luisa Galindo, RN2, Dr. Cristobalina Mayorga, PhD3, Dr. Gabriela Maria Isabel Monta~nez, PhD1, Dr. Maria Salas, MD, PhD3, Ms.
Canto, MD, PhD1 and Dr. Miguel Blanca, MD, PhD2, 1Allergy Ser- Maria Dolores Ruiz3, Ms. Lidia Melendez, Lab. Tech.1, Mrs. Maria
vice, Infanta Leonor Hospital, Madrid, Spain, 2Allergy Service, D Ca~namero3, Dr. Miguel Blanca, MD, PhD3 and Dr. Maria J
Carlos Haya Hospital, Malaga, Spain, 3Research Laboratory, Carlos Torres, MD, PhD3, 1Research Laboratory for Allergic Diseases,
Haya Hospital, Malaga, Spain, 4UMH Alicante G.University Hospi- Hospital Regional Universitario de Malaga - IBIMA, Malaga,
tal - Allergy Sect., Alicante, Spain, 5De La Cruz Roja Hospital, Ma- Spain, 2Research Laboratory for Allergic Diseases, Hospital Re-
drid, Spain, 6Research Laboratory, Carlos Haya Hospital- gional Universitario de Malaga - FIMABIS-IBIMA, Malaga, Spain,
3
FIMABIS, Malaga, Spain Allergy Service, Carlos Haya Hospital, Malaga, Spain
913 Non-Steroidal Antiinflammatory Drugs (NSAIDs)-Induced 920 Persistence Of Penicillin Allergy Label Despite Documented
Acute Urticaria: A Genome-Wide Association Study In The Tolerance
Spanish Population Matthew Feldman, MD and Dr. David A. Khan, MD, FAAAAI,
Dr. Jose A Cornejo-Garcia, PhD1, Dr. Mike Lee2, Dr. Natalia University Texas SW Medical Center, Dallas, TX
Blanca-L opez, MD, PhD3, Dr. Lieh-Bang Liou4, Dr. Chien-Hsiun 921 Allergy To Betalactams In Brazil: Placebo Effect Or Misdiagno-
Chen5, Dr. Inmaculada Do~na, MD, PhD6, Veronique Godineau1, sis?
Dr. Jose Julio Laguna7, Dr. F. Javier Fernandez, MD, PhD8, Dr. Manoela Crespo-Magalh~aes1, Dr. Marcelo Vivolo Aun, MD1,
Dr. Pedro Ayuso Parejo, PhD3, Mrs. Maria del Carmen Plaza- Dr. Roberta Almeida-Castro2, Dr. Marisa Rosimeire Ribeiro, MD3,
Seron, Bsc3, Dr. Gabriela Canto, MD, PhD3 and Dr. Miguel Dr. Laila Sabino Sabino Garro, MD, PhD3, Prof. Jorge Kalil, MD,
Blanca, MD, PhD6, 1Research Laboratory, Carlos Haya Hospital, PhD1, Prof. Antonio Ablio Motta, MD, PhD3 and Prof. Pedro Gia-
Malaga, Spain, 2Laboratory for International Alliance on Ge- vina-Bianchi, MD, PhD, FAAAAI1, 1Clinical Immunology and Al-
nomic Research, RIKEN Center for Integrative Medical Sciences, lergy Division, University of Sao Paulo, Sao Paulo, Brazil, 2Clinical
Yokohama Kanagawa, Japan, 3Allergy Service, Infanta Leonor Imunnology and Allergy Division, University of Sao Paulo, Sao
Hospital, Madrid, Spain, 4Division of Rheumatology, Allergy paulo, Brazil, 3Clinical Imunnology and Allergy Division, Univer-
and Immunology, Chang Gung Memorial Hospital at Lin-kou, sity of Sao Paulo, Sao Paulo, Brazil
TUESDAY
Kwei-san, Tao-yuan, Taiwan, 5Institute of Biomedical Sciences, 922 Prevalence Of Reported Penicillin Allergy In a Tertiary Allergy
Academia Sinica, Taipei, Taiwan, 6Allergy Service, Carlos Immunology Clinic In The United States
Haya Hospital, Malaga, Spain, 7Hospital De La Cruz Roja,, Ma- Dr. Sara M. May, MD, Andrew Nickels, MD and Dr. Michael
drid, Spain, 8UMH Alicante G.University Hospital - Allergy Park, MD, FAAAAI, Mayo Clinic, Rochester, MN
Sect., Alicante, Spain 923 Successful Oxacillin Desensitization With Interrupted Dosing
914 Tolerance To COX-2 Inhibitors In Children With Multiple Hy- Versus Continuous Infusion
persensitivity To Non- Steroidal Anti-Inflammatory Drugs Dr. Melinda Braskett, MD, UCLA Med Center - Mattel Childrens
Dr. Jose Luis Corzo Higueras, MD1, Dr. Maria Angeles Zambo- Hospital, Los Angeles, CA and Dr. Monika Saeedian, MD, Univer-
nino2, Dr. Candelaria Mu~noz1, Dr. Cristobalina Mayorga, PhD3, sity of California, Los Angeles
Dr. Gloria Requena1, Dr. Antonio Urda1, Dr. Miguel Blanca, MD, 924 IgE To Penicillins With Different Specificities Can Be Identified
PhD4 and Dr. Maria J Torres, MD, PhD4, 1Pediatric Service, Carlos By a Multiepitope Macromolecule. Bihaptenic Penicillin Struc-
Haya Hospital, Malaga, Spain, 2Allergy Service, Carlos Haya Hos- tures and IgE Specificities
pital, Malaga, Spain, Malaga, Spain, 3Research Laboratory for Al- Dr. Adriana Ariza, PhD1, Dr. Cristobalina Mayorga, PhD2, Dr.
lergic Diseases, Hospital Regional Universitario de Malaga - Maria Jose Jose Torres, MD, PhD3, Dr. Maria Isabel Monta~nez,
145
AB356 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
PhD2, Dr. Ezequiel Perez-Inestrosa, PhD4, Dr. Antonio Jesus Ruiz- Gomez7, Dr. Mabel Noemi Cuello, MD8, Dr. Paola Toche Pinaud9,
Sanchez, PhD5, Dr. Rosa Mara Rodrguez-Gueant, MD, PhD6, Dr. Dr. Blanca Maria Morfin-Maciel, MD10, Prof. Alicia De Falco11,
Taha Fernandez, PhD7, Dr. Jean Louis Gueant6 and Dr. Miguel Dr. Adolfo Salvatierra12, Dr. Juan F. Schuhl, MD, FAAAAI13, Dr.
Blanca, MD, PhD3, 1Research Laboratory for Allergic Diseases, Ivan Oswaldo Tinoco Moran, MD14, Dr. Susana Barayazarra15, Dr.
Hospital Regional Universitario de Malaga - FIMABIS-IBIMA, Andrea Zanacchi15, Prof. Ada Castillo Mendez16 and Dr. Mario
Malaga, Spain, 2Research Laboratory for Allergic Diseases, Hospi- Sanchez-Borges, MD, FAAAAI17, 1C.M.P. SA, Buenos Aires, Ar-
tal Regional Universitario de Malaga - IBIMA, Malaga, Spain, 3Al- gentina, 2Universidad de Antioquia, Medellin, Colombia, 3Catholic
lergy Service, Carlos Haya Hospital, Malaga, Spain, 4Andalusian University of Cordoba, Cordoba, Argentina, 4Universidade Federal
Centre for Nanomedicine and Biotechnology, BIONAND, Malaga, de S~ao Paulo, S~ao Paulo, Brazil, 5Division of Immunology, Medical
Spain, 5Andalusian Centre for Nanomedicine and Biotechnology- School, Universidad del Salvador, Buenos Aires. Head of the Divi-
BIONAND, and Department of Organic Chemistry, Faculty of Sci- sion of Allergy and Immunology, Clnica Santa Isabel, Buenos Aires,
ences, University of Malaga, Malaga, Spain, 6Laboratory of Cellu- Argentina, 6Hospital Universitario, Monterrey, Mexico, 7Hospital
lar and Molecular Pathology in Nutrition, Faculty of Medicine, San Bernardo, Salta, Argentina, 8Consultorios San Juan, San Juan,
University of Nancy, Nancy, France, 7Research Laboratory - FIMA- Argentina, 9Clnica Las Condes, Santiago, Chile, 10Hospital Mocel,
BIS Foundation, Malaga, Spain Mexico City, Mexico, 11Universidad Nacional de La Plata, La Plata,
925 Cephalosporin Prescribing Habits In Penicillin Allergic Pa- Argentina, 12Fundair, San Luis, Argentina, 13British Hospital, Mon-
tients tevideo, Uruguay, 14Clinica Torre Medica Para La Familia, Machala,
Dr. Shannon D. Tiedeken, MD, Nemours, A.I. duPont Hospital for Ecuador, 15Nuevo Hospital San Roque, Cordoba, Argentina, 16Hos-
Children, Conshohocken, PA, Dr. Christopher Chang, MD, PhD, pital Clinico Quirurugico Dr. Salvador Allende, La Habana, Cuba,
17
FAAAAI, Alfred I duPont Hospital for Children, Wilmington, DE Clinica El Avila, 6a transversal Altamira, piso 8, consultorio 803,
and Dr. Gang Ye, PhD, Nemours, Orlando, FL Caracas., Caracas, Venezuela
926 Radiocontrast Media Reactions: Rectifying Misconceptions 933 A New In Vitro Flow Cytometry Method For Detection Of De-
About Shellfish Allergy and Iodine Allergy In An Academic layed Drug Sensitization To Local Anesthetics. The Lymphocyte
Institution Activation Test (LAT)
Dr. Amber N. Pepper, MD1, Dr. Emma Westermann-Clark, MD, Dr. Massimo Caruso, PhD, FIT AAAAI, Dr. Rosalia Emma, Dr.
MA1, Dr. Neetu Talreja, MD2 and Dr. Richard F. Lockey, MD2, Raffaella Lizzio and Prof. Riccardo Polosa, MD, PhD, FAAAAI,
1
Department of Internal Medicine, University of South Florida University of Catania, Catania, Italy
Morsani College of Medicine, Tampa, FL, 2Division of Allergy 934 Utility Of ICD-9-CM Codes For Identification Of Allergic Drug
and Immunology, Department of Internal Medicine, University of Reactions
South Florida Morsani College of Medicine and James A. Haley Dr. Rebecca Saff, MD, PhD1, Dr. Carlos Camargo Jr., MD,
Veterans Affairs Hospital, Tampa, FL DrPH1,2, Dr. Susan A. Rudders, MD3, Dr. Sunday Clark, MPH,
927 Clinical Predictors Of The Outcome Of Medication Challenges ScD4, Dr. Aidan Long, MD, FAAAAI1 and Dr. Aleena Banerji,
Dr. Farah Khan, DO1,2, Dr. Christopher Chang, MD, PhD, MD1, 1Division of Rheumatology, Allergy, and Immunology, De-
FAAAAI2 and Dr. Gang Ye, PhD3, 1Thomas Jefferson University partment of Medicine, Massachusetts General Hospital, Harvard
Hospital, Philadelphia, PA, 2Alfred I duPont Hospital for Children, Medical School, Boston, MA, 2Department of Emergency Medi-
Wilmington, DE, 3Nemours, Orlando, FL cine, Massachusetts General Hospital, Harvard Medical School,
928 Clinical Experience With Oxaliplatin (O) Desensitization (OD): Boston, MA, 3Division of Asthma and Allergy, Department of Pe-
A Case Series diatrics, Rhode Island Hospital, Alpert School of Medicine at
Dr. Adam Updegraff, DO, University of South Florida, Tampa, FL Brown University, Providence, RI, 4Department of Emergency
and Dr. Devang R. Doshi, MD, FAAAAI, William Beaumont Hos- Medicine, Weill Cornell Medical College, New York, NY
pital, Royal Oak, MI 935 Vancomycin Use and Vancomycin Resistant Enterococcus Are
929 Clinical Value Of a Negative Skin Test To Contrast Radio Me- Increased In Patients With Reported Penicillin Allergy
dia (CR) In Further Exposures Dr. Vinitha Reddy, MD, Penn State Hershey Medical Center, Her-
Dr. Luiz C G Arcanjo, Dr. Tania M T Goncalves, Flavia C Loyola, shey, PA and Dr. Faoud T. Ishmael, MD, PhD, FAAAAI, The Penn-
Matheus Ribeiro, Alfredo Alves Neto, Tatiana L Carvalho and Dr. sylvania State University College of Medicine, Hershey, PA
Jose Luiz M. Rios, MD, PhD, Policlinica Geral do Rio de Janeiro, Brazil 936 Detection Of Causative Drugs Using Measurement Of Inter-
930 Perioperative Reactions: Are They So Infrequent? feron-~awith Quantiferon-TB Gold Test In Severe Drug Allergy:
Dr. Claude M. Urbain, MD1, Dr. Alberto Lafuente, MD2, Dr. Gra- Preliminary Study
cia Javaloyes, MD, PhD1, Dr. Paula Cabrera-Freitag, MD, PhD3, Dr. Dr. Young-Hee Nam, MD1, Dr. Kyeong-Hee Kim, MD2, Dr. Dong
Juan De La Borbolla Moran, MD4, Dr. M Jose Goikoetxea, Ph.D, Sub Jeon, MD3, Dr. Hye-Won Lee, MD3, Hee-Joo Nam4 and Mr.
MD4, Dr. Rafael Moncada, MD2, Dr. Maria L Sanz, MD, PhD1, Soo-Keol Lee, MD5, 1Department of Internal Medicine, College
Dr. Marta M. Ferrer, MD, PhD, FAAAAI4 and Dr. Gabriel Gasta- of Medicine, Dong-A University, Busan, South Korea, 2Department
minza, MD, PhD1, 1Department of Allergy, Clinica Universidad of Laboratory Medicine, College of Medicine, Dong-A University,
TUESDAY
de Navarra, Spain, 2Department of Anesthesia, Clinica Universidad South Korea, 3Department of Internal Medicine, College of Medi-
de Navarra, Spain, 3Department of Allergy, Clinica Universidad de cine, Dong-A University, South Korea, 4Department of Pharmacy,
Navarra, Spain, Pamplona, Spain, 4Department of Allergy, Clinica Dong-A University Hospital, South Korea, 5Dong-A University
Universidad de Navarra, Pamplona, Spain College of Medicine, Pusan, South Korea
931 Causes Of Perioperative Allergic Reactions Our Experience 937 Successful Rapid Desensitization To Glatiramer Acetate In a
In The Last Two Years Patient With Multiple Sclerosis
Dr. Lourdes Arochena, MD, Mrs. Deborah Hughes, RN, Dr. Dr. Ekaterini I. Syrigou, PhD, Department of Allergy, Sotiria
Bryan N. Fernandes, MD, Dr. Marina Tsoumani, MD and Dr. Sus- General Hospital, Athens, Greece, Dr. Photis Psarros, Department
ana F. Marinho, MD, PhD, University Hospital of South Manches- of Allergy, Athens Naval Hospital ,Greece and Prof. Konstantinos
ter NHS Foundation Trust, Manchester, United Kingdom Syrigos, Athens School of Medicine, Greece
932 Perianesthetic Hypersensitivity Reactions In Latin America 938 Hypersensitivity Reaction To Denosumab In Patient With Oste-
Dr. Edgardo J. Jares, MD1, Dr. Ricardo Cardona-Villa, MD2, Prof. oporosis: Desensitization Methodology
Carlos E. Baena-Cagnani, MD3, Dr. Luis Felipe C. Ensina, MD4, Dr. Dr. Antonio Foncubierta, MD, PhD MPH1,2, Dr. Diego Gutierrez,
Juan C. Ivancevich, MD5, Dr. Alfredo Arias Cruz6, Dr. Maximiliano MD, PhD3, Dr. Fermin Medina, MD3, Dr. Salvador Fernandez, MD,
146
J ALLERGY CLIN IMMUNOL Abstracts AB357
VOLUME 133, NUMBER 2
PhD4, Dr. Maria Jose Fernandez3 and Dr. Juan Luis Anguita, MD5, Hospital, Daegu, South Korea, 2Department of Internal Medicine,-
1
Servicio Andaluz de Salud: UGC Joaquin Pece, 2Universidad de Kyungpook National University School of Medicine, Daegu, South
Cadiz, 3Hospital Universitario Puerta del Mar, 4Hospital Universi- Korea, 3Department of Internal Medicine, Kyungpook National
tario Carlos Haya, 5Complejo Hospitalario de Jaen University School of Medicine, Daegu, South Korea
939 Patient With Severe Primary Igf-I Deficit and Mecasermine Al- 949 Successful Rapid Induction Of Temporary Drug Tolerance To
lergy: Desensitization Methodology Colistimethate Sodium
Dr. Diego Gutierrez, MD, PhD1, Dr. Antonio Foncubierta, MD, Dr. Colleen S. Adkins, MD, University of Alabama, Birmingham,
PhD MPH2,3, Alfonso M. Lechuga, MD, PhD1, Dr. Maria Jose Fer- AL and Dr. James Ryan Bonner, MD, FAAAAI, Alabama Allergy
nandez1, Juan Luis Anguita,MD, PhD4 and Jose Luis Lechuga, MD, & Asthma Center, Birmingham, AL
PhD3, 1Hospital Universitario Puerta del Mar, 2Servicio Andaluz de 950 Anaphylactic Reaction During a Folfox Scheme Administration
Salud: UGC Joaquin Pece, 3Universidad de Cadiz, 4Complejo Hos- Secondary To Calcium Folinate: A Case Report
pitalario de Jaen Dr. Maria Alicia Urena Tavera, MD1, Dr. Miriam Zamora Ver-
940 Drug-Induced Anaphylaxis: A Five Year Study In a Third Level duga1, Mrs. Denisse Angel Pereira2, Dr. Ricardo Madrigal-Burga-
Spanish Hospital leta, MD1, Dr. Pilar Berges, MD. PhD.1 and Dr. Emilio Alvarez-
Maria Elisa Caralli, M.D.1, Sarah Micozzi, M.D.1, Abdonias Cuesta1, 1Ramon y Cajal University Hospital, Spain, 2Ramon y Ca-
Rodrguez Gamboa, M.D.1, Dasha Roa Medellin, M.D.1, Alberto jal University Hospital, Madrid, Spain
Alvarez-Perea, MD2 and Manuel De Barrio, M.D.1, 1Hospital Gen- 951 Dual Hypersensitivity To Oxaliplatin Revealed Following Rapid
eral Universitario Gregorio Mara~ n
on, Allergy Department, Madrid, Drug Desensitization: A History Of Anaphylaxis and New-Onset
Spain, 2Hospital Materno Infantil Gregorio Mara~ n
on, Pediatric Al- Hemolytic Anemia
lergy Department, Madrid, Spain Dr. Jared Silver, MD, PhD1, Dr. Timothy Kyin, MD1 and Dr. Ma-
941 Quinolones Allergy In An Allergy Unit. Our Experience In 3 riana C. Castells, MD, PhD, FAAAAI2, 1Brigham and Womens
Years Hospital, Boston, MA, 2Division of Rheumatology, Allergy and Im-
Dr. Tamara Fernandez-Teruel1, Gabriela Zambrano, M.D.2, Celia munology, Department of Medicine, Brigham and Womens Hospi-
Pinto1, Beatriz Ameiro, M.D.2, Dr. Roberto Pelta1 and Manuel De tal, Harvard Medical School, Boston, MA
Barrio1, 1Department of Allergy, Gregorio Mara~ n
on University 952 Oupatient Lenalidomide Desensitization For Delayed Hyper-
Hospital, Madrid, Spain., 2Department of Allergy, Gregorio sensitivity Reactions In 5 Patients With Multiple Myeloma
Mara~non University Hospital, Madrid, Spain., Spain Dr. Min Jung Lee, MD1, Dr. Paige G. Wickner, MD2, Dr. Robert
942 A Successful Desensitization Protocol For Filgrastim Schlossman, MD3, Dr. Paul Richardson, MD3, Dr. Jacob Laubach,
Brett Hronek, MD, Washington University School of Medicine, St MD3 and Dr. Mariana C. Castells, MD, PhD, FAAAAI4, 1Brigham
Louis, MO and Anthony Kulczycki Jr., MD, FAAAAI, Washington & Womens Hospital, Boston, MA, 2Brigham & Womens Hospital,
University School of Medicine, St. Louis, MO Chestnut Hill, MA, 3Dana Farber Cancer Institute, Boston, MA,
4
943 Are Proton Pump Inhibitors(PPI) Naive? A Case Of Drug Re- Division of Rheumatology, Allergy and Immunology, Department
action With Eosinophilia and Systemic Symptom (DRESS) Sec- of Medicine, Brigham and Womens Hospital, Harvard Medical
ondary To Lansoprazole School, Boston, MA
Dr. Aditya Uppalapati, MD1, Dr. Sindhura Gogineni, MD1, Dr. 953 An Atypical Case Of Drug Reaction With Eosinophilia and Sys-
Sravantika Koneru, MBBS2 and Dr. Ghassan Kamel, MD3, 1St. temic Symptoms (DRESS) With Well-Formed Non-Necrotizing
Louis University, St. Louis, MO, 2Mamata Medical College, 3Saint Granulomas On Bone Marrow Biopsy
Louis University, St. Louis Dr. Katie Miro, MD, Rutgers- New Jersey Medical School, New-
944 Increased Of PCT and CRP In Dress Syndrome By Two Drugs ark, NJ and Dr. Eugenio Capitle, MD, Rutgers-New Jersey Medical
Structurally Unrelated Molecular In The Same Pacient School, Newark, NJ
Dr. Rafael A. Perez Arango, Ram on and Cajal University 954 Anaphylactic Reaction To Bacitracin Zinc Topical Antibiotic
Hospital,Spain Ointment: A Case Report
945 Non-Immediate Skin Reactions Due To Antibiotics Dr. Jake D. Lenington, MD, Oregon Health and Science Univer-
Gabriela Zambrano, M.D.1, Dr. Tamara Fernandez2, Beatriz sity, Portland, OR, Dr. David R. Scott, MD, Allergy and Asthma
Ameiro, M.D.1, Celia Pinto3, Alberto Alvarez-Perea, MD4 and Center of Western Colorado and Dr. Anthony Montanaro, MD,
Manuel De Barrio, M.D.5, 1Department of Allergy, Gregorio FAAAAI, Oregon Health Science University, Portland, OR
Mara~non University Hospital, Madrid, Spain., Spain, 2Hospital gen-
non, Madrid, Spain, 3Department of
eral universitario gregorio mara~
Allergy, Gregorio Mara~ n
on University Hospital, Madrid, Spain.,
4
Hospital Materno Infantil Gregorio Mara~ n
on, Pediatric Allergy
Department, Madrid, Spain, 5Hospital General Universitario Gre-
Ocular Allergy
gorio Mara~non, Allergy Department, Madrid, Spain
946 Multiple Drug Hypersensitivity Syndrome In Our Allergy Ser- 5208
TUESDAY
vice Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
Dr. Inmaculada Do~ na, MD, PhD, Dr. Maria J Torres, MD, PhD, 956 Ocular Surface Disease Index (OSDI) and Pollen Counts (PC)
Dr. Paloma Campo, MD, PhD, Dr. Francisca G omez, MD, PhD, Mr. Spencer H. Luster, STARx Allergy and Asthma Center, Spring-
Dr. Maria Salas, MD, PhD, Ms. Maria Dolores Ruiz, Ms. Maria field, NJ; University of Pennsylvania, Philadelphia, PA and Dr. Leo-
Auxiliadora Guerrero and Dr. Miguel Blanca, MD, PhD, Allergy nard Bielory, MD, FAAAAI, Rutgers University, New Brunswick,
Service, Carlos Haya Hospital, Malaga, Spain NJ; Robert Wood Johnson University Hospital, New Brunswick, NJ
947 Desensitization To Anakinra. Case Report 957 Efficacy and Safety Of a New Olopatadine Hydrochloride,
Dr. Miriam Zamora Verduga, Dr. Maria Alicia Urena Tavera, 0.77% Ophthalmic Formulation In Patients With Allergic Con-
Mrs. Denisse Angel Pereira, Dr. Ricardo Madrigal-Burgaleta, junctivitis Using The Conjunctival Allergen Challenge (CAC)
MD, Dr. Pilar Berges-Gimeno, PhD and Dr. Emilio Alvarez-Cuesta, Model (NCT01479374)
MD, PhD, Ramon y Cajal University Hospital, Madrid, Spain Gail Torkildsen, Andover Eye Associates, Andover, MA, Thomas
948 Vitamin K Anaphylaxis Confirmed With Skin Test Macejko, Apex Eye, Fairfield, OH, Abhijit Narvekar, Alcon Labo-
Dr. Min-Hye Kim1,2 and Dr. Jong-Myung Lee, MD1,3, 1Regional ratories, Inc., Fort Worth, TX and Mark Bergmann, Apex Eye, Cin-
Pharmacovigilance Center, Kyungpook National University cinnati, OH
147
AB358 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
958 Cytokine Secretion Profiles In The Tears Of Patients With MD, FAAAAI2, 1Hackensack University Medical Center, Hacken-
Chronic Allergic Conjunctivitis sack, NJ, 2Center for Allergy, Asthma and Immune Disorders Hack-
Dr. Naoko Okada1, Dr. Hiroshi Fujishima2, Dr. Kazumi Fukagawa3, ensack University Medical Center, Hackensack, NJ
Dr. Akio Matsuda, PhD1, Dr. Hirohisa Saito, MD., PhD.1 and Dr. 966 Nanoparticle Engineering For The Immunomodulation Of Den-
Kenji Matsumoto, MD, PhD1, 1Department of Allergy and Immunol- dritic Cells
ogy, National Research Institute for Child Health and Development, Dr. Xavier le Guevel, PhD1, Dr. Taha Fernandez, PhD2, Dr. Adri-
Tokyo, Japan, 2Department of Ophthalmology, Tsurumi University, ana Ariza, PhD3, Dr. Maria Isabel Monta~ nez, PhD4, Dr. Maria J
3
Department of Ophthalmology, Keio University School of Medicine Torres, MD, PhD5, Dr. Cristobalina Mayorga, PhD6 and Dr. Miguel
959 Severity and Frequency Of Allergic Conjunctivitis Symptoms Blanca, MD, PhD5, 1Bionand, Campanillas, Spain, 2Research Lab-
Dr. Milton M. Hom, OD FAAO, Private Practice, Azusa, CA, Dr. oratory - FIMABIS Foundation, Malaga, Spain, 3Research Labora-
Dominick Opitz, OD FAAO, Illinois College of Optometry, Chi- tory for Allergic Diseases, Hospital Regional Universitario de
cago, IL, Dr. Justin Kwan, OD FAAO, Marshall B. Ketchum Uni- Malaga - FIMABIS-IBIMA, Malaga, Spain, 4Research Laboratory
versity, Fullerton, CA and Dr. Leonard Bielory, MD, FAAAAI, for Allergic Diseases, Hospital Regional Universitario de Malaga
Robert Wood Johnson University Hospital, New Brunswick, NJ; - IBIMA, Malaga, Spain, 5Allergy Service, Carlos Haya Hospital,
Rutgers University, New Brunswick, NJ Malaga, Spain, 6Research Laboratory, Carlos Haya Hospital-FIMA-
960 Ocular Symptoms Are Proportionally More Bothersome In BIS, Malaga, Spain
Subjects With More Symptoms Of Cat Allergic Rhinoconjunc- 967 Specific Immunotherapy Modified T-Cells Responses In a Span-
tivitis ish Population Of Der p Allergic Patients
Dr. Peter Creticos, Associate Professor of Medicine; Johns Hop- Dr. Taha Fern andez, PhD1, Dr. Cristobalina Mayorga, PhD2, Dr.
kins School of Medicine, Johns Hopkins School of Medicine; Di- Enrique Gomez3, Mrs. Rosa Garcia4, Mrs. Maria Isabel Sanchez5,
vision of Allergy & Clinical Immunology, Crownsville, MD, Dr. Dr. Ana Aranda, PhD2, Ms. Miriam Osorio2, Dr. Miguel Blanca,
Stephen Durham, co-author, Imperial College, London, Dr. Mar- MD, PhD6 and Dr. Mara Jose Torres, MD, PhD6, 1Research Labo-
garet Maclennan, co-author, InVentiv Health and Dr. Rod Hafner, ratory - FIMABIS Foundation, Malaga, Spain, 2Research Labora-
PhD, Circassia Ltd, Oxford, United Kingdom tory, Carlos Haya Hospital-FIMABIS, Malaga, Spain, 3Research
961 Alcaftadine 0.25% Versus Olopatadine 0.2% In Prevention Of Laboratory of allergic diseases - Carlos Haya Hospital. FIMABIS
Ocular Itching In Allergic Conjunctivitis Foundation. Spain, Malaga, Spain, 4Allergy Service- Carlos Haya
Eugene B. McLaurin, MD, FACS1, Nicholas P. Marsico, MD, hospital. Spain, Malaga, Spain, 5Allergy Service -Carlos Haya Hos-
FACS2, Joseph B. Ciolino, MD3, Linda Villanueva, COT4, Julia pital. Spain, 6Allergy Service, Carlos Haya Hospital, Malaga, Spain
M. Williams, MA, BS4 and David A. Hollander, MD, MBA4, 1Total 968 Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In Grass
Eye Care P.A., Memphis, TN, 2East West Eye Institute, Los An- Pollen-Associated Allergic Rhinoconjunctivitis: Pooled Analysis
geles, CA, 3Massachusetts Eye & Ear Infirmary, Harvard Medical By Level Of Pollen Exposure
School, Boston, MA, 4Allergan, Inc., Irvine, CA Prof. Alain Didier, MD, PhD1, Prof. Ulrich Wahn, Prof Dr Med2,
962 Cetirizine Significantly Relieves Ocular Allergy Symptoms In Mr. Yann Amistani, Msc3 and Dr. Robert K. Zeldin, MD3, 1Larrey
Subjects With Seasonal Allergic Rhinitis Hospital, CHU, Toulouse, France, 2Charite, Berlin, Germany, 3Stal-
Dr. Mitesh Patel, PharmD1, Dr. Eduardo Urdaneta, MD1, Ms. lergenes S.A., Antony, France
Kathleen B. Franklin, BSN, RN2, Ms. Xiaoyan Tian, MS3, Dr. Mei- 969 The Print Survey II: Perceptions Regarding Injection Number
Miau Wu, Dr PH4 and Ms. Qiong Du, MS3, 1McNeil Consumer and Technique
Healthcare, Fort Washington, PA, 2Franklin Consultants, LLC., Phoe- Dr. Michael S. Tankersley, MD, FAAAAI1, Dr. Sandy Yip, MD2
nixville, PA, 3Johnson & Johnson Consumer Products, China, Shang- and Dr. Christopher A. Coop, MD2, 1Wilford Hall Ambulatory Sur-
hai, China, 4J & J Consumer Products, US, Morris Plains, NJ gical Center, Joint Base San Antonio, San Antonio, TX, 2Wilford
963 Cetirizine Effectively Relieves Both Ocular Allergy Symptoms Hall Ambulatory Surgical Center, Lackland AFB, TX
and Nasal Allergy Symptoms In Subjects With Seasonal Aller- 970 Allergy Immunotherapy: Characteristics and Risk Factors For
gic Rhinitis Recurrent Systemic Reactions
Dr. Eduardo Urdaneta, MD1, Ms. Xiaoyan Tian, MS2, Dr. Mei- Kerline Ductan, MD1, Ewa Schafer, MD, FAAAAI2, Rachel E.
Miau Wu, Dr PH3, Ms. Qiong Du, MS2, Ms. Kathleen B. Franklin, Story, MD2, Deeba Masood, MD2, Paul Detjen, MD3 and Ying
BSN, RN4 and Dr. Mitesh Patel, PharmD1, 1McNeil Consumer Zhou, PhD4, 1Department of Internal Medicine, University of Chi-
Healthcare, Fort Washington, PA, 2Johnson & Johnson Consumer cago-NorthShore, Evanston, IL, 2Allergy and Immunology, North-
Products, China, Shanghai, China, 3J & J Consumer Products, US, Shore University HealthSystem (NUHS), IL, 3Kenilworth Medical
Morris Plains, NJ, 4Franklin Consultants, LLC., Phoenixville, PA Allergy & Immunology, Kenilworth, IL, 4Center for Clinical and
964 Automated Evaluation Of Conjunctival Provocation Tests Research Informatics (CCRI), NUHS Research Institute, Evanston,
Mr. Torsten Sehlinger1, Mr. Jaron Zuberbier2, Dr. Oliver Kueh- IL
lert1, Mr. Frank Goergen1, Prof. Torsten Zuberbier3 and Prof. 971 Allergen Specific Immunotherapy In Monosensitized and Poly-
Karl-Christian Bergmann3, 1Bluestone Technology GmbH, Woerr- sensitized Allergic Rhinitis Patients
TUESDAY
stadt, Germany, 2Evangelic High-School Kleinmachnow, Germany, Dr. L. Maslova, Republican Scientific and Practical Center for Ep-
3
Allergy-Centre-Charite, Berlin, Germany idemiology and Microbiology.Minsk, Belarus, Dr. Leonid P. Titov,
MD, PhD, Republican Scientific and Practical Center for Epidemi-
ology and Microbiology, Minsk, Belarus and Prof. Lawrence M.
DuBuske, MD, FAAAAI, George Washington University School
of Medicine, DC
Allergen Immunotherapy 972 The Effect Of The Ragweed Sublingual Immunotherapy Tablet
MK-3641 On Rescue Medication Use
5209 Dr. Sandra M. Gawchik, DO, FAAAAI1, Dr. Peter S. Creticos, MD,
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM FAAAAI2, Kevin R. Murphy, MD3, Dr. Gary D. Berman, MD,
965 Aeroallergen Immunotherapy Reduces Wheal Diameter In Sea- FAAAAI4, Dr. David I. Bernstein, MD, FAAAAI5, Dr. Jennifer Ma-
sonal and Perennial Allergen Intradermal Skin Tests loney, MD6, Dr. Amarjot Kaur, PhD6 and Dr. Hendrik Nolte, MD,
Mr. Michael Hauk1, Mrs. Barbara A. McGoey, RN1, Mr. Parimal PhD6, 1Asthma and Allergy Associates, Chester, PA, 2Johns Hopkins
Patel1, Mrs. Nicole Argenzia, RN1 and Dr. Mary Ann Michelis, Division of Allergy & Clinical Immunology, 3Boys Town National
148
J ALLERGY CLIN IMMUNOL Abstracts AB359
VOLUME 133, NUMBER 2
Research Hospital, Boys Town, NE, 4Allergy and Asthma Special- Basic and Translational Immunology
ists, Minneapolis, MN, 5Bernstein Allergy Group, Cincinnati, OH,
6
Merck, Whitehouse Station, NJ 5602
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
978 Novel NK Cytotoxicity Assay Enables Drug Discovery For He-
mophagocytic Lymphohistiocytosis
Dr. Jinzhu Li, MD, PhD, Ms. Sarah E. Figueira, Ms. Julie Ferrel
Asthma Epidemiology and Risk Factors and Dr. Kimberly A. Risma, MD, PhD, FAAAAI, Cincinnati Chil-
drens Hospital Medical Center, Cincinnati, OH
5601 979 Exploitation Of The Host Ubiquitin System By Respiratory
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM Syncytial Virus Nonstructural Protein 2
Jillian N. Whelan1, Kim C. Tran1, Ruan R. Cox Jr.1, Damian B.
973 Exposures That Alter The Early Life Microbiome and The Risk
van Rossum2, Randen L. Patterson2 and Michael Teng1, 1Division
Of Asthma
of Allergy and Immunology, Department of Internal Medicine,
Amy S. Feldman, MD1, Pingsheng Wu, PhD, MS1,2, Kristina
and the Joy McCann Culverhouse Airway Diseases Research Cen-
James, MD3, Tebeb Gebretsadik, MPH1,2, Gabriel Escobar,
ter, University of South Florida Morsani College of Medicine,
MD4,5, Kecia N. Carroll, MD6, Sherian Xu Li, MS5, Eileen
Tampa, FL, 2The Pennsylvania State University, University
Walsh, RN, MPH5, Ed Mitchel, MS1 and Dr. Tina V. Hartert,
Park, PA
MD, MPH7, 1Division of Allergy, Pulmonary, and Critical Care
980 Epigenetic Regulation Of Dendritic Cell Migration
Medicine, Department of Medicine, and Center for Asthma and
Dr. Timothy P. Moran, MD, PhD1, Dr. Hideki Nakano, PhD2, Dr.
Environmental Sciences Research, Vanderbilt University School
Hrisavgi Kondilis-Mangum, PhD2, Dr. Paul Wade, PhD2 and Dr.
of Medicine, Nashville, TN, 2Department of Biostatistics, Van-
Donald Cook, PhD2, 1Duke University Medical Center, Durham,
derbilt University School of Medicine, Nashville, TN, 3Peninsula
NC, 2National Institute of Environmental Health Sciences, NIH,
Allergy & Asthma Center, Soldotna, AK, 4Kaiser Permanente
Research Triangle Park, NC
Medical Care Program, Oakland, CA, 5Kaiser Permanente North-
981 LRBA Subcellular Localization: Evidence Of The LRBAs Role
ern California, Perinatal Research Unit, Division of Research,
6 In Vesicle Trafficking From The Golgi To Cell Membrane and
Department of Pediatrics, Vanderbilt University School of Med-
Endocytosis
icine, Nashville, TN, 7Vanderbilt University School of Medicine,
Mrs. Michelle A. Reiser, MS1, Dr. Jia-Wang Wang, PhD1, Mrs.
Nashville, TN
Kunyu Li, BS1 and Dr. Richard F. Lockey, MD2, 1Division of Al-
974 Ethnic Differences Of Reported Asthma Symptoms In Urban
lergy and Immunology, Department of Internal Medicine, Univer-
School-Based Screening Surveys
sity of South Florida, Morsani College of Medicine, Tampa, FL,
Dr. Margee Louisias, MD1, Dr. Joanne Sordillo, ScD2,3, Mrs. 2
Division of Allergy and Immunology, Department of Internal
Chunxia Fu, MS4,5 and Dr. Wanda Phipatanakul, MD, MS,
Medicine, University of South Florida Morsani College of Medi-
FAAAAI3,6, 1Brigham and Womens Hospital, Boston, MA, 2Chan-
cine and James A. Haley Veterans Affairs Hospital, Tampa, FL
ning Division of Network Medicine, Brigham & Womens Hospital,
982 Differential Role Of Dendritic Cell Subsets In Shaping T-Cell
Harvard Medical School, Boston, MA, 3Harvard Medical School,
Responses To Respiratory Viruses
Boston, MA, 4Harvard School of Public Health, Boston, MA,
5 Dr. Meera Rani Gupta, M.D., Dr. Deepthi Kolli, PhD, Dr. Anto-
Channing Laboratory, Brigham and Womens Hospital, Boston,
nella Casola, M.D. and Dr. Roberto P. Garofalo, MD, University
MA, 6Boston Childrens Hospital, Boston, MA
of Texas Medical Branch, Galveston, TX
975 Year One Daycare Attendance Predicts Asthma At Age Seven:
The Cincinnati Childhood Allergy and Air Pollution Study
(CCAAPS)
Dr. Gang Cheng, MD, PhD1, Linda Levin, PhD2, Dr. Andrew M.
Smith, MD, FAAAAI3, Dr. Tolly Epstein, MD, MS4, Patrick Ryan, Environmental Risk Factors and Diseases
PhD5, Grace K. LeMasters, PhD2 and Dr. David I. Bernstein, MD,
FAAAAI1, 1Division of Immunology Allergy & Rheumatology,
Outcomes
University of Cincinnati Medical Center, CINCINNATI, OH, 2Uni-
versity of Cincinnati, Cincinnati, OH, 33255 Eden Ave., HPB 350, 5603
University of Cincinnati Medical Center, Cincinnati, OH, 4Allergy Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
Partners of Central Indiana, Indianapolis, IN, 5Cincinnati Childrens 983 Effect Of Prenatal Exposure To Indoor PM2.5 and Environ-
Hospital, Cincinnati, OH mental Tobacco Smoke Affecting Lower Respiratory Tract In-
976 Determining Risk Levels Of The Composite Asthma Severity fection Was Modified By ROS Genes: Cocoa Study
Index (CASI) Dr. Song I Yang, MD1, Dr. Eun Lee, MD1, Dr. Young Ho Jung,
TUESDAY
Rebecca A. Zabel1, Dr. Peter J. Gergen, MD, MPH2, Dr. Christine MD1, Kil-Yong Choi2, Mi-Jin Kang, MS2, Ho-Sung Yu2, Cheol
A. Sorkness, PharmD3, Jeremy Wildfire1, Mr. Agustin Calatroni, Min Lee3, Prof. Youn Ho Shin, MD, PhD4, Prof. Kangmo Ahn,
MA MS1 and Dr. Herman Mitchell, PhD1, 1Rho, Inc., Chapel MD, PhD5, Prof. Kyung Won Kim, MD, PhD6, Prof. Soo-Jong
Hill, NC, 2AAIB\DAIT\NIH, Bethesda, MD, 3University of Wis- Hong, MD, PhD1 and Cocoa study Group7, 1Childhood Asthma At-
consin, Madison, WI opy Center, Department of Pediatrics, Asan Medical Center, Uni-
977 BMI and Asthma Severity In An Elementary and Middle versity of Ulsan College of Medicine, Seoul, South Korea, 2Asan
School Inner City Population Institute for Life Sciences, University of Ulsan College of Medi-
Dr. Christina G. Kwong, MD1, Ms. Christina Mahl, RN2, Ms. Lisa cine, Seoul, South Korea, 3Institute of Environmental and Industrial
D. Henry, PNP-BC2, Dr. Deborah Loman, PhD, CPNP3, Dr. Robert Medicine, Hanyang University, Seoul, South Korea, 4Department of
C. Strunk IV, MD, FAAAAI1, Ms. Lisa A. Meadows, PNP-BC2 and Pediatrics, CHA Medical Center, CHA University College of Med-
Dr. Alysa G. Ellis, MD1, 1Washington University School of icine, Seoul, South Korea, 5Department of Pediatrics, Samsung
Medicine, Saint Louis, MO, 2St. Louis Childrens Hospital, Medical Center, Sungkyunkwan University School of Medicine,
Saint Louis, MO, 3St. Louis University School of Nursing, Saint Seoul, South Korea, 6Department of Pediatrics, Yonsei University
Louis, MO College of Medicine, Seoul, South Korea, 7COCOA study group
149
AB360 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
984 IgE Anti-Respiratory Syncytial Virus Antibodies In Older Asth- 990 Development Of Eosinophilic Esophagitis To Food After Devel-
matic Children opment Of IgE Tolerance To The Same Food
Mira Mandal1, Dr. Rauno O. Joks, MD, FAAAAI2, Dr. Kevin Noro- Dr. Solrun Melkorka Maggadottir, MD1, Dr. David Hill, MD,
witz, M.D.3, Dr. Diana Weaver, MD4, Dr. Helen G. Durkin, PhD5, Dr. PhD2, Dr. Terri F. Brown-Whitehorn, MD1 and Dr. Jonathan M.
Martin H. Bluth, MD, PhD6, Dr. Stephan Kohlhoff, MD5 and Dr. Tamar Spergel, MD, PhD, FAAAAI3, 1Childrens Hospital of Philadelphia,
A. Smith-Norowitz, PhD7, 1SUNY Downstate Medical Center, Philadelphia, PA, 2Childrens Hospital of Philadelphia, 3The Chil-
2
SUNY-HSC, Brooklyn, NY, 3SUNY Downstate Medical Center, Cen- drens Hospital of Philadelphia, Philadelphia, PA
ter for Allergy and Asthma Research, Brooklyn, NY, 4SUNY Down- 991 Mast Cells, Eosinophils and Eosinophilic Esophagitis
state Med. Ctr, Brooklyn, NY, 5Center for Allergy and Asthma Dr. Jay Jin, MD, PhD, Dr. Jeffrey Alexander, MD, Hirohito Kita,
Research, State University of New York Downstate Medical Center, MD, Ms. Diane Squillace, MS, Dr. Joseph A. Murray, MD, Dr.
Brooklyn, NY, 6Wayne State University Medicine, Detroit, MI, 7Center Amindra Arora, MD, Dr. Yvonne Romero, MD, Dr. Thomas
for Allergy and Asthma Research at SUNY Downstate, Brooklyn, NY Smyrk, MD and Dr. Catherine R. Weiler, MD, PhD, FAAAAI,
985 Asthma Symptoms and Rhinovirus In A Longitudinal Chil- Mayo Clinic, Rochester, MN
drens Cohort 992 CD3 and CD8 Cells Produce IL-9 In Pediatric Eosinophilic
Dr. Euan R. Tovey, PhD1,2, Dr. S. Stelzer-Braid, PhD3,4, Dr. B.G. Esophagitis
Toelle, PhD1, Ms. C.M. Willenborg, BSc3, Dr. H.K Reddel, PhD, Arjun Andrew Anilkumar, BS, Department of Medicine; Division
MBBS1,2, Ms. F.L. Garden, MPH1,2, Prof. A. Jaffe, PhD MD4,5, Ms. of Allergy/Immunology, Lisa Beppu, BS, Department of Pediatrics
R. Strachan5, Dr. B.G. Oliver, PhD1,2, Dr. Y.C. Belessis, MBBS4,5, University of California San Diego; Division of Allergy and Immu-
Prof. G.B. Marks, PhD, MD1,2 and Prof. W.D. Rawlinson, PhD, nology, Richard Kurten, PhD, University of Arkansas for Medical
MD3,4, 1Woolcock Institute of Medical Research, Sydney, Australia, Sciences, Little Rock, AR; Department of Physiology and Biophys-
2
University of Sydney, Australia, 3Virology Division, SEALS Micro- ics, Dr. Robert Newbury, MD, Department of Pediatrics; Division of
biology, Prince of Wales Hospital, Sydney, Australia, 4University of Pathology, Ranjan Dohil, MD, Department of Pediatrics, Division of
NSW, Australia, 5Sydney Childrens Hospital, Randwick Australia Gastroenterology; Division of Gastroenterology, UCSD, Rady Chil-
986 Maternal Transfer Of Der p 1 and Blo t 5 Allergens and Their drens Hospital, San Diego, David Broide, MB ChB, University of
Respective Specific Antibodies Trough Placenta and Colostrum California San Diego, Department of Medicine, Division of Allergy
Dr. Patricia Macchiaverni, Department of Immunology, Institute and Immunology and Seema Sharma Aceves, MD, PhD, FAAAAI,
of Biomedical Sciences, University of S~ao Paulo, SP, Brazil, Chris- Pediatrics, University of California San Diego, La Jolla, CA
tina Arslanian, University of S~ao Paulo, Dr. Valerie Verhasselt, IN-
SERM, Valbonne, France and Prof. Antonio Condino-Neto, MD,
PhD, Institute of Biomedical Sciences, Department of Immunology,
University of S~ao Paulo, Sao Paulo, Brazil
987 Rhinovirus Infection Is Associated With Changes In The Air-
way Microbiome
Population Health and Food Allergy
Dr. Kirsten Kloepfer, MD1, Dr. Valeriy Poroyko, PhD2, Mrs. Rose
Vrtis, BS3, Mrs. Tressa Pappas, BS3, Dr. Theresa Kang, PhD3, Dr. 5605
Wai-Ming Lee, PhD3, Mr. Michael D. Evans, MS3, Dr. Ronald E. Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
Gangnon, PhD3, Dr. Yury Bochkov, PhD3, Dr. Robert F. Lemanske 993 Longitudinal Effect Of Food Allergy Education On Epineph-
Jr., MD, FAAAAI3 and Dr. James E. Gern, MD, FAAAAI3, 1Riley rine Availability In Public Schools Dipika Patel, MD1, Gwendo-
Hospital for Children at Indiana University Health, Indianapolis, lyn Johnson, BSN, RN, MEd2, Danielle Guffey, MS1, Charles
IN, 2University of Chicago, Chicago, IL, 3University of Wisconsin Minard, PhD1 and Carla Davis, MD1, 1Baylor College of Medicine,
School of Medicine and Public Health, Madison, WI Houston, TX, 2Houston Independent School District, Houston, TX
994 Population Response To Change In Infant Feeding Guidelines
For Allergy Prevention
Dr. Dean Tey, MD1,2, Prof. Katrina Jane Allen, MD, PhD,
Eosinophilic Gastrointestinal Diseases FAAAAI1,2, Ms. Rachel Peters, MPH2, Dr. Jennifer Koplin, PhD2,
Prof. Mimi L. K. Tang, MD, PhD, FAAAAI3, Prof. Lyle Gurrin,
5604 PhD2,4, Prof. Anne-Louise Ponsonby, PhD2, Dr. Adrian Lowe,
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM PhD2,4, Prof. Melissa Wake, MD, PhD1,2 and Prof. Shyamali Dhar-
988 Natural History Of Esophageal Remodeling In Pediatric Eosin- mage, MD, PhD2,4, 1Royal Childrens Hospital, Victoria, Australia,
2
ophilic Esophagitis Treated For Four Years Murdoch Childrens Research Institute, Victoria, Australia, 3The
Dr. Jessica Rajan, MD1,2, Dr. Robert Newbury, MD3,4, Arjun Andrew University of Melbourne, Melbourne, Australia, 4University of
Anilkumar, BS2,5, Ranjan Dohil, MD6,7, Dr. David H. Broide, MB ChB Melbourne, Victoria, Australia
FAAAAI8 and Seema Sharma Aceves, MD, PhD, FAAAAI9, 1Scripps 995 Teasing and Bullying Among Adolescents With Food Allergy
TUESDAY
Clinic Medical Group, San Diego, CA, 2Division of Allergy/Immunol- Dr. Adora Lin, MD, PhD, National Institute of Allergy and Infec-
ogy, 3Department of Pediatrics, 4Division of Pathology, 5Department tious Diseases, Bethesda, MD and Dr. Hemant P. Sharma, MD MHS
of Medicine, 6Department of Pediatrics, Division of Gastroenterology, FAAAAI, Childrens National Medical Center, Division of Allergy
7
Division of Gastroenterology, UCSD, Rady Childrens Hospital, San and Immunology, Washington, DC
Diego, 8Department of Medicine, San Diego, CA, 9Pediatrics, Univer- 996 Differences In Food Allergy Quality Of Life Between Care-
sity of California San Diego, La Jolla, CA givers In a Clinic-Based and a Caregiver-Reported Food Aller-
989 Diagnostic Inaccuracy Of Biopsy Evaluations In Eosinophilic gic Population
Esophagitis Underscores The Value Of a Secondary Review Dr. Matthew J. Greenhawt, MD, MBA, MSc, Department of In-
Process ternal Medicine, The University of Michigan Medical School, Divi-
Emily Stucke, BA1, Dr. Katherine E. Clarridge, MD, MSc1,2, Dr. sion of Allergy and Clinical Immunology, Ann Arbor, MI
Margaret Collins, MD1, Dr. Lisa J. Martin, PhD1, Carol J. Hender- 997 Food Allergy Management In An Urban Pediatric Population
son, PhD RD LD1 and Dr. Marc E. Rothenberg, MD, PhD, Dr. Jennifer M. Camacho, MD, Dr. Stephanie Albin, MD, Dr.
FAAAAI1, 1Cincinnati Childrens Hospital Medical Center, Cincin- Doerthe A. Andreae, MD and Dr. Julie Wang, MD, FAAAAI,
nati, OH, 2University of Cincinnati The Icahn School of Medicine at Mount Sinai, New York, NY
150
J ALLERGY CLIN IMMUNOL Abstracts AB361
VOLUME 133, NUMBER 2
151
AB398 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
LATE-BREAKING ABSTRACTS
PRESENTED AT SCIENTIFIC SESSIONS
AAAAI ANNUAL MEETING
FEBRUARY 28-MARCH 4, 2014
The following abstracts were accepted for presentation after the deadline for the abstract supplement
152
J ALLERGY CLIN IMMUNOL Abstracts AB399
VOLUME 133, NUMBER 2
153
AB400 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
L9 IL-13/CD14 Polymorphisms and Prenatal Risk Factors That Shape cheon, South Korea, 2Division of Molecular and Life Sciences, Department of
Gut Microbiota Influence the Development of Atopic Dermatitis Life Science, Pohang University of Science and Technology (POSTECH),
in Infancy in a Synergistic Manner: A Birth Cohort Study Pohang, South Korea, 3Department of Internal Medicine, Gachon University
(COCOA) Gil Medical center, Incheon, South Korea, 4Department of Internal Medicine,
Prof. So Yeon Lee, MD, PhD1, Prof. Hae-Ran Lee2, Kang Mo Ahn3, Seoul National University College of Medicine, Seoul, South Korea, 5Institute
Prof. Kyung Won Kim, MD, PhD4, Prof. Youn Ho Shin, MD, PhD5, of Allergy and Clinical Immunology, Seoul National University Medical
Gyeong-shin Lee6, Seo Ah Hong7, Dr. Young-Ho Ho Jung, MD8, Research Center, Seoul, South Korea.
Dr. Eun Lee, MD9, Song-Yi Yang10, Dr. Ju-Hee Seo, MD11, Ji-Won BACKGROUND: Chitin is a potent adjuvant in immune responses of Th2,
Kwon12, Dr. Byoung-Ju Kim, MD, PhD13,14, Dr. Byoung-Ju Kim, MD, Th1 and Th17. In our previous study, tumor necrosis factor alpha (TNF-a) is
PhD13,14, Dr. Hyo-Bin Kim, MD, PhD14,15, Prof. Soo-Jong Hong, MD, a key mediator in the development of Th2 cell response to inhaled allergens.
PhD16; 1Department of Pediatrics, Hallym University College of Medicine, OBJECTIVE: We investigated the role of chitin in the induction of Th1,
Seoul, South Korea, 2Hallym University, South Korea, 3Department of Pe- Th2, and Th17 response, sensitizing and challenging mice intranasally with
diatrics, Samsung Medical Center, Sungkyunkwan University School of OVA and chitin in this study. We also evaluated the role of TNF-a and the
Medicine, Seoul, Korea, South Korea, 4Department of Pediatrics, Severance size of chitin in the development of Th2 immune response induced by chitin,
Childrens Hospital, College of Medicine, Yonsei University, Seoul, Korea, using TNF-a-deficient mice and chitinase-treated chitin, respectively.
Seoul, South Korea, 5Department of Pediatrics, CHA Medical Center, CHA METHODS: A mouse model was generated via simultaneous intranasal
University College of Medicine, Seoul, South Korea, 6Childhood Asthma administration of 75 mg of ovalbumin (OVA) and 100 mg of house dust mite
Atopy Center, Asan Medical Center, University of Ulsan College of Medi- (HDM)-derived chitin in the presence or absence of chitinase. The effect of
cine, South Korea, 7Research Center for Standardization of Allergic Dis- TNF-a on adaptive immune response was also evaluated using TNF-a-
eases, Asan Institute for Life Sciences, University of ulsan College of deficient mice.
Medicine, South Korea, 8Childhood Asthma Atopy Center, Department of RESULTS: HDM-derived chitin induced airway inflammation and
Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, increased the expression of all cytokines of Th1, Th2, and Th17 as well
Seoul, South Korea, 9Childhood Asthma Atopy Center, Asan Medical Cen- as the serum level of OVA-specific IgE, IgG1, and IgG2a. In the absence of
ter, University of Ulsan College of Medicine, South Korea, 10Childhood TNF-a or in the presence of chitinase, the expression of Th2 cytokines and
Asthma Atopy Center, Department of Pediatrics, Asan Medical Center, Uni- the serum level of OVA-specific IgE were alleviated, while the expression
versity of Ulsan College of Medicine, South Korea, 11Department of pediat- of Th1 and Th17 cytokines and the serum level of OVA-specific IgG1 and
rics, Korea Cancer Center Hospital, South Korea, 12Department of Pediatrics, IgG2a were preserved or more enhanced.
Seoul National University Bundang Hospital, South Korea, 13Department of CONCLUSION: HDM-derived chitin is size-dependent multifaceted
Pediatrics, Hae-undae Paik Hospital, Inje University College of Medicine, immune adjuvant inducing Th1, Th2, and Th17 immune response, and
Busan, South Korea, 14Research Center for Standardization of Allergic TNF-a produced by airway exposure to HDM-derived chitin is a key
mediator in the development of Th2 cell response to inhaled allergens.
154
J ALLERGY CLIN IMMUNOL Abstracts AB401
VOLUME 133, NUMBER 2
155
AB402 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
156
J ALLERGY CLIN IMMUNOL Abstracts AB403
VOLUME 133, NUMBER 2
157
AB404 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
158
ACGME ComPETENCY INDEX
160
exhibits
Accredo ALK
1640 Century Center 1700 Royston Lane
Memphis, TN 38134 Round Rock, TX 78664
Phone: (877) 222-7336 Phone: (866) 255-7722
www.accredo.com www.alk.net/us
Booth #110 Booth #1005
ALK is a research driven, global pharmaceutical company focusing
AD RescueWear on allergy treatment, prevention and diagnosis. As the world leader
3801 S. Grape Street in allergy immunotherapy, a treatment given to increase immunity to
Denver, CO 80237 substances causing allergic symptoms, ALK is devoted to improving
Phone: (303) 953-4137 the quality of life for people with allergies by creating products that
www.ADRescueWear.com treat the cause of allergies. ALK is also committed to supporting the
Booth #724 business of allergy by providing diagnostic tools, automation software
AD RescueWear is the 1st and only U.S. company to manufacture and and customized business, technical and clinical consulting services.
sell wet wrap therapy products for the treatment of childhood atopic
dermatitis/eczema. These products are a breakthrough for parents, Allergan
doctors and nurses who have struggled with wet wrapping children 2525 Dupont Drive
with atopic dermatitis/eczema. Parents and caregivers can now do a Irvine, CA 92612
full body wet wrap treatment in under 2 minutes with our ultra soft Phone: (714) 246-4500
fabric that absorbs 50% more moisture than cotton. 6% Spandex www.allergan.com
keeps the fabric close to the childs skin for fast, easy and extremely Booth #815
effective wet wrap therapy. The Wrap-E-Soothe products are also great Recently celebrating its 60th anniversary, Allergan is a global leader
worn dry for dry wrapping eczema and are excellent as a protection in discovering and developing therapeutic agents to advance patient
layer for healing skin. Machine washable makes AD RescueWear care. Allergan is also one of the fastest-growing eye care companies
products more cost effective than traditional gauze. worldwide. Eye care professionals and patients rely on Allergan
products to treat a variety of eye conditions. Visit www.allergan.com for
Aerocrine more information.
5151 McCrimmon Parkway
Suite 260
Morrisville, NC 27560
Phone: (919) 518-3073
www.aerocrine.com
Booth #425
Aerocrine AB is a medical technology company focused on the
improved management and care of patients with inflammatory airway
diseases. As the pioneer and leader in the technology to monitor and
manage airway inflammation, Aerocrine markets NIOX Flex and NIOX
MINO. Both products enable fast and reliable management of airway
inflammation and may therefore play a critical role in more effective
diagnosis, treatment and follow-up of patients with inflammatory
airway diseases such as asthma. Aerocrine is based in Sweden with
subsidiaries in the US, Germany and the UK. Aerocrine shares were
listed on the Stockholm Stock Exchange on June 15 2007.
161
exhibits
162
exhibits
163
exhibits
164
exhibits
165
exhibits
166
exhibits
167
exhibits
HAE: Learn About It, Talk About It Immune Epitope Database & Analysis Resource
730 Stockton Dr (IEDB)
Exton, PA 19335 9420 Athena Circle
www.letstalkHAE.com La Jolla, CA 92037
Booth #740 www.ledb.org
Booth #1036
HollisterStier Allergy The IEDB is an NIH-supported, freely available resource that provides
3525 N Regal Street access to published data related to antibody and T cell epitopes, as
Spokane, WA 99207 well as online tools for prediction and further analysis of immune
Phone: (800) 992-1120 epitopes. The IEDB has data for infectious and autoimmune diseases,
www.hsallergy.com allergens, and alloantigens.
Booth #215
HollisterStier Allergy manufactures a full line of products for allergy Indoor Biotechnologies, Inc.
practices. Our line includes allergenic extracts for diagnostic testing 1216 Harris Street
and immunotherapy, complete skin testing systems, latex-free vials/ Charlottesville, VA 22903
diluents, and other ancillary supplies. Phone: (434) 984-2304
www.inbio.com
Hycor Biomedical Booth #126
7272 Chapman Avenue Indoor Biotechnologies specializes in products and services in
Garden Grove, CA 92841 environmental sciences, allergy and asthma, configured for research
Phone: (800) 382-2527 or for consumer use. We serve academic and government researchers,
www.hycorbiomedical.com Fortune 500 companies, the indoor air quality industry, allergy vaccine
Booth #321 manufacturers and the biopharmaceutical industry. Our mission is
HYCOR Biomedical is a manufacturer and supplier of high-quality to improve patient care through research, education and developing
diagnostic instrumentation and in-vitro diagnostics for allergy and cutting edge technologies that serve our clients and customers
autoimmune testing. The HYTEC 288 Plus Automated Immunoassay worldwide.
System yields rapid, accurate results and represents an automated,
cost-effective platform for clinical laboratories, hospitals and Inflamax Research Inc.
physician office testing. The HYTEC 288 Plus offers a broad allergy 1310 Fewster Drive
and autoimmune testing menu optimized on a single platform. For Mississauga, ON L4W 1A4
moderate to higher-volume labs, HYCOR offers the Ultra- Sensitive EIA Canada
System which combines the precision and accuracy of fully automated Phone: (905) 282-1808
robotic reagent dispensing with a newly formulated high-sensitivity www.inflamaxresearch.com
assay design, resulting in superior test performance. HYCORs mission Booth #624
is to drive new products, technologies and medical education materials Inflamax Research is a full-service Contract Research Organization
designed to improve patient care and advance healthcare globally. that specializes in allergy, asthma, COPD and dermatology with
extensive experience in design and conduct of clinical trials Phase I-IV.
Immune Deficiency Foundation Inflamax offers proprietary Natural Environmental Exposure Chamber
40 West Chesapeake Avenue, Suite 308 models, available for clinical research studies. Allergy models have
Towson, MD 21204 been validated for Ragweed, Grass, Tree, House Dust Mite and Cat.
Phone: (800) 296-4433 Inflamax has a unique, patented mobile EEC model which can be
www.primaryimmune.org located anywhere worldwide for use in multicenter trials. Inflamax is
Booth #1029 developing a consortium of specialized investigators and have access
The Immune Deficiency Foundation is the national patient organization to specific patient populations. For more information, please contact
dedicated to improving the diagnosis, treatment and quality of life of Cynthia OBrien at 507-252-1749 or cobrien@inflamaxresearch.com.
persons with primary immunodeficiency diseases through advocacy,
education and research.
168
exhibits
169
exhibits
170
exhibits
171
exhibits
172
exhibits
173
exhibits
174
exhibits
175
exhibits
176
exhibits
177
exhibits
Xtract Solutions
9495 SW Locust St, Suite E
Portland, OR 97223
Phone: (503) 379-0110
www.xtractsolutions.com
Booth #129
Discover the NEW STANDARD OF CARE in Allergy Immunotherapy.
Xtract Solutions is a team of physicians and engineers that looked
at the process of serum formulation from the beginning to end and
analyzed the causes of inefficiency and uncertainty. We took these
liabilities and developed solutions that ensure every step is performed
correctly in a quantifiable, verifiable, and reproducible way. The
Complete Allergen Preparation System (CAPS) is the culmination of
these efforts and a new standard in allergy immunotherapy.
Yodle
50 West 23rd Street, Ste 401
New York, NY 10010
Phone: (877) 276-5104
www.yodle.com
Booth #429
Yodle, a leader in local online marketing, connects thousands of local
businesses with consumers in a process so simple and cost-effective
that business owners cant imagine any other way to advertise.
Yodle has developed an integrated approach to signing up and serving
local businesses that are transitioning their marketing budgets online
178
exhibits
179
exhibits
Physician Education
Allergy Guardian. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 423
Clinical Immunology Society. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1027
European Academy of Allergy and Clinical Immunology. . . . . . . . . . 927
Federation of Clinical Immunology Societies. . . . . . . . . . . . . . . . . . 935
HAE: Learn About It, Talk About It. . . . . . . . . . . . . . . . . . . . . . . . . . . 740
International Eosinophil Society, Inc . . . . . . . . . . . . . . . . . . . . . . . . 937
The American Board of Allergy and Immunology. . . . . . . . . . . . . . 1028
The Mastocytosis Society. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1032
USIDNET. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1031
180
Exhibit Hall Floor Plan
ALK
McNeil
MCAN Vasculitis
Foundation OTIS USIDNET IDF CIS Consumer
Bio
Products
1051 1049 1047 1045 1043 1041 1039 1033 1031 1029 1027 CONCESSION C Healthcare 1011 1005 1003
9'-5"
25' x 45' 9'-5"
1054 1052 1050 1048 1046 1044 1042 1040 1036 1034 1032 1028 1026
ModuleMD Elsevier
Corporation
855 853 851 849 847 845 843 841 829 827 821 815
FE FE
Genentech
10' FH 10' FH 10'
USA
12 11
854 852 850 848 846 844 842 840 Kirkman
828 826 824 822 American
820
Group, Express
Inc. Open
712
AAFA
Regeneron
Lineage
Therapeutics
Pharmaceuticals,
Rosch Panatrex,
Inc.
Mylan
755 753 751 749 747 745 743 741 733 Inc. 721
735 727 723
GSK
RescueWear Medical
Care Affairs
Times
10'-1" 10'
National Allergy
10' Baxter Merck 10'
Solutionreach Allergy Laboratories,
Supply Inc.
655 653 651 649 647 645 643 641 633 629 627 625 623 621 607 601
CSL
Karger
Fisher
Edge
Research Pharmaceuticals Publishers
Scientific
Inc. Novartis
Sunovion
Pharmaceuticals
Corp Behring
Axelacare Red Pharmaceuticals
Allergy Corp
Vitalograph,
Health Control Maple
Hall C
Inc.
Products
555 553 551 549 547 545 543 541 533 Solutions 527 525 Trials523 521 515 507 501
Santarus
524
Osia
522
Medical
Allergy520
and
Asthma Greer
Alcon
Laboratories
Proceedings
Laboratories,
GSK
Micro
Burkard Yodle Aerocrine
Allergy
Direct, Inc.
Inc.
Guardian
Inc.
455 453 451 449 447 445 443 441 435 433 429 425 423 421 413 401
Sanofi
Biogenics
Caremark Wiley- Millennium Medical Xoran
Specialty
Research Forest Blackwell Medical Products, Technologies
Chamber
ViroPharma,
Sanofi
Pharmacy Inc Inc.
Perrigo Hycor
Inc.
355 353 351 349 347 345 343 341 Company 325
Biomedical
321 315 301
6 5
10' FH FE
10' FH FE
10'
354 352 350 348 346 344 342 340 328 326 324
Walgreens
Medical322 320
Crowell College Abbott
Infusion
Systems Services
of Nutrition
Wisconsin Hollister-Stier
Laboratories Merck
Ora nSpire Mission:
Well LLC
US Buzzy4
Amy, SmartPractice
Health Allergy
Bioservices shots.com
255 253 251 249 247 245 243 241 235 LLC233 229 227 225 221 215 207 201
Respiratory
Pharmaceuticals
Quest Mission The
Red
Honeywell
Xtract
Pharmacal JAMA Shire
Diagnostics
Solutions
Company Network River
155 153 151 149 147 145 141 137 135 133 129 125 123 121 115 109 101
C3 C2 C1
FE TL FE
FIRST AED # 7 TL
13'6"
AID HP HP HP HP
10'
WF WF WF WF
181
San Diego Convention Center
Upper Level:
Mezzanine Level:
Ground Level:
182
San Diego Convention Center
Press
Speaker Room
Resource
Room
Posters
General
Session
Exhibit Registration
Hall
183
San Diego Marriott Marquis
& Marina Hotel
Lobby Level:
TO BAYSIDE CABANAS
& (LEVEL 1)
ROYS
RESTAURANT
PRESIDIO
ROOMS
RANCHO SANTA FE
SAN DIEGO BAY ROOMS
THE
BA
CELLAR MEDIA
R
E
IV
R
DR
YE
TEQUILA
FO
LL
BAR & GRILLE
HA
LL
EXCHANGE
HA
T
OT
(LEVEL 1)
TT
RI
IO
AR
R
AR
M
M
BUSINESS
CENTER/
UPS STORE
S
Level 1 Lobby Level
MARCH 2012
Level 1:
CABANAS
Speaker
VISTA
Resource
Room
TEQUILA
BAR & GRILLE
Hospitality
Suite
184
San Diego Marriott Marquis
& Marina Hotel
South Tower: Level 3
LA JOLLA
LA MESA
CATALINA
LA COSTA
DANA POINT
MALIBU
185
Keyword Index
This index lists all Annual Meeting sessions by the relevant keyword Controversial Tests / Misuse of Standard Tests: 2824
from the ABAIs topic outline. Controversial Treatments: 2301, 3005, 3043, 4823
ABPA / AFS: 4811, 5503 COPD: 1101D, 1604, 1613, 4001, 5504
Acquired (Secondary) Immunodeficiencies: Non-HIV/AIDs-related: Cough: 1101A, 5004
2005, 2806
Cytokine and Cytokine Receptor-Mediated Therapy (IFNs, CSFs,
Adverse Event Reporting: 4012 ILs): 2015, 3002, 3101, 5305, 5307
Aerobiology: 1201, 1601, 1803, 2007, 2305, 2314, 3006, 5053, 5101 Cytokines: 2001, 2506, 3013, 3014, 5005, 5502
Air Quality: 2507 Cytokines / Chemokines and Their Receptors: 2813, 4015, 4810,
Allergen Avoidance: 1210, 2021, 3523, 3551, 5002, 5053, 5802 5805
Allergen immunotherapy: 1209BC, 1609AD, 1609BC, 1905, 2013, Data Analysis and Biostatistics: 1610, 2624, 4006
2301, 2510, 2512, 2812, 2821, 3011, 3313, 4012, 5009 Dermatologic and Ophthalmic Treatments: 1208, 4821, 4830, 5052
Anaphylaxis (including Idiopathic, Exercise, Latex): 1101B, 1605, Drug Reactions: 1207, 2009, 2022, 2302, 2508, 2807, 4101, 4803,
2014, 2252, 2302, 2311, 2526, 2809, 2816, 2821, 3009, 3011, 3044, 4821, 5522, 5807
4008, 4012, 4801, 4826, 4827, 5007, 5807
Eczema / Atopic Dermatitis: 0001, 2023, 2312, 2803, 3315, 3524,
Anti-inflammatory Agents (including COX-1 & 2): 2815, 4809, 4815, 5003, 5303
5302
Effect of Mediators on Target Organs: 2515
Antibody-Mediated Immune Regulation: 4305, 5306
EHR/EMR: 1203, 1701, 2004, 2011, 2504, 2802, 4004
Anticholinergics: 3001
Endothelial / Epithelial / Smooth Muscle / Fibroblasts: 2813, 2815,
Antigens / Antigen Presentation/Superantigens: 5051 4303
Asthma: Adults: 1111, 1202, 1302, 1613, 1802, 1901, 2001, 2002, Environmental Controls: 1210, 2007, 5101
2304, 2308, 2314, 2506, 2507, 2510, 2522, 2524, 2801, 2804, 2809,
2810, 2815, 3001, 3002, 3010, 3041, 3101, 3301, 3308, 3312, 3521, Environmental Issues: 2823, 3006
3525, 4001, 4002, 4007, 4015, 4301, 4303, 4305, 4307, 4805, 4808, Eosinophilic Esophagitis: 2010, 5802
4811, 4812, 4813, 4822, 4824, 4825, 5001, 5006, 5301, 5312, 5313,
Eosinophils: 1904, 2525, 3003, 3008, 4307, 4808, 4810
5503, 5504, 5805
Epidemiology: 3525
Asthma: Children: 1202, 1302, 1802, 1804, 2002, 2008, 2251, 2304,
2306, 2307, 2314, 2501, 2506, 2507, 2521, 2524, 2801, 2805, 3001, Evidence-based/Clinical Practice Guidelines: 1610, 2026, 2502,
3010, 3015, 3304, 3314, 4301, 4304, 4805, 4812, 4813, 4822, 5001, 2824, 3012, 3524, 4803, 4807, 5314
5002, 5006, 5301, 5312, 5801, 5804 Experimental Design: 2811
Billing and Coding: 1209BC, 1603, 1805, 2011, 2315, 2623, 2808, Food Allergy: 1101, 1111, 1205, 1301, 1402, 1804, 1903, 2010,
4828 2021, 2024, 2025, 2301, 2302, 2312, 2509, 2514, 2523, 2622, 2803,
Bronchial Provocation: 2002 2805, 2825, 3008, 3044, 3305, 3311, 3315, 3520, 3551, 4008, 4009,
4011, 4807, 5003, 5008, 5524, 5802, 5806
CD4+ Cells (TH1, TH2) and T regulatory cells: 2515, 4015, 5305
Food Challenge: 1402, 2024, 2509, 2523, 3311, 4807, 4826, 5524
Cell Surface Markers and Receptors (Flow Cytometry): 5051
Foods: 1402, 2509, 3551
Chronic Cough: 1101A, 5004
Gastrointestinal System: 2021, 2525, 2825, 4009
Congenital (Primary) Immunodeficiencies: B Cell / Antibody
Deficiencies: 1206, 1607, 2003, 2303, 2527, 2806, 4302, 4804, 4829, Gene Transfer: 4823
5803 Glucocorticoids: 5314
Congenital (Primary) Immunodeficiencies: Complement Health Informatics: 1203, 1401, 1701, 2004, 2316, 2701, 3004,
Deficiencies: 2527, 4829, 5521 4004, 4802
Congenital (Primary) Immunodeficiencies: Neutrophil Deficiencies: Health Literacy: 1101C, 2521, 3004
1206, 2006, 2303, 2505, 2527, 4302, 5307
Healthcare Disparities: 2307, 3308, 4825, 5804
Congenital (Primary) Immunodeficiencies: T Cell Deficiencies:
1206, 1604, 1607, 2005, 2303, 2505, 4302, 4806 Hereditary and Acquired Angioedema: 2503, 5304, 5506
Contact Hypersensitivity: 1208, 1604, 3303, 3523 Hypereosinophilic Syndromes: 1904, 2015, 2525
186
Keyword Index
Ig Measurement / Total & Specific: 2012, 2523, 3042 Mucosal Immunity: 2306, 3307, 4014, 5306
IgE Receptor / Allergen Binding: 5311 Nasal Provocation: 2513, 2811
IgE-Mediated Biochemical Events: 5005 Neutrophils: 2014
Immune Complexes: 3522 NK / NKT Cells: 3307, 5502, 5806
Immunogenetics / Molecular Biology: 1610, 4003 Non-invasive diagnostic measures: 4824, 5006
Immunoglobulin Replacement Therapy: 2313, 2806, 4051, 4804, Occupational Diseases: 2305, 2809, 3041, 3303, 4007, 4824, 5101
5803 Patch testing: 3303, 3523, 5303
Immunoglobulins (including IgE): 1902, 2514, 3306, 5311 Patient Education: 1203, 1207, 1301, 1302, 1603, 1802, 1805, 2316,
Immunohematologic Diseases: 4306 2625, 2823, 2824, 3043, 3308, 3312, 3314, 4011, 4051, 4802, 5003,
5054
Immunologic Eye Diseases: 5052
Platelets: 2810
Immunologic Skin Diseases: 4003, 5523, 5809
Pollens: 1201, 2012, 3305, 5053
Immunomodulators / Suppressives (including anti-IgE, DNA,CpG
ODNs): 1901, 2524, 3304, 5523 Pollutants: 1803, 2801
Immunoprophylaxis Vaccine: 4304 Practice Management: 1501, 2315, 2316, 2504, 2621, 2623, 2802,
2808, 2822, 2823, 3044, 4004
Immunoregulation / Tolerance: 1804, 1905, 2514, 3015, 3527, 5051
Pulmonary Function Tests: 1613, 2502, 3041
Immunotherapy: 1011, 1209, 1609, 1901, 1905, 2013, 2101, 2611,
2621, 2821, 3005, 3313, 3526, 5009, 5505 Quality and Outcomes: 1102, 1112, 1611, 1621, 2004, 2307, 2313,
2504, 2510, 2521, 2621, 2808, 2814, 3010, 3302, 3314, 3525, 4001,
Indoor Allergens: 1608, 2013, 3007, 5002 4010, 4303, 4803, 4812, 4825, 5054, 5312, 5801, 5804
Infectious Agents: 2008, 3015, 3304, 3306, 4304, 4805, 5313 Rhinitis: 1204, 1612, 1903, 2513, 2811, 3011, 4808
Inflammatory Gastrointestinal Diseases: 3008 Rhinoscopy: 1204, 1612
Innate Immunity/TLRs: 1801, 2306, 2308, 3307, 4014, 4306, 4809, Serologic Tests for Autoimmunity: 2003
5305, 5307, 5805
Serologic Tests: ELISA, Western Blot: 3042
Insurance Issues (e.g. contracts, appeals): 1102, 1401, 1603, 1805,
2011 Sinusitis: 1204, 1612, 2308, 2511, 3012, 3101, 4013, 4305, 4814,
4815, 5302, 5306, 5525
Leukotriene Pathway Modulators: 4301
Skin: 1208, 2023, 2312, 2803, 4007, 4830, 5303
Lipid Mediators: 2515, 2810, 3013, 3527, 4809
Skin Testing: Scratch and Intradermal: 1207, 1209AD, 1903, 2508,
Lymphocyte Function: Proliferation, Cytotoxicity: 4005 2807
Lymphocytes: T cells/B cells/NK cells/LAK cells: 1602, 3042, 4005, Skin tests (Immunoassay for Total and Specific IgE): 1209
4014, 4051, 5311, 5502, 5808
Spirometry: 2502
Lymphoid System & Organs: 4005
Standardization of Antigens: 1209AD
Mast Cell Stabilizers: 1605
Stinging Insect Allergy: 3305
Mast Cells / Basophils: 2014, 2526, 3013, 3014, 3306, 4801, 4810,
4827, 5005 Surgical Intervention with Sinuses / Middle Ear: 4814
Mastocytosis: 1605, 2526, 3009, 4801 Systemic Autoimmune Disease: RA/SLE/Vasculitis/Other
Disorders: 1606, 5808
Mediator Measurement: 2513, 5807
T and B Cell Ligand-Receptor Interactions and Signal Transduction
Microbiome: 2008, 3007, 3521 / Cell Activation / Anergy: 3014
Modulation of Mediator Release: 2001 Upper Airway, Nose, Sinuses, Middle Ear: 3012, 4013, 5302, 5525
Molds and Fungi: 1210, 1601, 1803, 2007, 2012, 2305, 3006, 4811, Urticaria: 0001, 3302, 3524, 4008, 4827, 5304, 5523, 5809
5503
Vaccine (Principles and Reactions): 1607, 2005, 4306, 4701, 5808
Molecular Biology Technology including TRECs. RTPCR, in situ
hybridization, cell purification, gene chips: 2701, 4701 Venoms: 1209, 2816
Monocytes / Macrophages / Dendritic Cells (i.e., Antigen-
Presenting Cells): 5301
187
faculty index
188
faculty index
Castro, Mario, MD MPH, St. Louis, MO - 1101, 2304, 2522 Dreyfus, David H., MD PhD FAAAAI, Waterbury, CT - 5523
Caubet, Jean-Christoph, MD, Geneva, Switzerland - 4009 Duff, Carla M., CPNP MSN, St Petersburg, FL - 2023, 4051
Celedon, Juan C., MD, DrPH, FAAAAI, Pittsburgh, PA - 1802 Durban, Raquel Z., MS RD LDN, Charlotte, NC - 2625
Cerutti, Andrea, MD, New York, NY - 5306 Durham, Stephen R., MA MD FRCP, London, United Kingdom - 1602,
Chambers, Christina, PhD MPH, San Diego, CA - 2804 2101, 2611
Chandra, Rakesh, MD, Chicago, IL - 3012 Dykewicz, Mark S., MD FAAAAI, St. Louis, MO - 2503
Chang, Christopher, MD PhD FAAAAI, Wilmington, DE - 1102 E
Chaudhry, Sofia, MD, Silver Spring, MD - 4808
Ebisawa, Motohiro, MD PhD FAAAAI, Kanagawa, Japan - 1607, 2302
Chehade, Mirna, MD MPH, New York, NY - 2010, 2525
Eichenfield, Lawrence F., MD, San Diego, CA - 1208
Cheung, Dorothy S., MD FAAAAI, Milwaukee, WI - 2306, 3306
Ellis, Anne K., MD MSc FAAAAI, Kingston, ON, Canada - 2513, 2811
Chipps, Bradley E., MD FAAAAI, Sacramento, CA - 2501
Elverson, Wendy, RD LDN, Boston, MA - 3315
Chiu, Asriani M., MD FAAAAI, Milwaukee, WI - 1112, 5054
Epland, Kristin, NP, Plymouth, MN - 2313, 4051
Choo, Eugene M., MD FAAAAI FACAAI, Houston, TX - 1205
Epstein, Tolly, MD MS, Indianapolis, IN - 1802, 3011
Chou, Janet S., MD, Boston, MA - 4302
Escribano, Luis, MD PhD FAAAAI, Salamanca, Spain - 1605
Chowdhury, Badrul A., MD PhD FAAAAI, Potomac, MD - 4808
Espinosa-Rosales, Francisco J., MD, Naucalpan de Juarez, Mexico -
Christiani, David C., MD, Boston, MA - 5101
4829
Christie, G. Lynn, MS RD, Little Rock, AR - 2825, 3551
Ciaccio, Christina E., MD FAAAAI, Kansas City, MO - 1210, 3007 F
Cianferoni, Antonella, MD PhD, Philadelphia, PA - 1610 Fanning, Laura B., MD, Boston, MA - 1611
Cicardi, Marco, MD PhD, Milan, Italy - 5304, 5506 Farrar, J. David, PhD, Dallas, TX - 5305
Cockcroft, Donald W., MD FAAAAI, Saskatoon, SK, Canada - 1613, 2002 Fasano, Mary Beth, MD FAAAAI, Iowa City, IA - 1011, 1112
Cohn, John R., MD FAAAAI, Philadelphia, PA - 5053 Feldweg, Anna M., MD, Boston, MA - 4826
Collins, Limone C., Jr., MD, Falls Church, VA - 0001 Fineman, Stanley M., MD MBA FAAAAI, Marietta, GA - 1603, 1805,
Commins, Scott P., MD PhD, Charlottesville, VA - 4008 2803
Condino-Neto, Antonio, MD PhD, Sao Paulo, Brazil - 1607 Finkelman, Fred D., MD, Cincinnati, OH - 2302
Corazalla, Edward O., MS RPFT, Minneapolis, MN - 1101D, 3041 Fleischer, David Mark, MD FAAAAI, Denver, CO - 4807
Corren, Jonathan, MD, Los Angeles, CA - 1901, 3002, 4002 Fleisher, Thomas A., MD FAAAAI, Bethesda, MD - 1111, 2805
Covar, Ronina A., MD, Denver, CO - 5313 Fonacier, Luz S., MD FAAAAI, Mineola, NY - 1208, 1604, 3303
Cox, Linda, MD FAAAAI, Fort Lauderdale, FL - 1011, 1111, 2101, 2302, Frank, Michael M., MD FAAAAI, Durham, NC - 5304
2611, 5505 Freeman, Alexandra F., MD, Bethesda, MD - 1902, 2006
Cox-Ganser, Jean M., PhD, Morgantown, WV - 5101 Fritz, Patricia Mason, Albany, NY - 2507
Craig, Timothy J., DO FAAAAI, Hershey, PA - 1802, 3521 Fuleihan, Ramsay L., MD, Chicago, IL - 2806
Crain, Maria G., CPNP AE-C, Dallas, TX - 2622 G
Crameri, Reto, PhD, Davos, Switzerland - 2012
Galli, Stephen J., MD, Stanford, CA - 4810
Crawford, William W., MD, Harbor City, CA - 3525
Gelfand, Erwin W., MD FAAAAI, Denver, CO - 5502
Creticos, Peter S., MD FAAAAI, Crownsville, MD - 1209AD, 2512
Geller, Mario, MD FAAAAI, Rio de Janeiro, Brazil - 4827
Crotty, Shane, PhD, La Jolla, CA - 5808
Georas, Steve N., MD, Rochester, NY - 3101, 5805
Cunningham-Rundles, Charlotte, MD PhD FAAAAI, New York, NY - 2003
George, Maureen, PhD RN AE-C, Philadelphia, PA - 1101, 1302, 3043
Curtin-Brosnan, Jean, MA, Baltimore, MD - 2624
Gergen, Peter J., MD MPH, Bethesda, MD - 1608
Cush, John J., MD, Dallas, TX - 1606
Gern, James E., MD FAAAAI, Madison, WI - 1611, 2008, 5313
D Gleich, Gerald J., MD FAAAAI, Salt Lake City, UT - 4307
Darr, Jennifer M., MSW LCSW, Denver, CO - 1301 Goldberg, Pinkus, MD FAAAAI, Indianapolis, IN - 1402
Davies, Donna, BSc PhD, Southampton, United Kingdom - 3101 Goldblum, Randall M., MD, Galveston, TX - 2801
Davis, Ray S., MD FAAAAI, St. Louis, MO - 2816 Golden, David B.K., MD FAAAAI, Baltimore, MD - 1011, 2816
De Benedetto, Anna, MD, Rochester, NY - 5303 Goleva, Elena, PhD, Denver, CO - 5001
De Jong, Nicolette, PhD, Rotterdam, Netherlands - 1101 Goronzy, Jorg, MD PhD, Stanford, CA - 4306
De La Morena, M. Teresa, MD, Dallas, TX - 1206, 2303 Gould, Hannah J., PhD, London, United Kingdom - 5005, 5311
Demain, Jeffrey G., MD FAAAAI, Anchorage, AK - 3523, 5503 Graham, Barney S., MD PhD, Bethesda, MD - 4304
Derrico, Thomas J., Albany, NY - 2823 Grammer, Leslie C., MD FAAAAI, Chicago, IL - 2801, 4007, 4811, 5101
Dimov, Ves, MD, Chicago, IL - 1203, 2802, 4802 Grayson, Mitchell H., MD FAAAAI, Milwaukee, WI - 1611, 2306, 3306,
Dinakar, Chitra, MD FAAAAI, Kansas City, MO - 2805, 4010, 4813, 5006 3527, 5311
Dioun, Anahita F., MD FAAAAI, Boston, MA - 1207, 2009 Green, Brett J., PhD, Morgantown, WV - 3007
Dixit, Anupma B., PhD, St. Louis, MO - 2007 Green, Linda D., MD FAAAAI, Havertown, PA - 1203
Doherty, Taylor A., MD FAAAAI, San Diego, CA - 1611, 3307 Greenberger, Paul A., MD FAAAAI, Chicago, IL - 1605, 2526
Dooley, Mary Anne, MD, Chapel Hill, NC - 1606 Gregory, Karen L., DNP APRN-BC RRT AE-C, Edmond, OK - 1101D,
Dowling, Paul J., MD FAAAAI, Kansas City, MO - 1210 2312, 2821
189
faculty index
Grimshaw, Kathryn E., PhD RD, Southampton, United Kingdom - 2825, Jariwala, Sunit, MD, New York, NY - 2314
3551 Jarvinen-Seppo, Kirsi M., MD PhD, Albany, NY - 4826
Grodofsky, Marshall P., MD FAAAAI, West Hartford, CT - 1603, 2011 Jerath, Maya R., MD PhD, Chapel Hill, NC - 4008
Groetch, Marion E., MS RD, New York, NY - 2021, 3551 Johnson, Kimberly S., MD, Abilene, TX - 0001
Gronert, Karsten, PhD, Berkeley, CA - 3527 Johnson, Sarah, Philadelphia, PA - 2814
Gross, Gary N., MD FAAAAI, Dallas, TX - 1209BC, 2808, 4828 Johnston, Sebastian L., MD PhD, London, United Kingdom - 4304
Gruchalla, Rebecca S., MD PhD FAAAAI, Dallas, TX - 1207, 2807 Jones, Stacie M., MD, Little Rock, AR - 2523
H Joseph, Christine L.M., PhD, Detroit, MI - 4825
Haczku, Angela, MD PhD FAAAAI, Philadelphia, PA - 2813, 4014, 4809 K
Hagan, John B., MD FAAAAI, Rochester, MN - 4813 Kabourek, Jamie L., MS RD, Lincoln, NE - 3551
Hague, Angela R., PA-C, Dallas, TX - 2625 Kamilaris, Janet S., RN, Charlotte, NC - 1621
Hamilos, Daniel L., MD, Boston, MA - 1204, 2511, 4814, 5503 Kaplan, Allen P., MD FAAAAI, Charleston, SC - 5809
Hamilton, Robert G., PhD D.ABMLI FAAAAI, Baltimore, MD - 1011, 3305 Kaplan, Michael R., DO FAAAAI, Jacksonville, FL - 0001
Han, Joseph K., MD, Norfolk, VA - 5525 Kastner, Daniel L., MD, Bethesda, MD - 5307
Hanania, Nicola A., MD, Houston, TX - 5504 Katial, Rohit, MD FAAAAI, Denver, CO - 1111, 1609BC
Hanifin, Jon M., MD FAAAAI, Portland, OR - 4830 Kato, Atsushi, PhD, Chicago, IL - 5306
Hankin, Cheryl S., PhD, Moss Beach, CA - 1609 Kavanaugh, Arthur, MD FAAAAI, San Diego, CA - 1606
Hansel, Trevor Thomas, MD PhD, Paddington, United Kingdom - 2308 Keating, Richard, MD, San Diego, CA - 1606
Hanson, I. Celine, MD FAAAAI, Houston, TX - 1206 Kelso, John M., MD FAAAAI, San Diego, CA - 4306, 4805
Hare, Nathaniel D., MD FAAAAI, Lewisburg, PA - 2802, 3004, 4802 Kennedy, Josh L., MD, Little Rock, AR - 2506
Harrison, Rayn, Philadelphia, PA - 2814 Kennedy, Kevin, MPH CIEC, Kansas City, MO - 1210
Hartert, Tina V., MD MPH, Nashville, TN - 4304, 4805 Kern, Robert C., MD, Chicago, IL - 1204
Hartman, Joel M., MD, Winston Salem, NC - 1205 Khan, David A., MD FAAAAI, Dallas, TX - 0001, 1011, 2807, 3524, 4101
Hauswirth, David W., MD FAAAAI, Columbus, OH - 1205, 4814 Khoury, Paneez, MD, Bethesda, MD - 1111, 3003
Hawkins, Joan E., Worcester, MA - 1501, 2315, 2623, 2823 Kidon, Mona I., MD FAAAAI, Rishon, Israel - 1607
Hernandez-Trujillo, Vivian P., MD FAAAAI, Miami, FL - 1101B, 2311, Kiley, James P., PhD, Bethesda, MD - 2304
4804 Kim, Haejin, MD, Detroit, MI - 1604
Herzog, Ronit, MD FAAAAI, New York, NY - 4003 Kim, Jennifer S., MD FAAAAI, New York, NY - 4821
Heymann, Peter W., MD, Charlottesville, VA - 5313 King, Eva-Maria, PhD, Charlottesville, VA - 1608, 1803
Hiegel, Anne M., RN CRC, Little Rock, AR - 2024 Kingdom, Todd T., MD, Aurora, CO - 1204, 2527
Hoffman, Hal M., MD FAAAAI, La Jolla, CA - 5307 Kita, Hirohito, MD, Rochester, MN - 2813, 5502
Hogan, Mary Beth, MD FAAAAI, Reno, NV - 2014 Kleine-Tebbe, Joerg R., MD FAAAAI, Berlin, Germany - 1209, 2523, 3305
Holbreich, Mark, MD FAAAAI, Indianapolis, IN - 3008 Klion, Amy D., MD, Bethesda, MD - 1205, 1904
Holbrook, Teri, RN CRNP, Baltimore, MD - 3311 Kloepfer, Kirsten, MD, Indianapolis, IN - 2008
Holtzman, Michael J., MD FAAAAI, St. Louis, MO - 2306 Knight, Adina Kay, MD FAAAAI, Rockville, MD - 1111, 5521
Holzhauer, Robert J., MD MBA FAAAAI, San Luis Obispo, CA - 1805 Kobrynski, Lisa J., MD MPH FAAAAI, Atlanta, GA - 1206
Honsinger, Richard W., MD MACP FAAAAI, Los Alamos, NM - 2521, Koepke, Jerald W., MD FAAAAI, Littleton, CO - 1612
2808 Korenblat-Hanin, Melissa T., ACSW LCSW, Saint Louis, MO - 1301
Horner, Anthony A., MD FAAAAI, San Diego, CA - 1803, 4809 Kosisky, Susan E., BS MHA, Burtonsville, MD - 0001, 1609AD
Horner, W. Elliott, PhD LEED AP FAAAAI, Marietta, GA - 1601 Kraft, Monica, MD, Durham, NC - 4303
Horowitz, Edward, M., BA, Baltimore, MD - 2625 Kuhn, Julie, A., MSW, Chicago, IL - 2625
Hossny, Elham M., MD PhD FAAAAI, Cairo, Egypt - 1607 Kumararatne, Dinakantha, MD PhD, Cambridge, United Kingdom - 1801
Hsu Blatman, Karen S., MD, Brookline, MA - 4827, 5807 L
Huang, Yvonne, MD, San Francisco, CA - 2001
LaBelle, Ginger S., CPNP, Cary, NC - 2313
Hulse, Kathryn E., PhD, Chicago, IL - 4305, 5306
LaForce, Craig F., MD FAAAAI, Raleigh, NC - 1401
Huston, David P., MD FAAAAI, Houston, TX - 1606
Laidlaw, Tanya M., MD FAAAAI, Boston, MA - 1611, 2810
I Land, Michael H., MD FAAAAI, San Diego, CA - 1604
Idzko, Marco, MD, Freiburg, Germany - 5301 Lang, David M., MD FAAAAI, Cleveland, OH - 3302
Irish, Jonathan M., PhD, Nashville, TN - 1610 Lanz, Miguel J., MD FAAAAI, Coral Gables, FL - 4812
Ishmael, Faoud T., MD PhD FAAAAI, Hershey, PA - 4002, 5001 Larche, Mark, PhD, Hamilton, ON, Canada - 4012
J Larenas Linnemann, Dsire E.S., MD FAAAAI, Mexico D.F., Mexico -
2611, 2812, 3526
Jackson, Daniel J., MD, Madison, WI - 2308, 3304, 5313
Lawrence, Monica G., MD, Bethesda, MD - 1604, 5307
Janevic, Mary, MPH PhD, Ann Arbor, MI - 3308
Jardetzky, Theodore S., PhD, Stanford, CA - 5311
190
faculty index
Le, Tao T., MD MHS FAAAAI, Elizabethtown, KY - 1203, 1603, 1805, Metz, Gregory M., MD, Edmond, OK - 2312, 2821
2004, 2521, 2802 Meyerson, Karen L., MSN FNP-C AE-C, Grand Rapids, MI - 2625
LeBovidge, Jennifer S., PhD, Reading, MA - 3315 Midoro-Horiuti, Terumi, MD PhD FAAAAI, Galveston, TX - 2801
Ledford, Dennis K., MD FAAAAI, Tampa, FL - 1205 Mikita, Cecilia, MD MPH FAAAAI, Bethesda, MD - 1609AD
Lee, Gerald B., MD FAAAAI, Louisville, KY - 1205, 4802 Milewski, John D., Med. Admin., Denver, CO - 1501, 2316, 2621, 2822
Lee, Rachel Umi, MD, San Diego, CA - 0001 Miller, Eva K., MD, Nashville, TN - 2506, 5313
Legge, Kevin, PhD, Iowa City, IA - 2306 Miller, Rachel L., MD FAAAAI, New York, NY - 1202, 2305, 2801
Lenehan, Patrick J., Baltimore, MD - 2624 Milligan, Ki Lee, MD, Bethesda, MD - 0001
Leo, Harvey L., MD FAAAAI, Ann Arbor, MI - 2521 Milner, Joshua D., MD, Bethesda, MD - 1610
Leung, Donald Y.M., MD PhD FAAAAI, Denver, CO - 1111 Mitchell, Allen A., MD, Boston, MA - 2804
Levetin, Estelle, PhD FAAAAI, Tulsa, OK - 1201, 1601, 5053 Mitchell, Herman, PhD, Chapel Hill, NC - 1608
Levi-Schaffer, Francesca, PhD FAAAAI, Jerusalem, Israel - 3014 Modell, Fred, New York, NY - 1607
Levinson, Arnold I., MD FAAAAI, Philadelphia, PA - 1606 Mosnaim, Giselle, MD MS FAAAAI, Chicago, IL - 2307, 3525, 5804
Li, H. Henry, MD PhD, Chevy Chase, MD - 3303 Moss, Mark H., MD, Madison, WI - 5054
Lieberman, Jay A., MD, Memphis, TN - 1209AD Mudd, Kim E., RN MSN CCRP, Baltimore, MD - 1621, 2022, 3311
Lieberman, Phillip L., MD FAAAAI, Germantown, TN - 1205, 2526 Mullol, Joaquim, MD PhD FAAAAI, Barcelona, Spain - 5302
Lim, Kaiser G., MD FAAAAI, Rochester, MN - 4010 Munitz, Ariel, PhD, Tel Aviv, Israel - 3013
Lima, John, MD, Jacksonville, FL - 4301 Murphy, Kevin R., MD, Boys Town, NE - 1612
Limb, Susan Lee, MD FAAAAI, Silver Spring, MD - 4808 Mustillo, Peter J., MD FAAAAI, Columbus, OH - 2006
Ling, Morris, MD, Boston, MA - 5805 N
Lio, Peter A., MD, Chicago, IL - 1208, 4821
Naclerio, Robert M., MD FAAAAI, Chicago, IL - 2811
Lipworth, Brian J., MD, United Kingdom - 2815
Nadeau, Kari C., MD PhD FAAAAI, Stanford, CA - 1202, 2301, 5806
Lloyd, Clare M., PhD, London, United Kingdom - 5305
Nagler, Cathryn R., PhD, Chicago, IL - 2514
Lund, Frances E., PhD, Birmingham, AL - 5311
Nair, Parameswaran K., MD PhD FRCP, Hamilton, ON, Canada - 4307
Lundberg, Cory A., DO, Bethesda, MD - 0001
Namazy, Jennifer A., MD FAAAAI, San Diego, CA - 2804
Luong, Amber U., MD PhD, Houston, TX - 4013, 5525
Nelson, Harold S., MD FAAAAI, Denver, CO - 1609, 2815, 4812
Luster, Andrew D., MD PhD, Charlestown, MA - 1602, 4810
Nelson, Michael R., MD PhD FAAAAI, Bethesda, MD - 0001, 1011,
Lynch, Susan V., PhD, San Francisco, CA - 2810
1112, 1609, 1609AD, 3313
M Newcomb Baker, Dawn C., PhD, Nashville, TN - 4015, 5301
MacGinnitie, Andrew J., MD PhD, Boston, MA - 2503 Noone, Sally A., RN MSN CCRC, New York, NY - 1701, 2023
Macy, Eric M., MD FAAAAI, San Diego, CA - 2508 Nowak-Wegrzyn, Anna H., MD FAAAAI, New York, NY - 1903, 2523, 4009
Mahr, Todd A., MD FAAAAI, La Crosse, WI - 2805 Nyenhuis, Sharmilee M., MD FAAAAI, Chicago, IL - 4306
Maleki, Soheila J., PhD, New Orleans, LA - 5524 O
Mallam, Dee, RN AE-C, Mercerville, NJ - 2821
OByrne, Paul M., MD FAAAAI, Hamilton, ON, Canada - 4813
Mancia, Sonia C., RN, Fairfax, VA - 3044
Ober, Carole, PhD, Chicago, IL - 1202
Manning, Michael E., MD FAAAAI, Scottsdale, AZ - 5504
Ochs, Hans D., MD, Seattle, WA - 1902
Markert, M. Louise, MD PhD FAAAAI, Durham, NC - 2005, 2303, 4051
Odom, Laura, MSN FNP, Knoxville, TN - 2625
Marsh, Rebecca A., MD, Cincinnati, OH - 2505
Ogbogu, Princess U., MD FAAAAI, Columbus, OH - 1205, 3003
Martin, Bryan L., DO FAAAAI, Columbus, OH - 1609BC
Ollert, Markus W., MD, Munich, Germany - 3305
Martin, Richard J., MD, Denver, CO - 2815
Olson, Grant C., MD, Denver, CO - 1612
Martinez, Fernando D., MD, Tucson, AZ - 3304, 4813
Oppenheimer, John, MD FAAAAI, Denville, NJ - 1209AD, 5505
Mathur, Sameer K., MD PhD FAAAAI, Madison, WI - 2015, 4306
Ortiz, Gabriel, MPAS PA-C, El Paso, TX - 1101B, 2311
Mathuria, Adhuna C., MD, Chantilly, VA - 1805
Ostrov, David A., PhD, Gainesville, FL - 4101
Matsui, Elizabeth, MD, Baltimore, MD - 5002
Owens, Tiffany J., MD, San Antonio, TX - 0001
McClimon, Brad, J., MD, Dubuque, IA - 2510
McCormack, Meredith C., MD, Baltimore, MD - 1613 P
McCormick, Margaret J., MS RN, Baltimore, MD - 2625 Pacheco, Karin A., MD MSPH FAAAAI, Denver, CO - 2305, 3303, 3523
McDowell, Karen, MD, Cleveland, OH - 5801 Pajno, Giovanni B., MD FAAAAI, Messina, Italy - 2301
McGeady, Stephen J., MD FAAAAI, Philadelphia, PA - 2625, 3314 Palmer, James, MD, Philadelphia, PA - 2308
McHeyzer-Williams, Michael G., PhD, La Jolla, CA - 5808 Panettieri, Reynold A., MD, Philadelphia, PA - 4303
McKnight, A. Sean, MD FAAAAI, Henderson, NV - 1203, 2504, 2802 Papadopoulos, Nikolaos G., MD FAAAAI, Athens, Greece - 3301
Meadows, J. Allen, MD FAAAAI, Montgomery, AL - 2808 Park, Miguel A., MD, Rochester, MN - 2022, 2508
Meffre, Eric, PhD, New Haven, CT - 5808 Pashley, Catherine A., PhD, Leicester, United Kingdom - 4811
Mehta, Vinay, MD FAAAAI, Lincoln, NE - 1805 Passalacqua, Giovanni, MD, Genoa, Italy - 1905, 3526, 5009
Melton, Alton Lee, MD, Cleveland, OH - 4011 Patel, Minal R., PhD MPH, Ann Arbor, MI - 2307
191
faculty index
Patterson, David L., MD MS MBA FAAAAI, Noblesville, IN - 1603 Sampson, Hugh A., MD FAAAAI, New York, NY - 2301, 4807
Paulson, James C., PhD, La Jolla, CA - 5051 Sanak, Marek, MD, Krakow, Poland - 3301
Peebles, R. Stokes, Jr., MD FAAAAI, Nashville, TN - 2524, 4015, 4304 Sanders, Georgiana M., MD MS FAAAAI, Ann Arbor, MI - 3308
Perez, Elena E., MD PhD FAAAAI, Miami, FL - 2505, 4302, 4804 Sands, Mark F., MD FAAAAI, Buffalo, NY - 1613, 2522, 4822
Perry, Tamara T., MD, Little Rock, AR - 2307 Santos, Alexandra F., MD MSc, London, United Kingdom - 1602
Perzanowski, Matthew S., PhD, New York, NY - 2314 Sastre, Joaquin, MD PhD FAAAAI, Madrid, Spain - 2809
Peters, Anju T., MD FAAAAI, Chicago, IL - 1204, 4305, 5302 Savage, Jessica R., MD, Baltimore, MD - 5806
Peters, Stephen P., MD PhD FAAAAI, Winston Salem, NC - 4301, 5504 Schatz, Michael, MD MS FAAAAI, San Diego, CA - 2804, 3525
Phipatanakul, Wanda, MD MS FAAAAI, Boston, MA - 1210, 2305 Schleimer, Robert P., PhD FAAAAI, Chicago, IL - 2810, 3101
Pichler, Werner J., MD, Bern, Switzerland - 4101 Schlosser, Rodney J., MD, Charleston, SC - 4013
Pien, Lily, MD FAAAAI, Cleveland, OH - 5054 Schmid-Grendelmeier, Peter, MD PhD, Zuerich, Switzerland - 2012,
Pityn, Peter J., PhD, London, Canada - 3006 5303
Platts-Mills, Thomas A.E., MD PhD FAAAAI, Charlottesville, VA - 2524, Schnaar, Ronald L., PhD, Baltimore, MD - 5051
3015 Schneider, Lynda C., MD FAAAAI, Boston, MA - 1208, 3524, 5303
Plaut, Marshall, MD FAAAAI, Bethesda, MD - 1602 Schultz, Fallon, MSW LCSW CAM, Howell, NJ - 2625
Polosa, Riccardo, MD PhD FAAAAI, Catania, Italy - 1613, 4822 Schwartz, David A., MD, Aurora, CO - 1202
Pongdee, Thanai, MD FAAAAI, Jacksonville, FL - 1112 Schwartz, Lawrence B., MD PhD FAAAAI, Richmond, VA - 1112, 4801
Poole, Jill A., MD FAAAAI, Omaha, NE - 2305, 5101 Scott, James, PhD, Toronto, ON, Canada - 1601
Porteus, Matthew, MD PhD, Stanford, CA - 4823 Sears, Malcolm R., MD FAAAAI, Hamilton, ON, Canada - 5313
Portnoy, Jay M., MD FAAAAI, Kansas City, MO - 1210, 1803, 4803 Secord, Elizabeth A., MD FAAAAI, Detroit, MI - 1112
Price, Christina C., MD, New Haven, CT - 2806 Sedlak, Debra A., MSN CPNP, Durham, NC - 1101, 2021, 2311, 3042,
Prograis, Lawrence J., MD, Bethesda, MD - 4006 4051
Prussin, Calman, MD FAAAAI, Bethesda, MD - 3307 Shaker, Marcus S., MD MS FAAAAI, Lebanon, NH - 4803, 5312
Puck, Jennifer M., MD, San Francisco, CA - 4302, 4806 Shamji, Mohamed H., BSc MSc PhD, South Kensington, United Kingdom
Pulver, Donald W., MD FAAAAI, Rochester, NY - 1612 - 1905, 2512
Q Sharma, Hemant P., MD MHS FAAAAI, Elkridge, MD - 3311
Sheikh, Javed, MD FAAAAI, Los Angeles, CA - 3008, 3302
Quinn, James M., MD FAAAAI, San Antonio, TX - 2502
Sher, Mandel R., MD FAAAAI, Largo, FL - 5004
Quirce, Santiago, MD PhD, Madrid, Spain - 2809, 4007
Shreffler, Wayne G., MD PhD FAAAAI, Boston, MA - 1602
R Shulan, David J., MD FAAAAI, Albany, NY - 1203, 4004
Raby, Benjamin A., MD MPH, Boston, MA - 1202 Sicherer, Scott H., MD FAAAAI, New York, NY - 4807
Rachid, Rima A., MD FAAAAI, Boston, MA - 2003, 4804 Silvers, William S., MD FAAAAI, Denver, CO - 1804, 3043
Rance, Karen S., DNP RN CPNP AE-C, Indianapolis, IN - 1402 Silviu-Dan, Fanny, MD FAAAAI, Montreal, Canada - 1112
Rand, Cynthia S., PhD, Baltimore, MD - 5312, 5804 Simon, Dagmar, MD, Bern, Switzerland - 4830
Rank, Matthew A., MD FAAAAI, Scottsdale, AZ - 1209, 2510, 2812 Simons, F. Estelle R., MD FAAAAI, Winnipeg, MB, Canada - 2302, 4808
Rao, V. Koneti U., MD, Bethesda, MD - 4005 Singh, Anne Marie, MD, Chicago, IL - 1604
Rathkopf, Melinda M., MD FAAAAI, Anchorage, AK - 1203, 2004, 2802, Skoner, David P., MD, Pittsburgh, PA - 5009
4802 Skripak, Justin M., MD, Hoboken, NJ - 2509
Ray, Prabir, PhD, Pittsburgh, PA - 5311 Skypala, Isabel J., PhD, London, United Kingdom - 2025, 3551
Reijula, Kari E., MD PhD FAAAAI, Helsinki, Finland - 1803 Slavin, Raymond G., MD MS FAAAAI, Saint Louis, MO - 3012, 4811
Ren, Bing, PhD, San Diego, CA - 1202 Sloane, David E., MD, Boston, MA - 1207, 5807
Renz, Harald E., MD, Marburg, Germany - 4809 Smart, Brian A., MD FAAAAI, Long Grove, IL - 1603
Ricketti, Anthony J., MD, Trenton, NJ - 1101C Smith, Alisa M., PhD FAAAAI, Washington, DC - 2507
Riedl, Marc A., MD MS, Los Angeles, CA - 5304, 5506 Smith, Andrew M., MD FAAAAI, Cincinnati, OH - 5052
Ring, Johannes, MD PhD FAAAAI, Munich, Germany - 5003 Smith, Lewis J., MD, Chicago, IL - 4301
Risma, Kimberly A., MD PhD FAAAAI, Cincinnati, OH - 1111 Sokol, Caroline L., MD PhD, Boston, MA - 3306
Roberts, Joseph L., MD PhD, Durham, NC - 3042 Solensky, Roland, MD FAAAAI, Corvallis, OR - 2807, 5522
Robinson, Humaira, BSN RN, Washington, DC - 3044 Somech, Raz, MD PhD, Ramat Gan, Israel - 1607
Romano, Antonino G., MD, Rome, Italy - 1207 Soong, Weily, MD FAAAAI, Birmingham, AL - 1805
Rosenstreich, David L., MD FAAAAI, Bronx, NY - 2314 Spahn, Joseph D., MD, Denver, CO - 1802, 4812, 5801
Rosenwasser, Lanny J., MD FAAAAI, Kansas City, MO - 2302 Spencer, Lisa A., PhD FAAAAI, Boston, MA - 4307
Ross, Jaime, RN, New York, NY - 1621 Spergel, Jonathan M., MD PhD FAAAAI - 2525
Routes, John M., MD FAAAAI, Milwaukee, WI - 2527, 3005, 4806 Sperling, Anne, PhD, Chicago, IL 2813, 4014, 5805
S Sprunger, Anna C., PA-C, Washington, DC - 2625
Stadtmauer, Gary J., MD FAAAAI, New York, NY - 5004
Salo, Paivi M., PhD, Research Triangle Park, NC - 1608
Steele, Pamela H., MSN CPNP AE-C, Chapel Hill, NC - 2622
192
faculty index
193
AAAAI Staff
194
Notes
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
195
Notes
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
196
ANNUALMEETING.AAAAI.ORG
SAN DIEGO
AAAAI Executive Office
555 East Wells Street, Suite 1100
Milwaukee, WI 53202-3823
Tel: (414) 272-6071
Fax: (414) 272-6070
Email: annualmeeting@aaaai.org